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ON THE COVER 
A Marine rests during operations 
in Parwana, Iraq, in August. The 
Marines were seeking insurgents 
in the western Iraqi town just 
days after a roadside bomb killed 
14 of their comrades. 
BACKGROUND 
Soldiers guard the scene of an 
attack on an armored personnel 
carrier, still blazing in the distance, 
in West Baghdad in April. 
AP/Wide World Photos 
On the Web 
yalemedicine.yale.edu 
On our website, readers can sub¬ 
mit class notes or a change of 
address, check the alumni events 
calendar, arrange for a lifelong 
Yale e-mail alias through the vir¬ 










Books & Ideas 
Capsule 
Letter from Kathmandu 
In January 2004 Johnnie Yates, m,d. ’95, took a job as a physician 
in an international clinic in Kathmandu, where a typical day 
provided insights into medicine in Nepal. 
By Johnnie Yates, m.d. ’95 
The unseen wounds of war 
As long as humans have waged war, the horrors of the battle¬ 
field have caused psychological damage. As troops return 
from Iraq, therapists, psychiatrists and veterans of previous 
wars are helping them return to civilian life. 
By Cathy Shufro 
Breaking the back of polio 
Working in a Yale laboratory in the 1940s, Dorothy Horstmann 
solved a puzzle that would lead to the first polio vaccine. 
By David M. Oshinsky, ph.d. 
A year at the helm 
Since he arrived at Yale in 2004, Dean Robert Alpem has led 
faculty to a new vision of the medical school, with a focus on 
clinical expansion and the application of great science. 
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ethical aspects of stem 
cell research 
I was disappointed with the 
Chronicle piece by Marc Wortman 
[“For Stem Cell Researcher, 
Connecticut’s Initiative Offers 
a New Avenue for Progress,” 
Summer 2005] that involved an 
interview with Diane Krause, 
m.d., ph.d., and focused on her 
support for human embryonic 
stem cell research. 
The superficial approach 
of the article minimized the 
ethical controversies of human 
embryonic stem cell research 
and offered readers an unbal¬ 
anced and misleading feel¬ 
good article. 
Lacking was acknowledge¬ 
ment that, with the technology 
currently available, human 
embryonic stem cell research 
involves the destruction of 
human embryos. As a former 
human embryo myself writing to 
another former human embryo 
(yourself), it should not need to 
be stated that human beings 
come from human embryos, but 
advocates of human embryonic 
stem cell research seem unwill¬ 
ing to acknowledge this basic 
biological fact. I was particularly 
chilled by Dr. Krause's statement 
that she wants “the freedom to 
use embryonic stem cells as a 
tool.” I think the piece should 
have noted that there exist some 
serious and complicated moral 
and ethical concerns in this type 
of research even if Dr. Krause is 
seemingly not troubled by them. 
If anything, Dr. Krause's own 
work with adult stem cells 
suggests that we have much to 
gain from that line of research, 
which does not have the same 
moral and ethical difficulties as 
research with human embryonic 
stem cells. The article failed to 
mention that to date thousands 
of living patients have been 
helped with adult stem cell tech¬ 
nology. This includes patients 
with spinal cord injuries, genetic 
and metabolic disorders, 
impaired heart function and so 
on. It did not mention that no 
one has yet been helped in any 
way by embryonic stem cells. 
I would like to have seen a 
better analysis of these grave 
and pressing issues in your maga¬ 
zine. I hope Yale Medicine will 
take on this controversial topic 
in a more comprehensive man¬ 
ner with a future feature article. 
Robert Kaladish, m.d. 
Amherst, N.H. 
Article on schistosomiasis 
was inspiring 
I want to congratulate Kohar 
Jones for her impressive 
and beautiful article [“The Silent 
Scourge of Development," Sum¬ 
mer 2005], and you, for publish¬ 
ing it. Especially in this period 
when greed and deception are 
often so dominant, to see some¬ 
thing like that article is particu¬ 
larly inspiring and a reminder 
that there are wonderful people 
in this world, young as well as 
old. Please pass my comments 
on to her. She deserves any 
recognition she gets. 
John Strauss, M.D. 
Professor emeritus of psychiatry 
New Haven 
Ibn Sina’s roots 
I enjoy reading the articles in 
Yale Medicine very much and I 
think the magazine offers an 
excellent selection of topics. 
Just as a quick note, in the 
mustard gas article [“From the 
Field of Battle, an Early Strike 
at Cancer,” Summer 2005], you 
refer to Ibn Sina, the 10th- 
century physician and scholar. 
Fie was actually Persian, not 
Arab. The reason he wrote in 
Arabic was that the official lan¬ 
guage for science in Iran was 
Arabic after the Arabs conquered 
the Persian Empire. 
Thanks again for the excel¬ 
lent ideas and articles! 
Setareh Vistamehr, m.d. 
Instructor, Department of 
Ophthalmology and Visual Science 
New Haven 
As Dr. Vistamehr notes, Ibn Sina, 
known as Avicenna in Europe, 
was not an Arab. Because he was 
born in what is now Uzbekistan 
and died in what is now Iran, his 
roots are a subject of debate. For 
more on Avicenna, see "From the 
Middle East, in the Middle Ages,” 
p. 16, in this issue. —Eds. 
Have an opinion? 
Write to us at 
ymm@yale.edu 
HOW TO REACH US 
Yale Medicine welcomes news and 
commentary. Please send letters 
to the editor (250 words or less) 
and news items to Yale Medicine, 
P.O. Box 7612, New Haven. 
CT 06519-0612, or via electronic 
mail to ymm@yale.edu, and 
include a daytime telephone num¬ 
ber. Submissions may be edited 
for length, style and content. 
VISIT US ON THE WEB 
yalemedicine.yale.edu 
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parting point 
lostalgia of another kind 
la 1980, years after the last troops returned home from 
ietnam, the military and medical establishments put 
name on the psychiatric sequelae that have afflicted sol¬ 
ders for as long as there has been war—post-traumatic 
ness disorder (ptsd). Documented since the time of 
1 omer and variously known as nostalgia, combat fatigue 
id shell shock, it is marked by anxiety, flashbacks, 
ritability and withdrawal from society, among other symp- 
>ms. In our cover story we examine ptsd and its impli- 
ations for troops coming home from Iraq. To find out 
'hat has been learned about ptsd and how the experi- 
nce of Vietnam veterans is helping today’s troops, writer 
!athy Shufro spoke with Vietnam and Iraq veterans 
Is well as psychiatrists and social workers at Yale and the 
IA Connecticut Healthcare System in West Haven. 
We also look back half a century to the days when 
parents kept children away from public pools and beaches 
p the summertime. Polio was a dread disease, but scien- 
' sts were getting closer to discerning how it acted and how 
jp prevent it. Among those scientists was the late Dorothy 
1 Horstmann, m.d., fw ’43, a member of the Yale Polio- 
lyelitis Study Unit, who made a key discovery about polio 
iSecond opinion by Sidney Harris 
‘...AND Vc-dR SYMPTOMS >lSAPP<MA~ WITHinI THREE 
OA'iS, I'LL GET A LARGE 
antibodies that paved the way for development of vaccines. 
We asked David M. Oshinsky, ph.d., a historian at the 
University of Texas at Austin, and author of Polio, An Ameri¬ 
can Story, to profile the first woman to become a professor 
of medicine at Yale. 
Finally, in this issue we profile Robert J. Alpern, m.d., 
who took over as dean almost a year and a half ago. As 
Yale Medicine’s editor, Michael Fitzsousa, reports, Alpern has 
spent the time assembling his management team, getting 
to know the medical school and launching a strategic plan to 























chronicle news from cedar street 
A mouse offers a new 
way to test vaccines 
By implanting a human immune 
system into mice, scientists plan to 
study vaccines. 
The laboratory mouse—resilient, easy 
to breed and ideally suited to the generic 
manipulations that form the basis of 
much of modern biomedical research— 
has been invaluable to immunologists 
such as Richard A. Flavell, ph.d., chair 
and Sterling Professor of Immunobi¬ 
ology. But there are limits to the useful¬ 
ness of this most versatile of research 
animals in immunology, because the 
mouse immune system has been tai¬ 
lored over evolutionary time to deal with 
pathogens different from those that 
infect humans. To compensate, scien¬ 
tists like Flavell supplement their work 
in mice with studies of human immune 
cells in culture, but here, too, there are 
inherent compromises. The immune 
system, a multifaceted mechanism dis¬ 
tributed throughout the body, is difficult 
to emulate in a petri dish, and the 
behavior of cells in culture can be a 
poor predictor of how a drug will work 
in the living human body. 
Since ethical considerations pro¬ 
hibit testing drugs in humans before 
they’ve been proven safe and effective, 
these intrinsic limitations of the tools 
available to immunologists mean that 
bringing vaccines and other cures 
from the laboratory to the clinic often 
requires a leap across an unavoidable 
knowledge gap. 
“You don’t really want to be studying 
mouse cells; you want to study human 
cells, and ultimately you study humans 
in clinical trials,” said Flavell, who is 
also a Howard Hughes Medical Insti¬ 
tute investigator. “There are enormous 
difficulties making sure that what you 
do in clinical trials is safe and isn’t 
going to adversely affect the patient.” 
But a remarkable advance in a 
Swiss laboratory may provide a long- 
sought bridge between the bench 
and the bedside for immunologists. 
In 2004, Markus G. Manz, m.d., and 
colleagues at the Institute for Research 
in Biomedicine created a rudimentary I 
human immune system in mice by 
injecting human umbilical-cord blood 
containing stem cells and other pro¬ 
genitor cells into a mutant strain of 
mice that lack immune systems. 
Manz’s paper appeared just as the I 
Grand Challenges in Global Health 
initiative was accepting final proposals II 
for grants. The initiative, funded by 
the Bill & Melinda Gates Foundation, J 
the Canadian Institutes of Health 
Research and the Wellcome Trust, 
and administered by the Gates Foun- j 
dation, planned to distribute more 
than $436 million to support innova¬ 
tive research on diseases that afflict 
the world’s poorest people. Flavell 
proposed that his team join forces 
with Manz and with Tarrytown, N.Y.- 
based biotech company Regeneron 
Pharmaceuticals to perfect a mouse 
model of human immunity for testing I 
II 
vaccines. In late June, Flavell learned 
that the initiative would award $17 
million to the project. 
“It’s akin to a ‘Manhattan Project,’ 
to make this work like a true human 
immune system, so you could really do 
experimentation that is predictive of 
the human response,” Flavell said. 
A mouse model of human immu¬ 
nity, for example, would allow scien¬ 
tists to test a vaccine for hiv, which 
has heretofore been impossible because 
mice are normally not susceptible to 
the virus. But Flavell said that the tech¬ 
nique will have any number of appli¬ 
cations. “This system, once it’s up and 
running, could be used to study all 
kinds of things,” he said. 
Elizabeth E. Eynon, ph.d., a 
research scientist in Flavell’s lab, said 
that the model could make clinical 
trials much more efficient. “The fda 
will require people to do just as many 
Phase I and Phase II trials as they 
do now,” she said, “but the likelihood 
of failure at those stages would be 




t/Varna Borgstrom named to 
ead Yale-New Haven Hospital 
ind Health System 
! since she joined Yale-New Haven 
Hospital (ynhh) as a junior adminis- 
rator in 1979, Marna P. Borgstrom, 
vi.p.h. ’79, has become a vice presi¬ 
dent, the chief operating officer and, as 
rf October 1, the ceo and president of 
| ;he hospital and the Yale New Haven 
Health System (ynhhs). She succeeds 
[oseph A. Zaccagnino, m.p.h. ’70, 
who retired on September 30 after a 
35-year career at the hospital. 
During more than a quarter-century 
at the hospital she has watched it grow 
into the 944-bed flagship of a health 
system that stretches along Long Island 
Sound from Rye, N.Y., to Westerly, R.I. 
It is the hub of a New Haven health 
icare delivery network that includes 
!a children’s hospital, a psychiatric hos¬ 
pital, two independent ambulatory 
surgical centers, a large radiology prac¬ 
tice and the Shoreline Medical Center 
in Guilford. 
Working with Zaccagnino, Borgstrom 
oversaw the hospital’s $850 million 
budget and served as the primary liai¬ 
son to the School of Medicine. She 
led the planning and construction of 
the children’s hospital, and headed up 
a patient safety program that trained 
40 senior managers under General 
Electric’s process-improvement initia¬ 
tive known as Six Sigma. As the second- 
in-command at the hospital for 
more than a decade, Borgstrom helped 
develop ynhhs, an affdiation of 
several dozen organizations including 
ynhh and two other large hospitals, 
in Bridgeport and Greenwich, that 
encompasses their networks of physi¬ 
cian practices, surgical centers, diag¬ 
nostic facilities, rehabilitation centers, 
pharmacies and visiting nurses. 
“We want to be the provider of 
choice—locally, of course, but also re¬ 
gionally and nationally,” she said. 
The hospital’s regional and national 
distinction, which Borgstrom intends 
to build on, reflects joint investments 
in unique clinical programs with 
the School of Medicine. She is looking 
forward to the construction of a 
$440 million clinical cancer center, 
cur-rently awaiting approval from 
New Haven zoning officials, that will 
provide needed capacity for current 
and emerging clinical initiatives. 
Other recent achievements of 
ynhhs include the creation of an 
emergency angioplasty program at 
Greenwich Hospital in collaboration 
with ynhh and physicians at the 
School of Medicine. Previously, emer¬ 
gency patients in Greenwich had to be 
transported out of town for the proce¬ 
dure. Now they can be treated locally, 
and elective angioplasty cases and car¬ 
diac surgeries will be referred from 
Greenwich to New Haven. 
A revamped liver transplantation 
program that began operations in July 
has the potential to draw pediatric 
patients from the region and beyond, 
and many joint programs—in epilepsy, 
endocrine surgery and maternal-fetal 
medicine, to name several—already 
bring patients to New Haven from 
across the country. Borgstrom would 
like to see the list grow, so that more 
out-of-state patients come to the city 
for care. 
Her appointment came a little more 
than a year after the arrival of medical 
school Dean Robert J. Alpern, m.d., in 
Marna Borgstrom became the head 
of the Yale-New Haven Hospital and 
the Yale New Haven Health System 
on October 1. 
June 2004. Based on her work with 
Alpern during his first year here, Borg¬ 
strom sees “unprecedented opportuni¬ 
ties” ahead for the hospital and medical 
school. Alpern called Borgstrom “an 
excellent choice for the job of ceo.” 
Borgstrom earned her public health 
degree in hospital administration 
at Yale in 1979. She said the program 
gave her a footing in how to analyze 
and solve problems at a large health 
care organization, and also an apprecia¬ 
tion for the public health challenges 






















Artist Laura Ferguson uses medical images 
in her Visible Skeleton Series, which was 
displayed at the National Museum of Health 
and Medicine in Washington in the spring 
of 2005. This work from the series incorporates 
oils, bronze powder, charcoal, colored pencil, 
pastel and oil crayon on paper. 
Portraits in light— 
artists blend medical imagery 
into their work 
In the 1990s, when Bettyann H. Kevles, 
m.a., asked listeners of the National 
Public Radio program Science Friday 
to imagine their bodies intertwined 
with medical technology, she received 
seven responses, all from artists. All 
seven had experienced imaging tech¬ 
niques such as X-rays, magnetic reso¬ 
nance imaging, computed tomography 
(CT) scans and other routine proce¬ 
dures. One described them as “por¬ 
traits in light.” 
A lecturer in Yale’s Program in the 
History of Medicine and Science, Kevles 
studies how new technologies become 
a part of everyday life. But having 
grown up in a family of painters and 
having studied painting herself, Kevles 
has a long-standing interest in art. Over 
the years, she has built up a library of 
work by visual artists who explore their 
medical conditions in their paintings. 
She explored this theme, in part, in her 
1997 book, Naked to the Bone: Medical 
Imaging in the 20th Century, and in 
Picturing DNA, written with Marilyn 
Nissenson and published online 
in 2000. 
At a symposium on brain imaging 
at the annual meeting of the American 
Association for the Advancement of 
Science in Washington in February, 
Kevles presented the work of visual 
artists who had used medical imaging 
to create self-portraits. The survey 
reached back to the early 20th century 
and the work of Mexican painter Frida 
Kahlo, whose spine was severely injured 
in an accident when she was an 18-year- 
old student, and whose self-portraits 
show her body and spine from the 
inside in a manner reminiscent of X- 
rays. Many contemporary artists have 
incorporated more modern techniques. 
New York artist Laura Ferguson, who 
suffers from scoliosis, studied anatomy, 
consulted with orthopaedic surgeons 
and radiologists and imaged her body 
with a 3D spiral CT scan, which allowed 
her to visually manipulate her skeleton 
to observe it from different angles 
and in different postures. Her Visible 
Skeleton Series, a visual autobiography 
created by blending many layers of 
colors on paper, was on display at the 
National Museum of Health and 
Medicine in Washington this spring. 
Since writing her 1997 book, 
Kevles has continued her study of 
artists such as Jennifer Hall of Boston, 
who has temporal lobe epilepsy 
and used an electroencephalogram 
to capture her brain waves during 
a seizure. She then used a computer 
program to transform the erratic 
spikes into a three-dimensional image 
and cast it in silver in the shape of 
a tiara. 
In her more recent work, Kevles 
has explored the idea that turning 
medical imaging techniques into tools 
of self-exploration allows artists to 
work through their illness so they can 
get past seeing themselves as victims 
of it. “Having seen whatever it is— 
plaques in their brain, or an eeg of a 
crazy electrical storm—they no longer 
think of themselves as epileptics, for 
example. They’re people with particu¬ 
lar parts of their bodies that don’t 
work," Kevles said. “Many artists feel 
that their art, in this way, gives them 
power over their conditions.” 
—Alla Katsnelson 
7 
PREY NAMED DEAN OF NURSING 
argaret Grey, R.N., dr.p.h., was named dean of the School of 
ursing in July. Grey, previously associate dean for scholarly 
ffairs, joined the faculty in 1993. She succeeds Catherine L Gilliss, 
b.N.sc., who served as dean from 1998 until last year. Grey, an 
nternationaSSy known researcher in the natural history of adapta- 
ion to chronic illness in childhood, is the author of more than 
“11160 publications. 
Yale endowment earns 
22 percent, as investment 
steward earns plaudits 
News of outstanding returns on Yale’s 
endowment came as the university’s 
I chief investment officer was already rid¬ 
ing a wave of favorable publicity. David 
F. Swensen, ph.d. ’80, had recently 
published his book Unconventional 
Success: A Fundamental Approach to 
Personal Investment (Free Press), and 
finance journalists were calling him the 
best money manager in academia. They 
pointed to Swenseris track record as 
manager of Yale’s endowment over the 
past 20 years, which has seen average 
returns of 16 percent. For the 2004 fis¬ 
cal year, the endowment earned returns 
of 22.3 percent, bringing total assets 
to $15.6 billion. And under Swenseris 
leadership, the Yale endowment rou¬ 
tinely outperforms Standard & Poor’s 
500. Fie credits his success to a nontra- 
ditional asset allocation with an empha¬ 
sis on equity investments. 
In numerous interviews with the 
press, however, Swensen cautioned that 
individual investors are unlikely to reap 
his returns, even if they read his book. 
Those who spend a few hours a week 
on their portfolios simply can’t compete 
with institutions such as Yale that have 
a team of full-time professionals 
actively managing the endowment. 
“The outstanding performance by 
the investments office in the past year 
has matched a record of achievement 
over time that has earned David 
Swensen and his colleagues the highest 
possible praise and admiration from 
their peers,” President Richard C. Levin 
said in a press release. “Yale’s capacity 
to fulfill its ambitious mission has been 
greatly enhanced by their superb stew¬ 
ardship of the endowment.” 
Because of Swenseris efforts, the 
endowment’s share of the university’s 
operating budget has more than dou¬ 
bled over the past decade. The endow¬ 
ment now contributes almost a third of 
the university’s revenues—$610 mil¬ 
lion this fiscal year—the largest single 
source of support. 
—John Curtis 
GOLDMAN-RAKIC FELLOW NAMED 
Susheel Vijayraghavan, a graduate student in 
neurobiology at the School of Medicine, has 
been selected as the recipient of the 2005 
Patricia S. Goldman-Rakic Fellowship. This fel¬ 
lowship, established by Yale and the phar¬ 
maceutical maker Pfizer in 2003, honors the 
memory of the late Yale professor Patricia 
Goldman-Rakic, ph.d., and highlights excel¬ 
lence in neuroscience research at the medical 
school. According to Lynn Cooley, ph.d., direc¬ 
tor of the Combined Program in the Biological 
and Biomedical Sciences, Vijayraghavan’s 
selection is a “tribute to Dr. Goldman-Rakic’s 
distinguished career and to Susheel’s devel¬ 
oping career.” 
Vijayraghavan studies the effects of 
dopamine on working memory in primates 
and was Goldman-Rakic’s final graduate stu¬ 
dent before her death in 2003. As the fellow¬ 
ship recipient, he will receive tuition, a stipend 
and health care coverage, as well as addi¬ 
tional funds for travel to scientific meetings. 
—J.C. 
YALE WEBSITE DESIGNERS HONORED 
Patrick J. Lynch, wv.s., director of the Med- 
Media Group of Yale’s Information Tech¬ 
nology Services, and C. Carl Jaffe, m.d., pro¬ 
fessor of medicine (cardiology), received the 
2005 Pirelli Prize for Multimedia Education 
and the Top Pirelli Prize for 2005 for the edu¬ 
cational website “Introduction to Cardio- 
thoracic Imaging.” The prizes, which they 
received in Rome in June, honor technical 
innovations and contributions to science 
education through the outstanding commu¬ 
nication of science and technology. 
The Pirelli S.p.A. Group, one of Europe’s 
major telecommunications and manufactur¬ 
ing firms, has underwritten the awards since 
their inception in 1996. The Pirelli jury cited 
the extraordinary depth and breadth of 
the cardiothoracic imaging site (http://info. 
med.yaie.edu/intmed/cardio/imaging). 
“At no time in history does the intersec¬ 
tion of media and science education matter 
more,” said Jaffe, who retired in July after 
35 years on the faculty of the School of Medi¬ 
cine. “Ignorance of or, more importantly, 
denial of the truths of science obscures recog¬ 





















ROUnds MEDICINE AND HEALTH AT YALE 
Biomarkers warn 
of a “silent killer” 
High or low levels of certain 
proteins can signal the likelihood 
of ovarian cancer. 
Epithelial ovarian cancer ranks as the 
most lethal of gynecological malignan¬ 
cies. It is only 10 percent as common 
as breast cancer, but its mortality rate 
is three times as high. The reason is 
simple: routine mammography and 
breast examinations can catch breast 
cancer early, but no such screening 
exists for ovarian cancer in its early 
stages. With few early symptoms, the 
disease passes under the medical radar 
until it has reached later stages of 
malignancy, and therapeutic options 
are often limited. 
Now a group headed by Gil Mor, 
m.d., ph.d., associate professor of 
obstetrics, gynecology and reproductive 
sciences, has found a way to detect 
the “silent killer" in its earliest stages, 
according to a report in May in the 
Proceedings of the National Academy of 
Sciences. The researchers at Yale, 
George Washington University and 
the Nevada Cancer Institute devised a 
still-unapproved screening test that 
measures levels of four cancer-related 
proteins—leptin, prolactin, osteopon- 
tin and insulin-like growth factor II 
(igf-II)—in blood samples. These bio¬ 
markers are proteins that change in 
response to several different forms of 
cancer, perhaps as part of the immune 
response. “Our strategy is unique in 
that we are using a combination of 
proteins representative of how the total 
system reacts to cancer, rather than 
focusing on one protein,” said Mor. 
Previous studies had identified each 
of the four proteins as possible bio¬ 
markers, but Mor’s team found that 
individually none of the proteins 
served as a reliable indicator of cancer. 
The researchers began with 169 
proteins linked to epithelial ovarian 
cancer. They then narrowed the list to 
35 proteins that were either far more 
or far less prevalent in women with 
advanced cancer than in healthy 
women. They further refined the bio¬ 
marker pool to the four proteins, two of 
which are consistently overproduced 
(prolactin and osteopontin) and consis¬ 
tently underproduced (leptin and igf- 
II) in women with cancer. 
To put these findings to clinical use, 
women need only have blood drawn. 
Levels outside of the normal range of 
two or more of the biomarkers predict 
cancer. Follow-up analyses, such as 
ultrasound, can verify the diagnosis. 
In a preliminary study of more than 
200 women, the screen accurately 
detected ovarian cancer in 95 percent 
of cases. The specificity of the test— 
those correctly diagnosed as disease- 
free—also stood at 95 percent, but Mor 
stressed that the test is not ready 
for screening the general population. 
“ Because this disease is relatively 
rare, a specificity of 95 percent means 
that 5,000 out of every 100,000 
women tested by this method would 
give a false-positive result. That’s not 
acceptable," he said. To increase the 
screen’s specificity to an acceptable 
99.6 percent, Mor’s team is looking at 
adding three more proteins to the 
biomarker pool. 
—Kara Nyberg 
With the Canary Database, 
animals become sentinels 
for environmental hazards 
Before the effects of mercury poisoning 
■ishowed up in the children of Minamata, 
Japan, in the 1950s, cats were getting 
sick with a neurological ailment dubbed 
“dancing cat disease.” In Africa, human 
outbreaks of the lethal Ebola virus fol¬ 
low the dying off of animals including 
apes and deer. And epidemiologists are 
keeping a watchful eye on avian flu, 
which has jumped from chickens to 
humans in Asia and Europe. 
Since 2002 an interdisciplinary 
group of researchers at Yale has been 
creating a database that makes the 
connections between diseases in ani¬ 
mals and diseases in humans. With 
funding from the National Library of 
Medicine, the Canary Database hopes 
to harness this information so that 
animals can serve as sentinels of 
impending human disease. 
“If you have an animal that is sick 
from an environmental hazard, should 
human health professionals be con¬ 
cerned?” asked Peter M. Rabinowitz, 
m.d., m.p.h. ’95, fw ’98, associate pro¬ 
fessor of medicine and principal inves¬ 
tigator of the database. The question is 
not hypothetical. It was a veterinarian 
at the Bronx Zoo who in 1999 reported 
the occurrence of dead crows to public 
health authorities, who did not initially 
recognize that the birds were signaling 
the emergence of West Nile virus in 
this hemisphere. “That is a good exam¬ 
ple,” Rabinowitz said, “of the commu¬ 
nication barrier and world-view barrier 
we are trying to bridge.” 
In order to overcome gaps between 
experts in animal health and those in 
human health, the Canary Database 
makes animal sentinel studies from a 
variety of biomedical databases easily 
accessible. Researchers can search the 
database for a wide variety of environ¬ 
mental hazards, both toxic and infec¬ 
tious; learn how these hazards have 
been studied in animal populations; 
and discover whether there is evidence 
linking the animal disease event to 
human health risk. 
The database takes its name from 
the proverbial canary used by coal 
miners to warn of the presence of car¬ 
bon monoxide. A collaboration of the 
Yale Occupational and Environmental 
Medicine program, the Yale Center 
for Medical Informatics and the U.S. 
Geological Survey National Wildlife 
Health Center, the database culls from 
veterinary literature papers on animal 
disease that might have relevance to 
humans. Five curators, including vet¬ 
erinarians and physicians around the 
country, review and curate the papers, 
adding information about epidemio¬ 
logical methods and linkages to 
human health outcomes. 
The information they collect could 
be used to help public health practi¬ 
tioners detect impending disease out¬ 
breaks or terror attacks involving 
chemical or biological weapons. “We 
want to be a continuing resource,” 
Rabinowitz said. 
—John Curtis 
ALCOHOL LOWERS CANCER RISK 
The incidence of non-Hodgkin’s lymphoma 
(nhl) is rising throughout the world—in 
industrialized nations it ranks as the sixth 
most common cancer among men and the 
eighth most common among women. 
Although studies have suggested that alco¬ 
hol consumption may lower the risk of nhl, 
results have been inconsistent. 
In July a team at the Department of 
Epidemiology and Public Health reported in 
the journal Lancet Oncology that alcohol con¬ 
sumption does indeed lower the risk of nhl. 
Unlike prior studies, this one pooled data 
from nine studies covering more than 15,000 
people in the United States, the United 
Kingdom, Sweden and Italy. “This study with 
a large sample size allows us sufficient statis¬ 
tical power to analyze the data by type of 
alcohol consumed and disease subtype,” said 
principal investigator Tongzhang Zheng, sc.D., 
professor of epidemiology. 
Further studies are needed to explore 
the link between alcohol consumption and 
the lower risk of nhl. 
—J.C. 
MUSIC AND SEDATIVES 
For decades, doctors and nurses in the oper¬ 
ating room have turned to music to soothe 
the nerves of anxious patients. Several 
studies have found that patients who listen 
to music are less anxious before surgery 
and need less anesthesia. 
But Zeev N. Kain, M.D., HS ’92, FW ’93, 
professor of anesthesiology, pediatrics 
and child psychiatry, wondered whether 
music did more than simply drown out 
the racket in the operating room. With col¬ 
leagues at Yale and the American Univer¬ 
sity of Beirut in Lebanon, he designed a 
study in which patients who had received 
spinal anesthesia—but were awake—could 
control the dosage of a sedative. They lis¬ 
tened through headphones to either music 
of their choice or white noise generated 
by a relaxation device. As reported in May 
in the journal Anesthesia and Analgesia, 
patients who listened to music used signifi¬ 
cantly less sedative. 
“Doctors and patients should both note 
that music can be used to supplement 





















10 Findings from the bench 
A moth’s gene helps 
discern gene functions 
A piece of dna from a moth could 
signal a major leap in the under¬ 
standing of what specific genes do. 
A new tool for genome research, 
developed in the Yale laboratory of Tian 
Xu, ph.d. ’90, professor and vice 
chair of genetics, professor of molecular 
oncology and development and a 
Howard Hughes Medical Institute 
investigator, promises to greatly acceler¬ 
ate the work of assigning purpose to 
thousands of unexplored human genes. 
The tool is a jumping gene, a small 
piece of dna called a transposon that 
moves around the genome, usually 
settling in other genes and allowing 
scientists to suppress the activity of 
existing genes or insert new ones. 
Transposons are active in many plant 
and insect genomes and have helped 
to make the fruit fly Drosophila the dar¬ 
ling of geneticists, as these mobile dna 
fragments were used to decipher the 
role of nearly every gene in that model 
organism. But for decades scientists 
could not find an equivalent transposon 
for mammals. 
As reported in the August 12 issue 
of the journal Cell, Xu and his col¬ 
leagues manipulated a transposon 
called piggyBac, found in the cabbage 
looper moth, so that it can be easily 
cut and pasted into the genomes of 
higher organisms, including mice and 
humans. “With this transposon, we now 
have the ability to systematically inacti¬ 
vate each and every gene in a model 
organism like the mouse,” Xu said. 
In mouse studies, scientists have 
traditionally used chemicals to modify 
genes, but this approach is painstak¬ 
ingly slow, and it can be difficult to 
locate the genes that have been mutated. 
The piggyBac transposon, when injected 
into fertilized mouse eggs along with 
an enzyme called transposase, is 
remarkably efficient at inserting itself 
into important coding regions of the 
genome, and as its name implies, it car¬ 
ries genetic tags that allow researchers 
to locate mutations quickly. 
Moreover, piggyBac has the added 
feature of total reversibility, which 
should allow scientists to verify that par¬ 
ticular mutations have particular effects. 
In the presence of transposase, piggyBac 
easily hops into genes, and it remains 
in place in any offspring in subse¬ 
quent generations that do not inherit 
the enzyme. But when these mice 
are mated with others who carry the 
transposase gene, piggyBac hops back 
out of genes without leaving a trace. 
These traits make piggyBac a 
“dream tool” for geneticists, Xu said. 
“This new technology will completely 
change the game of using mutagen¬ 
esis to understand the function of 
mouse genes and, by extension, their 
human counterparts.” PiggyBac 
could also be a promising new vehicle 
for human gene therapy, according 
to Xu, who said that, in addition 
to carrying tags, piggyBac can be engi¬ 
neered to carry new genes into 
the genome. 
To demonstrate the potential of 
this genetic piggybacking, Xu and his 
colleagues used piggyBac to insert a 
gene for a protein that glows red under 
ultraviolet light into a mouse. How¬ 
ever, many more experiments will be 
required to determine whether the 
transposon, or some variation of it, 
could reliably and safely transfer thera¬ 
peutic genes to humans. 
Xu’s immediate goal is to use 
piggyBac to inactivate every gene in 
the mouse, one by one, a project that 
would be unthinkable with traditional 
mutagenesis methods. “For the past 
two decades, it has routinely taken 
about a year to mutate one gene in a 
mouse, and altogether about 3,000 
genes have been knocked out in mice, 
out of a total of about 25,000 that are 
in the genome,” Xu explained. With 
the help of piggyBac, he said, “in three 
months, with two students, we have 
done 75 genes.” 
—Pat McCaffrey 
USING LASERS TO DETERMINE CELL FUNCTION 
Through genetic tweaking, researchers at the School of Medicine 
have made fruit flies walk, jump and fly on command—by flash¬ 
ing a light at them. The scientists inserted rat ion channels into 
nerve cells that control flies’ escape movements, then injected the 
flies with a chemical that would activate the ion channels when 
exposed to light. Gero A. Miesenbock, m.d., associate professor of 
cell biology at the medical school, who led the study that 
appeared in the journal Cell in April, said that the research offers 
a new way to learn how nerve cells govern behavior. 
NEW TARGET FOR MELANOMA 
A livestock virus may offer 
a new approach to treating 
glioblastoma 
( Viruses are hijackers, wreaking infec- 
i tious havoc by taking over a cell’s 
machinery and using it to replicate. 
But their wily ways may not be all 
bad. Yale professor of neurosurgery 
Anthony van den Pol, ph.d., is har- 
Inessing their destructive power to 
develop a novel treatment for glioblas¬ 
toma, the most common and aggres¬ 
sive form of brain cancer. 
Glioblastoma strikes about 7,000 
Americans each year, and most patients 
live just a year after diagnosis. Although 
jit can be treated with surgery, radiation 
and chemotherapy, said van den Pol, 
the cancer usually comes back. 
The idea of unleashing viruses to 
destroy tumor cells is beginning to gain 
validity, not just for brain cancers but 
also for ovarian, prostate and other kinds 
of tumors. When this line of research 
j began two decades ago, scientists feared 
that the viruses would spread to healthy 
cells, so they genetically altered them to 
prevent them from replicating. But 
those inactivated viruses kill relatively 
few brain tumor cells. The Yale team 
hypothesized that a replicating virus 
would be much more effective. 
Van den Pol and his colleagues 
bred several generations of vesicular 
stomatitis virus on glioblastoma cells, 
selecting for strains with the highest 
tumor-killing capacity. Then they tested 
the virus and saved those strains that 
did not infect normal cells. In a study 
published in the Journal of Virology in 
May, the researchers reported that the 
strain they developed selectively killed 
glioblastoma cells in vitro, and was able 
to infect and kill whole tumors in mice. 
The results are promising, but 
van den Pol stressed that they are still 
preliminary. The team plans to expose 
the virus to different types of cells 
found in the brain to make sure that it 
will not infect them. “This is a high- 
risk strategy,” he said, “but we’re deal¬ 
ing with a disease for which at present 
there is no cure.” 
—Alla Katsnelson 
Using a technology devised at Yale five 
years ago, researchers have found what 
may be a new target for treatment 
of melanoma. The Yale team used aoua 
(automated quantitative analysis) to 
measure protein expression in melanoma 
tissue microarrays. In a study in Nature 
in July they reported that microphthalmia- 
associated transcription factor (mitf), a 
protein involved in cell survival, abnormally 
copies itself many times over.This over¬ 
expression was prevalent in metastatic dis¬ 
ease and correlated with decreased rates 
of patient survival. 
This suggests, said David L. Rimm, m.d., 
ph.d., hs ’93, an author of the study and 
associate professor in the Department of 
Pathology, that mitf may represent a dis¬ 
tinct class of oncogene that is necessary for 
tumor progression. Reduction of mitf activ¬ 
ity sensitizes melanoma cells to chemo¬ 
therapeutic agents, and targeting mitf in 
combination with other drugs may offer 
a new approach to treating melanoma. 
—John Curtis 
A TOLL ON INFECTIONS 
In 1997 the late Charles A. Janeway Jr., m.d., 
and Ruslan M. Medzhitov, ph.d., professor of 
immunobiology, discovered fo//-like recep¬ 
tors, or tlrs, molecules that alert the body’s 
acquired immune system to the presence of 
microbial or viral invaders. 
Scientists have since identified over a 
dozen types of tlrs, which detect proteins 
in bacteria and viruses but not those in the 
eukaryotic cells that make up our bodies. 
Some pathogens, however, are also eukary¬ 
otes, and a team at Yale and the National 
Institutes of Health wondered whether tlrs 
could recognize them. 
In the June 10 issue of the journal Science, 
the group reported that tlrii, discovered 
in mice at Yale last year, triggers an immune 
response after it detects a protein in the 
virus that causes toxoplasmosis. 
Team member Sankar Ghosh, ph.d., pro¬ 
fessor of immunobiology, said that while it is 
not yet clear whether humans have a func¬ 
tional version of tlrii, these studies should 
lead to development of novel strategies to 




















12 Books & ideas bookshelf 
Cardiologist Harlan Krumholz has 
published a handbook that he 
hopes will encourage patients to 
be involved in their treatment 
for heart disease. 
Guiding patients through heart disease 
A cardiologist provides a handbook so patients can better 
understand their disease and how to treat it. 
Half of all patients don’t take the medications that their 
doctors prescribe. And the majority of cardiac patients leav¬ 
ing the hospital don’t know the target numbers for optimal 
blood pressure or cholesterol. For cardiologist Harlan M. 
Krumholz, m.d., m.sc., the Harold J. Hines Jr. Professor of 
Internal Medicine and of Epidemiology and Public Health, 
these findings reflect lost opportunities for patients to 
participate in their care. Hopes of fostering better patient 
involvement in their care motivated Krumholz to write 
The Expert Guide to Beating Heart Disease: What You 
Absolutely Must Know (HarperResource, $14.95). 
Krumholz said that patients who understand their 
disease and the options for treating it can collaborate more 
effectively with their physicians in choosing and following the 
strategies that are most likely to help them reach their goals. 
“If patients understand the rationale behind the strategies, 
they’re more likely to follow them.” Krumholz also argued 
that informed patients are more likely to get good care. 
“We have this illusion that medicine is being practiced 
uniformly and is of high quality throughout the country,” he 
said. “That perception is just not true. There is ample evidence 
that treatment strategies that are well-established by the litera¬ 
ture and endorsed by national guidelines are not uniformly 
being recommended by doctors or pursued by patients.” 
Unfortunately, patients are not often encouraged to 
become well-educated about their condition, said Krumholz. 
“We’re still in an era when most people come in, they’re told 
what to do and given a prescription, and if they don’t comply, 
they’re seen as letting down the physician.” 
Patients seeking to educate themselves about heart 
disease may feel overwhelmed, however. “If you got sick, 
where would you start? There’s such an avalanche of infor¬ 
mation,” said Krumholz. He views his 152-page book as a 
“travel guide” that provides essential facts about how heart 
disease develops and what can be done to treat it. The book 
describes seven key strategies: controlling blood pressure, 
managing cholesterol, exercising, maintaining a healthy 
weight, managing blood sugar, quitting smoking and using 
medication effectively. 
BOOK NOTES 13 
For more on the book, visit . 










Krumholz chose these seven strategies based on 
national guidelines and his expertise in evaluating the qual¬ 
ity of heart disease care. A prolific researcher himself, he has 
helped set national standards for cardiovascular care for 
organizations ranging from the American College of 
Cardiology to the Department of Defense. Based on the pub¬ 
lished evidence, his book describes approaches that work 
(such as taking beta-blockers after a heart attack or control¬ 
ling cholesterol with statins), those that probably help (eat¬ 
ing fish regularly), those of uncertain value (taking vitamins) 
and those that have proven harmful (hormone replacement 
therapy for women). 
A grant from the John A. Hartford Foundation in New 
York allowed Krumholz to hire a researcher—Susan Cheng, 
m.d., then a medical student at McMaster University in 
Ontario, now a resident in internal medicine at Johns 
Hopkins. Krumholz and Cheng field-tested the book: they 
sent about 100 copies to relatives, friends, friends of friends 
with heart disease and patients, asking them to circle sec¬ 
tions that were confusing and to pencil in questions. 
“We said, ‘Write all over this. It won’t hurt our feel¬ 
ings.’” Their approach seems to have worked; a critic for 
Kirkus Reviews writes that “Dr. Krumholz has a gift for trans¬ 
lating jargon into clear, accessible language that the con¬ 
cerned reader can easily absorb.” 
Writing for a general audience was a departure for 
Krumholz. He has clinical responsibilities one day each 
week, and as director of the Robert Wood Johnson Clinical 
Scholars Program at Yale, he spends a lot of his time guid¬ 
ing postdoctoral fellows in the program as they do research 
on improving clinical care and population health. His own 
research appears in 40 to 50 articles annually. But he called 
those papers “just a means to an end.” 
“At the end of the day, it’s not about the number of 
publications but about whether people can benefit from the 
work we’ve done. The book is a tool to help promote that.” 
—Cathy Shufro 
Bookshelf is a column focusing on matters related to books and 
authors at the School of Medicine. Send ideas to Cathy Shufro at 
cathy.shufro@yale.edu. 
Nanoscale Technology in 
Biological Systems 
by Ralph S. Greco, m.d. ’68, 
hs ’73, et al. (CRC Press) 
This book presents the latest 
information on the interface 
between nanotechnology and 
biology, examining the princi¬ 
ples underlying the application 
of nanotechnology to basic 
science research, applied 
research and clinical practice. 
Songs From the Black Chair: 
A Memoir of Mental Interiors 
by Charles Barber, m.h.a., associ¬ 
ate of the Yale Program for 
Recovery and Community Health 
(University of Nebraska Press) 
In his account of working with 
homeless mentally ill patients in 
New York, Barber tells their tales 
of prison, aids, heroin, crack and 
sexual abuse and of the voices 
that plague them. 
The Craft of Psychodynamic 
Psychotherapy 
by Angelica Kaner, ph.d., assist¬ 
ant clinical professor in psychia¬ 
try, and Ernst Prelinger, ph.d., 
clinical professor of psychology 
and psychiatry (Jason Aronson) 
Clinical vignettes illustrate 
the fundamentals of psycho¬ 
dynamic theory and technique, 
tackling questions such as: 
What is psychotherapy? How 
long will it take? How does 
change happen? 
Information Systems Research: 
Relevant Theory and Informed 
Practice 
edited by Bonnie Kaplan, 
ph.d., lecturer in anesthesiology 
(medical informatics), et al. 
(Springer) This volume is organ¬ 
ized in seven sections, with 
33 full research papers providing 
reviews on the Information 
Systems (IS) discipline. It also 
includes papers featuring 
critical interpretive studies, 
action research, theoretical per¬ 
spectives on IS research and 
the methods and politics of IS 
development. 
Attention Deficit Disorder: 
The Unfocused Mind in Children 
and Adults 
by Thomas E. Brown, ph.d., 
assistant clinical professor of psy¬ 
chiatry (Yale University Press) 
Drawing on recent findings in 
neuroscience and a variety of case 
histories from his own clinical 
practice, Brown defines Attention 
Deficit Disorder, describes how to 
recognize it in people of different 
ages and discusses how it can 
best be treated. 
Heart Care for Life: How to 
Develop the Long-Term Personal 
Program That Works Best for You 
by Barry L. Zaret, m.d., the 
Robert W. Berliner Professor of 
Medicine and professor of radiol¬ 
ogy, and Genell Subak-Sharpe, 
m.s. (Yale University Press) The 
authors outline the constants 
for the full range of cardiovas¬ 
cular conditions, from angina 
and heart attacks to high blood 
pressure and cardiac arrhyth¬ 
mias.They then guide readers 
through the process of assessing 
personal variables in order to 
develop an individual treatment 
and lifestyle program. 
Emotional Comfort: 
The Gift of Your Inner Guide 
by Judith M. Davis, m.d. ’63 
(Wilder Press) This book pro¬ 
vides a seif-hypnotic technique 
for attaining emotional com¬ 
fort. According to Davis, the 
technique helps its practitioners 
to resolve chronic difficulties 
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Personal librarians help students 
navigate research 
Multiple Sclerosis as a 
Neuronal Disease 
by Stephen G. Waxman, ph.d., 
m.d., professor of neurology, 
pharmacology and neurobiology 
(Elsevier Academic Press) This 
illustrated book brings together 
the latest information from 
clinical, pathological, imaging, 
molecular and pharmacological 
realms to explore the neuro¬ 
biology of multiple sclerosis. 
One Nation Under Therapy: 
How the Helping Culture Is 
Eroding Self-Reliance 
by Sally L. Satel, m.d., hs '88, 
lecturer in psychiatry, and 
Christina Hoff Sommers (St. 
Martin’s Press) The authors 
believe that talking about prob¬ 
lems is no substitute for con¬ 
fronting them. They argue that 
“therapism" and the "trauma 
industry" have begun to under¬ 
mine the self-reliance and 
fortitude that Americans have 
traditionally valued. 
Physicians’ Cancer Chemotherapy 
Drug Manual 2005 
by Edward Chu, m.d., professor 
of medicine (oncology) and phar¬ 
macology, and Vincent T. DeVita 
Jr., m.d., hs ’66, the Amy and 
Joseph Perella Professor of 
Medicine (Jones and Bartlett 
Publishers) Completely revised 
for 2005, this handbook is a 
guide to all aspects of cancer 
chemotherapy, including a 
catalog of over 100 drugs com¬ 
monly used in cancer treatment. 
Bone Regeneration and Repair: 
Biology and Clinical Applications 
edited by Jay R. Lieberman, m.d., 
and Gary E. Friedlaender, m.d., 
hs ’74, the Wayne O. Southwick 
Professor of Orthopaedics and 
Rehabilitation (Humana Press) 
This collection of articles by 
leading orthopaedic and cranio¬ 
facial surgeons and researchers 
reviews the biology of bone for¬ 
mation and repair and the basic 
science of autologous bone 
graft, allograft, bone substitutes 
and growth factors, and explores 
the clinical application of this 
knowledge to patients with 
bone repair problems. 
The Cadaver’s Ball: 
A Novel of Revenge 
by Charles Atkins, m.d., lecturer 
in psychiatry (St. Martin’s 
Minotaur) Atkins creates char¬ 
acters with a range of motiva¬ 
tions in this psychological 
thriller of the lives and loves of 
three medical school friends. 
The Lobotomist: A Maverick 
Medical Genius and His Tragic 
Quest to Rid the World of 
Mental Illness 
by Jack El-Hai (Wiley Publishers) 
In the early 1940s, lobotomy was 
the last resort in an attempt to 
relieve intractable psychiatric 
symptoms. This type of surgery 
was first performed in the United 
States in 1936 by neurologist 
Walter J. Freeman, m.d., who 
received his undergraduate 
degree from Yale in 1916, and 
neurosurgeon James W. Watts, 
m.d.—who helped pave the 
way for psychosurgery by con¬ 
ducting research on chimps 
at the Laboratory of Primate 
Physiology at Yale. The practice, 
now discredited, continued 
for more than 40 years. 
The descriptions above are based on 
information from the publishers. 
SEND NOTICES OF NEW BOOKS TO 
Cheryl Violante, Yale Medicine, 
P.O. Box 7612, New Haven, CT 
06519-0612, or via e-mail 
to cheryl.violante@yale.edu 
Second-year medical student Kurtland Ma ran into a snag while doing 
research last summer in Hong Kong: he couldn’t download an article 
on alternative hiv therapies that he’d found online. Luckily, Ma had 
someone to turn to—his “personal librarian” 8,000 miles away in 
New Haven. 
That librarian was Lynn H. Sette, m.l.s., a reference librarian 
and one of 10 librarians at the Cushing/Whitney Medical Library 
paired with students in medicine, in the Physician Associate Program 
and in the Combined Program in the Biological and Biomedical 
Sciences. Just as Sette had introduced herself to Ma during his medi¬ 
cal school orientation, each of the personal librarians meets new stu¬ 
dents as they arrive, establishing librarian-student partnerships. 
When Ma sought help from Sette via e-mail in July, she sent 
him the article he needed. Normally, said Ma, he does well on his own. 
“I’ve done so many PubMed/Ovid searches in the past and the web¬ 
site is so good that I don’t feel like I need all that much help—having 
a personal librarian seems more like a luxury,” Ma wrote by e-mail 
from Hong Kong. “I obviously didn’t expect to be asking for her help 
from here in Hong Kong, but now I’m starting to realize that having 
her is quite helpful.” 
Education Services Librarian Jan Glover, m.l.s., who helped 
create the program nine years ago, said students often turn to their 
librarians when they begin third-year clinical rotations. They ask for 
guidance—in person or by e-mail—when they’re looking for “the per¬ 
fect bit of information to answer a clinical question.” Students also 
ask for help with technical problems such as downloading a medica¬ 
tion database onto a personal digital assistant. 
The most common questions are about complicated literature 
searches. During the past year, third-year medical student Argo P. 
Caminis estimated that she has asked Glover for advice two or three 
times a week while doing research for two journal articles on adoles¬ 
cent sexual behavior. Glover showed Caminis how to avoid being 
inundated by thousands of citations on a broad topic. 
“I was getting tons of hits. She helped me to focus it by the 
types of journals I was looking at: whether they’d been peer-reviewed, 
looking for literature review articles, limiting the search to recent 
or relevant articles. She taught me principles of research that I think 
were helpful to learn early on in medical school,” said Caminis, who 
was a co-author on an article published last spring and who will be 
lead author on a second. “It’s a good way to reach out to students.” 
—Cathy Shufro 
In Circulation is a column focusing on activities at the Cushing/Whitney 
Medical Library. Send ideas to Cathy Shufro at cathy.shufro@yale.edu. 
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DOUGLAS MELTON 
In the stem cell debate, 
asking the right question 
The intertwined debate that 
links abortion to embryonic 
stem cell research has revolved 
around the wrong question, 
said Douglas A. Melton, ph.d., 
co-director of the Harvard Stem 
Cell Institute. “I would suggest 
to you,” he said in his keynote 
address at the annual meeting 
in May of the Associates of 
the Cushing/Whitney Medical 
Library,“that the question 
of when does life begin is the 
wrong question. The real 
question is:'When does person- 
hood begin?’ ” 
A sperm and an egg are 
already alive before they meet, 
Melton said, rendering the 
notion of the beginning of life 
an arbitrary matter of timing. 
When does personhood 
emerge? “This is a metaphysi¬ 
cal question that everyone 
should think about.” 
Harnessing the plasticity 
of stem cells and inducing their 
differentiation into a desired 
tissue is years away, Melton said, 
but within reach. "I predict the 
2ist century will be a century 
not about genes and dna, but 
about cells and stem cell 
research.... Genes are not the 




A new role for rna as a 
regulatory molecule 
In the last few years scientists 
have been surprised by small 
nucleotide sequences, microRNAs 
and siRNAs (small interfering 
rnas), that appear to play a role 
in both suppressing and promot¬ 
ing cancer. “We are at a transi¬ 
tion in our understanding of 
rna,” said Phillip A. Sharp, ph.d., 
Nobel laureate and Institute 
Professor at the Massachusetts 
Institute of Technology, “rna 
is taking on a new role. It is a 
regulatory molecule.” 
These small rnas are double- 
stranded sequences of about 22 
nucleotides that act by disrupt¬ 
ing messenger rna. According 
to Sharp, they regulate up to a 
fifth of human genes, a function 
once thought to be the exclusive 
province of proteins. “The dou¬ 
ble strand is the signature key 
that converts the rna into a 
regulatory molecule,” Sharp said 
in June as he gave the Adelberg 
Lecture sponsored by the 
Department of Genetics. 
This regulatory role could 
have therapeutic value if it 
can be harnessed to turn off 
mutant, disease-causing genes. 
“The big problem with using 
siRNAs is how to introduce 
them into the cell," Sharp said. 
"That delivery problem stands 
between this being a very broad 
platform for therapeutics and 
where we are at now.” 
—J.C. 
GLORIA STEINEM 
Research that makes 
women visible 
Surveying a packed ballroom at 
New Haven’s Omni Hotel in which 
women were disproportionately 
and diversely represented, 
renowned feminist author and 
activist Gloria Steinem noted the 
changes since she first spoke at 
Yale at the dawn of the women’s 
movement in the 1960s. "The 
phrase gender-specific could have 
applied to all of Yale,” Steinem 
said in April. "And Cod and Man 
at Yale has at least become 
Cod and People. There are glori¬ 
ous racial and ethnic and eco¬ 
nomic differences and diversity 
and richness. So times have 
really changed.” 
Speaking at a gala event in 
which she received a Women of 
Vision award from Women’s 
Health Research at Yale (whry), 
Steinem lauded the work of 
whry, which supports research 
on sex-specific factors in health 
and disease. "Their questions at 
a time when mostly old answers 
rule the top are really very, very 
crucial,” she said. "The rock-solid 
research that is going on makes 
the female half of the world visi¬ 
ble and is clearly something we 






A 62-year-old man led a choir 
through a flawless rehearsal 
and performance, but by the 
end of the day he could remem¬ 
ber none of the day’s events. 
He was experiencing tran¬ 
sient global amnesia (tga), a 
malady believed until the 1950s 
to be the product of hysteria 
or malingering, said Joshua 
R. Steinerman, m.d., a senior 
resident in neurology who 
described the disorder at clini¬ 
cal neuroscience grand rounds 
in June. 
Physicians now know what 
triggers tga, without knowing 
what causes it.Triggers include 
swimming in cold water, sex¬ 
ual intercourse, an emotional 
event, stress and exertion. “The 
history and proximal events 
leading to the episode are cru¬ 
cial,” Steinerman said. 
Episodes usually last four 
to six hours. Sufferers—typically 
people between the ages of 
50 and 79—know something’s 
wrong, but they can’t recall 
answers to the questions 
they ask as they try to orient 
themselves. 
Over the years, several theo¬ 
ries have been proposed about 
what causes tga. “None is 
entirely satisfactory," Steiner¬ 
man said. "The great thinkers 
who proposed mechanisms 
have always hedged their bets.” 
—J.C. 
i6 capsule 
From the Middle East, 
in the Middle Ages 
An exhibit at the Sterling Memorial Library highlights the contributions 
to medicine of Muslim physicians. 
By Jennifer Kaylin 
When we check into a hospital, take 
our children to the pediatrician or 
undergo a surgical procedure, it’s likely 
we’re benefiting from the work of 
medieval Muslim doctors and scholars. 
“Muslims’ Contributions to 
Medieval Medicine and Pharmacology,” 
an exhibit of manuscripts from the 
Medical Historical collection at the 
Harvey Cushing/John Hay Whitney 
Medical Library, was on display in 
Sterling Memorial Library’s exhibit 
corridor until September. The exhibit, 
said Simon Samoeil, curator of 
Sterling’s Near East Collection, was 
designed to “provide positive insight” 
into the important contributions made 
by medieval Muslims at a time of 
high tensions between our nation and 
areas of the Muslim world. 
In the seventh century, when for¬ 
mer empires such as those of the 
Greeks, Persians and Romans fell 
under Arab domain, the new Islamic 
empire inherited many scholarly 
disciplines, including the developing 
fields of medicine and pharmacology. 
Recognizing their importance, 
Islamic leaders had works from other 
languages translated into Arabic, so 
research and study could continue. 
The exhibit includes some remark¬ 
able examples of these early texts, 
including an illustrated Persian treatise 
on human anatomy, with six pages 
of detailed drawings. There is also a 
human anatomy book that was trans¬ 
lated from Greek into Arabic by the 
nth-century scholar and physician 
Avicenna. “His textbook was used in 
the West until the mid-iyth century,” 
Samoeil said. 
Other artifacts in the exhibit include 
a medical dictionary and a book 
containing 31 chapters of practical 
information about hygiene, sexual 
intercourse and other topics. These 
Arabic translations of Greek scholar¬ 
ship led to later translations into 
Latin, Samoeil says, paving the way 
for Greek knowledge to become 
accessible to the scientists and scholars 
of the Renaissance. 
17 
In addition to these important 
translations, Muslims introduced new 
fields of medical research and clinical 
practice, including gynecology, embry¬ 
ology and a focus on the care of 
mothers and children. Samoeil said 
medieval Muslims saw the larger value 
in protecting the health of women, 
j “Women are the mothers of men,” he 
said. “If the Arab empire was to flour- 
;! ish, the women needed to be healthy.” 
Early Arabs also contributed to 
the diagnosis, treatment and preven¬ 
tion of diseases such as smallpox and 
measles, and Muslim doctors were 
the first to incorporate surgery, then 
a separate discipline, into the study 
of medicine and to develop its practice 
: and techniques. 
Perhaps the most concrete legacy 
f is the structure of today’s hospitals, 
i1 which follow the model of ninth- 
century Islamic hospitals. These early 
health care centers had open admis¬ 
sion policies for patients of all eco¬ 
nomic backgrounds, regardless of sex, 
i religion or ethnicity. They were run 
by a large administrative staff and 
organized into wards by gender and 
I nature of illness. In addition, early 
Islamic hospitals pioneered the idea 
| of having on-site pharmacies and 
i training programs for students to get 
j; practical experience under the guid- 
): ance of a physician. 
Samoeil said the exhibit drew a 
| favorable response from the Yale 
I community and visitors. “The other 
I day, I overheard three tourists,” 
I he said. “One called out to another, 
‘Come look at this. It’s amazing. 
I didn’t know the Arabs and the 
Muslims had done all this.’ ” 
His goal in organizing the exhibit, 
he said, was to draw connections 
between the past and the present. “It’s 
important to do that,” he said. “When 
we look at modern materials and manu¬ 
scripts, it’s important to understand 
how we got there, to see the connection 
with what came before.” 
Jennifer Kaylin is a contributing editor of 
Yale Medicine. 
opposite TOP The 11th-century Persian 
manuscript Farah namah was also known as 
Ajayib al-dunya (Wonders of the World). 
Multicolored illustrations of animals, birds, 
plants, stones and humans adorn the text. 
BELOW The Kitab al-Hawi, believed to have 
been written in the gth or 10th century, was 
still in use in the 1600s, when the Shah of Iran 
ordered it copied for his chief physician. The 
page shown below describes the structure of 
the brain as well as ailments that afflict it. 
OPPOSITE bottom The 11th-century scholar 
and physician Avicenna wrote a medical 
text that was used until the mid-iyth century. 
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In January 2004 Johnnie Yates, m.d. ’95, took a job as a 
physician in an international clinic in Kathmandu, the capital 
of Nepal. The post offered a chance for Yates to pursue his 
interests in travel medicine, and as he recounts in the article 
that follows, a typical day in his life provided insights into 
medicine in Nepal. 
Article and photographs by 
Johnnie Yates, m.d. '95 
CHINA 
INDIA 
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opposite On the path to the base camp 
of the world’s highest peak. 
below During his i8 months in Nepal, 
medical school alumnus Johnnie Yates took 
frequent trips to mountain locations, such 
as Poon Hill in the Annapurna Himalaya. 
The rain starts innocently with scattered 
sprinkles—warning enough for street 
vendors to cover their wares and for 
pedestrians to seek cover. The sky 
darkens and the downpour begins. Rain 
pounding on the roof can make a tele¬ 
phone conversation next to impossible. 
And then it stops. “Must be the begin¬ 
ning of the monsoon,” I presume, 
but I learn that June is too early. Once 
the monsoon season (July to Septem¬ 
ber) starts in earnest, the rain becomes 
a daily occurrence and provides relief 
from the heat and humidity. 
Premonsoon rains herald the end of 
the spring trekking season, and work at 
the ciwec Clinic Travel Medicine Center 
in Kathmandu, Nepal, slows down. 
ciwec stands for Canadian International 
Water and Energy Consultants, the 
nongovernmental organization (ngo) 
that established the clinic in 1982. It 
has since become an independent cen¬ 
ter staffed by three physicians (a U.S.- 
trained Nepali internist, who is also the 
medical director, and two American doc¬ 
tors). ciwec is internationally renowned 
for its Western standard of care and its 
research into the health problems of 
foreigners. Most patients are diplomats, 
staff from development agencies and 
ngos, aid workers, volunteers and 
tourists. During busy periods the wait¬ 
ing room resembles a mini-United 
Nations, with British diplomats, Tibetan 
monks, Israeli backpackers and Ameri¬ 
can parents and their newly adopted 
Nepali children awaiting consultations. 
Trekkers and climbers felled by altitude 
sickness come to the clinic as well. 
I never imagined living in Nepal, a 
landlocked country between India and 
China. Apart from reading Jon 
Krakauer’s Into Thin Air, about the 
1996 Mt. Everest climbing disaster, or 
listening to Bob Seger’s version of 
“Kathmandu,” I never thought about 
the place. I graduated from medical 
school in 1995, completed a residency 
in family practice at Middlesex 
Hospital in Connecticut, and was liv¬ 
ing in Hawaii when I received the 
unexpected offer to work at ciwec. I 
had done medical school electives and 
volunteer work abroad but always pre¬ 
ferred the tropics to the mountains. 
Nonetheless, the opportunity allowed 
me to pursue my interest in travel 
medicine full time. So in January 
2004, I packed away my “aloha” shirts, 
dusted off my cold-weather clothing 
and moved to Nepal. 
Slightly smaller than New England, 
Nepal has a population of approxi¬ 
mately 25 million, with over 1.5 million 
people living in Kathmandu. It is best 
known as home to Mt. Everest, at 
29,035 feet the world’s highest moun¬ 
tain, but its lowland tropics offer 
a chance to go on safari in search of 
rhinos and tigers. The latter part 
of the dry season (February to May) is 
a popular time to visit the country, 
especially for trekkers and climbers. 
On that rainy day in June, my first 
patient was Shyam, a 4I/2-year‘°lcl 
Nepali boy adopted a week earlier by 
an Italian couple. His cheeks had 
become swollen and painful over the 






















Trekkers hike in the shadow of Mt. Ama 
Dablam, a 6,856-meter peak in the Khumbu 
region of Nepal, along a popular route to 
Mt. Everest Base Camp. 
Both of his parotid glands (salivary 
glands below the ears) were swollen 
and tender, and he was mildly dehy¬ 
drated. He also had scabies and a 
scalp infection, conditions present in 
nearly all of the children that I see 
from orphanages. Shyam’s new parents 
said the orphanage had no proof of 
any vaccinations, thus increasing my 
clinical suspicion of mumps. 
For a country in which the burden 
of infectious disease is high, diag¬ 
nostic capabilities can be woefully lim¬ 
ited. While some medical technology 
has reached Nepal, it does not mean 
that a system of modern health care 
delivery has come along with it. One 
night I had to obtain a CT scan of 
a patient with fever, convulsions and 
delirium (ultimately diagnosed as 
encephalopathy due to typhoid fever). 
After an initial noncontrast CT at 
the university teaching hospital, the 
radiologist inquired if I wanted one 
with contrast, which would highlight 
an abscess. Upon my affirmative 
reply, he scribbled on a scrap of paper. 
Sensing my confusion, he explained 
that I would have to take the note to 
the pharmacy down the street, buy 
the contrast agent and bring it back 
for him to administer. 
Shyam was stoic, even as an IV 
was inserted to provide hydration. 
I wondered what was going through 
his mind. He had spent most of his 
young life in an orphanage before 
he was taken away by a friendly for¬ 
eign couple he could not understand. 
Did he realize that in one week he 
would board an airplane for the first 
time and fly to his new home in Italy? 
After 1 finished caring for Shyam, 
I called for the next patient. There was 
no answer from the waiting room. 
At ciwec, that means that the patient 
is in the bathroom. Diarrheal illness 
accounts for a third of what we see, 
and the incidence increases between 
May and July. Regardless of how care¬ 
ful one is, the pathogens that cause 
diarrhea are impossible to avoid—I 
realized this after being stricken five 
times in my first two months in Nepal. 
Bacteria are responsible for most 
of the diarrhea among foreigners in 
Nepal. However, the premonsoon sea¬ 
son ushers in the seasonal parasite 
Cydospora cayetanensis, which causes 
cyclosporiasis, a debilitating diarrheal 
disease characterized by marked 
fatigue and anorexia and first identi¬ 
fied in Nepal in 1989 by a ciwec 
lab technician. 
The patient emerged from the bath¬ 
room with a big sigh and recounted 
how he had had intermittent diarrhea 
for two weeks. Every time he thought 
he was recovering, the diarrhea would 
return. He had no energy or appetite 
and was losing weight. His stool 
examination confirmed Cydospora. 
He was treated with trimethoprim/ 
sulfamethoxazole and reassured that 
his appetite should improve within 
a few days. Untreated, cyclosporiasis 
is self-limiting, but it can last up to 
several weeks. 
After lunch Mr. Sherpa, a 40-year- 
old Nepali, presented with four days 
of fever and headache. His symptoms 
put typhoid at the top of the list of 
possible diagnoses. However, Sherpa 
had recently returned from the West 
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Bengal region of India, an area 
endemic for malaria. A blood smear 
revealed severe Plasmodium falciparum 
malaria, the most dangerous of the 
disease’s four forms. I started an IV, 
administered an antimalarial and 
transferred him to the hospital for 
closer monitoring. In Kathmandu one 
can lose valuable time while waiting 
for an ambulance, so Sherpa was sent 
to the hospital by the quickest means 
available—a taxi. 
As it turned out, Sherpa’s ride to 
the hospital was held up by political 
demonstrations in the streets. What 
should have been a 15-minute ride took 
nearly an hour. Nepal has become 
increasingly plagued by political prob¬ 
lems: an eight-year-old Maoist insur¬ 
gency and a Maoist-imposed blockade 
of the Kathmandu valley in August 
2004 made international headlines. 
Political parties calling for a return to a 
democratically elected government 
(dissolved by the king in 2002) fre¬ 
quently stage demonstrations and call 
for strikes. In addition to delaying 
patient transport, the protests can 
directly affect a patient’s health as 
well—on one occasion police threw 
tear gas into a hospital because politi¬ 
cal agitators had fled there. 
Later in the afternoon a frantic call 
came from Mrs. Paddington, whose hus¬ 
band worked for a British development 
agency. Her 4-year-old daughter Daisy 
had stuck a bead deep into her right nos¬ 
tril. Daisy was more preoccupied with 
the toys in the waiting room than the 
commotion that her action had caused. 
After a few unsuccessful attempts at 
blowing the bead out (by pinching off 
the opposite nostril and exhaling into the 
child’s mouth, a task assigned to Daisy’s 
Swayambhunath, a center of Buddhist thought 
on a hill overlooking Kathmandu, is also known 
as the “monkey temple,” because of the wild 
monkeys that live nearby. 
mother), I used forceps to retrieve a 
bean, rather than a bead. Mom had no 
idea where the bean came from, and 
Daisy denied putting anything up her 
nose. After a scolding from mom and a 
sticker from the nurse, she skipped hap¬ 
pily out of the clinic. I then headed 
home on my bicycle. 
It takes me about 15 minutes to 
ride home. I live in a quiet residential 
neighborhood a few blocks from the 
prime minister’s residence. On the 
rare days when the air is unpolluted 
and the skies are crystal dear, I can see 
the Himalayas from the second floor 
of my house. The traffic in Kathmandu 
is a tangle of bicycles, motorcycles, 
tempos (local three-wheeled transport), 
cars and buses, all negotiating the con¬ 
gested streets. Vehicles swerve and 
stop without warning to avoid oblivious 
pedestrians, crater-like potholes and 
sacred cows (literally—Nepal is a pre¬ 
dominantly Hindu country). The 
chaotic traffic combined with the nox¬ 
ious pollution frequently tests my 
patience, and one day I found myself 
laughing after I realized I had “road 
rage” from riding my bicycle. 
As I reached my doorstep, the 
telephone rang. A British volunteer 
called to say she had been attacked 
by several monkeys while walking near 
a temple. The attack was unprovoked 
and, interestingly, the woman’s two 
friends were unmolested. She had sev¬ 
eral scratches on her legs and was 
frightened about contracting rabies. 
Rabies is endemic in Nepal and mon¬ 
keys are potential reservoirs. Because 
she had not been immunized, she 
required human rabies immune globu¬ 
lin along with a series of five vaccina¬ 
tions over four weeks. 
“Not your typical day back home,” 
I mused. However, as I thought about 
what I had seen that day, something 
was bothering me. Most of the prob¬ 
lems were preventable—mumps is 
rare in the United States due to rou¬ 
tine immunizations; better sanitation 
and a safe water supply would prevent 
much of the diarrhea in Nepal; Sherpa 
would not have contracted malaria 
had he taken prophylaxis; and the vol¬ 
unteer’s risk of rabies and her anxiety 
about it would have been alleviated 
had she been vaccinated prior to com¬ 
ing to Nepal. As for the bean in the 
nose ... well, I’ve seen that back home 
and I suppose there’s no way to curb 
a child’s curiosity, ym 
Johnnie Yates, m.d. ’95, recently took a position 




















As long as humans have waged war, the horrors of the 
battlefield have caused psychological damage. Since 
the war in Vietnam, this damage has had a new name- 
post-traumatic stress disorder. 




















24 The unseen wounds of war 
111 but one of the 12 veterans 
sitting around the plastic laminate conference table appear 
worn and tired. Their world-weary look comes from decades 
in which, among them, they shot heroin, smoked and 
drank too much, wasted years in jail, picked fights, gambled, 
divorced and shuttled from job to job. They all fought in 
Vietnam, and more than 30 years later, as they enter their 
late 50s and early 60s, they are still paying the price. 
Except for Luke. The former Marine is only 24 years 
old, 18 months back from Iraq, and he looks good. Blond, 
fit and handsome, he could model for a recruiting poster. 
But he has joined the other veterans in a United Way meet¬ 
ing room in Meriden, Conn., because he is hurting, too. 
If someone yells at him, he'll yell back, or worse. If someone 
steps into his bedroom, he’ll smell the alien scent hours 
later. If someone touches him when he’s sleeping, he’ll 
attack. Thunderstorms scare him. In the months after 
returning from war, he went to bars, got drunk and picked 
fights with strangers nearly every day. 
Luke provides a sense of purpose for the other vets. 
Guided by 57-year-old social worker and Vietnam veteran 
James J. Gavin, m.s.w., the older men talk about their own 
problems over coffee and doughnuts this morning. All, 
including the social worker, have been diagnosed with post- 
traumatic stress disorder (ptsd). For these men, the psycho¬ 
logical and physiological adaptations that helped them 
to survive war persisted at home. Veterans traumatized by 
war—or people distressed by an event in which they fear 
death or great harm to themselves or others—suffer from 
ptsd if they meet three criteria: re-experiencing, hyperarousal 
and avoidance. That is, people with the disorder unwillingly 
revisit traumatic events in flashbacks or nightmares: they are 
hypervigilant, feeling irritable about trivial frustrations, con¬ 
stantly scanning a room or a street for danger, seeming 
to sleep with one eye open; and they retreat from life and 
relationships because they feel emotionally numb or because 
they hope to avoid situations that trigger bad memories. 
Gavin has helped the Vietnam veterans at the table to 
understand, after all these years, that they have not been mess¬ 
ing up their lives simply because they have bad memories of 
Vietnam, but rather because their brains have been changed 
by war. The changes that helped them to survive Vietnam have 
made their lives back home a kind of purgatory, from the 
aisles of Stop & Shop to the family dinner table. The men gen¬ 
erally took decades to realize that they had ptsd. 
Gavin recognized that Luke had ptsd shortly after 
Luke came home in July 2003 after five months in Iraq. They 
met when Luke stopped by the Vet Center in West Haven, 
Conn., a community center sponsored by the Department of 
Veterans Affairs (VA), to ask about college money. During 
several conversations about benefits, Gavin tried to assess 
whether Luke had ptsd. He already knew from his Vietnam 
experience that many veterans come home with ptsd; a 
landmark study in 1988 showed that one in three men who 
served in Vietnam would experience ptsd. Gavin saw it in 
Luke and persuaded him to join the therapy group in the 
winter of 2004. 
One of the men explains why he is glad Luke is 
among them. “It helps us share our experience dealing with 
this for 30 or more years,” says Vincent, a slight man with 
gold-rimmed glasses and curly black hair who looks like 
a professor and spent a year in a homeless shelter. “Luke has 
the advantage of all this wealth of understanding. We didn’t 
have any of this.” 
They talk mostly about feeling rage. Joe tells his story 
first. His huge, muscular arms are covered with many-colored 
tattoos, and he wears a T-shirt that reads: “When it absolutely, 
positively, has to be destroyed overnight: U.S. Marines.” He 
describes the time that an elderly woman banged her super¬ 
market shopping cart into his. Once. Twice. The third time, 
James Gavin was diagnosed with post-traumatic stress disorder 
after fighting in Vietnam. Now a social worker, he leads other veterans 
in discussions of their problems. 
Joe overturned the woman’s cart and kicked her groceries 
across the floor. After security guards ejected him from 
| the store, he rushed to his car and drove away. “I felt terrible, 
j This poor lady just ran into me a few times.” I “You can’t help it,” explains Craig, a mild-mannered 
man wearing glasses and a red sweatshirt. Vincent adds: 
■ “You have a sense of being attacked.” 
“You wake up one day and you’re out of toothpaste, 
and you want to nuke the whole neighborhood," says Bob. 
He says that driving brings out anger in all the men at the 
table. But nowadays, says Bob, he stays a bit calmer when 
other drivers cut him off on the highway. “I’ve gotten better," 
he says with a wry smile. “I don’t chase them to their 
doorsteps any more.” 
Luke is making progress, too, even though he went to 
1 the emergency room recently after he became angry at his 
1 brother and slammed his fist through a door. 
“You’re doing better,” Gavin tells him. “Six months 
; ago you would have hit him.” 
The 12 men around the table speak of rage and 
regret, of wasted years. But toward each other, they express 
compassion. With Gavin’s help, these men are going to 
take care of Luke. 
A malady with roots in ancient times 
| The deep psychological wounds of war have been docu- 
f mented since the time of Homer in ancient Greece. His 
account of the Trojan War tells of Achilles’ disintegration fol¬ 
lowing the battlefield death of his best friend. The psycho¬ 
logical impact of war was called “nostalgia” during the Civil 
War and “shell shock” in World War I. But it was not until 
1980 that the military and medical establishments in the 
United States formally recognized the damage done by com¬ 
bat stress. The age-old psychiatric illness is now called ptsd. 
A Yale psychiatrist was one of the first clinicians in 
li the nation to recognize a distinctive set of symptoms related 
l to the Vietnam War. Arthur S. Blank Jr., m.d., hs ’65, who 
■; practices psychoanalysis and psychiatry in Bethesda, Md., 
had spent a year in Vietnam working in hospitals in Long 
Binh and Saigon after finishing his Yale psychiatry resi¬ 
dency. Soon after the war ended, Blank reviewed the charts 
1 of 60 Vietnam veterans and concluded that many had been 
misdiagnosed with maladies ranging from alcoholism to 
schizophrenia. Blank invited those men to a therapy group 
at the veterans hospital in West Haven, Conn., now called 
the VA Connecticut Healthcare System. That was in 1973, 
1 the year that most of the remaining American soldiers came 
home from Vietnam; the ptsd diagnosis would not be 
included in the American Psychiatric Association’s diagnos- 
! tic manual for seven more years. 
“Very early on, West Haven became a center where they 
really understood ptsd,” says Steven M. Southwick, m.d., 
hs ’85, professor of psychiatry, who does research at the West 
Psychiatrist Steven Southwick studies the 
neurobiology of stress responses. 
Haven VA hospital. Other clinicians nationwide also began to 
notice the distinctive effects of war trauma that Blank had 
observed, and by the late 1970s, mental health professionals 
united to push for the official definition of ptsd. 
Soon after, Yale endocrinologist John W. Mason, m.d., 
now professor emeritus of psychiatry, showed that the 
behavioral changes of ptsd had neurobiological correlates. 
Combat veterans with ptsd had elevated levels of stress 
hormones such as noradrenaline and adrenaline. 
“This was a giant step,” says Southwick, “because 
people began to understand that there was a biological basis 
to many of the 'psychological responses’ they were seeing 
in people who were severely traumatized.” 
Since then, Yale investigators at the VA have remained 
at the center of ptsd research and have helped improve 
the care of returning veterans nationally; West Haven is 
home to the Clinical Neurosciences Division of the VA 
National Center for ptsd, whose other divisions are located 
in Massachusetts, Vermont, California and Hawaii. Yale 
researchers have found that veterans with ptsd not only 
undergo changes in stress hormone levels but may also have 
hyperreactive sympathetic nervous systems; exaggerated 
increases in heart rate and blood pressure; and reductions in 
the volume of the hippocampal region of the brain, which 
is critical for memory and learning. 
Yale researchers are studying the neurobiology of 
ptsd from several vantage points. John H. Krystal, m.d. ’84, 
fw ’88, the Robert L. McNeil Jr. Professor of Clinical Phar¬ 
macology, is working with Robert A. Rosenheck, m.d., 
hs ’77, professor of psychiatry, to study whether the antipsy¬ 
chotic medication risperidone helps veterans who don’t 
respond to antidepressants like Prozac and Zoloft. Krystal is 
planning to investigate whether genetic factors influence 
how people respond to these antidepressants. C. Andrew 



















26 The unseen wounds of war 
has worked with the military to study how military person¬ 
nel respond to severe stress. He found that personnel who 
responded best to stress had elevated levels of neuropeptide 
Y, a brain chemical linked to stress. 
Southwick, who is deputy director of the Clinical 
Neurosciences Division of the national VA ptsd center, is 
taking part in another ptsd study. The study is a collabo¬ 
ration with Deane E. Aikins, ph.d., assistant professor of 
psychiatry, and Maj. Paul M. Morrissey, m.d., fw ’00, 
hs ’02, a psychiatrist and chief of behavioral health at Fort 
Drum in upstate New York. Using functional mri scans, 
they are charting variations in brain function between con¬ 
trols and veterans diagnosed with ptsd. Southwick says that 
studying the neurobiology of stress responses—and finding 
a physical manifestation of a psychological problem—had 
helped clinicians to understand ptsd better. “Before, it was 
all interpreted psychologically,” he says. 
Depression and an adrenaline rush 
Since October 2001, more than 1.1 million men and women 
have served in Iraq and Afghanistan, according to the 
Department of Defense. A research team at the Walter Reed 
Army Institute of Research reported in the July 1, 2004, 
issue of The New England Journal of Medicine that nearly one 
in six Iraq veterans and one in nine Afghanistan veterans 
suffered from ptsd, major depression or generalized anxiety. 
Such studies provide the best window into ptsd rates, 
because according to Defense Department physician Michael 
E. Kilpatrick, m.d., “the Department of Defense would 
only know of those service members who reported problems 
and sought a diagnosis.” And many do not report their dis¬ 
tress: in the Walter Reed study, between 60 and 77 percent 
of the study participants who had a mental disorder did not 
seek help. 
The most exposed of those fighting in Iraq and 
Afghanistan may be members of the Reserve and National 
Guard, which make up 35 percent of those deployed, notes 
Morgan. They are vulnerable, he says, because Reservists 
and National Guard members generally have less training 
than do full-time troops. He notes that the high rate of 
redeployment in the wars in Iraq and Afghanistan hurts 
morale and increases burnout; by last summer, 280,000 
of the 1.1 million had gone back, according to the Depart¬ 
ment of Defense. 
Blank agrees that redeployment can intensify harm: 
returning for a second tour worsened ptsd for troops 
who served in Vietnam. “There’s some evidence that it has 
something to do with addiction to the adrenaline rush, 
which may have a physical as well as an emotional compo¬ 
nent." (As one Connecticut veteran of Iraq described it, 
“Nothing can compare to it when you come home. Every¬ 
thing is boring. You can’t but be drawn into that intensity. 
Everyone I’ve talked to feels the same way.”) 
The effects of trauma can last a long time. The con- 
gressionally mandated Research Triangle Institute study in 
1988 that compared 1,625 Vietnam veterans with 750 other 
veterans and 750 civilian counterparts found that 15 years 
after the war’s end, 15 percent of male veterans and 9 per¬ 
cent of female veterans were suffering from ptsd. This com¬ 
pares to a rate of about 1 percent of the general population. 
For those fighting in Iraq and Afghanistan, Blank pre¬ 
dicts that the changing character of the wars will increase 
the rates of psychological trauma. “Unfortunately the situa¬ 
tion in both combat zones is one of general terror,” says 
Blank. “There are no safe places, and as the guerrilla fighters 
know all too well, it’s highly psychologically debilitating to 
have random terror.” Blank notes that anecdotal reports sug¬ 
gest that at least some troops think the war is unjustified, 
and for those men and women “the questionable character 
of the war in all likelihood will contribute to the occurrence 
of ptsd, because there is not the buffering factor of feeling 
that despite the difficulties one has encountered, there is 
at least a sturdy justification for what one has experienced.” 
Blank points out one “good-news aspect” of the situa¬ 
tion: Reservists and National Guard members tend to be older 
than full-time service members, and age protects against ptsd. 
The most vulnerable to the disorder are 18- and 19-year-olds. 
Another positive aspect is that now veterans can get care 
much more quickly than did Vietnam vets. But the majority 
of veterans have historically shunned care. They avoid it in 
part because society stigmatizes people with ptsd, says Blank, 
who helped to establish and then directed the VA network of 
Vet Centers like the one that employs Gavin. The community- 
based counseling centers now number 206 nationwide. 
Military officials are working against the stigma, 
according to Fort Drum’s Morrissey. He says that troops 
leave for war knowing that psychological distress is normal 
and that, even in a war zone, the military will provide 
support. That’s a big change from the military’s approach 
during the Vietnam War. 
“The main thing that’s changed is that now the pos¬ 
sibility of combat stress and other mental health problems, 
including ptsd, is mentioned up front,” says Morrissey. 
He says that this kind of openness is helpful, because men 
and women anticipating combat inevitably worry about 
what will happen if they fall apart. They ask themselves: 
‘“What if I am really scared? What if I lose it when I’m 
there?’ They’re all thinking about this stuff,” says Morrissey. 
He and his staff train soldiers how to recognize problems 
not only in oneself but also in others. “If they can be looking 
out for someone else, that helps them regain some mastery.” 
Making it clear that those with problems will get support, 
says Morrissey, “lets them push themselves a little further.” 
Those who do have trouble coping can seek help from 
“combat stress control teams.” Stationed in the war zones, 
the teams are composed mostly of mental health specialists 
Social worker Susan Hill helps veterans with their re-entry to civilian life. 
1 who have completed basic training and then spent eight 
months studying emergency medicine and mental health 
i care. They are backed by psychologists, psychiatrists and 
social workers. The combat stress control teams offer those 
< in distress a short break and medication, if necessary. Once 
i symptoms are mitigated, the service members return to their 
posts. As Luke describes it, the goal of a battlefield psychiatric 
i evaluation is to find out: “Are you fit to pull the trigger?” 
Finding help at home 
Once home, veterans can seek help at a VA hospital or a VA 
Vet Center, says Dolores Vojvoda, m.d., assistant professor 
of psychiatry at the medical school and head of the ptsd and 
: anxiety disorder service at the West Haven VA. Vojvoda says 
some veterans are referred by VA physicians but most call 
the VA for help on their own. The West Haven staff includes 
| five part-time psychiatrists, a psychologist, three social 
! workers, a registered nurse and three advanced-practice 
! mental health nurses. 
Vojvoda reported that by mid-summer, therapists in 
the ptsd clinic at the West Haven VA hospital had seen 
about 50 Iraq and Afghanistan veterans. She expected the 
numbers to grow, and the VA had recently awarded 
Vojvoda’s group a grant to hire a new psychiatrist and two 
more social workers in anticipation of an influx of combat- 
I ants returning with ptsd and anxiety disorders. 
The VA staff provides both individual and group 
therapy. In the groups, veterans learn about the symptoms of 
f ptsd and how to manage them. Treatment may also include 
j antidepressants, sleeping pills, antipsychotic medication for 
intrusive memories and anger, and alpha blockers for night¬ 
mares and exaggerated startle reflex. The VA also offers pro¬ 
grams to help veterans recover from alcohol and drug abuse, 
common mechanisms for coping with ptsd. 
Group and individual therapists at VA hospitals often 
treat patients using cognitive processing therapy, a technique 
developed in the 1980s for rape survivors. Patients are asked 
to focus on a traumatic event and to examine whether they 
have interpreted it realistically. For instance, a soldier may 
take the blame for a bad event, but the idea of fault implies 
some control over what happened. In reality, he or she may 
have been powerless to prevent what happened. The therapy 
also addresses overgeneralizations, such as when a person 
harmed by another concludes that no one can be trusted. 
Therapists counseling returning service members face 
a paradox because so many returnees must go back to war. 
Susan R. Hill, m.s.w., assistant clinical professor of psychia¬ 
try (social work) at the medical school and a social worker at 
the West Haven VA hospital, worries about helping those 
with ptsd relax their vigilance if they are to be returned to a 
combat zone where they will once again need to be hyper- 
vigilant. “It’s a really questionable outcome at the moment 
for the ones going back.” 
Joining a group is difficult for those with ptsd, 
since avoidance and withdrawal are hallmarks of the disor¬ 
der. Nonetheless, says Hill, “We are convinced that there’s 
tremendous benefit in being around folks who are dealing 
with re-entry.” She notes that many veterans withdraw from 
other people, “and then they’re pretty much isolated in their 
own heads, as we all are when we are alone, only their heads 
are full of carnage. ... The opportunity to speak with other 
people who are having trouble with re-entry breaks down the 
military ‘strong-men-dorit-cry’ theory.” 
Luke, for one, is doing better. “You learn when you 
are in danger of getting set off, and you learn to avoid any 
kind of stress, any situation where you’re going to get set 
off,” he says. 
At the restaurant where he works as a cook, the boss 
yells at other employees—but not at Luke. “I told him when 
I got hired: ‘You can’t yell at me.’ ” 
He told his girlfriend: “If I hit you in my sleep, I’m 
really sorry. If I hit you hard, I'm really, really sorry. If 
I’m screaming, get out quick.” So far the two have co-existed 
peacefully in bed. 
Although he finished his military service more than 
two years ago, Luke still toys with the idea of going back to 
war. He is attracted by “the rush that was associated with it. 
When things start going bad here, I think, ‘The hell with it, 
I’ll go back.’” 
Instead, Luke has enrolled in college. He wants 
to emulate James Gavin and become a social worker. 
“I look at the way I was before I met Jimmy and how much 
better I am now, and I think it’s a rewarding job to help 
somebody with what they’re going through. ... He’s been 
through the same shit I’ve been through, and he was 
my age when he did. He was in a bad place, and he pulled 
himself out. Now he’s helping other people.” ym 






















back of polio 
In the 1940s, Yale’s Dorothy Horstmann 
solved a puzzle that would lead to the first 
polio vaccines 50 years ago this year. 
by David M. Oshinsky, ph.d. 
Fifty years ago this year, following the largest public health 
trial in American history, a killed-virus polio vaccine 
developed by Jonas Salk, m.d., was found to be safe, potent 
and effective. The news set off a national celebration. Salk 
became an instant hero, the country’s first celebrity-scientist, 
a miracle worker in a starched white lab coat. But as the 
years passed, the essential contributions of other researchers 
to this lifesaving vaccine were lost to history. Dozens of 
men and women had been involved—at Harvard and Yale, at 
Johns Hopkins and the Rockefeller Institute for Medical 
Research, at the University of Michigan, the University of 
Pittsburgh and the University of Cincinnati. What follows is 
the story of Dorothy Millicent Horstmann, m.d., fw ’43, 
Patients stricken with the most 
severe form of polio were confined 
to iron lungs, such as those seen 
in this ward at Haynes Memorial 
Hospital in Boston in August 1955. 
above Dorothy Horstmann, in 
her laboratory in the 1970s, was 
the first woman to become a full 




















30 Breaking the back of polio 
The national trial of the Salk 
polio vaccine began in 1954, 
when Richard Mulvaney gave 
an injection to Randy Kerr at 
Franklin Sherman Elementary 
School in McLean, Va. 
whose patience and intuition produced a stunning break¬ 
through that made polio vaccines possible. 
The story begins in June 1916, with a health crisis in 
Pigtown, a densely populated immigrant neighborhood of 
Brooklyn, N.Y. Frightened Italian parents had approached local 
doctors and priests, according to news accounts, “complaining 
that their child could not hold a bottle or that the leg seemed 
limp.” When the first deaths followed a few days later, health 
department investigators rushed to Pigtown for a house-to- 
house inspection. All signs pointed to a disease known as 
infantile paralysis, or poliomyelitis (soon shortened to “polio” 
by the newspapers to save headline space). As it spread from 
Brooklyn, communities across the Northeast closed their 
doors to outsiders, using heavily armed policemen to patrol 
the train stations and the roads. The epidemic, which lasted 
through October 1916, claimed 6,000 lives and left 27,000 
people paralyzed. New York City alone reported 8,900 cases 
and 2,400 deaths, 80 percent of the fatalities being children 
under 5. There had been minor polio outbreaks in previous 
years, but nothing like this. 
“The menace for the future,” warned a federal health 
official, “is very real.” 
Polio is an intestinal infection spread by contact with 
fecal waste. The virus enters the body through the mouth, 
travels down the digestive tract and is excreted in the stool. 
Usually the infection is slight, with minor symptoms. In 
a small number of cases—about one in 100—the virus 
invades the central nervous system, destroying the motor 
neurons that stimulate the muscle fibers to contract. At its 
worst, polio causes irreversible paralysis, most often in the 
legs. Most deaths occur when the breathing muscles are 
immobilized, a condition known as bulbar polio, in which 
the brain stem is badly damaged. 
Though poliovirus has long been present in the envi¬ 
ronment, the disease, unlike smallpox or influenza, had trig¬ 
gered no major outbreaks around the world. Why it took root 
in Western nations, especially the United States, during the 
20th century is still a matter of debate. Some researchers 
pointed to more careful reporting and better diagnostic tech¬ 
niques. Others noted the circulation of more virulent strains 
of poliovirus, capable of multiplying at a ferocious rate. Still 
others saw a correlation between the spread of polio and the 
ever-increasing standards of personal hygiene in the United 
States—people were less likely to come into contact with 
poliovirus early in life when the infection is milder and mater¬ 
nal antibodies offer temporary protection. Put simply, Ameri¬ 
ca’s antiseptic revolution brought risks as well as rewards. 
A dread disease strikes at random 
By mid-century, polio had become the nation’s most feared 
disease. And with good reason. It hit without warning. 
It killed some victims and marked others for life, leaving 
behind vivid reminders for all to see: wheelchairs, crutches, 
leg braces and deformed limbs. In 1921, it paralyzed 39-year- 
old Franklin Delano Roosevelt, robust and athletic, with a 
long pedigree and a cherished family name. If a man like 
Roosevelt could be stricken, then no one was immune. 
Each June in America, like clockwork, came news¬ 
paper photos of jam-packed polio wards and eerily deserted 
beaches. Newspapers ran tallies of the victims—age, sex, 
type of paralysis—akin to baseball box scores. Children were 
warned not to jump into puddles or share a friend’s ice 
cream cone. Parents checked for every known symptom: a 
sore throat, a fever, the chills, nausea, an aching limb. Some 
gave their children a daily "polio test.” Did the neck swivel? 
Did the toes wiggle? Could the chin reach the chest? 
In truth, polio was never the raging epidemic por¬ 
trayed by the media, not even at its height in the late 1940s 
and early 1950s. Ten times as many children would be 
killed in accidents in these years, and three times as many 
would die of cancer. What had changed following World 
War II was the incidence of polio in the United States as well 
as the rising age of the victims, a quarter of whom were now 
older than 10. From 1940 to 1944, reported polio cases dou¬ 
bled to eight per 100,000, doubled again to 16 per 100,000 
between 1945 and 1949, and climbed to 25 per 100,000 from 
1950 to 1954, before peaking at 37 per 100,000 in 1952. 
“The United States had never experienced a higher crest of 
the epidemiological wave,” a journalist noted of the 57,000 
reported cases that year, “and never would again.” 
The drive to combat polio was led by the National 
Foundation for Infantile Paralysis, now known as the March of 
Dimes. The genius of this foundation lay in its ability to single 
out polio for special attention, making it seem more ominous, 
and curable, than other diseases. Its strategy would revolution¬ 
ize the way charities raised money and penetrated the world 
of medical research. Millions of foundation dollars would be 
spent to set up virology programs and polio units across the 
below During World War II 
Horstmann traveled as a member 
of the Yale Poliomyelitis Study 
Unit to Hickory, N.C., site of one 
of the worst outbreaks in the 
20th century. 
right The March of Dimes 
campaign allowed anyone 
to make a contribution. In the 
1940s the campaign used a 
“dime card” for collections. 
country, with the first grant going to the Yale School of 
Medicine in 1936. Although research funding went in many 
directions, one point became increasingly clear: the best way 
to prevent polio would come through a vaccine. 
This was hardly a revelation. Vaccines already had 
proved successful against other viruses—smallpox and 
rabies being notable examples. But producing a safe and 
effective one against polio would not be easy. Three major 
problems had to be solved. First, researchers would have to 
determine how many different types of poliovirus there 
were. Second, they would have to develop a safe and steady 
supply of each virus type for use in a vaccine. Third, they 
would have to discover the true pathogenesis of polio—its 
route to the central nervous system—in order to fix the exact 
time and place for the vaccine to do its work. 
The first problem took the longest to solve. Dozens of 
e strains were examined, using the stools, throat cultures and, 
in fatal cases, nerve tissue of polio victims. Most of this work 
was done by ambitious young researchers hoping to attract 
e March of Dimes grant money. (The list included Salk at the 
University of Pittsburgh.) As it turned out, all of the 196 
tested strains of poliovirus fit neatly into three distinct types. 
The poliovirus family proved remarkably, conveniently, small. 
A polio vaccine, then, would have to protect against all 
three virus types to be successful. The next step involved the 
harvesting of poliovirus that was safe enough, and plentiful 
enough, for use in that vaccine. At Harvard, John F. Enders, 
ph.d., a Yale College graduate, Frederick C. Robbins, m.d., 
and Thomas H. Weller, m.d., using in vitro cultivation, grew 
poliovirus in non-nerve tissue—a breakthrough that would 
win them the Nobel Prize in physiology or medicine. By 
cultivating these viruses in a test tube, rather than in the 
brain or spinal column of a monkey, researchers could get a 
better look at the changes occurring in polio-infected cells. 
Far more important, a safe reservoir of poliovirus had now 
been created, free from the contaminating effects of animal 
nerve tissue. And that, in turn, made possible the mass 
production of a vaccine. 
But a major problem remained to be solved. Though 
Albert B. Sabin, m.d., and others had speculated that 
poliovirus entered the body through the mouth and worked 
its way down the digestive tract, no one had yet discovered 
traces of the virus in the victim’s bloodstream. How, then, 
did it wind up in the central nervous system? The answer 
would come from a research laboratory at Yale. 
A girl’s impossible dream in a world of men 
Horstmann had a powerful fantasy as a child: she imagined 
herself as a doctor. Born in Spokane, Wash., in 1911, she 
grew up in San Francisco, where as a teenager she accompa¬ 
nied a physician friend of the family as he made his rounds 
through the local hospital. Earning her undergraduate 
(1936) and medical (1940) degrees from the University of 
California, San Francisco, Horstmann recalled that it had 
“never crossed my mind that [this] was in any way unusual 
for a woman. ... It was quite natural.” 
In 1941, Horstmann applied for a residency at 
Vanderbilt University Hospital in Nashville, where the 
chief of medicine, Hugh Morgan, m.d., had a strict policy 
of choosing only men. “I got back a polite letter, saying 
no,” she recalled in an unpublished interview with histo¬ 
rian Daniel J. Wilson, ph.d., of Muhlenberg College in 
Pennsylvania. “I wasn’t exactly crushed, but I was disap¬ 




















32 Breaking the back of polio 
below Celebrities joined in the 
campaign against polio. In 1954 
actress Grace Kelly distributed 
March of Dimes literature to lead¬ 
ers of the Mothers’ March on Polio. 
enter private practice in San Francisco, she received a note 
from Morgan asking if “Dr. Horstmann” was still inter¬ 
ested. She was, indeed. Somehow, Morgan had forgotten 
that Dr. Horstmann was a woman. Horstmann later 
learned from his secretary that when Morgan discovered 
his error, he “all but went into shock. ... But we became 
friends, and I had a very good year there.” 
When Horstmann subsequently applied for a post¬ 
doctoral fellowship at Yale, her first visit to New Haven did not 
go well. She had hoped to study with John R. Paul, m.d., a 
young pathologist who had co-founded the Yale Poliomyelitis 
Study Unit in 1931 with James D. Trask, m.d. As luck would 
have it, Paul had been called away to study a polio epidemic, 
leaving Horstmann to meet with Francis G. Blake, m.d., the 
acting dean. A giant in the field of infectious disease who 
was known to generations of medical students as “stuffy and 
remote,” Blake couldn’t quite picture Horstmann at Yale. 
Indeed, she recalled, he “went on to tell me how the last 
woman he had on the house staff did something awful.” 
Offended, and blissfully ignorant of the dean’s imposing repu¬ 
tation, she replied that “if a woman on the house staff did not 
live up to expectations it was remembered for the next 50 
years, but if the person was a man, it was forgotten by the next 
year.” Horstmann was told the decision would be up to Paul. 
“He accepted me,” she said, “and that is how it all began.” 
In 1942, with World War II under way, she arrived at 
Yale. As head of the Commission on Neurotropic Virus 
Diseases of the Army Epidemiological Board, Paul was con¬ 
stantly traveling to remote parts of the world. Concentrating 
on the spread of polio among Allied troops in North Africa, 
Paid confirmed the theory that adults from areas with high 
sanitary standards, such as Western Europe and the United 
States, were far more susceptible to the disease than the 
local population, which had built up immunity following 
generations of exposure. 
In New Haven, Horstmann joined the Yale polio 
unit. Missing its two founders—Trask died of a bacterial 
infection in 1942 while working at an Army camp—the 
ranks included a handful of superb researchers, such as 
Joseph L. Melnick, m.d., and Robert Ward, m.d. Using an 
approach pioneered by Paul and known as “clinical epi¬ 
demiology,” the polio unit, including Horstmann, tracked 
polio epidemics in Connecticut, Illinois, New Jersey, west¬ 
ern New York state and Hickory, N.C., site of one of the 
worst outbreaks of the 20th century. The unit tested water 
and sewage, trapped flies and other insects and took blood 
samples from those who had the disease and those without 
symptoms, hoping to discover both the route of poliovirus 
through the body and the manner of transmission from 
one person to another. For Horstmann, who had come to 
Yale to study Streptococci, the switch to polio was inspiring. 
“It had a dramatic immediacy,” she said. “When you deal 
with an epidemic you realize it’s an urgent thing. There 
was so much to be learned.” 
Tracking polio’s pathogenesis 
Like others in the polio group, Horstmann combined her 
clinical studies with laboratory research. During a polio 
epidemic in New Haven in 1943, she collected blood speci¬ 
mens from every patient admitted to the hospital with symp¬ 
toms of the disease—hi in all. Only one tested positive for 
poliovirus, a little girl with minor neck pain. Was it possible, 
Horstmann wondered, that poliovirus was only present in 
the bloodstream during the brief period before a victim took I 
sick and the physical symptoms became apparent? 
To test this theory, she began a series of experiments 
on monkeys, feeding them poliovirus by mouth to determine 
if, and when, it turned up in their blood. The results were 
dramatic. Poliovirus was detected within days of the feed- 
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below left Braces and the 
iron lung became symbols of the 
feared disease. The epidemic 
reached its peak in the early 1950s, 
climbing to 37 cases per 100,000 
in 1952. 
BELOW RIGHT This 1953 
cartoon offered simple instruc¬ 
tions for avoiding poliovirus. 
ings. Why had so many others failed to discover this? The 
answer was deceptively simple: they had waited too long 
| before looking. Horstmanrfs discovery, published in 1952, 
would pave the way for both the Salk killed-virus polio vac- 
i cine and the Sabin live-virus polio vaccine. 
Working independently at Johns Hopkins, researcher 
David Bodian, ph.d., m.d., later reported almost identical 
results. When poliovirus enters the blood, it creates the 
very antibodies that will soon destroy it, wiping away the 
:j! signs of its existence. Horstmann had determined the time 
(early in the infection) and the place (the bloodstream) for 
the battle against polio to be waged. Her findings meant 
that an immunizing vaccine, packing low levels of anti¬ 
body, could destroy the virus before it entered the central 
.nervous system. In a personal letter to Horstmann in 1953, 
John F. Fulton, m.d., d.phil., Yale’s distinguished histo- 
rian of medicine, proclaimed: “This disclosure is as excit¬ 
ing as anything that has happened in the Yale Medical 
School since I first came here in 1930 and is a tremendous 
credit to your industry and scientific imagination. ... It is 
; also medical history.” 
1! 
That history would continue. In 1959, the World 
Health Organization sent Horstmann to the Soviet Union, 
Czechoslovakia and Poland to evaluate the massive public 
health trial involving Sabin’s oral polio vaccine. Her favorable 
report led the way to its licensing, and widespread accept¬ 
ance, in the United States and beyond. Worldwide the inci¬ 
dence of polio fell to 1,919 cases in 2002, a decline of 99 
percent since 1988, when 350,000 cases were reported. The 
United States has not seen a case of wild polio since 1979. 
In later years, Horstmann became the first female 
professor of medicine at Yale (1961), the first woman in the 
university to hold an endowed chair (1969) and an elected 
member of the National Academy of Sciences (1975). 
Horstmann died in 2001. Today her portrait hangs 
at the School of Medicine in a gallery of luminaries from the 
19th and early 20th centuries. She is the only woman hon¬ 
ored on these walls, ym 
David M. Oshinsky, ph.d., the George Littlefield Professor of American 
History, University of Texas at Austin, is the author of Polio, An American 
Story: The Crusade That Mobilized the Nation Against the 20th Century’s 
Most Feared Disease, published this year by Oxford University Press. 
POLIO 
PRECAUTIONS 
Gamma Globulin—obtained from hu¬ 
man blood—gives protection for a few 
weeks. However, it is in VERY SHORT 
SUPPLY. 
A vaccine is not ready for 1953. But 
there is hope for the future. 
Meanwhile—when polio is around— 
follow these PRECAUTIONS. 




Dean Robert Alpern has spent his 
first year at Yale getting to know 
the medical school and bringing 
the faculty together in a strategic 
planning process. 
A year at the helm 
Since he arrived at Yale in 2004, Dean Robert Alpern has led faculty to a new vision of 
the medical school, with a focus on clinical expansion and the application of great science. 
By Michael Fitzsousa 
It’s 8 a.m. on a Wednesday morning in late July, and Robert J. 
Alpern, m.d., has assembled his senior leadership group for 
its weekly meeting. About halfway through today’s agenda, 
the five people at the table are discussing options for an elec¬ 
tronic medical record, or emr. The computer-based patient 
chart is becoming a must-have in medicine’s transition to the 
digital age. Computerized record-keeping lessens the likeli¬ 
hood of a mistake being made—preventing a medication 
from being prescribed at a dangerous dosage, for example, 
or ordered for an allergic patient. It also holds promise for 
clinical researchers hunting for patterns in the illnesses, 
interventions and outcomes of patients, to determine which 
treatments work best for which groups of individuals. 
The problem is that the medical school and its affili¬ 
ated practice and hospitals do not yet share an emr or a data 
repository, the computerized warehouse where data from 
medical visits, tests and surgical procedures are stored. There 
are competing software products, a still-shifting technology 
platform, major costs to implement and maintain a system 
and many questions remaining about how to get doctors to 
adapt to new ways of charting patient information and order¬ 
ing drugs and tests. A central dilemma, Alpern notes, lies in 
the trade-off between ease of use and specificity: the systems 
that are most practical for physicians are the least useful for 
researchers, while those that standardize data entry in a way 
that makes sense for research are unwieldy for busy doctors. 
This issue is just one of eight or nine broached at 
today’s weekly meeting, unusual in that the agenda is fairly 
short. Some weeks it grows to as many as 25 or 30 items, all 
of which need to be moved forward during the three-hour ses¬ 
sion. Today’s topics include the potential reorganization of 
one of the academic departments, planning for a new center 
for clinical research, two or three new fund-raising opportuni¬ 
ties, a review of the medical school’s website, the retreat for 
department chairs in the fall, a proposal for a student-run free 
clinic and renovations to the school’s day care facility. Alpern, 
a nephrologist and Ensign Professor of Medicine, moves 
things along but allows the discussion to meander enough to 
pull in many points of view. From time to time, he takes an 
index card out of his shirt pocket and jots down a few words 
on the back of his schedule for the day. 
The talk eventually leads to the perennial space crunch 
at the medical school and the constant juggling of lab, office, 




















36 A year at the helm 
institution of 1,787 full-time faculty members, 1,150 students 
and more than 3,000 full-time employees. Two years ago 
the 457,000-square-foot Anlyan Center opened on Congress 
Avenue, and a new, smaller building on Amistad Street is 
almost complete, but still there is not enough room for new 
programs and people. Space is at such a premium that 
Alpern holds a weekly meeting to work on the ever-changing 
puzzle. “Everything is so dependent on facilities, and you 
view but is enough of a pragmatist to know that a higher rank¬ 
ing will help the school attract the best faculty and students. 
He also has two giant tasks ahead of him: leveraging 
Yale’s formidable strength in the basic sciences to translate 
knowledge about molecules and cells into new ways of treat¬ 
ing illness, and putting those treatments to work in a much 
larger patient base. Yale has long been known as a power¬ 
house in biological science but has not had the same scope 
“Everything is so dependent on facilities, and you always have to think years in advance. 
I still think we’re one building away from where we need to go.” 
always have to think years in advance,” he says. “I still think 
we’re one building away from where we need to go.” 
Before the discussion draws to a close, Alpern excuses 
himself to take a call, a rare interruption of the weekly meet¬ 
ing. As it turns out, the occasion is anything but ordinary: a 
successor to Joseph Zaccagnino, m.p.h. ’70, the president 
and ceo of Yale-New Haven Hospital (ynhh, the school’s pri¬ 
mary teaching hospital and clinical partner), has been named 
and will be announced later in the day. 
Opportunity in New Haven 
Alpern came to Yale the summer before last from the Univer¬ 
sity of Texas Southwestern Medical Center. Dallas is a world 
away from New Haven in its geography, politics, culture and 
climate, but it shares a rich tradition in science with the medi¬ 
cal school. It was a young Yale medical graduate, Donald W. 
Seldin, m.d. ’43, hs '46, who transformed the Southwestern 
campus from a compound of Quonset huts in the 1950s to the 
powerhouse in basic science and medical research that it has 
become. Alfred G. Gilman, m.d., ph.d., the Nobelist who suc¬ 
ceeded Alpern as dean there, is a Yale College alumnus and 
son of one of the Yale pharmacologists who developed the first 
I chemotherapy treatment for cancer in the 1940s. 
Alpern was recruited to Yale not only to lead a world- 
class medical school with an annual budget of more than $750 
million, but also to counter several unsettling trends, includ¬ 
ing a mounting operating deficit ($35 million in fiscal 2004) 
and a general perception that the school was beginning to 
slip in relation to some of its peers. Third in funding to medi¬ 
cal schools from the National Institutes of Health in 1993, 
the school still brings in more than $260 million in federal 
grants, but gradually dropped to eighth place during the 
1990s and early 2000s as other schools were expanding their 
campuses and research capacities. Its ranking in the U.S. 
News ef World Report annual survey of research medical 
schools dropped from third in 1996 to nth this past June. 
Many academicians dismiss the rankings, arguing they lack 
scientific rigor and rely too heavily on subjective assess¬ 
ments—reputation in particular. Alpern understands that 
and depth in clinical practice, despite a handful of subspecial¬ 
ties that attract patients from outside the region, a few of 
them internationally. Alpern wants to expand the medical 
school’s programs in cancer care, cardiovascular medicine, 
organ transplantation and other key areas of practice to raise 
Yale’s profile nationally. 
His honeymoon period as dean may still be in effect, 
but many faculty members are pleased by what he has done 
in his first year. Robert Udelsman, m.d., m.b.a., the Lampman 
Memorial Professor of Surgery and Oncology and chair of 
surgery, says Alpern is “available, approachable and affable, 
and he appears willing to delegate to others and empower 
them.” With the appointment of a new hospital ceo—Marna 
P. Borgstrom, m.p.h. ’79 (See Chronicle, p. 5)—and a new 
dean at roughly the same time, Udelsman says, the medical 
center is presented with an unusual opportunity. 
“Here is the entree for Yale-New Haven Medical Center to 
make a fundamental decision about what it wants to be, whether 
it wants to be the best [medical center] in the world—not just in 
the top 10, but number one,” Udelsman says. “The hospital can’t 
do it alone, and the medical school can’t do it alone.” 
David L. Coleman, m.d., hs ’80, the interim chair of 
the Department of Internal Medicine, says that Alpern worked 
hard during his first year on the school’s relationship with 
ynhh, the recruitment of department chairs and the launch¬ 
ing of a strategic planning process that occupied 70 faculty 
members on three committees from last December until 
August. Throughout the planning process, Alpern dropped in 
on meetings and participated in the discussion, helping guide 
it at times but mostly listening. “I would say the key word to 
my management style is consensus building,” he says. “I don’t 
try to force people to do things. I try to think things out so that 
I have a vision for where we should go, and then I try to build 
a consensus.” 
Planning for the future 
Alpern sees the strategic planning effort, which was shared by 
three committees evaluating basic science, clinical practice anc 
clinical and population-based research, as a major contributior 
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to the healthy functioning of the medical school. (A fourth 
committee has been evaluating the educational mission in a 
separate process.) “Two of the best things that have come out 
of it are communication and the creation of a common sense 
that the institution has a direction," he said in an interview in 
late summer, as the final reports were being circulated among 
the planning groups and edited into final form. “In a univer¬ 
sity, you have each faculty member marching to the beat of 
tive and convenient for patients without dampening the 
entrepreneurial spirit that has driven progress in the special¬ 
ties and subspecialties. 
“The faculty at Yale in general are all excellent doctors, 
but in many cases we don't have enough of them to provide 
good service to our local and more national constituency. In 
addition, we don't have the mechanisms in place to provide 
such service,” Alpern says. Patients should be able, with 
“We need to become a very user-friendly medical center that patients can navigate easily 
and where they can uniformly receive the highest level of care.” 
his or her own drummer, and if you get the best faculty, that 
works. But an institution should also have a sense of direc¬ 
tion, and people felt we didn’t.” 
Among the recommendations to come out of the plan¬ 
ning process was the establishment of large multidiscipli¬ 
nary programs in stem cell biology, cardiovascular medicine, 
;i cancer, genetics and the neurosciences. The planners also 
identified areas of infrastructure that needed strengthening, 
as well as strategic “cores,” or pooled resources, to provide 
the latest technology and expertise to faculty conducting 
'<>' research. One example, discussed at the dean’s group meet- 
\ ing, is a center for clinical and population-based investigation 
bringing together the statisticians, study designers, com¬ 
puter scientists, regulatory professionals and others who are 
essential to the conduct of large studies evaluating new 
i drugs and medical procedures. 
From the basic science committee, the dean received 
recommendations for expanding or starting academic pro- 
!i grams as well as bolstering certain portions of the academic 
ii infrastructure. For example, the group urged expansion 
! of the Combined Program in the Biological and Biomedical 
> Sciences (which has unified graduate education across the 
medical school and central campuses) and investment in ani¬ 
mal facilities, X-ray diffraction equipment for structural 
biologists, laboratories for drug development and testing, 
small-molecule screening systems, RNAi screening (a hot 
technology that promises to identify potential new drug tar¬ 
gets many times more quickly than previous methods) and 
; advanced biomedical imaging. 
The clinical committee focused on even more basic 
infrastructure: mechanisms for improved planning, commu¬ 
nications, marketing and support services, as well as an 
emr and a central scheduling service to standardize the way 
appointments are made. Like many medical schools, Yale saw 
its clinical departments grow quickly in the 1970s, ’80s and 
’90s with an autonomy that would surprise many outsiders. 
For years, each ran its own ship and handled its own schedul¬ 
ing and administrative operations. Now the challenge is to 
make sure the system as a whole works in a way that is effec- 
ease, to make appointments, schedule tests, obtain results, 
see multiple specialists and count on good communication 
among them and their referring physicians—things that can¬ 
not always be taken for granted, Alpern says. “We need to 
become a very user-friendly medical center that patients can 
navigate easily and where they can uniformly receive the 
highest level of care.” 
That task has been entrusted to David f. Leffell, m.d., 
hs '86, the newly appointed deputy dean for clinical affairs, 
who has been the driving force behind the 750-member 
Yale Medical Group since 1996. Other members of the senior 
leadership team are Jaclyne W. Boyden, m.b.a., the deputy 
dean for finance and administration; Carolyn W. Slayman, 
ph.d., the deputy dean for academic and scientific affairs; 
Martha E. Schall, m.b.a., the university’s associate vice presi¬ 
dent for development and director of medical development 
and alumni affairs; Maty J. Hu, m.b.a., the director of plan¬ 
ning and communications; and Julie B. Carter, j.d., an associ¬ 
ate general counsel of the university. 
Alpern cites the formation of the leadership group as 
one of the most important accomplishments of the past 
year. The group provides a structure for dealing with the com¬ 
plex problems the medical school must deal with, the emr 
being just one example from this week’s meeting. “The prob¬ 
lem is, it could be very easy. We could go real fast and do it 
wrong,” he says of the emr process. To make good decisions, 
Alpern does what most corporate ceos would do and works 
closely with a small group of senior leaders in whom he has 
complete confidence, delegating authority to them. There is 
a twist, however. 
“Most people would tell you that you should have 
no more than about six direct reports, and unfortunately, 
that’s where the system breaks down in academics,” he 
says. Such a business model would have the 27 academic 
departments reporting to one of the deputy deans, but 
Alpern says, “I couldn’t stand that model. It removes the 
dean from the academic presence of the medical school, 
and it would frustrate any good chair. Plus it would take 
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parts of the job.” Instead, Alpern meets weekly with his 
core group and at least biweekly with the department 
chairs. If something comes up, he adds, “any chair can get 
on my calendar within a week.” A newly formed dean’s 
advisory group of senior faculty will assist in major deci¬ 
sions affecting the school. In addition, Alpern has sched¬ 
uled regular meetings with the departmental faculty so that 
he visits with each department once a year. 
know is that you’re a professor. I really believe all the tracks 
are equal.” 
Teaching is also of critical importance to the school’s 
future, and Alpern says Yale has one of the best educational pro¬ 
grams in the world. “The Yale System, 1 think, is great, in that it 
allows the students to focus on learning rather than on grades 
and to explore their own unique interests through the thesis. 
It’s just terrific. It’s how you create the leaders of tomorrow.” 
If the bottom line drove every decision and no investments were made, 
it would be a disaster. 
A long commute 
Alpern is married to nephrology researcher Patricia A. Preisig, 
m.s., ph.d., who remained in Dallas for the first year of his 
deanship, while their daughter, Rachelle, finished high school 
(she entered Yale as a freshman this September, and their 
son, Kyle, is a sophomore at the Hopkins School in New 
Haven). Alpern spent the first year commuting home on the 
weekends to Dallas, where he held his weekly lab meeting— 
he moved his nephrology lab to Yale in August—and took up 
tennis again after many years, joined by his son. Originally 
from Long Island, N.Y., where his parents and his sister and 
her family still live, Alpern says he was happy at Southwestern 
but was attracted both by the opportunity to come to Yale 
because of its position as a leading medical school and by the 
chance to help solve its problems. 
"1 wouldn’t have moved for a school that wasn't as 
good as Yale,” he says, “and I’m not sure 1 would have come 
if it was not a chance to really put my fingerprint on Yale.” 
He sees empowering the clinical faculty as one of 
the most important tasks before him. He and Leffell speak 
daily about clinical issues and have put a great deal of 
effort into building up the Yale Cancer Center (more than a 
dozen cancer clinicians have been recruited in the past 
year), relaunching the school’s liver transplant program 
and placing faculty who are primarily clinicians on an 
equal footing with their counterparts in research. Getting 
promoted at a top medical school traditionally has hinged 
on prowess in the lab, for scientists and clinicians alike, 
but in recent years Yale and some of its peer institutions 
have introduced new faculty tracks that reward clinical 
excellence. Last year, Yale lifted its cap on the number of 
faculty in one of these categories, the clinician-educator 
track, because Alpern felt the clinical practice could not 
grow otherwise. “I told the provost, there’s no choice here. 
We must lift this cap, and [then-Provost] Susan Hockfield 
said okay,” he says. “Anyone who’s really an outstanding 
clinician and educator who has a national reputation will 
be promoted to professor. And when you’re a professor 
here, your title doesn’t say what track you’re on. All people 
Alpern says the least pleasant parts of the dean’s job are 
the schedule—he has meetings from 8 a.m. to 7 p.m. most 
days, is out several evenings a week, answers e-mail late into 
the night and works through the weekends—and getting and 
dealing with bad news. For example? “Faculty who want to 
leave,” he says. “That’s probably the most unpleasant and the 
most important to deal with. When you have a great faculty, 
they’re constantly under attack” by competing schools want¬ 
ing to recruit them. He is also under pressure to balance the 
budget while making major investments in the school’s 
future. Those two goals might seem contradictory, but Alpern 
says they go hand in hand. Cost containment is a critical 
piece of the equation, and so are fund-raising and a policy of 
well-thought-out expansion. If the bottom line drove every 
decision and no investments were made, he says, it would be 
a disaster. 
Encouraged by his first year, Alpern says he has no 
doubt the school will reach its goals. From his perspective, the 
good days in the dean’s office outnumber the bad days by 
a wide margin. “I’d say the proportion is about 10 to 1, good 
days to bad,” he says. 
Is he serious about that ratio? Well, yes, Alpern says, 
while acknowledging the extreme sunniness of the estimate. 
“You have to understand, I’m an optimist,” he adds. “You 
can’t ignore some of the bad news, but I try to focus on the 
good things.” ym 
Michael Fitzsousa is the editor of Yale Medicine. 
Essay DWIGHT F. MILLER, M.D. 
A half-century 
of change 
A retired pathologist looks back on 
50 years of evolution in medicine and 
what it means for the future. 
Reminiscing about the world of medi¬ 
cine my colleagues and I entered 50 
years ago is like flipping through old 
Life magazines. Not only has every¬ 
thing changed, but the rate of change 
continues to accelerate. I have seen 
these changes in my work as a labora¬ 
tory director at an inner-city teaching 
hospital, where I have been respon¬ 
sible since the early 1960s for intro¬ 
ducing new technologies. I have also 
been an ambivalent witness to the 
extraordinary transformation of the 
landscape in health care delivery. 
My first clinical laboratory was really 
an extension of those encountered in 
college premedical programs. There 
were guinea pigs, frogs and rabbits for 
microbiology. Photometers were just 
replacing the human eye for evaluating 
the color changes in chemical reactions. 
Of the 40 tests we offered, we had done 
about half as medical students. Fast for¬ 
ward: like most middle-size hospitals, 
mine now offers more than 2,000 diag¬ 
nostic tests, with 375 done in-house. 
Analytical systems are automated, from 
order entry to printing charts. Units of 
measure have shifted from grams to 
picograms or parts per billion. The origi¬ 
nal “big three” studies in radiology— 
the chest film, gall bladder series and 
barium enema—have been replaced by 
mris, pet and CT scans. 
When I graduated from Yale in 
1956 the physician-patient relationship 
was usually one-on-one. House calls 
’56, HS ’58 
were common. There were eight medi¬ 
cal specialties. Physicians generally 
knew all 20 or so major drugs. Office 
records were kept on 5-by-7 cards, and 
$3 in cash covered an office visit. My 
original malpractice bill for $100,000 
per incident/$300,ooo per year was 
$24. Bureaucracy and paperwork were 
minimal and overhead expenses negli¬ 
gible. Insurance companies paid fees 
without hassle, and the clinician had 
autonomy to make medical decisions. 
By the ’60s and ’70s massive ex¬ 
penditures in research began to gener¬ 
ate new knowledge, new technologies 
and sometimes unrealistic expectations. 
Younger, procedure-oriented subspecial¬ 
ists were riding the crest of the wave. 
However, the bulk of physicians, mostly 
older generalists, were less fortunate. 
Many found themselves caught in a tan¬ 
gle of double-digit overhead expenses, 
fixed reimbursement schedules, new 
mandates, audits, benchmarks, business 
models in which patients are “cus¬ 
tomers,” electronic records, “keeping 
up” and gloves-oflf competition for 
patients. By the late ’80s, for some clini¬ 
cians, compensatory mechanisms that 
had allowed them to maintain the status 
quo began to break down, sweeping 
away the lives they had known. Once 
unthinkable, “denying access” became a 
reality. Symptoms of “burnout” were 
growing. Some clinicians have retired 
early. Some, though disgruntled, plod 
on. Others have, for the first time, 
become active politically, especially to 
effect tort reform. Many physicians 
warn students not to go into medicine! 
The two great forces that changed 
our professional lives—new knowledge 
and limited resources—will have an 
even greater impact on those now 
entering the system. Consider this: 
The best estimates are that, worldwide, 
$90 billion annually is being spent on 
research and development in the bio¬ 
logical sciences—producing some 
8,500 articles per day! And with the 
national debt growing and with the fis¬ 
cal integrity of Social Security, 
Medicare and Medicaid threatened, 
massive increases in health care fund¬ 
ing are unlikely. These two forces will 
keep the lives of young physicians in 
perpetual turbulence. 
Yet I do not see the future of medi¬ 
cine as bleak. The core mission of 
medicine, enunciated throughout the 
ages, endures. The basic needs of the 
human race are not changing. What 
will continue to change are the tech¬ 
nology and the organizational frame¬ 
work, including financing, by which 
the potential of this technology will be 
made available to society as a whole. 
Fortunately those entering the system 
are already developing the necessary 
survival skills: they know they must 
keep learning and adapting, and they 
have expectations attuned to the cur¬ 
rent system. Some will come to under¬ 
stand the need to get active politically. 
They will not be caught unprepared, as 
our generation was, for the rapid trans¬ 
formation of health care. They enter 
the profession expecting change. 
Dwight F. Miller, M.D. ’56, HS ’58, is an 
associate clinical professor of pathology at 
the School of Medicine. 
WE WELCOME SUBMISSIONS 
Do you have an opinion to share on a vital 
topic in medicine, health or science? 
Send your thoughts to Essay, Yale Medicine, 
P.O. Box 7612, New Haven, CT 06519-0612, 
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D’Onofrio named 
head of emergency 
medicine 
GAIL D’ONOFRIO, M.S., M.D., 
associate professor of surgery 
(emergency medicine), has been 
named section chief of emergency 
medicine at the medical school 
and chief of adult emergency serv¬ 
ices at Yale-New Haven Hospital. 
She had led both services in an 
interim position since 2004. 
D’Onofrio practiced nursing for 
many years before getting her 
medical degree in 1987. She chose 
emergency medicine, she said, for 
the excitement of making a radi¬ 
cal difference in patients’ lives, lit¬ 
erally in seconds. She calls her 
practice one of “controlled chaos” 
and acknowledges that it takes a 
particular personality to cope. In 
addition to her clinical work, she 
has done research on using the 
emergency department to move 
alcohol and drug abusers into 
treatment. She recently received a 
$3.6 million grant from the National 
Institute on Alcohol Abuse and 
Alcoholism to test a counseling 
intervention with harmful and 
hazardous drinkers. Half of all 
major traumas are alcohol- or 
drug-related, so addressing sub¬ 
stance abuse can prevent visits to 
the emergency department. 
In her dual roles she manages 
emergency departments on-site 
and at a satellite clinic in Guilford, 
Conn., and conducts research, 
teaches medical students and is 
responsible for emergency physi¬ 
cians in residency. She is also 
medical director of Women’s Heart 
Advantage, a New Haven-based 
program aimed at educating 
patients and clinicians about the 
risks of cardiovascular disease in 
women. And she heads Project 
assert, a program in which health 
promotion advocates screen emer¬ 
gency department patients for 
drug and alcohol abuse. 
Fund honors a 
mentor, boosts young 
scientists 
When Applera Corp. of Norwalk, 
Conn., asked members of its board 
of directors last spring to suggest 
recipients for gifts from the com¬ 
pany,Carolyn W. SLAYMAN, 
PH.D., the medical school’s deputy 
dean for academic and scientific 
affairs and a member of Applera’s 
board, suggested a grant that 
would also promote her ideals in 
biomedical education. 
Slayman earmarked $300,000 
to endow a fund that will support 
Yale’s Combined Program in the 
Biological and Biomedical Sciences 
(bbs) and honor the memory of 
her mentor and thesis advisor, 
Edward L. Tatum, ph.d. She met 
Tatum at Rockefeller University in 
New York City, where she earned 
her doctorate under his supervi¬ 
sion in 1963, a few years after he 
won the Nobel Prize in physiology 
or medicine for pioneering work 
on genetic regulation of metabo¬ 
lism in the cell. “For a very famous 
man—he was at the height of his 
career—he nonetheless took 
extraordinary measures to work 
closely with every student and 
every postdoc in his lab group,” 
recalled Slayman, Sterling 
Professor of Genetics and profes¬ 
sor of cellular and molecular 
physiology. 
Tatum, who died in 1975, did 
part of the research that led to the 
Nobel while he was on the Yale 
faculty. Tatum and his graduate 
student Joshua Lederberg, ph.d. 
’47, who shared the prize, along 
with Harvard geneticist George 
Wells Beadle, PH.D., discerned how 
bacteria exchange and recombine 
genetic material, findings that 
paved the way for gene sequenc¬ 
ing and genetic engineering. 
Ever the scientist, Slayman said 
she hopes the Applera gift will 
be “autocatalytic”—a term from 
chemistry for the mechanism by 
which the products of a reaction 
provide fuel for further reac¬ 
tions—and will inspire others to 
support the BBS program. 
Applera’s contribution already 
shows signs of self-replication: it 
stands to benefit from a university 
policy that matches endowment 
gifts to the School of Medicine, 
which will double its impact. 
Applera is the parent company 
of Applied Biosystems, which 
develops and markets scientific 
equipment, and Celera, which 
played a major role in sequencing 
the human genome. 
Center renamed 
in honor of “father” 
of Head Start 
At a celebration in July, the Yale 
Bush Center in Child Development 
and Social Policy was renamed 
in honor of edward f. zigler, 
ph.d., Sterling Professor Emeritus 
of Psychology, considered the 
“father” of the Head Start pro¬ 
gram. Zigler was also the founder 
of the center, now called the 
Edward Zigler Center in Child 
Development and Social Policy. 
The center is one of the 
nation’s oldest centers for child 
and family policy research. It has 
been part of the Department of 
Psychology and the Child Study 
Center, where it serves a critical 
role in training and scholarly 
research. 
Walter S. Gilliam, ph.d., 
assistant professor at the Yale 
Child Study Center, who has 
been affiliated with the Zigler 
Center since 1995 and is known 
for his studies of state-funded 
prekindergarten systems, has 
been named director of the 
center. Matia Finn-Stevenson, 
ph.d., will remain as associate 
director, and Sandra J. Bishop- 
Josef, ph.d., will continue as 
assistant director. Zigler will 
serve as director emeritus. 
Zigler is regarded as the 
nation’s leading researcher of pro¬ 
grams and policies for children 
and families, having planned or 
implemented such national pro¬ 
grams as Head Start, Early Head 
Start and the innovative School of 
the 21st Century. Founded by Ziglei 
in 1978 with funding from the 
Bush Foundation of Minnesota, 
the center works to improve the 
lives of America's children and 
families by bringing the results of 
empirical research on child devel¬ 
opment into the policy arena. 
Edward Tatum 
NOTES 
Henry Binder Alison Calvani 
Sandra L. Alfano, PHARM.D., an 
associate research scientist in 
the department of medicine, has 
been appointed chair of one of 
the medical school’s two institu¬ 
tional review boards for research 
involving human subjects. 
As chair of Human Investigation 
Committee I, Alfano is respon¬ 
sible for overseeing several 
hundred research protocol appli¬ 
cations a year. 
Roland E. Baron, d.d.s., ph.D., pro¬ 
fessor of orthopaedics and reha¬ 
bilitation and of cell biology, 
received the D. Harold Copp 
Award from the International 
Bone and Mineral Society in 
June, for "outstanding achieve¬ 
ments in basic research in the 
fields of bone and mineral 
metabolism that have led to sig¬ 
nificant changes in understand¬ 
ing of physiology or disease.” 
Henry J. Binder, M.D., professor 
of medicine (gastroenterology) 
and of cellular and molecular 
physiology, received the 2005 
Distinguished Achievement 
Award from the American 
Gastroenterological Association 
in May. The award honors his 
research into the pathophysi¬ 
ology and treatment of diar¬ 
rheal diseases. 
Joyce A. Cramer, B.S., associate 
research scientist in psychiatry, 
was elected in May to the board 
of directors of the International 
Society for Pharmacoeconomics 
and Outcomes Research, an 
organization dedicated to trans¬ 
lating research into practices 
that lead to efficient and equi¬ 
table allocation of scarce health 
care resources. 
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Glenn Micalizio Lynne Regan Sandra Resnick Raymond Yesner Theodore Holford Akiko Iwasaki 
Stanley J. Dudrick, M.D., professor 
of surgery (gastroenterology), 
received the 2005 Jacobson 
Innovation Award from the 
American College of Surgeons in 
June. He was honored for his 
contributions to science, medi¬ 
cine and education through his 
research and achievements in 
nutritional support for surgical 
patients. In 1967 Dudrick demon¬ 
strated that infants could 
receive nutrition intravenously 
and still grow and develop. 
Alison P. Galvani, ph.D., assistant 
professor of epidemiology 
(microbial diseases), received a 
Young Investigators’ Prize in 
June from the American Society 
of Naturalists for her work in 
evolutionary ecology. 
Theodore R. Holford, PH.D. ’72, 
the Susan Dwight Bliss Profes¬ 
sor of Epidemiology and Public 
Health and head of the division 
of biostatistics, was elected a 
fellow of the American Statisti¬ 
cal Association. 
Akiko Iwasaki, ph.D., assistant 
professor of immunobiology, is 
one of n recipients of the 2005 
Burroughs Wellcome Fund 
Investigator in Pathogenesis of 
Infectious Disease Award, which 
will allow her to study the role 
of mucosal lining cells in the 
initiation of immune responses 
against viral infections. 
Becca R. Levy, ph.D., associate 
professor of epidemiology 
(chronic disease), has been 
named a fellow in the Behav¬ 
ioral and Social Sciences section 
of the Gerontological Society 
of America. Fellows are recog¬ 
nized by their peers for out¬ 
standing contributions to the 
field of gerontology. 
Judith H. Lichtman, PH.D., M.P.H. 
’88, assistant professor of epi¬ 
demiology (chronic disease), 
received the Women with Heart 
Research Award in June from 
the American Heart Association 
for her work on her research 
grant “Prospective Registry for 
the Predisposing Factors, Care 
and Outcomes of Myocardial 
Infarction in Young Women.” 
Glenn C. Micalizio, ph.D., assist¬ 
ant professor of chemistry, has 
been named a 2005 Beckman 
Young Investigator.The Young 
Investigator Awards are given 
annually by the Arnold and 
Mabel Beckman Foundation to 
support promising young faculty 
members in the early stages of 
their careers in the chemical and 
life sciences. 
Linda M. Niccolai, ph.D., assist¬ 
ant professor of epidemiology 
(microbial diseases), received a 
three-year, $240,000 grant from 
the Patrick and Catherine Weldon 
Donaghue Medical Research 
Foundation to examine sources 
of repeat chlamydia infections in 
young women. Niccolai’s multi¬ 
disciplinary study, which will con¬ 
tinue through 2007, will provide 
a more complete understanding 
of the factors that influence the 
trajectory from initial diagnosis 
to repeat infection. 
Lynne J. Regan, PH.D., professor 
of molecular biophysics and bio¬ 
chemistry and of chemistry, has 
won a fellowship from the John 
Simon Guggenheim Memorial 
Foundation for her studies of 
novel anticancer reagents. 
Sandra G. Resnick, PH.D., assistant 
professor of psychiatry, received 
the 2005 U.S. Psychiatric Reha¬ 
bilitation Association Carol T. 
Mowbray Early Career Research 
Award, one of five presented by 
the association for outstanding 
contributions to the field of psy¬ 
chosocial rehabilitation. Resnick 
is the associate director of the 
Northeast Program Evaluation 
Center of the Veterans Health 
Administration. 
Steven M. Strittmatter, M.D., 
ph.D., the Vincent Coates Pro¬ 
fessor of Neurology and profes¬ 
sor of neurobiology, is one of six 
scientists to receive the Senator 
Jacob Javits Award in the Neuro¬ 
sciences from the National Insti¬ 
tute of Neurological Disorders 
and Stroke. Strittmatter’s award 
will allow him to further study 
signaling pathways and loss 
of function studies in animal 
models of disease. 
Edward M. Uchio, M.D., assistant 
professor of surgery (urology), 
received the 2005 Dennis W. 
Jahnigen Career Development 
Scholars Award. The two-year 
career development awards 
allow junior faculty to begin a 
career in the geriatric aspects of 
their discipline. 
Raymond Yesner, M.D., professor 
emeritus and senior research 
scientist in pathology, received 
the Gold Medal from the United 
States and Canadian Academy 
of Pathology in May, one of the 
most prestigious awards in the 
field of pathology. 
SEND FACULTY NEWS TO 
Claire M. Bessinger, Yale Medicine, 
P.O. Box 7612, New Haven, CT 
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A call to 
professionalism 
As 100 new medical students begin 
their education, a physician defines 
the principles of their calling. 
At the beginning of the White Coat 
Ceremony in August, Dean Robert J. 
Alpern, m.d., assured the 100 mem¬ 
bers of the Class of 2009 that they 
were where they belong. “The admis¬ 
sions committee did not make any 
careless errors in admitting you to 
our medical school,” he told the crowd 
in Harkness Auditorium. “If we do 
our jobs, and you do yours, years from 
now students will walk these halls 
wondering if they belong in the same 
institution as the Class of 2009.” 
Before they received their white 
coats, keynote speaker David L. Cole¬ 
man, m.d., hs ’80, professor and 
interim chair of medicine, noted that 
the ceremony started in this country 
in 1993 as an effort to “acknowledge 
the professional ideals that are the 
essence of being a physician. 
“Professionalism,” Coleman con¬ 
tinued, “drives how we live, how 
we aspire and how we learn. ... I have 
come to believe that it is the insepa¬ 
rable weaving of scientific discipline 
with humanism that is at the core of 
professionalism. We cannot and 
will not be humane physicians with¬ 
out employing science. And we 
cannot and will not be medically com¬ 
petent physicians without employ¬ 
ing humanism.” 
The principles of professionalism 
rest on the pillars of nonmalevolence, 
beneficence, patient autonomy, justice, 
inquisitiveness, competence and 
teaching, Coleman said. They require, 
among other things, that physicians 
do no harm, advocate on behalf of 
patients rather than themselves, strive 
to do good, respect decisions made by 
patients and seek equity and justice in 
the delivery of care. “It should deeply 
David Coleman, Nancy Angoff, Herbert 
Chase and James Jamieson were among 
the faculty helping students with their 
white coats. 
Forrester Lee, assistant dean for multicultural 
affairs, welcomed Caleb Korngold to Yale. 
Hasani Baharanyi donned his white coat for the 
first time. 
below Back row, Fabienne Meier-Abt, Katherine 
Uyhagi, Ellen Vollmer, Martin Dominguez and 
Corey Frucht; front row, Maya Kotas, Rachel 
Rosenstein, Julie Xanthopoulos and Sara Crager. 
bother everyone in this room that 48 
million Americans are without some 
form of health insurance,” he said. 
In concluding, Coleman cautioned 
the students to prepare to make 
sacrifices. “Medicine will require a 
great deal from each of you, and very 
importantly, it will give back a great 
I deal to each of you,” he said. “If you 
I can find your balance while fulfilling 
I the ideals of professionalism, you will 
I attain the immeasurable and endur- 
I ing rewards that your new profession 
I offers. I hope your white coat will 
I always inspire your aspirations and 
I your ideals, from this day forward.” 
—John Curtis 
John Forrest helped Rebecca Bruccoleri on with Dean Robert Alpern welcomed Michelle Collins 
her white coat. to the medical school. 
Titilope Oduyebo after group portraits outside 
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Reunion 2005 
Alumni see the artistic side of surgeons, hear a talk on 
terrorism and, as ever, catch up and relive old times. 
Photographs by Terry Dagradi and John Curtis 
Surgeon-artists James Dowaliby, John Aniyan, 
Ralph Greco, Bernard Siegel, Paul Barcewicz, 
Eiji Yanagisawa and Michael O’Brien displayed 
photographs, paintings and sculptures at the 
Surgical Society Spring Reunion in June. 
Although the reunion in June officially 
kicks off with a Friday evening dean’s 
reception followed by the clambake on 
Harkness Lawn, in recent years a 
Thursday evening reunion of the Yale 
Surgical Society has increasingly 
drawn alumni to New Haven a day 
early. This year, early birds were 
treated to a discussion of the surgeon 
as artist. Other reunion talks included 
a discussion of terrorism by a psychia¬ 
trist who has worked with the Central 
Intelligence Agency (cia) and a panel 
on advances in treatment of pediatric 
diseases. This year’s reunion also saw 
the election of a new president and 
vice president of the Association of 
Yale Alumni in Medicine. 
At the New Haven Lawn Club on 
Friday, public health alumni heard 
a panel on the impact of genomics 
on their profession and, over lunch, 
a keynote talk on the potential for 
genetics and biotechnology to improve 
the lives of the poor. 
From surgeons to artists 
As an adult Bernard S. Siegel, m.d., 
hs ’61, returned to a boyhood hobby 
that had given him great pleasure. 
Painting, he said, is “a way of relieving 
the pressures of being a physician. 
It makes me lose track of time. I think 
it is the healthiest state I can be in.” 
Siegel, whose paintings of his family 
and a self-portrait in surgical scrubs 
were on display in the Cushing/Whitney 
Medical Library in June, was one of 
three speakers on “The Surgeon as 
Artist,” the theme of the 10th Annual 
Yale Surgical Society Spring Reunion 
in June. 
Joining him in the discussion in 
Harkness Auditorium were surgeon 
45 
Dean Robert Alpern outlined the state of the 
school and plans for its future at the annual 
meeting of the alumni association. 
and photographer James M. Dowaliby, 
m.d. ’67, hs ’72, associate clinical 
professor of surgery (otolaryngology), 
and surgeon and sculptor Ralph S. 
Greco, m.d. ’68, hs ’73, the Johnson & 
Johnson Distinguished Professor and 
chief of general surgery at the Stanford 
University School of Medicine. 
Dowaliby has been taking pictures 
for 52 years. With his digital camera he 
documents family events and vacations 
and records his surgeries, but his per¬ 
sonal and professional lives merged in 
this exhibit with two photographs of 
his sister-in-law as she prepared for 
radiotherapy to treat cancer. Dowaliby 
photographed her face as it was being 
fitted with a mask. He converted his 
color pictures to black and white, then 
increased the contrast to obtain stark, 
almost surreal images. 
Unlike the other speakers, Greco— 
a professional sculptor for more than a 
decade, with gallery shows and sculp¬ 
tures in private collections around the 
country—said he has failed to find 
a link between surgery and his art. 
“I have searched in vain to find a con¬ 
nection that makes any sense to me 
between surgery and sculpture,” he 
said. “Surgery is about the pursuit of 
technical perfection, sculpture about 
the pursuit of beauty. Perhaps what 
they have in common is that in both, as 
we learn, we come under the influence 
of masters who influence us in many 
ways, some of which are not easily rec¬ 
ognized.” Greco’s representational and 
abstract stone sculptures were among 
the photographs, paintings and sculp¬ 
tures by nine surgeon-artists on display 
at the symposium. 
Other works on display by Yale 
surgeon-artists included those of John 
A. Anlyan, m.d. ’45; Paul A. Barcewicz, 
m.d., assistant clinical professor of sur¬ 
gery (gastroenterology); Wayne O. South- 
wick, m.d., former chair of orthopae¬ 
dics; Michael O’Brien, m.d., ph.d., 
assistant clinical professor of surgery 
(gastroenterology); Eiji Yanagisawa, 
m.d., hs ’59, clinical professor of sur¬ 
gery (otolaryngology); and Ken Yana¬ 
gisawa, m.d., hs ’93, assistant clinical 
professor of surgery (otolaryngology). 
Of tyrants and terrorists 
Reunion activities started off Friday 
with a sobering presentation by psy¬ 
chiatrist and terrorism expert Jerrold 
M. Post, m.d. ’60, who has profiled 
terrorists and tyrants for the cia. 
Terrorists, he said, tend to be “normal 
individuals” who have more in com¬ 
mon with urban gang members 
or mobsters than with crazed fanatics. 
Indeed, terrorist groups screen out 
emotionally unstable individuals 
because they represent a security risk. 
“You can’t explain terrorism on the 
level of individual psychology,” said 
Post, director of the political psychol¬ 
ogy program at the George Washington 
University and founder of the cia’s 
Center for the Analysis of Personality 
and Political Behavior. The attractions 
of joining a terrorist group, he said, 
are rooted in collective psychology— 
alienated youth join to find purpose 
in their lives and they subordinate 
their individuality to the group cause 
as articulated by a destructive, charis¬ 
matic leader such as Osama bin Laden. 
Group psychology binds the members 
together, and group and organizational 
psychology can push them to risky and 
destructive behavior, as they recognize 
that dissent leads to expulsion or death. 
Jerrold Post discussed the psychology of 
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top Jocelyn Malkin was elected vice president 
of the alumni association and Frank Lobo was 
elected president. Donald Moore (center) is past 
president. 
middle Donald Moore, with his wife, Christine, 
and daughter, Crystal, ended his term as 
president of the Association of Yale Alumni in 
Medicine this year and was honored with the 
Distinguished Alumni Service Award. 
bottom Sherwin Nuland also received the 
Distinguished Alumni Service Award, for his out¬ 
standing dual careers as a surgeon and author. 
Religious terrorists are spurred by 
an ideology of hate toward nonbelievers. 
Although their war on modern influ¬ 
ences depends on modern technology, 
technology is not the key to fighting ter¬ 
rorism, said Post. He proposed a pro¬ 
gram of strategic communication 
designed to inhibit potential terrorists 
from joining the group, produce dissent 
in the group, facilitate exit from the 
group and reduce support for the group. 
But as he showed the photo of a i-year- 
old child wearing the bomb-draped vest 
of a suicide bomber, he cautioned that 
the so-called war on terror will be 
decades long. “We have already lost a 
generation,” he said. “Hatred and the 
attractions of martyrdom have been 
bred in the bone from childhood on.” 
The state of the school 
After Post’s talk, alumni moved up 
the street to the dean’s reception 
in the Historical Library, followed by 
the clambake on Harkness Lawn. 
The next morning the Association of 
Yale Alumni in Medicine (ayam) elected 
Francis M. Lobo, m.d. ’92, to a two-year 
term as president. Jocelyn S. Malkin, 
m.d. ’52, hs ’54, fw ’60, was elected 
vice president. Christine A. Walsh, m.d. 
’73, elected two years ago to a three-year 
term as secretary, will continue in that 
position for another year. 
Lobo said he is assuming the presi¬ 
dency at a moment of “tremendous 
excitement. ... The School of Medicine 
is seeing a vigorous expansion of the 
missions of research and patient care, 
as well as a very appropriate sensitivity 
to the special nature of our educational 
mission by Dean Robert Alpern. That 
will be a very exciting message to bring 
to the alumni,” he said. 
Malkin, who is in private practice 
as a psychiatrist in Maryland, said, 
“I am particularly interested in the 
issue of women faculty, promoting 
equal working conditions and salaries 
for women.” Malkin has served on 
the ayam executive committee and as 
a delegate and member of the board 
of governors of the Association of 
Yale Alumni. 
Outgoing ayam president Donald 
E. Moore, m.d. ’81, m.p.h. ’81, and 
Sherwin B. Nuland, m.d. ’55, hs ’61, 
each received the Distinguished 
Alumni Service Award at the Saturday 
morning business meeting. Moore 
was honored for his service to his com¬ 
munity in Brooklyn, N.Y., where he 
has a private practice and makes house 
calls. “You have always put the patient 
first,” read his citation, which also took 
note of his teaching of medicine and 
his leadership in “embracing the cul¬ 
tural diversity that is a vital part of our 
school’s—and our nation’s—growth.” 
Nuland was honored for his “distin¬ 
guished and outstanding” career as a 
surgeon, and for his second career as a 
scholar, writer and lecturer in the his¬ 
tory of medicine. His citation noted his 
humanitarianism as well. “When the 
Asian world was devastated by a 
tsunami, you immediately joined a Yale 
medical team to travel to Sri Lanka.” 
Following the awards, Dean Robert 
J. Alpern, m.d., Ensign Professor of 
Medicine, discussed the state of the 
school, which he described as one of 
advancement and expansion. A strategic 
planning process begun last year has 
created new venues for communication 
and identified areas for allocation of 
resources. “The school cannot and 
should not invest in every conceivable 
area," Alpem said. “The areas in which 
it does invest should be truly excellent 
and among the best in the nation.” 
Areas targeted for investment include 
faculty, new research and clinical pro¬ 
grams, facilities, new research build¬ 
ings, innovative medical education 
programs and student financial aid. 
Childhood diseases grow up 
Earlier that morning, at the annual sci¬ 
entific symposium, alumni heard from 
a panel of Yale researchers who are 
helping to rein in diseases that, in the 
not-too-distant past, presented parents 
with their worst possible nightmare: 
burying a young child. 
Certain congenital heart defects, 
type 1 diabetes and cancer were often 
associated with poor outcomes, but 
“the tide is turning on those diseases,” 
said Margaret K. Hostetter, m.d., 
the Jean McLean Wallace Professor of 
Pediatrics, chair of pediatrics, and 
moderator of the symposium From 
Embryo to Young Adult: New Frontiers in 
Pediatrics. Three Yale faculty members 
described their research. 
Martina Brueckner, m.d., fw ’90, is 
literally shining a light on the genetic 
roots of atrial isomerism—a condition 
in which the heart develops as a mir¬ 
ror image of its normal self. A team 
led by Brueckner, an associate profes¬ 
sor of pediatrics (cardiology), discovered 
in mice that a “molecular motor” 
gene called left-right dynein, mapped 
in 1997, is crucial to a developing 
embryo’s “biological handedness,” the 
ability to tell left from right. 
The process starts early. “By 56 
days of human development, the heart 
is fully formed,” Brueckner said. 
“Handedness” is determined as early 
as 20 days, and if it doesn’t happen 
correctly it “can lead to a very, very mal¬ 
formed heart.” By examining embryos 
under special lighting in a microscope, 
Brueckner’s team discovered that the 
cells of the nodes (organizing centers) 
have hair-like structures called cilia 
that move fluid around the embryo 
leftwards, leading to asymmetric devel¬ 
opment of the heart. This doesn’t 
happen in embryos with the mutated 
form of dynein. 
While only one in 8,500 people is 
born with inverted organs—and many 
live a healthy life without ever knowing 
of the inversion—the condition strikes 
one in 25 of Brueckner’s congenital 
heart patients. “They’re what we call 
our frequent flyers,” she said. “They 
keep coming back.” 
The progress against type 1 diabetes 
has come in several large waves— 
the discovery of insulin in the 1920s 
and the advent of glucose self-monitor¬ 
ing in the 1970s—rather than incre¬ 
mentally. The next wave is the develop¬ 
ment of an artificial pancreas, 
which Stuart A. Weinzimer, m.d., an 
associate professor of pediatrics 
(endocrinology), called “our best shot” 
at diabetes management. 
Researchers have two of the three 
elements needed, Weinzimer said. One 
is the insulin pump, developed at Yale 
in the 1970s, which is now portable 
enough (once the size and weight of a 
laptop computer, it is now no larger 
than a pager) to be in widespread use. 
A 2002 Yale study of the latest devices 
found that they cut episodes of hypo¬ 
glycemia in half. 
The second innovation is the 
round-the-clock glucose monitor. Some 
models can read blood sugar levels 
to p At the Saturday morning scientific 
symposium, Margaret Hostetter, chair of pediat¬ 
rics, moderated a discussion of advances in 
the treatment of childhood diseases. 
middle Martina Brueckner described her 
research into atrial isomerism, a condition in 
which the heart develops as a mirror image 
of its normal self. 
bottom Nina Kadan-Lottick directs a clinic 
that helps families deal with life after cancer. 
Many survivors of childhood cancer face health 
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without puncturing the skin, and others 
sound an alarm when levels are abnor¬ 
mally high or low. While “we have a lot 
of work do to on these,” Weinzimer 
said—they still don’t give a completely 
accurate picture over a 24-hour period— 
“there is a place for them.” The third 
component to creating an artificial pan¬ 
creas, under study at Yale, uses a com¬ 
puter that gets the insulin pump and 
glucose monitor “to talk to one another,” 
signaling the insulin pump to respond 
to a patient’s individual needs. “We’re 
getting closer and closer,” he said. 
In 1997, one in 640 Americans 
was a survivor of childhood cancer, and 
that rate is expected to rise to one in 
250 in five years. The progress is such 
that doctors face a task their peers 
could only dream of a generation ago— 
coping with problems faced by an 
ever-growing pool of childhood cancer 
survivors. “This is a growing popula¬ 
tion,” said Nina S. Kadan-Lottick, m.d., 
an associate research scientist in pedi¬ 
atrics (hematology/oncology), but 
“there are costs.” Many survivors have 
problems with growth and fertility, 
don’t do well in school, have self-image 
problems, suffer from neurocognitive 
impairment, develop subsequent malig¬ 
nancies and live shorter lives. To help 
the survivors of childhood cancer, espe¬ 
cially those recovering from leukemia, 
Kadan-Lottick directs the heros clinic, 
a unique clinical program within 
the section of pediatric hematology/ 
oncology at Yale. 
Kadan-Lottick said her team is look¬ 
ing at the role of family strains, mecha¬ 
nisms of coping with life after cancer 
and what types of chemotherapy are 
more likely to lead to other medical 
problems later. 
“There are many opportunities for 
screening and intervention,” she said. 
On the bright side, “cure is the rule, not 
the exception, for children with cancer.” 
Public health and the human genome 
“Race is really a social phenomenon, 
not a biological one,” said Kenneth K. 
Kidd, ph.d., professor of genetics, psy¬ 
chiatry and biology at Yale, the keynote 
speaker at alumni day at the School of 
Public Health, held at the Lawn Club 
on Friday, June 3. His speech kicked 
off a discussion of genomics and pub¬ 
lic health, an area in which health 
practitioners are still feeling their way. 
Citing studies of 42 genetically 
diverse populations from around the 
world, from the Mbuti of Africa to the 
Yakut of Siberia, he said that despite 
obvious, skin-deep differences, the 
genetic diversity found within any given 
human population far outweighs the 
diversity between populations. Nearly all 
potential genetic variations are found in 
every population. “It’s really impossible 
to define a boundary of a race based on 
these differences,” he said. 
Panelists at this year’s public health 
reunion explored how the genomic 
revolution might be applied to epidemi¬ 
ology, while cautioning against over¬ 
emphasizing genetic causes of disease 
and neglecting environmental and 
behavioral causes. At least two speakers 
said the promise of genomics has been 
“oversold” to the public. As Kidd stressed 
in his talk, there is still much to learn 
about human genetic variations. 
The 400 or so variants he has stud¬ 
ied represent a tiny, “Eurocentric” frac¬ 
tion of the estimated 6 million in the 
human genome. “We need to know 
how much variation there really is and 
how it is distributed around the 
world,” he said, before genomic data 
can be used to relate human diversity 
to public health problems. As an exam¬ 
ple, he cited a study that appeared to 
link variants in the dopamine trans¬ 
porter to smoking in the United States 
population. But when he looked at the 
same gene in populations around the 
world, he found much more variation 
among the populations, irrespective of 
smoking, that called the original 
results into question. 
Despite such caveats, public health 
professionals will be in the forefront of 
using genomic data, noted panel mod¬ 
erator Paul A. Locke, m.p.h. ’80, j.d., 
dr.ph., a visiting scholar at Johns 
Hopkins. Five panelists described how 
genomics is already affecting their 
piece of the public health puzzle. 
Alan Goldberg, ph.d., director of 
the Center for Alternatives to Animal 
Testing at Johns Hopkins, said 
genomics will eventually allow toxi¬ 
cologists to use fewer animals in 
tests. Genomics, he said, will lead to 
in vitro replacements “that are both 
good science and allow humaneness.” 
Lloyd M. Mueller, ph.d. ’84, an epi¬ 
demiologist at the Connecticut Depart¬ 
ment of Public Health, noted that 
genomics’ impact on policy is “promis¬ 
ing, but challenging to translate.” And, 
he cautioned, this promise is oversold 
to the public. For example, said Mueller, 
the Connecticut Legislature recently 
mandated an expanded battery of new¬ 
born screening tests, some of which 
have not been systematically studied 
and yield test results that do not lead to 
specific treatment decisions. Audience 
members worried about the potential 
legal and ethical ramifications of tests 
with still-unknown false-positive and 
false-negative rates that are designed to 
detect diseases for which there are no 
known interventions. 
Herbert Yu, m.d., ph.d., associate 
professor of epidemiology and director 
of Molecular Epidemiology Shared 
Resource at Yale Cancer Center, dis¬ 
cussed the effects of heredity, lifestyle 
and environment on dna methylation, 
a process involved in gene expression. 
Disruptions in methylation can cause 
disease, and Yu noted that methylation 
patterns can be inherited but can also 
be changed by environment, lifestyle 
and exposure to chemicals. 
This interplay of behavior, environ¬ 
ment and genetic luck was also 
addressed by Marta Gwinn, m.d., 
m.p.h., the director for science at the 
Office of Genomics and Disease 
Prevention at the Centers for Disease 
Control and Prevention, and Kathleen 
R. Merikangas, ph.d., senior investi¬ 
gator and chief of the Section on 
Developmental Genetic Epidemiology 
at the National Institute of Mental 
Health and a research affiliate in epi¬ 
demiology at the School of Public 
Health, where she was a professor 
until 2003. The underlying hetero¬ 
geneity in populations will allow doc¬ 
tors to distinguish between hereditary 
and sporadic cases of cancers or other 
diseases, and to identify subgroups 
that are more susceptible to environ¬ 
mental risk factors. “Risk factors cou¬ 
pled with genetics and biology become 
meaningful,” said Merikangas. 
She went on to add, however, that 
“genomics has been grossly oversold.” 
Discoveries such as the putative “gene 
for smoking,” she said, could make 
people feel they are absolved from 
Keynote speaker Kenneth Kidd said genetic 
differences do not define race, which is a social 
rather than a biological construct. 
Panelists discussing the implications of genomics 
for public health included, clockwise from top 
left, Kathleen Merikangas, Alan Goldberg, Lloyd 
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responsibility for their high-risk behav¬ 
iors. “We need to help people under¬ 
stand and not overinterpret the role of 
genes,” she said. 
Past progress, future challenges 
At the public health alumni day lunch¬ 
eon, Interim Dean Brian P. Leaderer, 
m.p.h. ’71, ph.d. ’75, began by praising 
his predecessor, Michael H. Merson, 
m.d., the Anna M.R. Lauder Professor 
of Public Health, who stepped down in 
December after 10 years as the first 
dean of public health at Yale. “I think it 
is really important to all of us as gradu¬ 
ates to acknowledge what he has 
done,” Leaderer said, citing a twofold 
increase in the size of the faculty, 
improved facilities, increased visibility 
for the school and the creation of the 
Center for Interdisciplinary Research 
on AIDS. 
As the search continues for a new 
dean, however, a report from the 
provost’s office has noted some areas 
for improvement. The report called for 
continuing a strong focus on research, 
an improved educational program and 
an examination of administrative struc¬ 
ture, Leaderer said. And, the report said, 
the school lacks a critical mass. “We are 
too small and we lack the money and 
infrastructure to grow,” Leaderer said. 
The subtext to this discussion, he added, 
was independence, eph, which is 
accredited as a school of public health, 
has long sought to be free-standing, 
rather than a department of the medical 
school. “The university’s response was 
that there will be no independence in 
the foreseeable future.” 
In response to the provost’s report, 
the school has begun a strategic plan¬ 
ning process. “We are paying more 
In his luncheon address Peter Singer argued 
that genetics and biotechnology can improve 
the lives of the poor. 
attention to the quality of our teach¬ 
ing,” Leaderer said. The school is also 
planning a one-year master’s program 
for those with a degree in health- 
related science. And a new program 
with Yale College would create a joint 
five-year program in which under¬ 
graduates could major in public health 
and after graduation spend another 
year obtaining an m.p.h. 
Jerald A. Fagliano, ph.d., m.p.h. ’85, 
was inducted into the Alumni Public 
Service Honor Roll for his service to 
Vermont and New Jersey in the area 
of environmental health. David A. 
Newman, m.p.h. ’96, received the Eric 
W. Mood Alumni Award, established 
in 2005 to recognize an alumnus or 
alumna demonstrating outstanding 
promise as a new professional in public 
health. As corporate director of environ¬ 
ment, health and safety at Millipore, a 
bioscience company headquartered in 
Billerica, Mass., he developed, imple¬ 
mented and evaluated programs for the 
company. James S. Marks, m.d., m.p.h. 
’80, the senior vice president and direc¬ 
tor of the health group at the Robert 
Wood Johnson Foundation, received the 
Distinguished Alumni Service Award. 
He was previously in a top leadership 
post at the Centers for Disease Control 
and Prevention. 
Marks said people often miss the 
connection between public health and 
their daily lives. “We have to make that 
connection—that screenings, getting 
your flu shot are connected to living 
the kind of life you want,” he said. 
"... those other 5 billion people ...” 
After lunch, Peter A. Singer, m.d., 
m.p.h. ’90, the Sun Life Financial Chair 
in Bioethics and director of the Joint 
Centre for Bioethics at the University of 
Toronto, received the 2005 Award 
for Excellence. He began his remarks 
by pointing out the difference in life 
expectancy in the United States and 
sub-Saharan Africa. “Eighty years and 
rising and 40 years and falling. If that 
isn’t the mother of all ethical challenges, 
what is?” he asked, before pondering 
how technology and genomics can 
improve global health. Showing a slide 
of children in a coastal village in India, 
he said, “They are all barefoot and they 
live in thatched houses. ... Right in the 
middle of their village is an informa¬ 
tion kiosk where they can access the 
Internet.” The point, he continued, is 
“the potential of science and technology 
and innovation to better the lives of 
the poor. I want to argue that genetics 
and biotechnology have comparable, 
if not greater, potential.” 
As an example he pointed to “the 
largest mass poisoning in world his¬ 
tory” in Bangladesh, where 50 million 
people are affected by exposure to 
arsenic in drinking water. At the bot¬ 
tom of the country’s wells are bacteria 
responsible for the arsenic, he said. 
But in Australia there are bacteria that 
remove arsenic from water. Genomics, 
Singer said, has the potential to solve 
the problem in Bangladesh. Sequenc¬ 
ing the genomes of these two bacteria 
could yield a way to offer a solution to 
the problem, he said. 
“We need to keep the focus on 
those other 5 billion people in the 
world, those that have half the life 





Although time and tide and the 
vagaries of advancing years 
have diminished the numbers 
and vigor of this class, we had a 
splendid turnout, attracting 
more attendees than some 
r classes junior to us. 
Making the trip to New 
Haven were John and Betty 
Anlyan (basking in the glory of 
the greatest gift ever to the 
School of Medicine), Dick and 
Verne Breck (appropriately 
enjoying the reunion they 
orchestrated), Sandy Cockerell 
(with son Dr. Charles and lovely 
history professor daughter-in- 
law Karen), Dick Dyer (white- 
haired but otherwise unchanged 
since his glory days), Sid 
Feuerstein (looking tanned and 
terrific), Ray and Pat Cagliardi 
(still the prettiest girl who found 
her husband in the air raid shel¬ 
ter in the library), Bill and Marj 
Jenney (he is the dignified and 
impressive doctor type), Lee and 
Barbara Jones (no one had a 
more gorgeous caregiver than 
Barb), Mike and Geri Lau (upbeat 
and optimistic and just plain 
fun), Charlie and Laura McLean 
(with daughter Patti, who has 
inherited the best from both— 
Charlie introduced me to my life¬ 
long addiction to golf). Our best 
surprise was Gove Hambidge, 
who was attending his first-ever 
reunion and had a great time. 
Gove still practices psychiatry 
full time in Golden Valley, Minn. 
We shared the spectacular 
clambake dinner and sherry 
lunch; we toured the magnifi¬ 
cent Anlyan Center and felt 
vicariously the pleasure that the 
donor was one of us; we took a 
tour of historic New Haven and 
heard some really informative 
lectures. Possibly the best was 
hearing from the new dean. He 
seems to be the right man in the 
right job at the right time. The 
city, the university and the medi¬ 
cal school campus have made 
tremendous strides since last 
reunion.The future looks great. 
Far and away the best of all, 
however, was the warm cama¬ 
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raderie of our group. It was 
almost as if it was June 1942, 
and we were young again. 
Our next reunion will be in 2010 
and Gove has already committed 





There are by our last count 60 
living members of our class. A 
total of 30 were able to attend 
the reunion for at least one day, 
and most for three days. Leo 
Cardillo, who is still in practice, 
was able to come for only a 
short time on Friday, but his 
presence brought our total 
attendance to 50 percent. Alan 
Stone was only able to come for 
Saturday, but also was a wel¬ 
come face. (He still looks like he 
did 50 years ago.) 
The committee had made a 
number of phone calls to mem¬ 
bers who had not responded to 
the initial letters. It was really 
nice to talk to them, but unfor¬ 
tunately the reasons for not 
coming were usually because of 
illness of the classmate or 
spouse. Some were quite ill, but 
as physicians, we would expect 
this in a group of people in their 
70s. What was encouraging was 
the general overall health of our 
group. Almost everyone is 
retired and finding many inter¬ 
esting and productive pursuits 
to keep them busy. 
The week after the reunion, I 
went to Atlanta for another 
event, and was able to have 
lunch with Roger Lester, who 
could not come to the reunion 
because of another commit¬ 
ment. He is doing some scholarly 
work in history and philosophy, 
and was giving some lectures 
the weekend of the reunion. He 
will be at the 55th. 
Again, one of our classmates 
was honored; Shep Nuland 
received the Distinguished 
Alumni Service Award. As usual, 
he was gracious and articulate 
in his acceptance speech. 
We were fortunate in having 
our oldest classmate, Pat Costa, 
attending as well as our 
youngest, Guy McKhann. Harry 
Kendall and Sandy Zuckerbraun 
traveled from distant California 
with Wanda and Ruth to attend. 
Sandy is still in practice and 
because he sees many Mexican- 
Americans, he has become flu¬ 
ent in Spanish. You see,you can 
teach an old horse new tricks. 
Frank Johnson is retired, but 
still lives in the vast outreaches 
of Montana. Milt Corn was in 
from Bethesda, Md„ where he is 
active in what seems like an 
important but somewhat con¬ 
fusing project at the nih. I’m 
sure with his involvement it is 
important. 
Jim Garlington is now work¬ 
ing on a project to collect digital 
pictures from the reunion and 
also some from people who 
could not attend. He is going to 
put them on a CD and send it to 
all class members. I thought it 
was a great idea, and he is to be 
congratulated for this work. See 




Our 45th reunion was a source 
of great pride for the Class of 
i960, because the keynote 
speaker for the entire alumni 
body was our own Jerry Post. 
Jerry, a distinguished professor 
of psychiatry and political sci¬ 
ence at George Washington 
University, has written six well- 
received books on subjects rang¬ 
ing from the psychopathology of 
political leaders to the origin 
and perpetuation of terrorism. 
Many of us had already been 
familiar with his thinking not 
only from his books, but also 
from his numerous appearances 
on cable TV. 
On Friday afternoon Jerry 
spoke eloquently and unset- 
tlingiy about the rapid propaga¬ 
tion and intensification of 
terrorism. His talk, subtitled 
"When Hatred Is Bred Into the 
Bone,” highlighted the bitter 
irony that our political leaders 
are confidently adopting belli¬ 
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ing the phenomenon worse. The 
fact that there are no panaceas 
and that terrorism will be with 
us for generations to come was 
deeply troubling to the audi¬ 
ence; this struck us as the mark 
of a highly successful talk. 
The festivities continued into 
the evening. During the clam¬ 
bake, which seems to get more 
delicious each time, we began to 
unwind and renew our old 
friendships. There was general 
agreement that the finalists for 
the Obscenely Young Forever 
category were Gerald Cimmino, 
Neil Cooper and Sue Kleeman. By 
virtue of his continued stature 
as basketball star, Lanny Ames 
was charitably awarded honor¬ 
able mention. Moreover, Cooper 
had lost so much weight that no 
one recognized him. We sus¬ 
pected they were all plants from 
the Class of 1990. However, the 
rest of us all looked so fit and 
terrific that no one really envied 
them, except for Kleeman. The 
Most Eloquent Award went to 
Bob Wallach, whose brave and 
moving reminiscences brought 
many of us to tears. 
On Saturday we were all 
pleased by Dean Alpern’s talk. It 
seemed engaged, thoughtful, 
serious and leaderly. We were 
persuaded that our school is in 
very good hands and will retain 
its outstanding rank for years 
to come. 
But the piece de resistance 
was, as always, the Saturday 
evening dinner at the Lawn 
Club.The tone was set by class 
agent Tom Kugelman, who 
reported that our class had con¬ 
tributed more than any other 
reunion class to the Annual 
Fund. This was due in large 
measure to one extremely large 
gift from Eric Kindwall, who 
spoke movingly of what Yale 
had meant to him. 
And so did the rest of us. We 
all got up in turn and gave 
accounts of ourselves and our 
lives. One common thread was 
that in many different ways, 
even for those of us who felt we 
had not thrived within the Yale 
System and had not been happy 
here, the Yale experience had 
somehow defined us—or more 
accurately, had helped us define 
ourselves—and helped us 
become what we are today. We 
discovered that on our first day 
of school each of us had been 
convinced that Yale had made a 
mistake in admitting us, and 
that each of us was convinced 
that he or she was the only one 
who felt that way. And over time 
we discovered that each of us 
had been wrong.That's quite a 
tribute to Art Ebbert and the late 
Tom Forbes—not to mention all 
the rest of our splendid faculty. 
Jerry led us in observing a 
brief silence in honor of our 
deceased classmates: Ormond 
Brody, Tom Carson, Stan Chung, 
Dave Dunn, Mai Golden, Irv 
Guttenberg, Arthur Martin, Kent 
Morest, Mike Moynihan, Ross 
Snyder, John St. Andre and 
Brian Welch. 
Present at this extraordinary 
occasion were Vic and Laura 
Altshul, Lanny Ames, Neil and 
Teresa Cooper, Jon and Carol 
Courtney, Jim and Kitty Euster- 
mann, Gene Gaenslen, Jim Gilman, 
Bill Kaden, Eric Kindwall, Sue 
Kleeman, Tom and Alice Kugeiman, 
Tom Lau, Bob Marcus and friend 
Vie Simons, Al and Barbara 
Newcomb, Tom and Danielle Okin, 
Fred and Ruth Palace, Jerry and 
Carolyn Post, Nancy and Bill 
Powell, Buzz Robinson, Al Ross and 
friend Jane Semmons, Dan and 
Lina Rubin, John and Suzanne 
Schrogie, Bob and Judy Wallach, 
May and George Wang, and Ron 
Yankee. Present in spirit was 
Malin Dollinger, who had intended 
to come before his wife, Lenore’s, 
sudden illness and who sent a 
warm and moving account of his 
recent life. 
Victor A. Altshul 
1965 
40th reunion 
The Class of ’65 had a wonderful 
40th reunion in early June. We 
enjoyed the traditional shore 
dinner under the tent at Hark- 
ness, and a lovely dinner at the 
Ouinnipiack Club on Saturday. 
Twenty classmates made it back 
and enjoyed catching up—some 
have been regulars at reunions, 
others first-timers. Attendees 
included Amy and Tom Aoki, John 
Coyle, Greg Culley, Mike and 
Susan Cummings, Carl and Emi 
Ellenberger, Chris Gates, Frank and 
Donna Grady, Gary Gross and 
Betsy Shure, Bob and Donna 
Gryboski, Reed and Ellie Heffner, 
Dave Hill, Edgar and Ellen Hull, 
Carl Hunt and Joyce Shoemaker, 
Ron Karpick, Mohandas and 
Joanne Kini, Larry and Linda 
Ossias, Bob and Mary Pickens, and 
John and Greta Seashore. Five of 
us have retired and some have 
switched career paths, but most 
are still practicing medicine 
actively. Just can’t keep this 
group down. There was consider¬ 
able sentiment for having the 
occasional mini-reunion more 
frequently, especially for those 
of us who live relatively near 
each other. Perhaps we North- 
easterners could gather at Carl 
Ellenbergers’ Mt. Gretna (Pa.) 
music festival next summer. If 
anyone is interested, let me 
know (john.seashore@yale.edu). 
Is anyone on the West Coast up 
for organizing something out 
that way? We hope to see even 




Our class reunion dinner was 
held in the library of the 
Ouinnipiack Club on Saturday 
evening and attended by 15 
members as well as their 
spouses and guests. Following 
numerous photo shoots to 
accommodate late-arriving 
members, we enjoyed an excel¬ 
lent dinner and had a nice time 
catching up on the personal and 
professional lives of what was 
truly an eclectic class.The atten¬ 
dees included Elissa and Dan 
Arons, John Blanton and Beth 
Balschi, Paul and Judy Braun, 
Romney and Mary Sue Burke, 
Anne Curtis, Jonathan and 
Rosanne Ecker, Rick and Ruth 
Edelson, Harvey Fernbach and 
Ann Birk, Tom Gouge, Paul and 
Patricia Hessler, Gerry Kennealey, 
Mark and Susan Korsten, Bob and 
Joan Rosa, Joellen Werne, and 
Karl and Diane Wustrack, as well 
as special guest Rose Papac. 
Rose, one of the outstanding 
educators and clinicians from 
the classical era of Yale medical 
school, announced that she will 
be retiring this July and plans to 
concentrate her efforts on writ¬ 
ing, including a book. All of her 
many grateful students wish her 
well. I will be sending out a com¬ 
posite of e-mails I have received 
that provides specific informa¬ 
tion about many members of 
our class. If you do not receive 
this communication and wish 





Once again, it was quality, not 
quantity in attendance, that had 
us all having a good time at new 
New Haven restaurant L’Orcio 
for our Saturday dinner. Liz 
Gawron and Paul Johnson came 
all the way from California. Paul 
is an expert diver and scuba 
instructor as well as an under¬ 
water photographer. Brendan 
Clifford, too, came in from the 
California beaches, noting he 
has retired from his surgical 
career—he will be spending 
some time this fall with his wife 
in Massachusetts. Dawn 
Hassinger came up from Atlanta. 
Dawn spends her time doing 
medical writing these days. 
Vivian Reznik spent several days 
visiting with me. Besides doing 
academic pediatrics at the 
University of California-San 
Diego, she is researching a book 
on the beginnings of coeduca¬ 
tion at Yale. Vivian and I were 
especially upset that Barbara 
Stoll, who has just been named 
chair of peds at Emory, didn’t 
make it up for the event—we 
were hoping we could cause just 
as much trouble as we used to. 
The more local contingent was 
Mark and Sharon Ruchman, com¬ 
ing down from Washington, 
Conn. Mark is a very active oph¬ 
thalmologist in Waterbury. And 
Frank Watkins, who is an 
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orthopaedic surgeon, came up 
from New Rochelle, and even 
though his lovely wife is a 
lawyer, we all had a good time. 
I have just recently given up 
obstetrics, only because of the 
malpractice insurance—and I 
E spend the time I should be 
:i delivering babies harassing as 
many politicians as I possibly can. 
We did receive some 
I "regrets” with information. 
Hymie Milstein is still happily 
practicing internal medicine at 
I Kaiser in LA—one suggestion is 
that we should hold a reunion 
out there, with so many class¬ 
mates there. Kathy Shepard is 
taking time off from pediatrics 
to spend the year in Italy with 
her husband, the newly retired 
dean of the Law School at 
Duquesne University. And 
George Noble was busy at many 
family graduations around cen¬ 
tral Iowa, where he is busy doing 
peds surgery. Sid Spiesel’s peds 
practice in New Haven is still 
very busy, but he couldn’t come 
to the reunion because his family 
held a 65th birthday party for 
him that evening. 
However, what I found most 
gratifying at the reunion was 
seeing our professors—folks like 
Dr. Braverman and Dr. Kushlan— 
having a good time, still practic¬ 
ing and teaching and reassuring 
me that we all have a lot of time 
left to have fun. And Vivian and I 
have a mission for the next 
reunion—to raise a bundle of 
money for the reunion fund— 
more on that in subsequent 
mailings! 
Mary Jane Minkin 
1980 
25th reunion 
Our 25th reunion was graced by 
good weather and a good 
crowd. Twenty-one classmates 
came, many with their spouses, 
and some with children. We 
enjoyed the traditional clam¬ 
bake Friday night, the sherry 
lunch Saturday and a wonderful 
class dinner at the Quinnipiack 
Club. The dinner was made spe¬ 
cial as each classmate shared 
memories and updated the 
group on the events of their life 
over the last 25 years—it barely 
seems possible as most people 
looked very much the same. 
The California contingent 
included Sittiporn Bencharit and 
wife Reylina. They have two chil¬ 
dren. Sittiporn has been happily 
engaged in a private Cl practice 
for 18 years. He says, "Keep in 
touch, be here at the 50th and 
support the medical school." 
Cesar Molina, irrepressible as 
ever, came with wife Linda from 
Los Altos. He has a satisfying 
career as a cardiologist and still 
meditates. He was eager to 
show photos of his two daugh¬ 
ters. Of special note, Cesar has a 
winery for sale and he provided 
samples of his award-winning 
wine at the class dinner. Nancy 
Todes Taylor is assistant chief of 
dermatology with the 
Permanente Medical Group in 
San Rafael, Calif., where she does 
mostly laser, skin cancer and 
cosmetic dermatology. She and 
husband Graham have two chil¬ 
dren. She goes to Australia 
(where her husband comes 
from) “almost all the time.” 
The mid-section of the coun¬ 
try was represented by Walter 
Williams, who is a professor of 
radiology at University of 
Arizona Medical School. Walter 
had the honor of seeing one of 
his two sons, Steven Williams, 
m.d. '98, finish this year as chief 
resident in plastic surgery at 
Yale. Walter also reports that he 
has a serious hobby as an ama¬ 
teur radio operator. Craig Brooks 
passed through at the class din¬ 
ner and recounted some of his 
adventures working as an ER 
physician for Aramco in Saudi 
Arabia for the last 12 years. Craig, 
his wife, Agneta, and their two 
children are moving to Colorado 
(someone has to keep those ski 
slopes busy!). 
From Miami came Eddie 
Alfonso, one of our stalwart class 
agents, and wife Molly along 
with one of their children, 
Eduardo. Eddie is busy as a profes¬ 
sor at the Bascom Palmer Eye 
Institute. Eddie and Molly have 
two other children, well into their 
20s and engaged now in chal¬ 
lenging careers. Patricia Brown, 
from Bethesda, Md., has experi¬ 
enced a number of transitions 
this year. “With the death of my 
father, I’m now a middle-aged 
orphan.” Another change has 
been taking on a new position at 
the fda reviewing new medi¬ 
cines for dermatology, while at 
the same time maintaining a 
toehold in clinical practice. 
The Big Apple contingent 
included Al Siu, who is professor 
and chair of geriatrics at the 
Mount Sinai School of Medicine. 
Al and wife Margaret have two 
fairly young children. Al proved 
his devotion to them by wishing 
them goodnight by cell phone at 
the Friday clambake. Jonathan 
Jacobs dropped by for the class 
dinner. He is professor of genera! 
internal medicine at Cornell. He 
and his wife, Carolyn, have two 
boys. Jonathan is proud to have 
been able to start a $75 million 
aids treatment program in New 
York City as well as a program in 
Nigeria. David Goldberg is busy in 
nearby New Jersey with his skin 
laser and surgery practice. He 
and wife Rachel have four chil¬ 
dren, one of whom wants to be 
a doctor despite today’s chal¬ 
lenges to the profession. 
Never having left the com¬ 
forts of New Haven are Gary and 
Debbie Dyett Desir. Gary, a neph¬ 
rologist, is chief of medicine at 
the Connecticut VA Healthcare 
System, West Haven campus, and 
associate chief at Yale. Debbie is a 
rheumatologist in private prac¬ 
tice. Together they have four chil¬ 
dren. Gary recalled how he met 
his wife while sharing an 
anatomy table. Jean Bolognia is 
professor of dermatology at Yale 
and her husband, Dennis Cooper, 
is also on the faculty, in oncology. 
Inside sources tell us Jean has 
become well-known within the 
specialty of dermatology for serv¬ 
ing in a number of leadership 
positions and for having been the 
co-editor of what is becoming a 
popular dermatology textbook. 
Ann (Henderson) Hoeffer, social 
chair for this reunion and greatly 
appreciated, continues to be 
happy in her private pediatric 
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Bradburn have two daughters. 
Larry Young and wife Lynn Tanoue 
(m.d. ’82) have three children. 
Larry is a professor of medicine in 
cardiology and Lynn is a pulmo¬ 
nologist. Larry states that it is spe¬ 
cial to be a part of the university 
community. Barbara Fallon and 
husband Bennett Bernblum live 
in nearby Old Lyme, Conn., and 
have two children. Barbara is in 
private practice in oncology and 
an assistant professor at the Uni¬ 
versity of Connecticut. Rose Papac 
was Barbara’s mentor at Yale. 
Marty Silverstein, from 
Newton, Mass., has a continuing 
career with the Boston Consult¬ 
ing Group. He helps biotech and 
biopharm companies improve 
their product development 
process. He and wife Andree, 
a dermatologist, have two 
children. Mary Hill Wise from 
Rochester, N.Y., came to the 
reunion on Friday. She practices 
holistic medicine and with hus¬ 
band Robert has four children. 
The final crew consists of 
three classmates who graduated 
in 1981 but maintain ties to the 
Class of 1980. Phil Lee and his 
wife, Diane, share a psychiatry 
practice in New York City and 
together have two children. 
Charles Shana is a gastroenterolo¬ 
gist in practice for the past 15 
years in Newport, R.I., and Fall 
River, Mass. He and wife Miriam 
have two sons. Donald Moore, 
wife Christine and daughters 
were present at many reunion 
events. Donald practices internal 
medicine and is on the faculty at 
Cornell. Donald also is past presi¬ 
dent of the Association of Yale 
Alumni in Medicine and was hon¬ 
ored to receive the Distinguished 
Alumni Service Award. 
OK, you laggards out there: 
you missed a good time (and 
some really fine wine). The 30th 
is only five years away, so mark 





Returning members of the Class 
of 1985 gathered for dinner at 
the home of pediatrician JoAnne 
Burger. While the reunion dinner 
was scheduled for Saturday, 
Brian Lombardo (ever the eager 
beaver) got a jump on his class¬ 
mates by showing up on Friday 
night. Brian is doing general 
practice in southern Vermont, 
having recently returned with 
his family from an extraordinary 
sabbatical experience during 
which he worked at a hospital in 
Kigali, Rwanda. Saturday’s festiv¬ 
ities reunited another dozen or 
so classmates, including oph¬ 
thalmologist Kimball Woodward, 
who is practicing in Middletown, 
N.Y., and pediatrician Fred 
Santoro, whose practice is based 
in East Lyme, Conn.The passage 
of time has not altered Fred’s 
trademark laugh. Pediatric 
endocrinologist Jon Nakamoto 
has joined Quest Diagnostics. He 
and his family came in from the 
West Coast for a week of med 
school and college reunions. 
Jonathan Lewin has moved from 
Cleveland to Baltimore to 
assume the chairmanship of the 
Johns Hopkins department of 
diagnostic imaging, a position 
only recently vacated by the cur¬ 
rent director of the nih. Gail 
Mattson-Gates is a plastic and 
reconstructive surgeon in Los 
Angeles, and she strenuously 
denies participating in any 
Hollywood extreme makeovers. 
Sam Goos is also plying the skin 
trade as a dermatologist, with a 
growing multisite practice in the 
Boston area. The Boston contin¬ 
gent included Guy Fish, who is 
working in venture capital, and 
Sue Korrick, who is on the faculty 
at Harvard and focusing her 
efforts on occupational medi¬ 
cine and exposure to environ¬ 
mental toxins. Prolific author 
Bob Klitzman is on the psychiatry 
and bioethics faculty at Columbia. 
He has written several books 
and has participated in televi¬ 
sion documentaries. Jackie 
Gutmann, who is a fertility spe¬ 
cialist in Philadelphia, blew out 
of a bar mitzvah before the 
waiters brought in the flaming 
desserts and raced to Connecti¬ 
cut in time to join the gathering. 
JoAnne was very gratified to 
have her entire anatomy four¬ 
some reunited (although the 
group’s cadaver was otherwise 
engaged).The group included 
ENT Barb Guillette, who came 
down from Providence, and 
rheumatologist Paula Rackoff, 
who came up from Manhattan. 
Completing the anatomy quar¬ 
tet was Jeff Lowell, who has 
acquired a fascinating skill set. 
In addition to serving on the fac¬ 
ulty of Washington University in 
St. Louis as a liver and kidney 
transplant surgeon, Jeff has 
been trained by the St. Louis 
police as a hostage negotiator 
and spent time working on dis¬ 
aster planning for the 
Department of Homeland 
Security. Harrison Ford has 
expressed interest in portraying 
Jeff when filming begins on the 
movie version of his life. The 
evening ended with the general 
agreement that the entire class 
still looks fabulous, is a lot of fun 
to be around and should get 




Some people may feel that the 
15th reunion wasn’t worth 
attending, but those of us who 
made it had a good time. It was 
my first time seeing my class¬ 
mates and my first time back to 
New Haven since graduation, 
and much has changed. I couldn’t 
believe that Grand Central had 
changed to a Walgreen's and 
Barnes and Noble bought out 
the Yale Co-op. 
I also had a chance to tour 
the new Anlyan Center—home 
to the new anatomy lab and one 
of the largest buildings on the 
Yale campus. It is second only to 
the Payne Whitney gym in size 
and holds educational space as 
well as research labs. 
Fortunately, none of our 
classmates have changed much! 
I caught up with Nancy Angoff 
and her husband, Ron, early on. 
As you all know, she is now the 
associate dean for student 
affairs for the medical school— 
but for us, she’s still known as 
55 
“mom.” Will Andrews made it 
from Boston with his family. Will 
still spends time with his private 
practice, but I believe he spends 
! more time as senior medical 
director of Sepracor. 
Chandler Samy came up from 
Ocaia, Fla., with his family. He is 
a retinal surgeon in private prac¬ 
tice. Jonathan Foster, an ob/gyn 
in Waterbury, came in with his [wife and parents. His father was 
present for his 50th reunion. 
New York was well- 
represented at our class dinner 
on Saturday. Sam Colin came in 
with his wife. He spends much 
of his time managing a health 
care investment fund with First 
Manhattan Co. Ethan Halm also 
|| made it. He is the chair of medi¬ 
cine at Mount Sinai. Finally, Julia !Schillinger also drove up from 
New York. She is director of sur¬ 
veillance, epidemiology and 
research at the New York City 
Department of Health and 
Mental Hygiene, Bureau of 
Sexually Transmitted Disease 
Control. Her business card is 
the size of a postcard! 
Robin Hornung probably wins 
the award for the longest trek 
to be with us. She came from 
Seattle by herself—but brought 
plenty of pictures of her son 
and husband. She is the head of 
pediatric dermatology at the 
University of Washington. 
Ercem Atillasoy (he’ll always be 
known as Tilly to us) came from 
Philadelphia. Tilly is a derma¬ 
tologist and the director of 
internal medicine, dermatology 
and tissue engineering at 
Novartis Pharmaceuticals Corp. 
We also had a chance to catch 
up with Jennifer Mark, who 
came in for the dinner. She’s 
been busy in an ER in New 
England (I can’t remember just 
where—a good reason for me 
to make it to the 20th). 
Finally, I came in by myself 
from Concord, N. C. There, I am 
an electrophysiologist with a 
group of eight other cardiolo¬ 
gists at a moderate sized com¬ 
munity hospital. I am married 
to Jane Rasmussen (Class of 
’89) and have twin g-year-old 
daughters! 
Overall, all had fun, but the 
evening did have a bit of a sad 
note. Dan Stryer passed away 
from a brain tumor this spring. 
He really had wanted to make 
the reunion, which filled us all 
with a certain sadness. We all 
decided that we wanted to do 
something meaningful in his 
name. I believe Nancy and Tilly 
are going to come up with some 
ideas. We need to move on this 
to make it really meaningful. 
Stay tuned for more information 
about this later. 
Well, that’s it. I hope to see 




I am glad to report a strong 
turnout for the Class of 1995. It 
was wonderful, considering how 
busy we all are with our careers 
and families. Chris Lykins traveled 
from his busy otolaryngology 
practice in Phoenix to share 
memories with his friends. Chris 
has found a great spot for all of 
us to visit in Arizona and invites 
us all to visit him at Burning 
Man next year. Chris Wahl 
traveled from the University of 
Washington in Seattle. It was 
really an expedition, since his 
five-month-old triplets accom¬ 
panied him. His wife, Rebecca, 
deserves most of that praise. 
Although we are sad that Chris 
has left the Yale community, we 
are happy to see that he is prac¬ 
ticing sports medicine at the 
very institution that he once 
passed on. Emily (Rosenberg) 
Roth (pediatrics) and Jake Roth 
(psychiatry) were able to join us 
at the clambake. They and their 
two children spent the past few 
years at Harvard. No degrees for 
the children thus far.They have 
all recently headed for warmer 
weather near Todd Alamin and 
Artis Montague in California. 
David Morales, his wife, Mary, 
and their two children traveled 
from Houston, where Dave is a 
pediatric cardiothoracic surgeon, 
after nine years of training. Nick 
Schwartz and his wife, Loretta, 
traveled from Seattle for the 
occasion. Nick is truly remark¬ 
able for being our only alumnus 
to have completed two resi¬ 
dencies. However, most of us do 
believe that he is best suited for 
psychiatry. While he did not stay 
at the President’s mansion we 
understand that his quarters in 
New Haven were comfortable. 
Jeff Algazy and his lovely wife, 
Abbey, came up from New Jersey 
for the event. Jeff has been 
doing consulting for a number 
of years and is happy spending 
time with his daughter. Brian 
Adams, Jilda Vargus and their 
daughter came back to Yale 
from Cincinnati. Brian is practic¬ 
ing dermatology and Jilda is 
practicing psychiatry. Brian and 
Jilda both exemplify the spirit of 
our class.Their assistance with 
fund-raising was appreciated 
by all of us. Tim Kinkead and his 
wife, Lisa, drove in from Cape 
Cod, where Tim is practicing 
orthopaedics. Tim now has a 
look-alike son, who fortunately 
has his mother’s temperament. 
Christine Brozowski came 3,000 
miles, from Berkeley. Her knowl¬ 
edge of wine makes her a very 
useful contact when traveling to 
Napa. My neighbor Jon Driscoll 
came with his wife, Jenna, and 
their 4-month-old twins. Jon has 
a great orthopaedic practice in 
Connecticut. He is even operat¬ 
ing on fellow alumni! It was 
great to see Margi Rosenthal in 
attendance. Although difficult 
events brought her back to New 
Haven, we are glad to see her 
practicing pediatrics at Yale. Chip 
Skowron and his wife, Cheryl, 
came in from Greenwich to 
catch up with old friends. Chip is 
happily running a successful 
hedge fund, and has three chil¬ 
dren. As for myself, I am living 
on a farm with my wife, Holly, 
and our two children. I also prac¬ 
tice pediatrics on the side. 
It was really wonderful see¬ 
ing everyone back at Yale. It was 
inspiring to see how far people 
traveled—particularly with kids! 
I am looking forward to seeing 
more of us back in the coming 
years. Barbara Garcia, Alice Chang, 
Ben LeBlanc, Erin LeBianc, Eric 
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Dorothy Novick and Eric Gomes 
all regret not being able to make 
it this time. We certainly have 
an exceptional class. I look for¬ 
ward to many memorable 




The Class of 2000 turned out in 
good numbers for our first 
reunion, with slightly under 20 
percent of the class in atten¬ 
dance. While most attendees 
were from the Northeast, we 
had a few long-distance travelers 
as well. Not too bad considering 
many are still in training. The 
weekend offered fine weather 
for the traditional New England 
clambake on Harkness Lawn, 
and a spectacular dinner hosted 
by the 50th reunion class at 
the Graduate Club. Our class has 
embarked on a wide range of 
paths since leaving Yale five 
years ago. 
Jen Dorosz was on an East 
Coast swing, having finished her 
first year of cardiology fellow¬ 
ship at the University of 
Michigan. She spent an extra 
year in Seattle as chief resident 
at the University of Washington. 
Arvind Venkat is now an emer¬ 
gency medicine attending at the 
University of Pittsburgh. He was 
accompanied by his wife.Veena, 
who is finishing a pediatric Gl 
fellowship, and their 6-month- 
old daughter. Jonathan Erulkar 
was recently married to Dierdre 
Carrol (ysn '00) and is now com¬ 
pleting his orthopaedic training. 
Next year he will join the Boston 
crowd as he pursues a spine fel¬ 
lowship at New England Baptist. 
The New Haven residents 
were well-represented. Oscar 
Colegio has finished a prelimi¬ 
nary year in internal medicine at 
ynhh and will go on to train in 
dermatology at Yale next year. 
He is married to Stephanie 
Colegio-Eisenbarth, who will be 
going on to a residency in labo¬ 
ratory medicine. Dan Negoianu 
has completed his chief resi¬ 
dency year at ynhh and will 
leave the Elm City for a nephrol¬ 
ogy fellowship at the University 
of Pennsylvania. Michelle Mak 
and her husband came to the 
clambake with their beautiful 
baby; Michelle is practicing der¬ 
matology in Bridgeport. Andrew 
White is finishing his ortho¬ 
paedic training, with plans to 
start a spine fellowship in July. 
John Mahoney braved the week¬ 
end with his wife and their 
infant son Jack, all before driving 
across the country to start a 
hand surgery fellowship in 
California. 
Joanna Sheinfeld and her hus¬ 
band, Mark Paltrowitz, are the 
proud parents of Leila. Joanna 
just finished her geriatrics fel¬ 
lowship at Yale and will be 
returning to Mt. Sinai, where she 
was chief resident along with 
Dan Jacoby. Dan and his wife, 
Stephanie, live in New York, 
where Dan is pursuing fellow¬ 
ship training in cardiology at 
Columbia. Joanna will be practic¬ 
ing alongside Jon Ripp as part of 
Mt. Sinai’s Visiting Doctors 
Program, which cares for home- 
bound elderly in New York City. 
Jon and his wife, Melissa, spent a 
year practicing in Alaska before 
returning to New York. 
Other New York attendees 
included Keri Adelson and David 
Grodberg; Keri is juggling a fel¬ 
lowship in hematology and 
oncology at Columbia with tak¬ 
ing care of Paley, an adorable 
toddler. Maya Salameh, having 
also finished a chief residency 
year at ynhh, will be moving to 
New York to practice vascular 
medicine at Columbia. Jodi and 
Elie Levine have three daughters; 
Jodi is completing training in 
dermatology and Elie is finishing 
his residency in plastic surgery. 
Members of the Boston con¬ 
tingent were distressed that 
they had to come to New Haven 
to meet up. Amy Nuernberg, 
another ynhh chief resident, is 
completing a fellowship in occu¬ 
pational health at the Harvard 
School of Public Health, and will 
go on to a fellowship in pul¬ 
monary and critical care. John 
Abraham is finishing up his resi¬ 
dency in orthopaedic surgery, 
and will go on to specialize in 
orthopaedic oncology. Karin 
Andersson is finishing up her 
clinical year in a Gl fellowship at 
Massachusetts General Hospital 
(mgh); she is married to Brett 
Cohen, who was also in New 
Haven for his roth college 
reunion. Deborah Wexler is fin¬ 
ishing up her chief residency 
year at mgh before continuing 
her fellowship in endocrinology. 
Her husband, David Friedman, is 
very happy to be back in the lab 
after finishing his training in 
nephrology. Carl Seashore is prac¬ 
ticing primary care pediatrics 
and working in the pediatric 
hospitalist program at 
MassGeneral Hospital for 
Children. His son, Luke, enjoyed 
the time with his grandparents 
as well as all the festivities. 
There were day trips, moun¬ 
tain bike rides, scenic tours and 
even lectures spread over the 
weekend for all to enjoy. It was 
truly wonderful to catch up with 
so many old friends, and see 
how we, as well as New Haven, 
have all changed in five short 
years. We hope to see more of 




In June alumni of Yale’s Physician 
Associate (PA) Program held their 
first reunion, bringing together 
graduates from the program’s 35 
years.The reunion is expected to 
become an annual event, said 
Mary L. Warner, pa-c, m.m.sc, 
program director and assistant 
dean. “Every year we will have a 
dinner and invite our graduates 
to participate in activities 
throughout the medical school.” 
About 50 graduates renewed 
friendships and made new ones 
at the Graduate Club. Warner 
also described the state of the 
program: its accreditation was 
renewed last year, and thanks 
to a change in school policy, pa 
faculty now have the standing of 
clinician-educator track faculty. 
And, Warner said, an alumni out¬ 
reach program is in the planning 
and development stages. 
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From Yale to Africa, an 
alumna finds her niche 
A decade after her graduation, Rachel 
Bronzan studies malaria in Malawi. 
On a typical morning in Malawi’s rainy 
season, which runs from November 
to May and brings mosquitoes out 
in force, Rachel N. Bronzan, m.d. ’95, 
m.p.h., sees patients with severe 
malaria. “It’s sort of a perverse lottery 
jackpot,” said Bronzan of the ward she 
works on at Queen Elizabeth Central 
Hospital in the city of Blantyre. “We 
can provide better care because we 
have fewer patients, but you have to be 
very, very sick to come to our ward.” 
In the dry season, Bronzan puts on 
her public health hat—she works for the 
Centers for Disease Control and Pre¬ 
vention (cdc) on epidemiological stud- 
ies and disease monitoring for Malawi’s 
National Malaria Control Program. 
It is in Malawi that Bronzan has 
combined her love of Africa with an 
interest in science and a desire to use 
medicine to help others. Malawi, in 
southeastern Africa, has been her home 
since 2002, but Bronzarfs interest in 
Africa started long before. “When I was 
young I was always taken with the idea 
of Africa—its natural beauty, diverse 
indigenous cultures, exotic wildlife and 
vast expanses of land and sky,” she said. 
She first traveled to Africa in 1991 as 
a Downs fellow studying hiv in 
Senegal. During her fourth year at Yale 
she went to Kenya for a clinical rotation 
and worked at a malaria research post. 
Now Bronzan lives in Blantyre, the com¬ 
mercial and industrial center of Malawi, 
a landlocked country of 94,000 square 
kilometers of rolling plains with me¬ 
andering rivers, vibrant green tea plan¬ 
tations and peaked highlands bounded 
by Mozambique, Zambia and Tanzania. 
Bronzan s foray into medicine seems 
natural when you understand her begin¬ 
nings. Her father, a theoretical particle 
physicist, taught at Rutgers, and her 
mother, a clinical social worker, coun¬ 
seled psychiatric inpatients. She absorbed 
her father’s methodical, logical approach 
to problem solving and her mother’s 
nurturance and respect for others. Grow¬ 
ing up with a younger brother only a 
half-mile from their maternal grand¬ 
parents, she was also inspired by her 
grandfather, a physicist who worked on 
the development of color television at 
rca. In his basement workshop they 
blew glass, built and detonated small 
cannons using compressed gas to fire 
bits of pencils and erasers, and created 
electromagnetic fields with wire coils 
(like an mri) in which Bronzarfs grand¬ 
father tested the effect on his vision. 
In 1990, after graduating from 
Stanford with a degree in chemistry 
and working in an infectious disease 
lab, Bronzan began medical school. By 
her fourth year she still felt the lure 
of research, but during her travels in 
Kenya she saw the rewards of treating 
patients. “I was impressed by the great 
impact that the family physicians 
made, with broad training and simple 
interventions skillfully applied in a 
resource-poor setting. I realized that if 
I were to practice medicine I would 
most likely do it in a setting like that, 
where basic need is high,” she said. 
She spent a fifth year at Yale, during 
which she got an m.p.h. at Harvard, 
and in 1995 began a residency in 
California at the Community Hospital 
of Santa Rosa. 
After working at hospitals in the 
Bay Area, Bronzan applied to the cdc’s 
Epidemic Intelligence Service (eis), 
which provides on-the-job training in 
epidemiology. While waiting for her 
first posting, she traveled to Malawi to 
care for seriously ill children at Queen 
Elizabeth Central Hospital with Terrie 
Taylor, d.o., a professor of internal 
medicine at Michigan State University. 
For six months she received housing 
and a $100 weekly stipend. “I thought 
this was a fantastic offer, although 
some of my friends wondered why 
I would be so happy about such a dra¬ 
matic salary cut,” she said. 
In July 2000 Bronzan started her 
job at eis, which over the next two 
Rachel Bronzan took time out from her clinical 
and laboratory duties for a trip to Mt. Mulanje, 
the largest and highest mountain in Malawi. 
years took her to Mali, Kazakhstan, 
South Africa and Florida for work in 
infectious diseases. 
Now, along with her malaria 
research, Bronzan works as a part-time 
clinician-researcher for Taylor. “What 
is unique about my position is that it 
allows me the opportunity to do clini¬ 
cal care of severely ill children, clini¬ 
cally related research, as well as field 
surveys and public health-related proj¬ 
ects,” said Bronzan. 
Her epidemiological studies and 
program planning could affect malaria 
control in Africa and abroad, but she 
finds that caring for children afflicted 
with malaria is her true reward. 
“Although mortality is high—between 
15 and 20 percent of comatose children 
die—those who survive tend to recover 
quite quickly, and the majority of them 
do not have long-term neurological or 
developmental problems. They come to 
the hospital in a severe coma and can 
walk home in as little as two or three 
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A pediatrician who treated 
not just the children, but the 
whole family 
As a research fellow at Yale in 1948, 
Morris A. Wessel, m.d. ’43, joined in the 
landmark “rooming-in” study by the late 
clinical professor Edith B. Jackson, m.d., 
which examined how keeping newborns 
in their mothers’ hospital rooms affected 
families. His participation in the study 
also helped Wessel decide what kind of 
pediatrician he wanted to be. 
His role in the study was to interview 
parents during pregnancy. Mothers- and 
fathers-to-be often burst into tears as 
they recounted traumatic childhood inci¬ 
dents such as the death of a parent. “Is 
there any way that we as pediatricians 
could support families during a crisis 
like that?” he asked himself. 
Jackson and Grover F. Powers, m.d., 
who headed Yale’s pediatric department 
in Wessel’s student days, also led him 
to a broader notion of his role as a 
pediatrician. “Anything that affects the 
child’s welfare is within the realm of 
the pediatrician’s responsibility,” Powers 
said. After graduating from the School 
of Medicine, Wessel worked at the 
Mayo Clinic under Benjamin M. Spock, 
m.d., med ’29, whom Wessel con¬ 
sidered a mentor throughout his career. 
Wessel’s training was informed by his 
own childhood experience. The loss of 
his father when he was only 11 months 
old and his own “various sicknesses 
and unhappinesses as a child” con¬ 
vinced him that young people needed 
friends and advocates whose commit¬ 
ment did not stop at the office door. 
He found a like-minded partner in 
another young pediatrician, Robert G. 
LaCamera, m.d., fw ’36, and in 1951 
started a practice marked by extraordi¬ 
nary involvement in the lives of fami¬ 
lies and by a commitment to improve 
the community. 
“They were always late,” laughed 
Donna Sandillo, r.n., their longtime 
practice manager. They were late 
because they made house calls and 
dashed across the street to the hospi¬ 
tal—the office was on Howard 
Avenue—when one of their patients 
was in trouble. 
“People waited for them,” she said. 
“They understood.” 
The doctors encouraged parents to 
call when they faced any major chal¬ 
lenge—medical or not. Families appre¬ 
ciated touches like handwritten notes 
on the anniversary of a death and calls 
to check on teens adjusting to college. 
New Haven is a city of rich and poor 
families, and the practice saw both. 
They accepted homemade pies as pay¬ 
ment for an office visit. 
Wessel spread his philosophy as a 
clinical professor at Yale and through 
his writings. In 1963, he published 
“Why Can’t Mothers Stay in Hospital 
With Their Children?” in Redbook. 
Mothers across the country waved the 
magazine in hospital admitting offices 
demanding, “Where’s my bed? Dr. 
Wessel says I should stay!” 
“I was not very popular,” he said, 
ducking his head to hide a grin. 
Together with Anthony Dominski, 
ph.d., a scientist from the School of 
Forestry & Environmental Studies, he 
investigated lead levels in children in the 
1970s and recommended a level then 
thought to be unrealistically low. Even¬ 
tually the American Academy of Pedi¬ 
atrics recommended an even lower level. 
With former Yale School of Nursing 
Dean Florence S. Wald, R.N., he studied 
the treatment of terminally ill patients, 
which Wald believed was often futile 
and dehumanizing. Wald told Wessel 
his role would be to help her under¬ 
stand doctors’ thinking. “I can’t explain 
why doctors do what they do,” he told 
her. But he agreed to help. Their work 
led to the opening of the nation’s first 
hospice, in Connecticut, in 1974. 
There he observed that friends and 
family were quick to comfort a surviv¬ 
ing spouse. “Nobody paid attention 
to the children,” he said. Wessel now 
writes about childhood grief and has 
worked in schools, dealing with every¬ 
thing from the loss of a beloved teacher 
to the loss of the class guinea pig. 
Morris Wessel took a broad view of his role as 
a pediatrician—one marked by involvement in 
the lives of families. 
Wessel retired in 1993, as did 
LaCamera three years later. Their New 
Haven practice moved to the suburbs, 
though their successors were adamant 
about being on a bus line so that inner- 
city patients would have access. Wessel 
works two days a week at the Clifford 
W. Beers Child Guidance Clinic in 
New Haven. 
Wessel’s daughter, Lois A. Wessel, 
rn., m.s., a nurse practitioner working 
with under served patients, said that 
both her father and mother, Irmgard 
Wessel, m.s.w., influenced her career. 
They “went out on a limb to help peo¬ 
ple have better lives,” by addressing 
issues, such as housing, that are not 
usually the province of a physician. But 
her parents were not grim saints. “They 
clearly enjoyed what they did and were 
very committed to it,” she said. As she 
accompanied them around the city, she 
saw patients and clients light up. “They 
were loved and liked and respected.” 
Upon his retirement, hundreds of peo¬ 
ple gathered in New Haven’s Edgerton 
Park for “Morris Wessel Day.” 
With hmos mandating shorter visits 
and with greater technical expertise 
expected of physicians, Wessel worries 
that pediatricians are discouraged from 
knowing their patients as deeply as he 
did. “There was something about our 
practice that was unique," he said. “But 
it should not be unique at all.” 
—Colleen Shaddox 
Tap dancing through 
medicine, from surgeon to 
song-and-dance man 
While a medical student at Yale, Brock 
Lynch, m.d. ’47, sang and tap danced 
in a hospital fund-raising play. He 
remembers thinking, “Should I be in 
show business or medicine?” But even 
though he’d started tap dancing when 
he was 8, Lynch wasn’t serious about 
changing careers. After World War II 
Navy service, he resumed his medical 
career and decided that someday he 
would return to the stage. 
And he has. Since he retired in 1995 
from practicing general medicine at 
the Northampton VA Medical Center in 
Leeds, Mass., he has been part of 
Young@Heart Chorus, a Massachusetts 
performing troupe, in which the aver¬ 
age age is 80. Other men and women 
who sing in the group were engineers, 
insurance executives, building contrac¬ 
tors and teachers in their younger days. 
Rather than croon Cole Porter songs 
or others of the same vintage, the 73- 
to 91-year-olds sing tunes from the 
Rolling Stones, Bruce Springsteen, U2, 
the Beatles, Jimi Hendrix, Led Zeppelin 
and the Clash—the same loud music 
that they once told their children to 
turn down. 
In the last seven years, the 22- 
member group has toured Europe 10 
times and visited Hawaii and Australia. 
Lynch sings tenor and dances, although 
there’s not much demand for tap when 
Brock Lynch, left, sings and dances with the 
Massachusetts-based Young@Heart Chorus, 
which specializes in classic rock. 
you’ve got an electric guitar and profes¬ 
sional drum set. Young @ Heart plays 
to sold-out audiences in Europe; in 
2001, the King and Queen of Norway 
gave them a standing ovation. 
Because of their age, choice of 
music and humorous and whimsical 
performances, last June they were writ¬ 
ten up in Time magazine. The group 
disco dances to the Bee Gees’ “Staying 
Alive,” and Lynch is one of three 
soloists in “Once in a Lifetime,” origi¬ 
nally sung by the Talking Heads. 
When they go abroad once a year, 
for a week or two, Young@Heart mem¬ 
bers face a grueling schedule, usually 
one performance each night over four 
nights. This fall, they traveled to London 
for two weeks, where the group per¬ 
formed 12 straight shows, including a 
matinee and evening event on a Satur¬ 
day. These performances come after 
long plane rides and jet lag. (They 
always travel with three wheelchairs just 
in case.) The group pays tribute to each 
country it visits, so it may learn a song 
in Dutch while in Antwerp or perform 
Olivia Newton-Johrfs “Let’s Get 
Physical” in Australia. 
Back in Northampton, there are 
weekly rehearsals, sometimes more, 
where Lynch and fellow members stand 
for two hours straight. That’s a feat 
for anyone, but particularly for septua¬ 
genarians, octogenarians and nona¬ 
genarians whose collective conditions 
include arthritis, heart disease, macular 
degeneration, hip replacements, high 
blood pressure and cancer. (There are 
chairs at the back of the stage for any¬ 
one who gets tired.) Lynch, who jogs 
three times a week for 10 minutes, 
doesn’t complain about the pace, how¬ 
ever. “Young @ Heart puts a schedule 
into my life,” said the 81-year-old, “and 
without it I’d be in a rocking chair.” 
These days, the only rocking Lynch 
does is on the dance floor. But that’s 
nothing new. Everywhere he studied 
or practiced medicine, he would tap 
dance and sing in charity hospital 
shows. After his New Haven theatrical 
debut, Lynch performed during a sur¬ 
gical internship at the University of 
Cleveland Hospital and his residency 
at Malden Hospital in his hometown 
of Malden, Mass., and at New England 
Medical Center and St. Elizabeth’s 
Hospital in Boston. He tapped his way 
through Mitchell Air Force Base on 
Long Island while he was chief of sur¬ 
gery and also when he became a teach¬ 
ing fellow at Memorial Sloan-Kettering 
Cancer Center. 
Then there was more performing 
while in private practice with his father 
in Malden for 18 years, followed by more 
dancing and singing when Lynch moved 
his work life in 1975 to the Veterans 
Administration hospital near North¬ 
ampton as a general practitioner. During 
the 20 years he practiced there, his sur¬ 
gical skills were frequently requested in 
the emergency room, leading to the say¬ 
ing, “In a Pinch, Call Lynch.” 
Within a month of retiring from his 
VA post in 1995, the self-taught tenor 
auditioned for Young@Heart. He danced 
and sang his way through “Button Up 
Your Overcoat” and “You’re the Cream in 
My Coffee”—a far cry from the rock and 
roll he would churn out as a group mem¬ 
ber. "In show business, when you audi¬ 
tion, the director always asks what your 
talent is,” said Lynch. “In my case I said, 
‘For you, I’m a singer who dances, but 
if you ask me what I really am, I’m a 
dancer who sings.’” 




Do you have a colleague who is making 
a difference in medicine or public 
health or has followed an unusual path 
since leaving Yale? We’d like to hear 
about alumni of the School of Medicine, 
School of Public Health, Physician 
Associate Program and the medical 
school’s doctoral, fellowship and 
residency programs. Drop us a line at 
ymm@yale.edu or write to Faces, 
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Albert W. Diddle, M.D. '36, is pro 
fessor emeritus and was the 
original chair of obstetrics and 
gynecology at Memorial 
Research Center and Hospital 
at the University of Tennessee 
in Knoxville. The author or 
co-author of 131 publications 
on anatomy, obstetrics and 
gynecology and the history of 
medicine, he has also privately 
published his memoirs for his 
family, U.S. Naval Duty During 
World War II: Key West, Florida; 
Guadalcanal; Okinawa; Guam; 
and Tientsin, China. 
I94OS 
B. Herold Griffith, M.D. ’48, was 
elected an honorary member of 
the British Association of Plastic 
Surgeons. Griffith, who retired 
in 1996, is professor emeritus of 
surgery and chief emeritus of 
plastic surgery at Northwestern 
University School of Medicine. 
Edward Wasserman, M.D. ’45, has 
been named Physician of the 
Year 2005 by the Greater Bridge¬ 
port (Conn.) Medical Association 
for his volunteer work at an 
AmeriCares Free Clinic. 
1960s 
Stephen M. Krant, M.D. '69, HS 
’76, has been in private practice 
in plastic surgery in La Jolla, 
Calif., for 29 years, specializing in 
aesthetic and reconstructive sur¬ 
gery. He and his wife, Lyn, have 
established the SK Institute, 
a nonprofit which sponsors a 
monthly Breast Cancer Nite, 
where breast cancer survivors 
listen to speakers, enjoy food 
and beverages and receive free 
spa treatments at the SK 
Sanctuary, which is affiliated 
with Krant’s practice. The insti¬ 
tute also holds melanoma, 
prostate and ovarian/uterine 
cancer nights. 
1970S 
Lloyd N. Friedman, M.D. ’79, clini¬ 
cal professor of medicine at the 
School of Medicine, received a 
grant from the National Insti¬ 
tute for Occupational Safety and 
Health to study new gamma 
interferon assays in the diagno¬ 
sis of latent tuberculosis. In 
April he received the David 
Lyman Russell Award from the 
Connecticut chapter of the 
American Lung Association for 
contributions to the prevention 
and treatment of tuberculosis. 
Friedman is the vice president of 
medical affairs and the medical 
director of Intensive Care and 
Respiratory Therapy at Milford 
(Conn.) Hospital. 
Robert H. Posteraro, M.D. ’73, 
hs '78, fw ’79, a radiologist with 
Lubbock Diagnostic Radiology 
in Texas, graduated from Oregon 
Health & Science University with 
a master of biomedical informat¬ 
ics degree in June. 
Eddie Reed, M.D. ’79, has been 
named the director of the Divi¬ 
sion of Cancer Prevention and 
Control, National Center for 
Chronic Disease Prevention and 
Health Promotion at the Cen¬ 
ters for Disease Control and 
Prevention. He started his new 
position in June. Reed previously 
worked at the National Cancer 
Institute and at The Mary Babb 
Randolph Cancer Center at West 
Virginia University. 
198OS 
Alan B. Astrow, M.D. '80, has 
been appointed director of the 
division of hematology/oncology 
at Maimonides Medical Center 
in Brooklyn, N.Y. Astrow moved 
from St. Vincent’s Hospital 
in Manhattan, where he was 
associate medical director of 
the cancer center. "We open a 
50,000-square-foot state-of- 
the-art cancer center this 
fall,” he writes. He is joined at 
Maimonides by classmate 
Carl F. Schiff, M.D. '80, who is 
director of rheumatology. 
Robert Hartman, M.D., HS '86, 
writes to say that he is a clinical 
associate professor of derma¬ 
tology at the University of 
Southern California School of 
Medicine. In October 2004 he 
passed a new board exam in 
pediatric dermatology. For four 
months each year he heads a 
pediatric dermatology clinic at 
Childrens Hospital in Los Angeles. 
Reginald J. Sanders, M.D. '85, 
hs ’86, chief of the retinal 
service at the Georgetown 
University/Washington National 
Eye Center, was named one 
of the top physicians in the 
Washington, D.C., metro area 
by Washingtonian magazine in 
July. Sanders also serves on the 
board of the American Society 
of Retina Specialists. 
Elizabeth Platzker and Steven Kawut 
Krystn R. Wagner, PH.D. '89, M.D. 
’96, assistant professor of medi¬ 
cine (infectious diseases/AiDS 
program) at the School of 
Medicine, and Jose F. Salvana, 
m.d., an infectious disease spe¬ 
cialist, were married in May in 
Baltimore. Wagner is the medi¬ 
cal director of the Nathan Smith 
hiv clinic at Yale-New Haven 
Hospital. Salvana is the hiv clini¬ 
cal director at the Hill Health 
Center, a community clinic in 
New Haven. 
199OS 
Alison L. Days, M.D. ’99, and 
Sergio Rico Jr., m.b.a., were mar¬ 
ried in Cancun, Mexico, in 
February. Days is a pediatrician 
at Texas Tech University in El 
Paso, and her husband is a main¬ 
tenance supervisor at Penske 
Truck Leasing. 
Mauricio J. Garrido, M.D. ’98, a 
cardiothoracic surgery fellow at 
Columbia University Medical 
Center in New York, and Louisa 
Terry, an executive director of 
the Ovarian Cancer Research 
Fund, a nonprofit agency in New 
York, were married on April 9 
in Miami. 
Steven M. Kawut, M.D. ’95, the 
Herbert Irving Assistant Profes¬ 
sor of Clinical Medicine in Epi¬ 
demiology at the Columbia 
University College of Physicians 
and Surgeons, and Elizabeth S. 
Platzker, a senior designer at Liz 
Claiborne, the clothing and 
accessories company, were mar¬ 
ried on May 29 in Los Angeles. 
Kawut teaches and conducts 
research on pulmonary hyper¬ 
tension and lung transplantation. 
6i 
Zimra Cordon James Moore 
Andrea Pernack, m.p.h. '98, a pro¬ 
gram officer at the Institute 
of Medicine, and Dean Anason 
were married on May 1,2004, 
in Warren, Mich. Pernack, now 
Pernack-Anason, has worked on 
studies involving the national 
smallpox vaccination program 
and data sharing for a vaccine 
safety research database. 
Lynn E. Sullivan, M.D. ’96, HS ’00, 
was married to David A. Fiellin, 
m.d., hs ’95, fw ’97, in Sep¬ 
tember in South Salem, N.Y. 
Sullivan is an assistant professor 
of medicine at the School of 
Medicine, where Fiellin is an 
associate professor of medicine. 
2000S 
Cristina Baseggio, M.D. ’05, 
was married in May to Seth 
Alexander, a director of invest¬ 
ments in the office of the Yale 
Endowment. Baseggio began a 
| residency in internal medicine at 
Brigham and Women’s HospitaI 
in Boston in June. 
Jonathan Solomon Erulkar, M.D. 
’01, and Deirdre“Dede” Holden 
Carroll, m.s.n. ’00, a.p.r.n., were 
married on August 1,2004, in 
Lake Forest, III. Fellow Yale 
Medicine grads who attended 
included John Abraham, m.d. 
’00, and Badri Rengarajan, m.d. 
’99. Erulkar is in his fifth year 
and a chief resident in the 
Department of Orthopaedic 
Surgery and Rehabilitation at 
Yale. Carroll, a psychiatric clinical 
nurse specialist and adult nurse 
practitioner, is a third-year 
ph.d. student at Boston College. 
Previously she spent several 
years as a co-investigator in the 
Clinical Trials Program at the 
Yale Child Study Center and on 
the clinical faculty of the Yale 
School of Nursing. Since their 
honeymoon on Anguilla, the 
newlyweds have settled into 
married life in Branford, Conn. 
In 2006, however, they will be 
moving to Boston, where 
Jonathan has accepted a spine 
surgery fellowship at the New 
England Baptist Hospital and a 
clinical faculty appointment 
with Tufts University School of 
Medicine. 
Zimra J. Cordon, M.P.H. ’02, D.V.M., 
and Steven J. Danzer, ph.d., were 
married on April 17. Gordon is 
a veterinarian at the Rippowam 
Animal Hospital in Stamford, 
Conn., and a research associate 
with the Yale Occupational and 
Environmental Medicine Pro¬ 
gram. Danzer is an environmen¬ 
tal planner for the town of 
Stratford, Conn. 
Elizabeth W. Holt, M.P.H. ’05, 
and Matthew J. Delfino Jr., 
m.b.a., were married in June 
in Greenville, S.C. After their 
honeymoon, the couple moved 
to Boston, where Delfino is 
employed at Brigham and 
Women's Hospital. 
Anita Kama, m.d. ’02, and Mehul 
A. Dalai, m.d., m.sc, were 
married in July in Knoxville,Tenn. 
Karne is chief resident in pri¬ 
mary care at New York University 
School of Medicine. Dalai is an 
attending physician in medicine 
at N.Y.U.-Bellevue Medical Center. 
Matthew P. Kronman, M.D. ’03, 
was married in September to 
Evelyn K. Hsu, m.d., in Seattle. 
They met at Children’s Hospital 
in Seattle, where both were 
residents in pediatrics. 
D. Scott McBride Jr., M.D., HS ’05, 
completed a residency in anes¬ 
thesiology in June and is now 
a staff anesthesiologist with 
the U.S. Air Force at Elmendorf 
Air Force Base near Anchorage, 
Alaska. He’s scheduled to be 
deployed to Iraq in May 2006 
to serve in a field hospital. 
James Moore, M.P.H. ’03, is one 
of 10 fellows selected to partici¬ 
pate in the newly established 
Association of Schools of Public 
Health/Centers for Disease 
Control and Prevention (cdc) 
International Global aids 
Fellowship Program.The pro¬ 
gram is part of cdc’s Global 
aids Program, which is part of 
President Bush’s five-year initia¬ 
tive to channel $15 billion into 
hiv/aids treatment and preven¬ 
tion in 12 African countries and 
Guyana and Haiti. 
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62 in Memoriam 
William T. Bachmann, M.D., HS 
’74, died on July 28 of cancer. He 
was 65. Bachmann, a dermatolo¬ 
gist, lived in Stonington, Conn., 
and maintained a practice in 
Westerly, R.I., for more than 30 
years. During the Vietnam War 
Bachmann served as a physi¬ 
cian on submarines based in 
Groton, Conn. He was known 
in the area not only as a physi¬ 
cian, but also for his enthusiasm 
for fishing for tuna and marlin. 
In recent years he began explor¬ 
ing area wildlife by boat and 
kayak. An activist and defender 
of healthy sea life, he recently 
completed a book about his 
fishing experiences and environ¬ 
mental insights. 
Horst N. Bertram, M.D., HS ’59, a 
radiologist, died on March 12 in 
Cornwall, Pa. A native of Berlin, 
Germany, Bertram completed his 
medical studies at the end of 
World War II, then began a resi¬ 
dency in Ohio. After serving as a 
battalion surgeon in the Army 
during the Korean War, he came 
to Yale to complete his residency 
in radiology. In 1965 he joined 
the staff of the Good Samaritan 
Hospital in Lebanon, Pa., where 
he stayed for 30 years. He served 
as chair of the radiology depart¬ 
ment and president of the 
Lebanon County Medical Society. 
Sister Mary Anne Fitzmaurice, 
r.n., m.p.h. '69, a member of 
the Sisters of St. Joseph, died on 
May 1 in West Hartford, Conn. 
She was 80. Fitzmaurice received 
her nursing degree from St. 
Francis Hospital School of Nurs¬ 
ing in Hartford, Conn., and in 
1955 became operating room 
supervisor at St. Mary’s Hospital 
in Waterbury, Conn. In 1967 she 
began studies in hospital 
administration at Yale. After her 
graduation in 1969 she spent 
a year at the Hospital of St. 
Raphael in New Haven as a resi¬ 
dent in administration. During 
her career she also worked at 
St. Francis Hospital in Hartford, 
the Provincial House of the 
Sisters of St. Joseph in West 
Hartford and the Intensive 
Education Academy in West 
Hartford. She was honored with 
a Certificate of Membership 
in the American College of 
Hospital Administrators, and in 
1979 the mayor of Hartford 
recognized her service with a 
Certificate of Award. 
Frederick P. dike, M.D. ’41, died 
on September 12 at his home in 
Meriden, Conn. He was 89. A 
lifelong resident of Meriden, 
Glike graduated from Harvard 
University before entering the 
medical school at Yale. During 
World War II he was a captain 
with the Third Battalion and 
participated in the Battle of the 
Bulge. He returned to Meriden, 
where he practiced medicine for 
40 years until his retirement. 
Glike loved music and played 
the clarinet in the Meriden 
Symphony. He also enjoyed the 
outdoors and took hiking trips 
with his family in the White 
Mountains, where he climbed all 
peaks over 4,000 feet. 
Victor C. Hackney, M.D. ’43, died 
on September 5 in Geary, Okla. 
He was 88. During World War II 
Hackney served in the Navy. 
Board certified in dermatology 
and pathology, he studied at the 
Armed Forces Institute of 
Pathology. He received academic 
appointments at the University 
of Southern California and 
at Stanford University before 
becoming founding chair of 
dermatology and professor of 
dermatology and pathology at 
Indiana State University School 
of Medicine. He retired in 1976. 
H. David Rearing, M.D., HS '68, 
died on September 9 at his 
home in Brackney, Pa. He was 
68. After receiving his medical 
degree from Cornell in New 
York, Rearing completed a resi¬ 
dency in ob/gyn at Yale. He 
subsequently served in the U.S. 
Army at West Point for two 
years. From 1972 to 1991 he prac¬ 
ticed ob/gyn in Binghamton, 
N.Y., with two partners, then 
went into private practice until 
2001, when he retired. 
Carter Lee Marshall, M.D. '62, 
m.p.h. ’64, died on February 18 in 
Tucson, Ariz. After service in the 
Army, Marshall was on the fac¬ 
ulty at the University of Kansas 
School of Medicine, the Mt. Sinai 
School of Medicine and the City 
University of New York. In the 
1970s he helped set up a medi¬ 
cal school at Morehouse College 
in Atlanta. He later served as 
director of medical education at 
the University of Medicine and 
Dentistry of New Jersey, before 
moving to Arizona to work at 
the Health Services Advisory 
Group, the state’s Medicare 
quality improvement organiza¬ 
tion. He co-authored an intro¬ 
ductory text for allied health 
workers and published more 
than 70 articles. 
Willys M. Monroe, M.D. ’41, a 
pathologist, died on March 18 
in Lynchburg, Va. Monroe was a 
life fellow of the College of 
American Pathologists, a fellow 
of the American Society for 
Clinical Pathology and a life 
member of the Medical Society 
of Virginia. During his career he 
spent five years in the U.S. Public 
Health Service, leaving as a lieu¬ 
tenant colonel to become chair 
of the department of pathology 
at Richmond Memorial Hospital, 
where he established a blood 
bank and trained lab techni¬ 
cians. He also taught pathology 
at Virginia Commonwealth 
University and the University of 
Virginia. He was the first chief 
of the Richmond Metropolitan 
Blood Service. 
Richard B. Ogrean, M.S. ’52, died 
on June 2 in Fort Myers, Fla. He 
was 83. After serving in the U.S. 
Army Medical Corps in Europe 
during World War II, Ogrean 
obtained a degree in public 
health administration at Yale, 
then worked as an assistant 
administrator at Yale-New 
Haven Hospital. In 1956 he 
became an administrator at 
Windham Community Memorial 
Hospital in Willimantic, Conn., 
where he stayed for 18 years. He 
worked at other hospitals until 
his retirement in 1983. He was 
also a deacon at the First Baptist 
Church in Willimantic. 
Howard Rasmussen, M.D., PH.D., 
a former professor of medicine 
and cell biology and chief of 
endocrinology and metabolism 
at the School of Medicine, died 
on April 20 in North Carolina 
after a long illness. He was 80. 
Rasmussen was one of the first 
scientists to recognize the 
importance of calcium as a sig¬ 
naling molecule. During his 
career he was chair of biochem¬ 
istry at the University of Penn¬ 
sylvania and founding director 
of the Institute of Molecular 
Medicine and Genetics at the 
Medical College of Georgia. 
Rasmussen was at Yale from 
1976 to 1993. 
Robert T. Sceery, M.D. ’50, died 
on February 18 of congestive 
heart failure in Cohasset, Mass. 
He was 84. Sceery, a pediatri¬ 
cian, was school physician in 
Cohasset for more than 40 
years. Known for his quiet man¬ 
ner, he made house calls and 
saw patients regardless of their 
ability to pay. Although retired 
for several years, Sceery saw 
occasional patients and attended 
weekly rounds at Massachusetts 
General Hospital. During World 
War II he joined the Navy, pilot¬ 
ing a tank landing ship to 
Normandy beach on D-Day and 
participating in assaults on 
southern France and Japan. 
Paul W. Sternlof, M.P.H. '57, died 
in Sharon, Conn., on August 12. 
He was 73. Sternlof served 
as assistant administrator of 
Baltimore General Hospital in 
Maryland from 1958 until 1962, 
when he became president of 
Sharon Hospital. He remained 
in that post until 1989. 
Daniel B. Stryer, M.D. ’90, director 
of the Center for Quality 
Improvement and Patient Safety 
at the Agency for Healthcare 
Research and Quality, U.S. 
Department of Health and 
Human Services, died on May 19 
in Rockville, Md„ of complica¬ 
tions from a brain tumor.The 
center provides information to 
patients and the health care 
industry to improve quality of 
care. Stryer took on his job in 
1997, after a residency in internal 
medicine at the University of 
California, San Francisco, and, 
with his wife, pediatrician Stacy 
Beller Stryer, m.d. ’91, spent 
three years with the Indian 
Health Service in Arizona. 
George Tyler, m.d. ’67, died on 
August 28 in Bethlehem, Pa. 
He was 65. Tyler, a fellow of the 
American College of Surgeons, 
was a senior surgeon at Lehigh 
Valley Hospital-Muhlenberg and 
an instructor for the "Advanced 
Trauma Life Support” course. 
He was a major in the U.S. Army 
Seventh Cavalry and served in 
Vietnam, where he received the 
Bronze Star. 
Vernon T.“Doc” Watley, M.D. ’49, 
died on August 30 in Beaumont, 
Texas. He was 83. In March 1942 
Watley enlisted in the U.S. Air 
Force and served at what later 
became Lackland Air Force Base 
in Texas. During the Korean 
War he was called back to duty 
and ran the neurological service 
at Lackland. After his military 
service, he was the superintend¬ 
ent of Abilene State Hospital 
for Epileptics and a psychiatrist 
at Austin State Hospital. 
During his career he was also 
an emergency room doctor 
and, until his retirement in 1981, 
a family physician. 
SEND OBITUARY NOTICES TO 
Claire M. Bessinger, Yale Medicine, 
P.O. Box 7612, New Haven, CT 





















64 F0ll0W-Up Archives 50 and 25 years ago 
A “perfume” to prevent disease 
Early in 1999 John R. Carlson, ph.d., the Eugene Higgins 
Professor of Molecular, Cellular and Developmental Biology, 
reported that his laboratory had identified 16 odor receptor 
genes in fruit flies (See "Researchers Discover Odor Receptor 
Genes in Fruit Flies,” Spring 1999). It was the first finding of 
such genes in insects. Carlson and his colleagues went on to 
find taste receptor genes in fruit flies and to identify the 
functions of specific odor receptors in mosquito antennae. 
Now Carlson’s laboratory is part of an international 
team that plans to harness those findings to reduce the spread 
of malaria, which kills 1 million people each year, mostly in 
the developing world. The female mosquitoes that spread the 
disease are drawn to certain human odors, which they"smell” 
with receptors in their antennae. The team, which includes 
scientists in the United States, the Netherlands,Tanzania and 
Gambia, hopes to create a “perfume” that will either lure 
malaria-carrying mosquitoes into traps or act as a repellent. 
Scientists at Yale and Vanderbilt University will identify 
odors that affect mosquitoes and will create the "perfumes.” 
Dutch researchers will study the effects of the odors on mos¬ 
quito behavior in the laboratory. And the African scientists 
will field-test the odors. The $8.5 million, five-year project is 
funded by the Bill & Melinda Gates Foundation’s Grand 
Challenges in Global Health initiative. Ultimately, the scien¬ 
tists hope the odors they develop will prevent malarial mos¬ 
quitoes from infecting humans, and will be inexpensive, safe 
and easy to use in rural areas. This approach could also be 
applied to mosquitoes that carry dengue fever or the West 
Nile virus. "With insect-borne diseases, the best way to control 
the disease is usually to control the insect,” Carlson said. 
“We smell good to the mosquitoes, so if we can understand 
in molecular detail how the insects are attracted to us, we 
might be able to devise new means of controlling them.” 
—John Curtis 




Students’ Loan Fund of Yale 
Men in Medicine 
"The following statement is pub¬ 
lished at the request of the 
officers and incorporators of the 
Students’ Loan Fund of Yale 
Men in Medicine, Inc. 
“It is estimated that it costs a 
student a minimum of $2,000 
for each of his four years of resi¬ 
dence at the Yale University 
School of Medicine. Although this 
represents only a fraction of the 
total cost of his medical educa¬ 
tion, it is nevertheless a consider¬ 
able sum.... In the present 
academic year, ninety students, 
or twenty-seven percent of the 
student body, have requested 
such help.... 
“The Students’ Loan Fund of 
Yale Men in Medicine has been 
for twenty years a modest but 
continuing source of help to our 
needy and worthy students. Since 
its inception in 1934, this Fund has 
provided loans to one hundred 





finds a new home 
“The completion of the third floor 
of the Nathan Smith Building has 
long been awaited by members of 
the Department of Human Genet¬ 
ics.‘It seems as though we had 
outgrown facilities in the LCI build¬ 
ing even before we moved in,’ a 
faculty member observed recently. 
“During the past two decades, 
the study of human genetics has 
become one of the most rapidly 
advancing and challenging fields 
in medical science.‘It is hard to 
believe now, that in the 1950s when 
I and many of my colleagues were 
in medical school, human genetics 
was a relatively minor subject,’ 
Dr. Leon Rosenberg, chairman of 
the Department, remarked a few 
years ago. 
“The Nathan Smith Building ... 
symbolizes the spirit in which the 
Department was founded in 1972. 
At the time, Dr. Rosenberg stated, 
‘The fundamental philosophy 
behind this departmental organi¬ 
zation is that the application of 
basic genetic knowledge to the 
problems of human illness can best 
be accomplished in a climate 
which encourages close interaction 
between those with expertise is 
basic laboratory genetic science 
and those who are concerned with 
patients with genetic problems. 
This is a new concept in academic 
medicine.” 
Stay connected 
Yale Medicine can help you stay connected with fellow alumni 
of the School of Medicine, School of Public Health, Physician 
Associate Program and the medical school’s doctoral, fellowship 
and residency training programs. Share your personal and pro¬ 
fessional news for publication in the Alumni Notes department 
of Yale Medicine and on the Web, using this card or the online 
form at info.med.yale.edu/ayam. 
□ _ 
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House Staff (hs) 
□  
Other Yale degree(s) and year(s) 
Share your news on the reverse of this card and mail to: 
Claire M. Bessinger 
Yale Medicine Publications 
Yale University School of Medicine 
P.O. Box 7612 
New Haven, CT 06519-0612 
Please include a photograph. 
























































































































































































































































































TULANE STUDENTS FIND A SAFE HAVEN AT YALE 
Dorota Ruszczyk had just returned to New Orleans from fieldwork 
in Kenya when she learned that Hurricane Katrina was about to 
land. She and her fiance stocked up on food, batteries and water, 
but as the storm approached, they left for Baton Rouge. Now 
Ruszczyk is with her family in New Haven and finishing her m.p.h. 
course work at Yale rather than Tulane. Memories of the days after 
the storm still haunt her. “You saw everyone around you with a 
blank stare on their face,” she said. The hurricane diverted Andrea 
Humphrey, m.p.h. ’05, from a doctoral program at Tulane back to 
Yale, where her former advisors helped her sign up for course 
work. Although her clothes, computer and textbooks are in New 
Orleans, Humphrey considers herself lucky. “It’s going to be very 
hard for people to get their lives back together,” she said. David 
Grew, who was about to enter public health school at Tulane, is 
taking classes at Yale. He weathered the storm with his landlord’s 
family in Houma, La., then spent time in Texas, including a day 
helping evacuees in Austin. “It had a real effect on me, in how 
I look at the way health care should be distributed,” said Grew. 
Grew, Humphrey and Ruszczyk are among five students from 
Tulane who have found temporary homes at the medical school 
after Hurricane Katrina forced the closing of Tulane University in 
late August. While the public health students are in the classroom, 
two Tulane medical students are at Yale for clinical clerkships. 
The day before Hurricane Katrina struck, fourth-year Conar 
Fitton left New Orleans with “three T-shirts, a pair of flip-flops 
and a dog.” Stephanie Malliaris, a third-year, had left a day earlier. 
“Most people leave for hurricanes thinking they’ll be back home 
in three or four days,” she said. Fitton spent two weeks at Yale in a 
hepatology rotation. Malliaris stayed eight weeks for a pediatrics 
clerkship. In September Tulane relocated its medical school 
to Houston. Other Tulane programs are expected to resume in 
January in New Orleans. 
Andrea Humphrey, center, who received her 
M.P.H. from Yale in May, returned to New 
Haven in September after Hurricane Katrina 
led to the closing of Tulane University, where 
she was about to begin doctoral studies. 
At Yale she took classes and also found work 
as a teaching assistant. 
—John Curtis 
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HOW TO REACH US 
Yale Medicine welcomes news and 
commentary. Please send letters 
to the editor (350 words or less) 
and news items to Yale Medicine, 
P.O. Box 7612, New Haven, 
CT 06519-0612, or via electronic 
mail to ymm@yale.edu, and 
include a daytime telephone num¬ 
ber. Submissions may be edited 
for length, style and content. 
VISIT US ON THE WEB 
yalemedicine.yale.edu 
News of my demise 
is premature 
According to the alumni reunion 
report for the Class of i960 
published in the Autumn 2005 
issue of Yale Medicine, Jerrold 
M. Post, m.d. '60, led the class in 
"a brief silence in honor of our 
deceased classmates,” including 
me. While I am deeply honored, 
I am completely undeserving. 
My wife, Rosemary, died three 
years ago. I am running an active 
research program at the Univer¬ 
sity of Connecticut Health Center. 
I have participated in the Class of 
1959 reunions, since I was closer 
to them, having taken a year off 
after the third year to do research 
before graduating. 
D. Kent Merest, m.d. '60 
West Simsbury, Conn. 
Dishonest reporting in 
Vietnam and ptsd 
As a combat surgeon in DaNang 
in 1968,1 experienced the Tet 
Offensive firsthand and saw 
more carnage than most civilian 
surgeons see in a lifetime. 
Cathy Shufro’s "The Unseen 
Wounds of War” [Autumn 2005] 
brings back memories—and 
prompts a few questions. 
Dishonest media coverage 
of Vietnam, specifically the 
reporting of the Tet Offensive as 
a defeat of our forces, was the 
reason our veterans returned to 
a hostile public. 
Did any of Ms. Shufro’s vets 
mention that our forces never 
lost a significant battle in Viet¬ 
nam? Did Ms. Shufro run across 
data showing that victorious 
combatants who return to be 
hailed as heroes suffer less post- 
traumatic stress disorder than do 
defeated forces? Could the confu¬ 
sion of returning to be spat upon 
and subjected to the disrespect 
and dishonor ordinarily reserved 
for the vanquished—after defeat¬ 
ing the enemy decisively in every 
encounter—be a factor in the 
symptoms experienced by those 
in Ms. Shufro’s group? 
Martin L Fackler, m.d. '59 
Retired Col., 
U.S. Army Medical Corps 
Cainesville, Fla. 
Chase leaving to study 
what makes good doctors 
In December the medical 
school’s deputy dean for educa¬ 
tion, Herbert S. Chase Jr., m.d., 
announced that he would be 
ending his six-year tenure at the 
end of the academic year on 
June 30. Chase will return to 
Columbia University’s College of 
Physicians and Surgeons, where 
he spent 22 years before coming 
to Yale, to continue his research 
into the kind of teaching that 
makes a good doctor. “I am 
interested in looking at physi¬ 
cian performance and patient 
outcomes, and asking whether 
and how one’s medical educa¬ 
tional background influences 
the quality of a physician’s per¬ 
formance,” Chase said. 
Recruited in 1999, Chase was 
asked to evaluate the medical 
school curriculum and recom¬ 
mend and implement changes 
necessary to meet the chal¬ 
lenges of a new landscape in 
medicine. He championed the 
merging of courses in related 
disciplines and encouraged 
a more fluid curriculum that 
would integrate the basic and 
clinical sciences over four 
years of study. As deputy dean 
he oversaw the revamping of 
the anatomy course for first- 
year students; the creation of 
the Society of Distinguished 
Teachers to reward outstanding 
faculty; and the implementation 
of the Clinical Skills Program, 
which provides rigorous instruc¬ 
tion and assessment during 
the first two years of medical 
school. According to Dean 
Robert J. Alpern, m.d., “Yale has 
benefited greatly from [Chase’s] 
commitment, enthusiasm and 
dedication to the medical stu¬ 
dents, and we take great pride 
in Herb’s accomplishments as 
deputy dean.” 
Chase said that credit for his 
achievements is not his alone. 
“Whatever was accomplished, 
was accomplished with great 
effort by dozens of faculty.” 
—John Curtis 
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A world of connections 
This issue’s feature lineup begins with a tale of connections— 
among Yale alumni and faculty, among doctors and patients 
and among old school friends. As related by Jill Max, these 
connections made it possible for a Yale medical student 
to do research in Italy, and also for her mother in Serbia to 
receive a critical, life-changing procedure. 
For our cover story, “The Virus Behind the Cancer,” 
Contributing Editor Jennifer Kaylin looks at a different type 
of connection. She traces the guesses, speculation and dis¬ 
coveries that led scientists to the viruses that underpin about 
io percent of all cancers. Those connections between viruses 
and cancer could yield clues that will put scientists on the 
path to vaccines and treatments. 
Contributing Editor Marc Wortman donned a jump¬ 
suit and entered the pathology labs to observe an autopsy 
for his article, “The Final Chapter.” Wortman examines why 
autopsies are so rarely done, even though it is through the 
autopsy that all of the patient’s medical history is connected 
in the last, most complete picture of his or her health. 
Finally, in “When Animals Sound a Warning," Rhea 
Hirshman explores the connections between human disease 
and the environment. Fler research took her back to Captain 
Cook’s discovery of Hawaii and the first Italian invasion of 
Ethiopia. In both instances new creatures introduced new 
diseases, forever altering the ecology and epidemiology of 
those lands. That interaction is the focus of Yale’s new 
Center for EcoEpidemiology, which brings together scien¬ 
tists in both fields. 
In the spring of 2004 we asked Amelia Shaw, m.p.h. ’03, 
who was in Haiti on a Fulbright Scholarship and making 
a documentary film about aids, to write about her experi¬ 
ences. Shaw cautioned us that although she’d interned 
at National Public Radio, she’d never written a feature- 
length magazine article. Her first drafts convinced us we’d 
made the right choice. Shaw’s passion and commitment 
infused every page of her story [“A Film to Finish,” 
Fall/Winter 2004]. 
This spring the Association of American Medical 
College’s Group on Institutional Advancement seconded our 
opinion by honoring Shaw with a Robert G. Fenley Writing 
Award of Excellence for her article. The award, given annu¬ 
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4 chronicle news from cedar street 
The Institute of Medicine elected a record 
number of Yale scientists to its ranks last year. 
From left, Pietro De Camilli, Gerald Shulman, 
Joan Steitz, Kelly Brownell, Margaret Grey and 
Joseph Schlessinger, joined by Carolyn Slayman 
and Dean Robert Alpern. 
Six at Yale named to 
Institute of Medicine 
Top honor goes to experts in 
drug development, diabetes, obesity, 
neuroscience and genetics. 
Six Yale researchers, five from the 
School of Medicine and one from the 
School of Nursing, were elected to 
the Institute of Medicine (iom) of the 
National Academies in October. Their 
election brings the number of Yale 
scholars in the iom to 37, including 
two at the School of Management and 
one at Yale-New Haven Hospital. 
“It is unprecedented in recent 
memory that so many from our insti¬ 
tution have been elected in a single 
year,” said Dean Robert f. Alpern, m.d., 
Ensign Professor of Medicine. Pre¬ 
viously, according to iom records, no 
more than three Yale scientists had 
been elected in one year. These elec¬ 
tions, Alpern said, give Yale one of the 
highest concentrations of members 
of any institution in the nation. 
The six were honored at a recep¬ 
tion in the Medical Historical Library 
in December. 
Elected this year are Kelly D. 
Brownell, ph.d., chair and professor 
of psychology, professor of epidemiol¬ 
ogy and director of the Rudd Center 
for Food Policy & Obesity; Pietro 
De Camilli, m.d., fw ’79, the Eugene 
Higgins Professor of Cell Biology and 
a Howard Hughes Medical Institute 
investigator; Margaret Grey, R.N., 
dr.ph., the Annie Goodrich Professor 
of Nursing and dean of the School of 
Nursing; Joseph Schlessinger, ph.d., 
the William H. Prusoff Professor of 
Pharmacology and chair of pharmacol¬ 
ogy; Gerald I. Shulman, m.d., ph.d., 
professor of medicine and of cellular 
and molecular physiology and a 
Howard Hughes Medical Institute 
investigator; and Joan A. Steitz, ph.d., 
Sterling Professor of Molecular 
Biophysics and Biochemistry. 
Brownell is perhaps best known for 
his efforts to curb obesity, which form 
part of his studies of the intersections 
of behavior, environment and health. 
De Camilli is a cell biologist interested 
in understanding molecular mecha¬ 
nisms in presynaptic function and the 
role of phosphoinositide metabolism 
in the regulation of membrane traffic. 
Schlessinger’s lab studies the mode of 
action of growth factor receptors and 
the intracellular signaling pathways 
that are activated by growth factor 
stimulation. Shulman is an expert on 
the mechanisms of insulin resistance, 
the role of the liver and muscle in 
the pathogenesis of type 2 diabetes 
and the benefits of exercise in dia¬ 
betes management. Steitz discovered 
snRNPs, small particles in cells that 
are necessary to convert genetic infor¬ 
mation into active proteins. Grey is 
renowned for her studies of adapta¬ 
tion to chronic illness in childhood, 
particularly in children with type 1 
diabetes mellitus. 
The Yale researchers are among 
64 new members elected to the iom 
in 2005. The iom was established in 
1970 by the National Academy of 
Sciences to honor professional achieve¬ 
ment in the health sciences and to 
serve as a national resource for inde¬ 
pendent analysis and recommenda¬ 
tions on issues related to medicine, 
biomedical sciences and health. 
—John Curtis 
5 
A son of Yale and the 
medical school receives 
aya’s highest honor 
At the end of World War II, Nicholas 
P.R. Spinelli, m.d. ’44, took leave from 
i; his Army unit in Germany and hitched 
a ride on a cargo plane to Rome. From 
there he traveled to Faeto, a village in 
southern Italy overlooking the Adriatic 
Sea that his parents had left 30 years 
earlier, where the villagers celebrated 
i the arrival of their native son. “I was 
there for three nights,” Spinelli said. 
“I had to make rounds and visit every 
sick person in the village.” 
His triumphant return to his 
family’s ancestral community was the 
result of his parents’ belief in educa¬ 
tion and Spinelli’s own belief in the 
value of his education at Yale, where he 
1 earned his undergraduate and medical 
degrees. Had they stayed in Italy, 
Spinelli said, his parents would never 
have been able to educate their yet- 
unborn children, Nicholas and his sis¬ 
ter, Viola, m.p.h. ’65. “Education was 
a passion with both my parents. That 
was why they were working so hard,” 
I he said. 
Throughout his career Spinelli has 
■ shown his loyalty to Yale by raising 
money for the school, establishing with 
his classmates a scholarship fund, 
serving as the medical school’s director 
of alumni affairs and sponsoring the 
first White Coat ceremony in 1992. 
In November the Association of 
Yale Alumni awarded Spinelli the Yale 
Medal, which, since 1952, has honored 
outstanding service to the university. 
In this recognition, Spinelli joins such 
other medical school graduates and 
faculty as pediatrician Grover F. 
Powers, m.d.; Russell B. Scobie, m.d. 
’29; William L. Kissick, m.d. ’57, 
m.p.h. ’59, DR.PH. ’61; Muriel D. Wolf, 
m.d. ’59, hs ’60; and the legendary 
Dean Milton C. Winternitz, m.d. 
Spinelli’s path to Yale began in 
Stratford, Conn., where his parents 
had settled. His father ran a succession 
of businesses, including a gas station 
and restaurant on the Boston Post 
Road, the main thoroughfare between 
New York and Boston. 
In 1937 Spinelli entered Yale College, 
planning to become a writer. At the 
end of his freshman year, however, he 
took a job in a biology laboratory, 
where a professor encouraged him to 
study medicine, and in the fall of 1941 
he entered the School of Medicine. 
A few months later, while preparing 
for an anatomy exam, he heard 
President Roosevelt announce on the 
radio that the nation was at war. 
Spinelli and his 42 classmates were 
inducted into the Army, and their 
medical education was accelerated to 
meet wartime needs. Upon his dis¬ 
charge Spinelli returned to Stratford 
to practice internal medicine. A heart 
attack forced his retirement in 1958, 
but he began a second career as direc¬ 
tor of medical education at Bridgeport 
Hospital. In the 1980s his second 
career gave way to a third career as 
director of alumni affairs at the medi¬ 
cal school. His main concern there 
was what he called “incubating 
alumni,” strengthening relations with 
students and bringing them into the 
fold by including them in alumni 
events. At that time he helped create 
the Committee on the Well-Being of 
Students, which makes a report each 
year on issues of concern to students. 
Perhaps his greatest gift to the 
medical school was his proposal to his 
classmates at their 40th reunion in 
1984. He asked them to contribute to a 
scholarship fund over the next decade. 
By then, he said, the fund woidd be 
large enough to offer its first scholar¬ 
ship. In 1994, with 100 percent partici¬ 
pation from the class, the fund paid 
half the expenses of a first-year stu¬ 
dent. Eleven years later the fund was 
supporting up to three students 
through their first year. 
“I have gotten letters from students 
who have been given the scholar¬ 
ship, saying how important it was and 
how they couldn’t have gone to medi¬ 
cal school without it,” Spinelli said. 
For his long-standing service to the university 
and the School of Medicine, Nicholas Spinelli 
received the Yale Medal from the Association of 
Yale Alumni. At the ceremony in November 
Spinelli signed the President’s Book. 
For his service to Yale, Spinelli 
received the Distinguished Alumni 
Service Award from the Association of 
Yale Alumni in Medicine in 1987 and 
the Peter Parker Medal in 1994. In 
recognition of his contributions to the 
medical school, two rooms were named 
in Spinelli’s honor in 2000, the medi¬ 
cal school’s Office of Alumni Affairs 
and one at the Center for Neuroscience 
and Regeneration Research at the 
VA Connecticut Healthcare System in 
West Haven. 
But no honor, he said, surpasses 
the first he received from the univer¬ 
sity when he was 16 years old. “The 
greatest gift I got was the letter saying 




















From Student Research Day 
to a scholarly publication 
and The Wall Street Journal 
Last May at Student Research Day, 
Hardean Achneck, m.d. '05, described 
a link between atherosclerosis and 
aortic aneurysms. The aneurysms, 
he found, seemed to protect against 
atherosclerosis, a deadly form of 
arteriosclerosis. 
By summer’s end Achneck’s 
research was published in the journal 
Chest and reported in The Wall Street 
Journal. Achneck was first author 
of the journal paper; the senior author 
was his advisor, John A. Elefteriades, 
m.d. ’76, hs ’81, fw ’83, professor and 
chief of cardiothoracic surgery. “I am 
very happy to see the results become 
so well-received,” said Achneck, now 
Yale researchers believe that aortic aneurysms, 
such as the annuloaortic ectasia aneurysm 
shown above, protect against atherosclerosis. 
KESSLER PORTRAIT UNVEILED 
a surgical resident at Duke University 
School of Medicine. 
The research began years ago and 
arose from repeated observations in 
the operating room. “Operating every 
day we noticed that in patients with 
aneurysms at the top of the chest, their 
arteries were pristine,” said Elefteriades. 
“They were like babies’ arteries, teen¬ 
agers’ arteries.” Typically, he said, 
even men in their early 20s have fatty 
streaks and plaque in their arteries. 
Elefteriades has long welcomed 
medical students working on their 
theses, and he first assigned this proj¬ 
ect to Biren P. Modi, m.d. ’02. With 
the research still ongoing when Modi 
graduated, Achneck picked up the 
project and spent a fifth year at Yale 
working on it. 
Literature searches, he said, yielded 
no articles exploring the links between 
two types of aneurysms located in the 
ascending aorta—annuloaortic ectasia 
and type A dissection—and athero¬ 
sclerosis. The next step was to find 64 
patients with both types of aneurysm, 
and a control group of 84 patients with 
no history of aneurysms. The control 
patients came from the emergency 
department, where they had received 
treatment for trauma and had had CT 
scans of their chests. 
The patients who had aneurysms, 
the study found, were less likely to have 
atherosclerosis. This was independent 
of all common risk factors for athero¬ 
sclerosis. “It was a statistically powerful 
finding,” Elefteriades said, adding that 
it fits with the results of laboratory 
research. “There are some strains of 
rodents that have been developed that 
are prone to aneurysms, and they are 
protected from arteriosclerosis.” 
Why and how aneurysms offer pro¬ 
tection from atherosclerosis remains 
unclear. Elefteriades and his colleagues 
are looking at enzymes called matrix 
metalloproteases (mmps), which 
degrade material that accumulates on 
arterial walls. “It may be, and this is 
not proven,” said Achneck, “that some 
of these mmps are causing aneurysms 
on the one hand and chewing up ath¬ 
erosclerosis on the other. 
The gene for MMP3 is on a section 
of chromosome n that is known to 
cause mutations that increase the risk 
of aortic aneurysms. Elefteriades and 
colleagues are working with Celera 
Diagnostics to explore the underlying 
genetics. 
Since his graduation Achneck 
has been focusing on his residency. 
“I’m trying to survive,” he said. 
—John Curtis 
David A. Kessler, m.d., former dean of the medical school, returned 
to the Sterling Hall of Medicine in December for the unveiling of 
his official portrait by artist Richard Whitney. At a ceremony in the 
Historical Library, colleagues and Yale President Richard C. Levin 
lauded the achievements of Kessler’s tenure from 1997 to 2003, 
specifically the construction of the Anlyan Center for Medical 
Research and Education and the recruitment of 11 department 
chairs. Kessler said that although the portrait is of one person, 
many people contributed to his accomplishments as dean. “These 
things do not happen alone,” he said. 
7 
New five-year public health 
program gives undergrads a 
head start 
Yale junior Sarah Milby has always 
been interested in pursuing a career in 
public health and community develop¬ 
ment, and a new joint-degree program 
may be able to give her a head start. 
Milby, a premed and history of science/ 
medicine major, plans on being one of 
the first applicants to a new five-year 
joint-degree program that will allow 
her to earn a b.a. or b.s. at Yale College 
and an m.p.h. from the Yale School of 
Public Health (eph). “I’m so excited to 
start preparing for my career in public 
health as a senior,” she said. 
The program is designed to give 
students a broad understanding of the 
factors that shape public health and 
to equip them with the tools necessary 
to address public health issues, such 
as the fight against chronic disease and 
the impact of environmental stressors 
on human health. It is open to all 
undergraduates, regardless of their 
major. Students would normally apply 
to eph during the spring of their 
sophomore year, but juniors may also 
apply this spring, when the first wave 
of applications will be considered. 
Developed over the past two years, 
the program is a response to increas¬ 
ing student interest in the held of pub¬ 
lic health and serves as an alternative 
to the two-year master’s program 
already in place. “There has been evi¬ 
dent a very large demand on the part 
of undergraduates, who are agitating 
for more course experiences and edu¬ 
cational opportunities that allow them 
to take their classroom knowledge and 
put it into more concrete and applied 
settings," said Mark J. Schlesinger, 
ph.d., director of undergraduate stud¬ 
ies at eph and professor in the Division 
of Health Policy and Administration. 
He also views the program as an 
opportunity for eph to connect itself 
more extensively with Yale College. 
In addition to completing the 
requirements for their undergraduate 
major, students in the new program 
will complete six public health courses, 
such as health policy, biostastics and 
principles of epidemiology, during their 
junior and senior years. Between the 
fourth and fifth year they will complete 
a public health internship, and during 
the fifth year they will be enrolled full¬ 
time at eph in one of the school’s eight 
divisions, where they will complete 
io courses and a master’s thesis. 
The five-year program and a new 
one-year mid-career program for health 
care professionals will bring both older 
and younger students to eph. “Each 
group will bring its own distinctive 
resources into the classroom,” said 
Schlesinger. “I think it will make the 
classroom experience much richer for 
all the students.” 
For undergrads who are anxious to 
begin earning a graduate degree in 
public health while working toward 
their bachelor’s degree, the combined 
program is a welcome addition. “I 
want to start my life and make a differ¬ 
ence,” said Milby. “That’s why this is 
just too good to be true.” 
—Jill Max 
GERMAN PHARMA FUNDS RESEARCH 
The School of Medicine and Boehringer 
Ingelheim Pharmaceuticals Inc. (bipi), the 
Ridgefield, Conn.-based division of the 
German pharmaceutical firm, have formed 
an alliance to explore treatments for cardio¬ 
vascular, inflammatory and autoimmune 
diseases. Under the agreement, formalized 
last July, bipi will fund research projects at 
Yale, several of which are already under way. 
The projects are investigating the role of 
inflammation in organ rejection and athero¬ 
sclerosis; channels that admit calcium into 
immune system cells; enzymes that act in 
the kidneys to regulate salt and fluid bal¬ 
ance; and the formation of new blood ves¬ 
sels in the heart. 
"Yale, with its excellence in immunology 
and cardiovascular research, offers a real 
opportunity for mutual benefit,” said Mikael 
Dolsten, m.d., ph.d., head of corporate divi¬ 
sion pharma research at bipi’s world head¬ 
quarters in Ingelheim, Germany. 
bipi will work with scientists in the 
Section of Immunobiology and in the 
Interdepartmental Program in Vascular 
Biology and Transplantation. 
—Peter Farley 
BRAIN DATA ON THE INTERNET 
In an effort to help neuroscientists quickly 
find the latest information about the brain, 
the National Institutes of Health has estab¬ 
lished a consortium to design a Neuroscience 
Information Framework (NiF).The consor¬ 
tium includes scientists at Yale, the California 
Institute of Technology, Weill Medical 
College of Cornell University, George Mason 
University and the University of California 
at San Diego. 
The nif will help guide scientists to 
resources on the Internet by identifying soft¬ 
ware tools and data, developing language to 
describe the resources and placing them in a 
Web-accessible database. “To use this infor¬ 
mation effectively, neuroscientists need to be 
able to locate the latest research results that 
are relevant to the particular behavior they 
are studying or neurological disease they are 
treating,” said Gordon M. Shepherd, m.d., 
ph.d., professor of neuroscience and neurobi¬ 





















ROUnds MEDICINE AND HEALTH AT YALE 
How to fix the 
broken telephone 
Phone conversations are a 
major source of miscommunication 
between doctor and patient. 
As soon as the words were out of her 
mouth, she regretted them: while 
returning phone calls for a colleague, 
Anna B. Reisman, m.d., assistant pro¬ 
fessor of medicine, told the woman 
who answered the call that her hus¬ 
band had tested positive for gonor¬ 
rhea. Not only should Reisman have 
declined to share test results with 
a family member, but as it turned out, 
she had misread the patient’s chart. 
The family accepted Reisman’s apology, 
but she’ll never forget her indiscretion, 
and in the seven years that have passed 
she’s often asked herself how it could 
have been avoided. 
Communication failures have been 
shown to play a key role in medical 
mishaps; telephone encounters, which 
account for 25 percent of interactions 
between physicians and patients, are 
particularly tricky. There are no visual 
cues to tell the physician how the 
patient is feeling, how he or she is 
reacting to a diagnosis or whether the 
patient can speak freely—all of which 
can set the stage for preventable errors. 
In a paper published in the October 
issue of the Journal of General Internal 
Medicine, Reisman and co-author 
Karen E. Brown, m.d., assistant pro¬ 
fessor of medicine, outlined scenarios 
in which communication errors com¬ 
monly occur, providing strategies 
to minimize mistakes. The scenarios 
involve sensitive test results, requests 
for narcotics, patients who are unwell 
but not sick enough for the emergency 
room, late-night calls, communicating 
with unintelligible patients and calls 
from patients’ family members. In one 
scenario, a patient calls his physician 
in the middle of the night with back 
pain. Irritated at being awakened for a 
seemingly petty concern, the doctor 
terminates the call before the patient 
can explain that his symptoms include 
chest pain; the patient ends up hospi¬ 
talized with a mild heart attack. In this 
situation, Reisman and Brown discuss 
the importance of careful questioning 
and suggest ways of drawing out hid¬ 
den concerns. They advise giving the 
patient time to describe the chief com¬ 
plaint before interrupting, asking the 
patient why he or she is calling at that 
time and finding out if there is any¬ 
thing else the patient wants to commu¬ 
nicate. In another scenario regarding 
sensitive test results, the strategies 
include scheduling an office visit 
(which can later be cancelled) when 
ordering tests that might have sig¬ 
nificant results; ensuring that patients 
can speak freely if the test findings 
are given over the phone; and not leav¬ 
ing results with family members or 
recorded on an answering machine. 
(Since the passage of the Health 
Insurance Portability and Accountability 
Act in 1996, all hospital staff have 
received training in protecting patient 
confidentiality.) 
Physicians assess patients by 
observing aspects of their appearance, 
but the opportunity for visual inspec¬ 
tion is missing in phone encounters. 
Improving phone skills can help doctors 
fill in some of that information. “Better 
communication improves doctor-patient 
relationships, decreases lawsuits and 
improves outcomes,” said Reisman. 
Despite advances in other commu¬ 
nication technologies, the telephone 
will continue to play a major role in 
doctor-patient relationships, yet accord¬ 
ing to a 1995 survey, telephone medi¬ 
cine is taught in only 6 percent of 
residency programs. Reisman began 
teaching it to residents and physicians 
when she noticed how frequently resi¬ 
dents talked about mistakes they had 
made when dealing with patients over 
the phone. By teaching the best way 
to handle telephone encounters, she 
hopes to help others avoid mistakes 
similar to the one she made almost a 
decade ago. 
(For a different view of the clinical 
use of phones, see “Cell Phones 
Reduce Errors” on the next page.) 
—Jill Max 
PESTICIDE LINKED TO INFERTILITY 
Study finds sleep apnea 
is a major risk factor for stroke 
and death 
Although previous studies have sug¬ 
gested links between sleep apnea and 
stroke, it was never clear whether the 
increased risk of stroke was related to 
such other factors as hypertension or 
diabetes. Now, in a study published in 
The New England Journal of Medicine in 
November, a Yale team has found that, 
regardless of other factors, sleep apnea 
can put people at risk for stroke—the 
third leading cause of death in the 
developed world. 
“Our study shows that sleep apnea 
doubles the risk for development of 
stroke and death, and severe sleep 
apnea more than triples the risk,” said 
H. Klar Yaggi, m.d., assistant professor 
of medicine and principal investigator 
of the study. “We know that this risk 
was independent of other risk factors, 
including high blood pressure.” 
As many as one in five adults in the 
United States suffer from sleep apnea, 
which causes them to stop breathing 
temporarily while they sleep. Their bed 
partners may notice such symptoms as 
loud snoring, gasping or pauses in 
breathing. Men are more at risk for 
sleep apnea than women; obesity is 
also a risk factor. 
The new study, conducted between 
January 1997 and December 2003, 
enrolled 1,022 patients over the age of 
50 who had gone to the Yale Center for 
Sleep Medicine for treatment. About 
68 percent, 697 patients, had been 
diagnosed with obstructive sleep apnea 
syndrome. Hypertension, diabetes and 
obesity were more prevalent in this 
group. The mean apnea-hypopnea 
Klar Yaggi found that sleep apnea doubles the 
risk for stroke and death and severe sleep apnea 
triples the risk. 
index—the number of episodes of 
breathing cessation per hour—of those 
with the syndrome was 35. Those in a 
comparison group who did not have 
obstructive sleep apnea syndrome had 
a mean index of 2. 
An unadjusted analysis found an 
association between obstructive sleep 
apnea syndrome and stroke or death 
from other causes. Age and diabetes, 
for example, were significant factors. 
But even after adjusting for age, sex, 
race, smoking, alcohol consumption 
and diabetes or cardiovascular disease, 
the study still found a significant link 
between sleep apnea and stroke or 
death. Only 16 in the comparison 
group suffered stroke or death, but 72 
patients with obstructive sleep apnea 
syndrome had a stroke or died. 
The study was supported by the 
National Institutes of Health, the 
Department of Veterans Affairs and 
the Yale Center for Sleep Medicine. 
—John Curtis 
A common pesticide may interfere with the 
reproductive tract, leading to reduced fertil¬ 
ity in women, according to Yale researchers. 
In an article published in Endocrinology 
last August, the researchers reported 
that in studies in mice and in human tissue, 
methoxychlor (mxc), a substitute for the 
banned pesticide dot, alters an estrogen- 
regulated gene in the reproductive tract and 
reduces the ability of the uterus to support 
embryo implantation, mxc, which is applied 
to crops, livestock, home gardens and pets, 
is one of several chemicals that can mimic 
the action of hormones and sometimes 
interfere with endocrine function. 
“mxc has an adverse effect on these 
mice similar to that of des, a synthetic 
estrogen,” said senior author Hugh S. Taylor, 
m.d., hs ’92, associate professor in the 
Division of Reproductive Endocrinology and 
Infertility in the Department of Obstetrics, 
Gynecology and Reproductive Sciences. 
“Female offspring of women exposed to des 
were more likely to have an abnormally 
shaped cervix and were more prone to can¬ 
cer of the vagina, miscarriages, early labor 
and other complications.” 
—J.C. 
CELL PHONES REDUCE ERRORS 
Cell phones have long been banished from 
hospitals over fears of interference with 
medical devices. A study by a Yale anesthesi¬ 
ologist and colleagues, however, suggests 
that mobile phones speed communications 
and reduce medical errors. And digital 
phones rarely cause interference. 
For a study published in Anesthesia & 
Analgesia in February, Keith J. Ruskin, M.D., 
associate professor of anesthesiology and 
neurosurgery, surveyed attendees at the 
2003 meeting of the American Society 
of Anesthesiologists. Based on more than 
4,000 responses, Ruskin found that 65 
percent of anesthesiologists relied on pagers 
to communicate and 17 percent used cell 
phones. Of those who used pagers, 45 per¬ 
cent reported delays in communications. 
Only 31 percent of those who relied on cell 






















IO Findings from the bench 
In separate studies, Matthew State and 
Jeffrey Gruen discovered links among genetic 
mutations, brain development and disease. 
Two Yale teams among 
Science Top io for 2005 
Genetic mutations linked to brain 
development and disease were 
among last year’s leading discoveries. 
Two findings by Yale scientists have 
been included in Science magazine’s 
list of the 10 leading scientific break¬ 
throughs of 2005. The teams found 
evidence that both Tourette syndrome 
(TS) and dyslexia could stem from 
genetic defects linked to brain develop¬ 
ment. Their work was among research 
cited under the category “Miswiring 
the Brain.” Although the article did 
not name specific scientists or institu¬ 
tions, it cited “clues about the mecha¬ 
nisms of diverse disorders including 
schizophrenia, Tourette syndrome, 
and dyslexia. A common theme seems 
to be emerging: Many of the genes 
involved appear to play a role in brain 
development.” 
Matthew W. State, m.d., ph.d. ’oi, 
the Harris Assistant Professor of 
Child Psychiatry and assistant profes¬ 
sor of genetics, and the senior author 
of a report in the October 14 issue of 
Science, led the team that identified 
for the first time a genetic mutation 
asso-ciated with TS. The gene, which 
contributes to neuronal growth and 
communication, accounts for less than 
2 percent of TS cases, but its discovery 
after years of searching offers the best 
chance yet to penetrate this socially 
debilitating disease. How the muta¬ 
tions participate with other genetic 
and environmental factors to increase 
risk for the disease is unknown. “We 
hope the dues this gene will give us 
will have widespread ramifications for 
understanding the basic biology of this 
disorder,” said State. 
In its search for “that one unusual 
patient who would lead us to a gene,” 
State’s team found a child, diagnosed 
with TS and attention deficit hyper¬ 
activity disorder, who had a telltale break 
on chromosome 13. That clue led re¬ 
searchers to the nearby SLITRKi (Slit 
and Trlc-like family member 1) gene, 
which had already been recognized to 
be active in the developing brains of 
rodents and to function in neuron 
growth. When they analyzed the gene 
from 174 people with TS, they found 
three individuals with mutations. No 
mutations of any kind were found in 
several hundred unaffected people, pro¬ 
viding strong evidence that SLITRKi was 
contributing to the disease. Studying 
SLITRKi gives a starting point, said State, 
who likened their discovery to a string 
the researchers can now pull on to start 
to unravel the rest of the disease. 
Another team at the School of 
Medicine found a genetic link to 
dyslexia, the reading disorder that 
affects millions of children and adults. 
A mutated version of a gene, located 
on chromosome 6 and called DCDC2, 
disrupts the formation of brain circuits 
that make reading possible. The find¬ 
ings deepen the “understanding of 
how the reading process works on a 
molecular level,” said Jeffrey R. Gruen, 
m.d., hs ’84, fw ’88, associate pro¬ 
fessor of pediatrics and lead author of 
the study published in a special issue 
of Proceedings of the National Academy 
of Sciences in November. 
In a study of dna markers in 153 
dyslexic families, Gruen’s team 
found that up to 20 percent of cases 
of dyslexia are due to defects in the 
DCDC2 gene. In the mutated version of 
the gene, a large regulatory region is 
deleted. Locating this gene explains, 
in part, why dyslexia occurs and could 
lead to early and more accurate diag¬ 
noses and more effective educational 
programs for dyslexic children. 
—Pat McCaffrey 
New twist on experiment 
unleashes the brain’s potential 
for healing 
When we pour concrete for a sidewalk 
or foundation, we want the material 
to be as fluid as possible, so that it will 
easily assume the shape we have in 
mind. But for our structure to be 
durable and useful, we want the con¬ 
crete to harden—quickly. 
The brain’s early development is a 
similarly delicate balancing act between 
malleability and permanence. The 
areas of an infant’s cerebral cortex 
devoted to sensory systems are highly 
plastic, so that cortical circuits can be 
efficiently sculpted in response to the 
sights, sounds and smells that make 
up the baby’s world. But as soon as a 
baby has had enough time to acquire 
adequate sensory experience—a 
developmental window known as the 
“critical period”—neural circuits 
become hard-wired. 
Fixed neural circuits ensure that 
cortical function is stable and reliable, 
but stability comes at a cost: if the brain 
or spinal cord is damaged by trauma, 
Stephen Strittmatter and colleagues used 
a fluorescent green marker to stain myelin in 
the cortex. Myelin contains the Nogo protein, 
which prevents the repair of damaged neural 
circuits. In recent experiments they found that 
knocking out the Nogo receptor permitted 
increased plasticity and healing. 
disease or stroke, it can rarely repair 
itself well enough to restore function. 
How the brain shuts the door on 
plasticity and how that process might 
be blocked to regenerate or repair neu¬ 
ral circuits are the focus of the labora¬ 
tory of Stephen M. Strittmatter, m.d., 
ph.d„ the Vincent Coates Professor of 
Neurology. 
In 2000, Strittmatter identified a 
protein called Nogo that suppresses 
self-repair in damaged axons. In order 
to establish whether Nogo shuts down 
plasticity more generally, Strittmatter 
and Nigel W. Daw, ph.d., professor 
of ophthalmology and visual science, 
married genetic techniques with a 
classic experiment devised by Nobel 
prize-winning neurobiologists David 
H. Hubei, m.d., and Torsten N. Wiesel, 
m.d., in the early 1960s. 
Normally the visual cortex is divided 
equally between inputs from each eye 
into regions known as ocular domi¬ 
nance columns, but Hubei and Wiesel 
showed that if one of an animal’s eyes 
is kept shut during the highly plastic 
critical period, tire active eye’s inputs 
will appropriate a larger share of the 
visual region, leaving vision in the other 
eye irreversibly impaired. However, as 
reported in the September 30 issue of 
Science, when Strittmatter, Daw and 
postdoctoral fellows Aaron W. McGee, 
ph.d., and Yupeng Yang, ph.d., per¬ 
formed the same experiment with mice 
specially bred to lack a functional Nogo 
receptor, the cortex remained plastic 
after the critical period, and an active 
eye could usurp cortical real estate from 
a deprived eye well into adulthood. 
Encouraged by these and other 
results, Strittmatter is searching for 
Nogo blockers that he hopes will revive 
the capacity for plasticity, and healing, 
of the damaged or diseased brain and 
spinal cord. “Limited nerve cell regen¬ 
eration and plasticity are central to a 
range of neurological disorders,” he 
said, “including stroke, head trauma, 
multiple sclerosis and neurodegener- 
ative disease.” 
—Peter Farley 
PROTECTION AGAINST MAD COW 
In 1996, during an epidemic of mad cow dis¬ 
ease—bovine spongiform encephalopathy— 
in British cattle, epidemiologists predicted 
that up to 100,000 people could contract 
variant Creutzfeldt-Jakob disease (vcjd), a 
rapidly progressing, invariably fatal neurode- 
generative condition, from infected beef. 
But that nightmarish scenario has not yet 
come to pass: 10 years later, only 151 cases 
of vcjd have been verified. 
Laura M. Manuelidis, m.d. ’67, hs ’70, 
fw ’70, professor and chief of surgery 
(neuropathology), may have discerned why. 
Manuelidis and colleagues reported in 
Science in October that exposure to less- 
virulent strains of CJD may protect against 
infection with the newly evolved bovine 
strain. The team found that when neuronal 
cell cultures were infected with either a 
weak or sporadic form of cjd, or with agents 
that cause sheep scrapie, a disease similar 
to cjd, they resisted infection by the more- 
virulent strain. 
—P.F. 
TASTE AND SMELL—THE NOSE KNOWS 
Although our taste buds distinguish sweet, 
sour, salty, savory and bitter, flavor arises 
from a combination of tastes with odors that 
enter our nasal passages through the back 
of the mouth. These “retronasal” odors 
get special treatment from the brain, accord¬ 
ing to a new study led by Dana Small, 
M.sc., ph.d., assistant professor of surgery 
(otolaryngology) and psychology at Yale 
and an assistant fellow at the John B. Pierce 
Laboratory. 
In a report published in Neuron in 
August, Small and colleagues at Yale and in 
Germany inserted tubes that pumped odors 
such as chocolate into subjects’ noses, either 
to the front of the nostrils or to the back 
of the nasal cavity. They found that a single 
odor could activate different brain regions, 
depending on the route it traveled. Odors 
presented retronasally activated brain areas 
devoted to the mouth, which Small said is 
“evidence of the existence of distinct olfac¬ 
tory subsystems”—one specialized for 
sensing objects at a distance, the other for 
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Steven Marans draws on clinical 
research and his own experiences 
to explore the fundamental fears 
all people share. 
Coping with life’s everyday fears 
Drawing lessons from trauma, author offers parents advice 
on a child’s anxieties, large and small. 
It was 3 a.m. on a summer night in 2004 when the sound 
of a pager awoke psychoanalyst Steven R. Marans, m.s.w., 
ph.d. The New Haven police were summoning him to a 
home where three children had witnessed a murder. Along 
with colleagues in tire city’s Child Development-Community 
Policing Program (which Marans founded with the late 
Donald J. Cohen, m.d. ’66, in 1991), Marans invited the 
children to draw pictures and to talk about any aspects 
of the event they wished to discuss. 
As a nationally known expert on children facing severe 
trauma, Marans spends much of his time helping children 
and those who care for them to cope with major upheavals— 
domestic violence, school shootings, the 9/11 attacks and 
such natural disasters as Hurricane Katrina. Since 2000 he 
has also directed the National Center for Children Exposed 
to Violence, a federal program based on Yale’s partnership 
with the New Haven police. 
Now Marans, professor of child psychiatry and psychiatry 
at the Yale Child Study Center and in the department of 
psychiatry, has applied his insights to writing a guide for 
parents that explores the day-to-day challenges of growing 
up. In his first book for a general audience, Listening to 
Fear: Helping Kids Cope, From Nightmares to the Nightly News, 
Marans suggests that children’s reactions to stress have 
a common source. Whether the stressor is as extreme as 
witnessing a murder or as ordinary as coping with teasing, 
the common source is fear. 
Marans, who has been trained in both child and adult 
psychoanalysis, shows in his book how fear enters into 
everyday events with a description of a supermarket tantrum 
by his toddler son (now a college student). For the child, 
fear played a role—perhaps he feared his lack of competence 
when his father had to lift him to reach a container of sour 
cream. Most likely the child also scared himself with his 
outburst. But the incident stirred Marans’ own fears: loss 
of control, loss of his self-image as someone skilled in 
understanding children—and loss of face as he imagined 
onlookers judging him a bad parent. Those fears Marans 
could explain rationally. 
Marans says that children’s fears also evoke their parents’ 
suppressed fears, fears that stem from the normal course of 
development and from their own childhood experiences. 
“We desperately want to wave the proverbial magic wand 
and wave our children’s feelings away, not only because we 
don’t like to see our children unhappy but also because it 
stirs up our own feelings—feelings that we’re reminded of 
by our kids’ experiences,” said Marans. 
Drawing on clinical research and his own experience, 
Marans said all people share five fundamental fears: loss of 
life (of loved ones and of oneself); loss of the love of others 
and for ourselves: bodily harm; losing control of our feel¬ 
ings, impulses or thoughts; and losing the assumed pre¬ 
dictability of daily life. By distinguishing our own fears from 
our child’s, Marans said, we become better parents. We need 
to listen, not only to words but also to behavior, which may 
be the child’s only means of expressing distress. 
“My interest in extreme situations is an extension of the 
concern that I always have: how we use our understanding of 
human behavior and human development as a way of illumi¬ 
nating people’s experience,” said Marans during an interview 
at the Child Study Center. “What I hope the book does is 
remind us that the worst of our fears, fears that can reach 
overwhelming or dramatic proportions, are elaborations of the 
basic fears and anxieties that are part of who we are as human 
beings. Discovering that there is, in fact, sense to what we feel 
and how we act can be tremendously reassuring.” 
—Cathy Shujro 
Bookshelf is a column focusing on matters related to books and 
authors at the School of Medicine. Send ideas to Cathy Shufro at 
cathy.shufro@yale.edu. 





THE DELICIOUS, BREAKTHROUGH PLAN TO 
TURN OFF YOUR HUNGER AND 
LOSE THE WEIGHT FOR GOOD 
David L. Katz,md,mph. 
Smoking 101: 
An Overview for Teens 
by Margaret O. Hyde and John F. 
Setaro, m.d., hs '86, fw ’92, 
associate professor of medicine 
(cardiology) (Twenty-First Century 
Books) This book provides infor¬ 
mation that will help teenagers 
considering whether to try ciga¬ 
rettes. For teens who already 
smoke, the authors describe pro¬ 
grams and techniques for 
quitting and list websites of 
organizations that can help. 
On Call: A Doctor’s Days and 
Nights in Residency 
by Emily R. Transue, m.d. (St. 
Martin’s Press) While a resident 
at the University of Washington, 
Transue, Yale College Class of 
1992, wrote about her patients 
as a way to guard against 
burnout and share her experi- 
I ences with friends and family. 
This collection of stories conveys 
the atmosphere of overwork, 
exhaustion and insecurity in 
which a resident works, as well 
as Transue’s compassion for 
her patients. 
Mortal Secrets: Truth and Lies in 
the Age of aids 
by Robert Klitzman, m.d. ’85, 
I and Ronald Bayer, ph.d. (The 
Johns Hoplcins University Press) 
The authors provide a portrait of 
moral, social and psychological 
decision making by drawing on 
interviews and testimonies from 
more than 70 gay men and 
women, intravenous drug users, 
sex workers, bisexual men and 
heterosexual men and women. 
For those who are Hiv-positive, 
decisions about disclosure of 
their diagnosis make them con¬ 
front intimate questions about 
truth, lies, sex and trust. 
Shields’Textbook of Glaucoma 
edited by R. Rand Allingham, 
m.d., Karim F. Damji, m.d., 
Sharon F. Freedman, m.d., 
Sayoko E. Moroi, m.d., ph.d., 
George Shafranov, m.d., associate 
professor of ophthalmology 
and visual science, and M. Bruce 
Shields, m.d., the Marvin L. 
Sears Professor of Ophthalmology 
and Visual Science (Lippincott 
Williams & Wilkins) Readers will 
find updated information on 
the cellular and molecular 
biology of the eye, molecular 
genetics of glaucoma and con¬ 
genital and developmental 
glaucomas. The book also 
describes management of glau¬ 
coma and approaches to treat¬ 
ment. Each chapter includes 
summaries of key points. 
Psychological Aspects of 
Reconstructive and Cosmetic 
Plastic Surgery: Clinical, 
Empirical and Ethical Perspectives 
edited by David B. Sarwer, ph.d., 
Thomas Pruzinsky, ph.d., 
Thomas F. Cash, ph.d., Robert 
M. Goldwyn, m.d., John A. 
Persing, m.d., professor of sur¬ 
gery (plastic) and neurosurgery, 
and Linton A. Whitaker, m.d. 
(Lippincott Williams & Wilkins) 
This volume examines the rela¬ 
tionships among physical 
appearance, body image and 
psychosocial functioning. The 
authors detail the psychological 
implications of specific disfig¬ 
urements and of reconstructive 
procedures, and discuss bioethi- 
cal, professional and legal issues. 
The Flavor Point Diet: 
The Delicious, Breakthrough 
Plan to Turn Off Your Hunger 
and Lose the Weight for Good 
by David L. Katz, m.d., m.p.h. 
’93, associate clinical professor of 
public health, and Catherine S. 
Katz, ph.d. (Rodale Books) This 
book introduces readers to the 
Flavor Point Diet and provides 
menu plans and recipes. By com¬ 
bining foods selected by flavor, 
the regimen “tricks the brain 
into being satisfied all day.” 
Globalization, Women, and 
Health in the 21st Century 
by Ilona S. Kickbusch, ph.d., 
former professor of public health, 
Kari A. Hartwig, dr.p.h„ assist¬ 
ant clinical professor of public 
health, and Justin M. List, m.div. 
’04 (Palgrave Macmillan) This 
book explores the complex set 
of interdependencies among 
gender, health and globalization. 
The Psychotherapist’s Own 
Psychotherapy: Patient and 
Clinician Perspectives 
edited by Jesse D. Geller, ph.d., 
associate clinical professor of 
psychiatry, John C. Norcross, 
ph.d., and David E. Orlinsky, 
ph.d. (Oxford University Press) 
The first-person narratives, clini¬ 
cal wisdom and research find¬ 
ings gathered in this book offer 
guidance for providing effective 
treatments to patients who are 
also therapists. 
Medical Complications During 
Pregnancy, 6th ed. 
edited by Gerard N. Burrow, m.d. 
’58, hs '66, the David Paige 
Smith Professor Emeritus of 
Medicine and dean emeritus, 
Thomas P. Duffy, m.d., professor 
of medicine (hematology), and 
Joshua A. Copel, m.d., fw ’85, 
professor of obstetrics, gynecolo¬ 
gy and reproductive sciences and 
of pediatrics (W.B. Saunders) 
This reference book presents 
multidisciplinary coverage 
of the full spectrum of compli¬ 
cations associated with preg¬ 
nancy. Postpartum depression 
and bioethics are two of the 
topics covered. 
Foundations of Anesthesia: 
Basic Science and Clinical 
Practice, 2nd ed. 
edited by Hugh C. Hemmings 
Jr., ph.d. ’86, m.d. ’87, and 
Philip M. Hopkins, m.d. 
(Elsevier) International experts 
provide complete coverage of 
basic and clinical science in anes¬ 
thesiology, emphasizing the prin¬ 
ciples and clinical applications of 
molecular and cell biology, physi¬ 
ology, pharmacology and physics 
and measurement. 
Maimonides 
by Sherwin B. Nuland, m.d. ’55, 
hs ’6i (Schocken Books) 
Maimonides was a physician, a 
Torah scholar, a community 
leader and a philosopher who 
attempted to reconcile scientific 
knowledge with faith in God. 
He was a Jew living in a Muslim 
world, a rationalist living in 
a time of superstition. Nuiand 
gives us a portrait of Maimon¬ 
ides that makes his life, his 
times and his thought accessible 
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Consortium seeks to boost 
minority presence in health 
information professions 
Get Hired! How to Land the 
Ideal Federal Job and Negotiate 
a Top Salary 
by Lily Whiteman, m.p.h. '90 
(fpmi Solutions) This book, 
based on the experiences of 
people who found federal jobs, 
provides tips for breaking 
into the federal job market— 
from entry-level to executive 
positions. The author provides 
strategies for finding domestic 
and overseas openings, lists 
the latest federal jobs websites 
and offers tips for mastering 
online applications. 
Reconceiving the Gene: 
Seymour Benzer’s Adventures 
in Phage Genetics 
by the late Frederic L. Holmes, 
ph.d., the Avalon Professor 
of the History of Medicine and 
chair of the Section of the 
History of Medicine, and edited 
by William C. Summers, m.d., 
ph.d., professor of therapeutic 
radiology and of molecular bio¬ 
physics and biochemistry (Yale 
University Press) More than any 
other individual, biologist 
Seymour Benzer is considered to 
have led geneticists from the 
classical gene into the molecular 
age. Drawing on Benzer's record 
of his experiments, correspon¬ 
dence and published sources, this 
book reconstructs how the for¬ 
mer physicist initiated his work 
in phage biology and achieved 
his landmark investigation. 
Nuclear Cardiology, the Basics: 
How to Set Up and Maintain a 
Laboratory 
by Frans J.Th. Wackers, m.d., 
ph.d., professor of diagnostic 
radiology and medicine, Wendy 
Bruni, and Barry L. Zaret, M.D., 
the Robert W. Berliner Professor 
of Medicine and professor of 
diagnostic radiology (Humana 
Press) This guide offers a concise, 
action-oriented plan for solving 
the many practical and technical 
problems involved in establishing 
and running a nuclear cardiol¬ 
ogy lab.The authors answer basic 
questions about purchasing 
equipment and determining 
space requirements. 
Rewards for Kids! Ready-to-Use 
Charts & Activities for Positive 
Parenting 
by Virginia M. Shiller, ph.d., lec¬ 
turer in the Child Study Center, 
and Meg F. Schneider 
(Magination Press) This book 
shows how to motivate children 
to improve their behavior and 
fulfill their responsibilities, using 
a variety of child-friendly sticker 
charts and other tools. The 
authors teach parents positive 
techniques for helping children 
to overcome such common 
behavior problems as bedtime 
procrastination and fighting 
with siblings. 
The descriptions above are based on 
information from the publishers. 
SEND NOTICES OF NEW BOOKS TO 
Cheryl Violante, Yale Medicine, 
P.O. Box 7612, New Haven, CT 
06519-0612, or via e-mail to 
cheryl.violante@yale.edu 
A senior at Hill Regional Career Magnet High School in New Haven, 
Jordon Thomas was impressed when he first set foot in the Cushing/ 
Whitney Medical Library last summer. “I didn’t know there were 
so many resources that were right in front of me,” said Thomas, who 
attended a science program sponsored by the School of Medicine. 
Thomas is just the type of student that Charles J. Greenberg, 
m.l.s., m.ed., coordinator of medical library curriculum and research 
support, would like to attract to the health sciences information 
professions: a college-bound minority student who might consider 
becoming a medical librarian or health information specialist. (As it 
turns out,Thomas, who is African-American, plans to be a phar¬ 
macist.) Greenberg is the project coordinator for a newly formed con¬ 
sortium of eight university medical libraries that is trying to interest 
minority students in careers in medical librarianship. Nancy K. 
Roderer, m.l.s., former director (1992-1999) of Yale’s medical library 
and now director of the William H. Welch Medical Library at Johns 
Hopkins, is the principal investigator. Funded with a three-year, 
$640,000 matching grant from the federal Institute of Museum and 
Library Services, the group comprises Yale, Georgetown University, 
Houston Academy of Medicine, Howard University, the University of 
Colorado at Denver, Johns Hopkins University, the University of 
Tennessee and Washington University in St. Louis. Currently, 9 percent 
of medical librarians are members of minority groups. 
The effort to interest minority students is part of a broader 
attempt to recruit health care professionals who reflect the ethnic 
and racial diversity of their patients. ‘‘Health care providers are 
very concerned with cultural competence,” said Greenberg. “We want 
to become part of that mosaic of health careers.” The medical librar¬ 
ianship project is just in the planning stage, but libraries in the group 
plan to sponsor tours, internships and other outreach programs. 
The group’s task in part is to replace the image of a dowdy 
librarian with a more up-to-date view of a computer-savvy “informa¬ 
tion specialist.” 
Yale’s medical library has been “at the forefront of the univer¬ 
sity’s partnerships with the New Haven public schools,” said Claudia 
R. Merson, director of public school partnerships at the Office of 
New Haven and State Affairs. For instance, Yale medical librarians 
taught Internet skills to Career High School teachers and administra¬ 
tors in the mid-1990s. “This is another opportunity,” said Merson. 
“There’s been so much exposure to health professions, but librarian- 
ship has not been one of them. It’s new and exciting, and it looks 
like it’s going to be cool.” 
The project’s website is http://www.bioinfo-career.org/. 
—Cathy Shufro 
In Circulation is a column focusing on activities at the Cushing/Whitney 
Medical Library. Send ideas to Cathy Shufro at cathy.shufro@yale.edu. 
ON CAMPUS 15 
Emergency care in the wake 
of Katrina 
If there was a good news story 
about Hurricane Katrina, it 
was the medical response to the 
disaster, said Paul K. Carlton Jr., 
m.d., director of the Office of 
Homeland Security of the Texas 
A&M University System Health 
Science Center. Speaking at the 
Yale New Haven International 
Congress on Disaster Medicine 
and Emergency Management in 
September, Carlton described 
how emergency "surge” hospitals 
mobilized to handle thousands 
of patients in Baton Rouge. 
“Your worst nightmare is to 
lose an entire medical network, 
and that is what happened 
in Katrina,” said Carlton, a pro¬ 
ponent of the surge concept, in 
which hospitals expand facilities 
or open new ones in emergen¬ 
cies. Within days, he said, health 
and disaster teams had set up 
four surge hospitals in Baton 
Rouge, including one at a former 
Kmart store that had been closed 
for 10 years. "It was filthy,” Carlton 
said. Crews found portable air- 
conditioning units, got power to 
the building, bought portable toi¬ 
lets and converted the big-box 
store into a 1,000-bed hospital. 
Driving the medical teams, 
Carlton said, was a basic princi¬ 
ple: “We will not break trust 
with our patients.” 
—John Curtis 
Bright future for a roller¬ 
coaster compound? 
In 1998, Endostatin, a protein 
that inhibits blood vessel 
growth, was touted as a silver 
bullet for cancer after tests in 
mice showed it killed tumors by 
cutting off their blood supply. 
But six years later, the future 
looked bleak: Fortune magazine 
said the angiogenesis inhibitor 
"failed dramatically” in clinical 
trials, and EntreMed, a Maryland 
biotech company, abandoned 
the drug in 2004 after flirting 
with bankruptcy. 
But Endostatin is not dead 
yet, according to its creator, 
Judah Folkman, m.d., who spoke 
at Yale in October. Folkman, a 
Harvard researcher, said both 
reports exaggerated the reality. 
His work led to fda approval in 
2004 of another angiogenesis 
drug, Avastin, which is expected 
to reach $6 billion in sales and 
may become the largest-selling 
anticancer drug in history. 
Three weeks before Folkman’s 
Yale talk, China approved an 
Endostatin product developed 
and tested by the Chinese bio¬ 
tech company Medgenn. A trial 
involving 493 late-stage lung 
cancer patients showed that 
its Endostar drug was effective, 
doubling survival time from 
three to six months when com¬ 
bined with chemotherapy. 
Folkman hopes the Chinese find¬ 
ings will revive the future of 
Endostatin in the American mar¬ 
ket, “it’s had a tough life,” he 
said, “but it’s been resuscitated.” 
—Michael Fitzsousa 
A pioneering lobotomist’s 
mixed legacy 
When he began his biography of 
Walter J. Freeman, m.d., a Yale 
College graduate who pioneered 
lobotomy in the United States, 
journalist Jack El-Hai expected 
he would be writing about 
“a monster." 
The truth was more compli¬ 
cated, said El-Hai, author of The 
Lobotomist: A Maverick Medical 
Cenius and His Tragic Quest to 
Rid the World of Mental Illness, 
speaking at a master’s tea at 
Yale in November. Psychiatrists 
embraced the crude surgery 
that severed neural pathways 
between the frontal lobes and 
the thalamus, El-Hai argued, 
because until the advent of 
Thorazine in 1954 they had few 
effective treatments for psy¬ 
chiatric illnesses. “They were 
willing to try something experi¬ 
mental, something desperate.... 
because at least it held out 
some hope,” said El-Hai. 
From 1936 to 1967 roughly 
40,000 patients underwent 
lobotomies nationwide, for con¬ 
ditions ranging from depression 
to schizophrenia. Freeman did 
3,400 of them, including one on 
a sister of John F. Kennedy. Some 
patients felt better, some became 
disabled and 2 percent died. 
Freeman, El-Hai noted, “was 
one of the few advocates of a 
biological orientation for psy¬ 
chiatry. That is his most positive 
legacy today, if you can find one.” 
—C.S. 
nba star makes a giant impact 
in his African homeland 
As he walked through campus 
last September, Dikembe 
Mutombo, all-star center for the 
Houston Rockets, cut a some¬ 
what startling figure. With an 
impeccably tailored deep-blue 
suit draped over his 7-foot, 
2-inch frame, Mutombo towered 
over his hosts like a grade- 
school teacher minding charges 
on a field trip. 
He came to Yale at the invita¬ 
tion of Anup Patel, a second- 
year medical student who had 
heard of the Dikembe Mutombo 
Foundation’s humanitarian 
work in Mutombo’s native 
Democratic Republic of Congo 
(drc). Mutombo contributed 
$10 million for the construction 
of a 300-bed hospital in the 
capital of Kinshasa, which will 
open in June to provide care to 
the city’s poorest residents and 
to train its health professionals. 
Yale and the foundation are 
considering a partnership that 
would provide opportunities 
for medical students to travel to 
the drc for clinical clerkships. 
“I grew up poor and I never 
forgot where I came from,” 
said Mutombo, in an address at 
Battell Chapel. ”lf I was going 
to do something that will carry 
my legacy, I wanted to make 
sure it was very good, that it will 
stop the suffering, that it will 
help the people that don’t have 
a chance to go on a plane to 























the man, the surgeon and the father 
By Peter Farley A new biography of the pioneering neurosurgeon explores different facets 
of the man who revolutionized brain surgery. 
17 
| 
J. Michael Bliss, ph.d., author of a 
new biography of Harvey W. Cushing, 
m.d., assumed the lectern at the 
Hope Auditorium last October to face 
i what a Catskills comic might call a 
tough crowd: Cushing’s descendants 
and relatives, who had gathered to 
,j celebrate the renowned neurosurgeon’s 
life and to plan for a permanent 
home at Yale for Cushing’s rich collec- 
i tion of brain specimens, photographs, 
drawings and memorabilia. 
But Bliss, a historian at the Univer¬ 
sity of Toronto, proceeded without 
fear or favor as he discussed his book, 
j Harvey Cushing: A Life in Surgery, 
and wasted no words in raising an issue 
of interest to those with a personal 
connection to the notoriously demand¬ 
ing Cushing. “There’s vigorous debate 
about Cushing’s professional motives 
and his professional personality, and 
this is the kind of thing we have to talk 
about so long after his death,” Bliss 
declared. “The question is whether or 
not he was an egotistical, hard-driving, 
selfish, mean son-of-a-bitch." 
Perhaps to smooth the way for that 
question, Bliss first emphasized that 
Cushing, an 1891 Yale College graduate 
and one of the most lauded figures 
in the history of medicine, truly was as 
great as his admirers would have it. 
In diligence, innovation and pure skill, 
Bliss said, Cushing—father of modem 
neurosurgery, artist, Pulitzer Prize¬ 
winning biographer of Sir William 
Osier and more—had no equal. Before 
Cushing, patients routinely bled to 
death during intracranial surgery, which 
had a mortality rate approaching 50 
percent. Thanks to his introduction of 
rigid haemostasis, asepsis, electroco¬ 
agulation and other procedures, mortal¬ 
ity rates plummeted to 10 percent. 
In his professional life Cushing was 
a “tough hombre" who “reduced nurses 
to tears and residents to nervous break- 
downs with withering scorn and sar¬ 
casm,” Bliss said. Cushing’s punishing 
schedule—including regular 9 8-hour 
weeks—exacted a toll on his wife and 
children, who “found it difficult to relate 
to their stern Victorian father, who dis¬ 
approved of jazz, the movies, fashion¬ 
able dress, telephone calls, boyfriends, 
women in medicine, women smok¬ 
ing—probably women at college—and 
young men who did not attend to their 
studies and the need to get on with 
qualifying for Yale.” 
His patients, however, knew another 
Cushing. “His bedside manner was 
absolutely wonderful: his dedication to 
his patients absolutely boundless,” 
Bliss said. 
Cushing’s reaction to his son Bill’s 
death poignantly captured his complex 
sense of duty. While Cushing was teach¬ 
ing surgery at Harvard Medical School 
and the Peter Bent Brigham Hospital in 
Boston, Bill died in an automobile acci¬ 
dent after a night celebrating the end of 
his junior year at Yale. Cushing “called 
[his wife] Kate to tell her, then carried 
out a scheduled operation, which was a 
success, then told his team about the 
family tragedy and left for Connecticut 
to claim his son’s body.” 
Though Cushing spent almost his 
entire professional life at Johns Hopkins 
and at Harvard, his undergraduate 
years at Yale College were so formative 
and important to him that he returned 
to Yale at the end of his surgical career 
to be Sterling Professor of Neurology 
and director of studies in the History of 
Medicine. There could be no more 
appropriate place than the School of 
Medicine to house the Cushing 
Collection, Bliss said. 
“He was one of Yale’s most illustri¬ 
ous graduates, and the preservation 
of his work and legacy at Yale—his 
books, his papers, and now his wonder¬ 
ful collection of patient photographs 
and specimens—is a fitting aspect of 
the university’s service to generations 
past, present and future. Although 
Harvey Cushing learned a lot and did a 
lot at Johns Hopkins and at Peter Bent 
Brigham,” Bliss said, “Yale was his 
alpha and his omega.” 
Peter Farley is a contributing editor of Yale 
Medicine and the managing editor of the medical 
school’s bimonthly newsletter, Medicine@Yaie. 
opposite TOP Harvey Cushing in 1907 at 
his desk at Johns Hopkins, six years after 
he began his residency under the tutelage of 
surgeon William Stewart Halsted. While at 
Hopkins, Cushing rose to fame as a neurosurgeon 
and an expert in the pituitary gland. 
opposite bottom An undated photo of a 
Cushing operating room. Cushing’s innovations 
in intracranial surgery reduced mortality rates 
from about 50 percent to 10 percent. 
above Throughout his career Cushing kept 
meticulous records of his cases, including 
photographs of his patients, such as this one 
showing a surgical incision. He also made 
detailed drawings of the brain. His collection 
of notes, microscopic slides, brain specimens 
and photographs are now known as the 
Cushing Brain Tumor Registry. The knowledge 
gleaned from the registry revolutionized 

















































Yale connections around the world 
A medical student’s summer research journey 
becomes a Yale—and family—reunion like no other. 
Medical student Tamara Lazic 
traveled to Italy last summer for a 
research project with her advisor, 
interventional radiologist Robert 
White. During her stay she was 
reunited with her mother, who 
lives in Serbia, and introduced to 
a world of Yale connections. 
By Jill Max 
When Tamara Lazic, now a second-year student at the School 
of Medicine, sought to combine a passion for languages 
with research for her thesis, she had no idea the project would 
take her halfway around the world to work in a clinic where 
a Yale physician collaborating with a former Yale fellow would 
perform a life-changing procedure on her mother. 
A native of Belgrade, Serbia, Lazic traveled to Los 
Angeles in 1999 to live with her father, and in 2004 came to 
New Haven, after graduating from ucla with a degree in 
physiological science. Like many students at the School of 
Medicine, she wanted to begin research for her thesis during 
the summer between her first and second years. But Lazic, who 
speaks Serbo-Croatian, English, Spanish and some Russian, 
also wanted to learn another language. She set her sights on 
Italy, which had the added bonus of being located just across 
the Adriatic Sea from her mother, a legal advisor in the Ministry 
of Internal Economic Relations of Serbia and Montenegro. 
While researching overseas projects, Lazic came across 
the work of Robert I. White Jr., m.d., professor of diagnostic 
radiology and director of the Yale Vascular Malformation 
Center. An interventional radiologist, White travels widely to 
treat patients and educate physicians about hereditary hemor¬ 
rhagic telangiectasia (hht), a vascular disorder. Patients with 
hht, also called Osier-Weber-Rendu syndrome, lack the capil¬ 
laries that normally form between arteries and veins. This 
lack creates fragile sites that can rupture and bleed due to the 
flow of high-pressure arterial blood directly into veins. About 
95 percent of people with hht have recurrent nosebleeds, but 
lesions and malformations can occur in many parts of the 
body. Defects in smaller blood vessels, such as those inside the 
nose or on the skin, are known as telangiectases, while those 
in the larger blood vessels in the liver, lungs, brain and gastro¬ 
intestinal tract are called arteriovenous malformations (avms). 
hht affects approximately one person in 5,000, involves mul¬ 
tiple organs and often goes undiagnosed. White has been on a 
mission to understand and treat hht since 1990, when he 
helped found the Hereditary Hemorrhagic Telangiectasia 
Foundation International (www.hht.org). Since then he has 
been instrumental in establishing 20 hht Centers of Excel¬ 
lence in the United States, Europe and Japan. “For every 100 
patients with hht, 40 have lung or brain malformations, and 
half of those will be disabled or die prematurely from some¬ 
thing that can be fixed,” he said. Treatment usually involves 
embolization, a minimally invasive procedure in which the 
blood supply to the abnormal blood vessels is cut off. 
White’s enthusiasm for the hht cause is contagious, 
and Lazic quickly signed on to spend last summer at the hht 
center at the University of Bari in southern Italy, where she 
did research on diffuse pulmonary avms, the most severe 
form of the disease, in which multiple avms form in one or 
both lungs. White has close ties to the Bari center, which he 
visits twice a year to help treat patients. The center was estab¬ 
lished thanks to hht patient Nicola Signorile, whom White 
met at a conference in Denmark in 1999. Signorile, a retired 
accountant, had suffered severe nosebleeds for 30 years before 
being diagnosed with hht in 1997, but had been unable to 
find a physician to treat him. White encouraged him to seek 
out a physician in Italy who would be interested in learning 
more about diagnosing and treating the disease. Signorile’s 
search led him to Carlo Sabba, m.d., fw ’90, a professor 
of medicine at the University of Bari, who had completed a 
two-year hepatology fellowship at Yale in 1990. Signorile 
introduced Sabba to White at a conference in Toronto in 2000 
and Sabba was hooked: with the help of university President 
Giovanni Girone, a college classmate of Signorile, the Uni¬ 
versity of Bari opened the Interdepartmental hht Center in 
2001 with Sabba as its director. 
Four years after it opened, the Bari center now treats 
300 families from all over Italy and southern Europe. “Our 
center came about as Yale’s offspring, but is now growing into 
a beautiful adolescent,” said Sabba. White has helped train doc¬ 
tors there to repair avms and continues to assist in complex 
cases during his regular visits. In 2005 he convinced Signorile, 
who had suffered a cardiac arrest following a severe nosebleed 
in which he lost two liters of blood, to come to Yale for a septal 
dermoplasty, a procedure perfected by Yale hht team member 
Douglas A. Ross, m.d., associate professor of surgery (otolaryn¬ 
gology). Last June Signorile underwent the procedure, which 
involves replacing the lining of the nose with a skin graft from 
the thigh. He couldn’t be happier with the results. “It was 
extraordinary,” he said. “I want everyone to know, because peo¬ 
ple are afraid of this operation, especially in Italy.” 
Meanwhile, Tamara Lazic’s mother, Vesna Lazic, 51, 
had a different problem. She had been suffering from pelvic 
pain and bleeding so severe that it was sapping her energy 
and making her daily activities difficult. When Lazic showed 
White her mother’s medical records, he suspected, correctly, 
uterine fibroids. In his travels, White also teaches uterine- 
fibroid embolization, a procedure similar to the one used to 
treat avms, in which the fibroid’s blood supply is cut off, liter¬ 
ally starving the tumor to death. Viewing Vesna Lazic’s case 
as both a teaching opportunity (the procedure is unavailable 
in Serbia and had not been done at Bari) and a chance to help 
both her and her daughter, he offered to perform the proce¬ 
dure in Bari. Sabba and Girone immediately arranged to accept 
Vesna Lazic as a patient at no charge, but the next obstacle 
was getting her to Italy. It normally takes a month to obtain 
a visa to enter Italy from Serbia, but White had to leave the 
country in just a few days. Girone used his contacts at the 
Italian embassy in Belgrade to prevail upon authorities to 
speed the process. 
Lazic and her mother see each other only once a year, 
and were overjoyed to be reunited and to resolve Vesna Lazic’s 
medical problems. Vesna Lazic arrived in Bari in August; 
White successfully performed the embolization and taught 
doctors there how to do the procedure. “It opened a lot of 
doors for them,” said Lazic, who is grateful for the help she 
and her mother received. 
Looking back, Lazic is amazed at the turn of events that 
led to her mother’s uterine-fibroid embolization. As a Yale 
medical student, she traveled 3,000 miles for her thesis proj¬ 
ect, where she met a former Yale patient, worked with a 
Yale-trained specialist in a center whose existence was sparked 
by Yale research and saw “image-guided therapy” performed 
on her mother by a Yale physician. All these encounters were 
in a sense made possible by Sanfurd G. Bluestein, m.d. ’46, 
a retired radiologist who is sponsoring Lazic’s medical educa¬ 
tion through a scholarship fund he established in 1996. It’s 
quite a journey for a young woman who grew up in war-tom 
Serbia and who sees the opportunity to attend Yale as a dream 
come true. “If you told me six years ago that I would end up 
at Yale,” she said, “I wouldn’t have believed you.” 






















One in io human cancers starts with a viral infection, often the 
ubiquitous human papillomavirus. Yale scientists want to know why— 
and are hot on the trail of new vaccines and therapies to treat 
the virus 
behind the cancer 
21 
By Jennifer Kaylin 
Illustrations by Yasuo Tanaka 
Photographs by Terry Dagradi 
More than 50 years ago, a young woman named Henrietta 
Lacks was diagnosed with cervical cancer. Despite surgery 
and aggressive radiation therapy, the cancer soon spread 
throughout her body, and on October 4, 1951, she died. 
It was a cruel death for the 31-year-old mother of five, I but Lacks’ story didn’t end there. George O. Gey, m.d., head 
of tissue culture at Johns Hopkins University, where Lacks 
was treated, had been searching, for research purposes, 
for a line of human cells that could live indefinitely outside 
the body. He got his wish when cells from Lacks’ cancerous 
tumor were cultured. Just as they had done in her body, the 
cells multiplied ferociously in the lab, crawling up the sides 
i of test tubes and consuming the medium around them. 
An entire generation of the cells reproduced every 24 hours. 
Referring to Lacks’ cells, Gey declared at the time, “It 
is possible that, from a fundamental study such as this, we 
will be able to learn a way by which cancer can be completely 
wiped out.” To this day, Lacks’ cells, known as the HeLa 
cell line, are some of the most robust and rapidly growing 
cells known to science. They are still used by thousands of 
researchers around the world to decipher the complexities 
1 of cell biology, particularly as they apply to cancer. 
At Yale, scientists are using the HeLa cell line to study, 
among other things, tire human papillomavirus (hpv) that 
causes the cervical cancer that lulled Lacks. “Her legacy,” says 
Daniel C. DiMaio, m.d., ph.d., the Waldemar Von Zedtwitz 
Professor of Genetics and professor of therapeutic radiology, 
“is that her cells are helping us unravel the pathogenesis of cer¬ 
vical cancer, so that some day we might be able to prevent and 
treat it. It’s rather remarkable.” 
The field of human tumor virology is still a relatively 
new area of scientific inquiry. Although it has been known 
for nearly a century that viruses can cause tumors in ani¬ 
mals, only in recent decades have human tumor viruses 
been identified. Researchers at Yale, among them I. George 
Miller, m.d., have contributed to our understanding of the 
mechanisms of viral tumorigenesis. 
Miller, the John F. Enders Professor of Pediatrics and 
professor of epidemiology and of molecular biophysics and bio¬ 
chemistry, was the first to show that a human virus can cause 
tumors in primates. Experiments he conducted at Yale in the 
1960s showed that the Epstein-Barr virus (ebv) could cause 
lymphoma in cotton-top marmosets. He also showed that the 
virus was very effective at changing normal human lympho¬ 
cytes into cells with properties of cancer cells in culture. 
More recently, DiMaio’s lab demonstrated that cervical 
cancer cells need the viral proteins to grow, thus raising 




















22 The virus behind the cancer 
drugs. DiMaio, Janet L. Brandsma, ph.d. ’81, and others 
are currently working on a vaccine to treat patients with cer¬ 
vical cancer. 
Besides these advances, Yale researchers who special¬ 
ize in tumor virology believe their work could have wider 
applications, potentially expanding knowledge of a range of 
cancers and other illnesses and biological processes, such 
as cellular aging. “It will help us understand all cancers,” 
says Brandsma, an associate professor of comparative medi¬ 
cine and pathology. “Most small mutations in cellular genes 
are very subtle, but with viral cancers, the viral genome 
in the cancer cell is foreign and easier to recognize. It’s an 
excellent model." 
Chickens, rabbits, warts and mice 
More than 10 percent of all cancers in humans are strongly 
associated with infection by tumor viruses, and roughly 15 
percent of all cancer deaths worldwide are caused by viruses. 
“It’s a very important problem,” DiMaio says. But he also 
sees tumor virology as a tremendous opportunity. “Once you 
know that a cancer is caused by a virus, you are far ahead of 
where you’d be for any other cancer, because you’ve identi¬ 
fied the target, you’ve identified the cause and you have well- 
established ways to prevent or treat the disease that just 
don’t exist for spontaneously arising tumors.” 
To say that certain viruses cause certain cancers can be 
misleading. You can’t catch cancer from another person, and 
most people who are infected with hpv, for example, won’t 
get cervical cancer. However, everyone who gets cervical can¬ 
cer has the hpv infection. “Other things have to go wrong in 
order for the cancer to develop,” DiMaio explains, “but the 
virus contributes in an essential way. If you prevent virus 
infection by vaccination, you don’t get the cancer, and if you 
turn off the virus, the cancer can’t grow.” 
hpv is the best-understood example of how a virus 
leads to cancer. Two things have to happen: First, viral gene 
products cause the cells to become genetically unstable 
and accumulate mutations that render cells unresponsive to 
aspects of growth control and the immune response. Second, 
the viral oncogenes provide a sustained stimulus to cell growth. 
The first clue that there was a viral link to certain 
cancers came in 1911. Using a virus found in chickens, F. 
Peyton Rous, m.d., a scientist at the Rockefeller Institute for 
Medical Research, showed that the chicken sarcoma could 
be induced in other chickens. “There was a lot of doubt 
about what applicability it had, if any, to human disease,” 
says Miller. But in 1966 Rous shared the Nobel Prize in 
physiology or medicine for his research on the link between 
viruses and cancer, and the chicken virus became known 
as the Rous sarcoma virus. 
Another important development, Miller says, came 
in the 1930s, when Richard Shope, m.d., one of Rous’ collabo¬ 
rators and the father of the late Yale epidemiologist Robert 
E. Shope, m.d., hs ’58, was out hunting with a friend. The 
friend mentioned that he’d seen rabbits with horns—actually 
giant warts. Shope asked his friend to send him some of the 
horns, which he then ground up, so he could isolate the virus 
causing the warts. When he injected the virus into other rab¬ 
bits, they also grew horns. Interestingly, when New Zealand 
white rabbits were inoculated with the virus, they grew horns, 
but Shope couldn’t recover the virus; in cottontail rabbits, 
the vims was retrievable. This discovery raised the question 
of viral latency, which scientists now know is intrinsic to the 
behavior and biology of tumor viruses. (Miller is currently 
researching latency as it relates to the Kaposi sarcoma vims. 
He’s trying to determine what the suppressor mechanism 
is and why latent-state viral genomes are suppressed in the 
tumor cells and then periodically reactivated.) 
In the early 1950s Ludwilc Gross, m.d., head of cancer 
research at the Bronx (N.Y.) VA Hospital, opened the field 
of tumor virology in mammals with his discovery of what 
became known as the Gross mouse leukemia virus. Gross 
showed that a virus led to mouse leukemia and could be 
passed from one generation to the next. 
Although these and other studies unequivocally 
showed that viruses can lead to tumors in animals, making 
“When I arrived at Yale in 1983, 
people didn't think these 
viruses were important to cancer. 
At conferences the human 
papillomavirus was always the 
last talk of the meeting. Now 
it’s taken center stage.” 
—Daniel DiMaio 
I the leap to human tumor viruses wasn’t easy. Researchers ! encountered several obstacles. For starters, only a small 
percentage of people who are infected actually develop can- 
cer; it takes more than a virus infection for a tumor to 
form; and other factors, such as immunosuppression or 
exposure to another carcinogen, must be present. Finally, it 
can take decades for symptoms to appear. 
Despite these challenges, in 1965 the first bona fide 
;; example of a human tumor virus—ebv—was discovered 
in cells from Burkitt lymphoma. Since then scientists have 
>; identified six viruses that have been shown to play a role 
I in human cancers. 
hpvs are a family of small dna viruses that typically 
cause benign warts. However, certain high-risk hpv types 
have been linked to a variety of carcinomas, the most preva¬ 
lent being cervical cancer, hpv is also thought to play a role 
' in other anogenital cancers, skin cancers and some head 
and neck tumors. 
Hepatitis B virus and hepatitis C virus are genetically 
unrelated, but both can cause acute and chronic liver dis- 
, ease, which, under certain conditions, can progress to pri¬ 
mary hepatocellular carcinoma, ebv is a herpes virus that 
can cause mononucleosis. However, ebv has also been 
I linked to Burkitt lymphoma and nasopharyngeal carcinoma, 
and it has been implicated in some forms of Hodgkin dis¬ 
ease and gastric carcinoma. Human herpes virus 8 (hhv-8), 
also known as Kaposi sarcoma herpes virus, is related to ebv. 
It was first identified in the tumor dna of a patient with 
Kaposi sarcoma, a rare tumor until the aids epidemic, when 
it became one of the most common causes of cancer deaths 
among aids patients, hhv-8 is also believed to play a role 
in Castleman disease and body cavity lymphoma. Finally, 
human T lymphotropic virus type 1 leads to a rare tumor, 
adult T-cell leukemia/lymphoma, in the Far East and the 
Caribbean basin, as well as to some nonneoplastic diseases. 
“It used to be a job to convince people that viruses 
were an important part of the cancer story. There had been a 
lot of research, but people just didn’t believe it. They won¬ 
dered, for example, why so many people who are infected 
don’t get cancer,” says Miller. “We had to fill in the details. 
Now people pretty much accept the idea.” 
“When I arrived at Yale in 1983, people didn’t think 
these viruses were important to cancer,” DiMaio says. “At 
conferences the human papillomavirus was always the last 
talk of the meeting. Now it’s taken center stage.” That’s 
partly because, of all the viruses found to play an etiologic 
role in human cancers, the hpv types (16 and 18) linked to 
cervical cancer are probably the best-understood and the 
ones that hold the greatest promise for vaccines to be used 
for prevention and treatment. 
Tight corsets and hpv 
Early thinking on cervical cancer and what causes it would 
hardly suggest such a rosy scenario. In 1842 an Italian 
physician in Florence observed that married women in the 
city were getting cervical cancer, but nuns in nearby con¬ 
vents weren’t. Although this observation would seem to 
point to a link between sexual activity and cervical cancer, 
the physician did not make this connection. He also 
observed that nuns had higher rates of breast cancer, and 
suggested that the nuns’ corsets were too tight. “Clearly 
they had no clue,” DiMaio says, “but the observation 
was significant.” 
Beginning in 1975, the virologist Harald zur Hausen, 
m.d., d.sc., figured out what had eluded the Florentine 
physician. Zur Hausen, who for 20 years headed the German 
Cancer Research Center in Heidelberg, showed that hpv, 
a common infection spread through skin-to-skin contact and 
sex, could lead to cervical cancer. He and his research team 
successfully isolated several genotypes of the virus, some of 
which they linked to genital warts and others to cervical cancer. 
Today, cervical cancer is responsible for 250,000 deaths 
each year worldwide, according to Charles J. Lockwood, m.d., 
the Anita O’Keefe Young Professor of Women’s Health 
and chair of the Department of Obstetrics, Gynecology and 
Reproductive Sciences. In the United States, where early 
“Cervical cancer is the ideal 
cancer in which to demonstrate 
the principle of anticancer 
vaccines, because we know what 





















24 The virus behind the cancer 
screening has greatly reduced the mortality rate due 
to cervical cancer, about 5,000 women a year still die of 
the disease. 
“From a mortality standpoint, the problem in this 
country is largely contained, but worldwide it’s a huge prob¬ 
lem,” says Lockwood. “From a financial standpoint it remains 
a major problem in this country. The cost of surveillance and 
preventive treatments is astronomical ($200 million a year 
just for screening), and a woman who has multiple surgical 
treatments for precancerous conditions of the cervix, such 
as cone biopsies or loop electrocautery excision procedures, is 
at a higher risk of giving birth to a preterm baby.” 
Even though cervical cancer in this country is largely 
under control, women still get it, and when they do, it can 
be devastating. Thomas J. Rutherford, ph.d., m.d., fw ’94, 
associate professor of obstetrics, gynecology and reproductive 
sciences and director of gynecological oncology, recalls a 
patient in her mid-30s who was pregnant. The results of a 
routine Pap smear were abnormal. A colposcopy revealed a 
very high-grade squamous cell lesion. To save his patient’s 
life, Rutherford recommended an immediate radical hysterec¬ 
tomy, but that would have meant losing the baby. “The 
patient finally agreed,” Rutherford says, “but after the surgery 
she said to me, ‘I can’t believe I gave up one of my children.’ 
It was a difficult choice she made, but she probably would 
have died if she hadn’t.” 
Another patient was a 20-year-old college student who 
had adenocarcinoma of the cervix, which is also caused by 
hpv. She underwent a cone biopsy, but the Pap smear still 
revealed abnormalities in her cervical cells, “We couldn’t 
repeat the procedure, because she wanted to have children,” 
Rutherford recalls. “We put everything on the table: This is 
the situation. Your best option is to have a child now.” The 
patient took Rutherford’s advice and had a baby, after which 
Rutherford performed a radical hysterectomy. “There she 
was, getting married, having a baby and then having a hys¬ 
terectomy, all before she turned 21,” he says. “I assure you 
that wasn’t what she foresaw for herself.” 
Even when a patient isn’t diagnosed with a precancer¬ 
ous lesion, the ordeal of getting a positive test result, going 
back for more tests and possibly having to have a colposcopy 
or a biopsy before finally getting a clean bill of health is 
stressful. “It’s also a very expensive way to prevent cervical 
cancer,” Brandsma says. “It’s a lot of money and anxiety.” 
A far better approach, she and other hpv experts say, 
would be to vaccinate people against the disease. Researchers 
at Yale and elsewhere have been working on two types of 
vaccines with promising results. A prophylactic vaccine 
being developed at the National Cancer Institute and the 
University of Washington, among other places, would pre¬ 
vent infection by generating a neutralizing antibody. 
Brandsma, DiMaio and other researchers at Yale and else¬ 
where are working on a therapeutic vaccine that would 
generate killer T-cells that could recognize tumor cells as 
being foreign and destroy them. “Cervical cancer is the 
ideal cancer in which to demonstrate the principle of anti¬ 
cancer vaccines, because we know what the tumor antigens 
are. Viral E6 and E7 are the oncoproteins expressed in all 
lesions. They’re always required,” Brandsma says. 
Two versions of the prophylactic vaccine have shown 
encouraging results in clinical trials. Both prevented per¬ 
sistent infection by the hpv types contained in the vaccine 
in 100 percent of vaccinated women and reduced cervical 
abnormalities by more than 90 percent. Merck & Co., the 
maker of one vaccine, reported in the fall of 2005 that, in a 
Phase III trial of more than 12,000 women, the vaccine 
prevented virtually 100 percent of growths that can lead to 
cervical cancer. The company has since announced plans 
to file for approval with the U.S. Food and Drug Administra¬ 
tion before the end of the year. GlaxoSmithKline, maker 
of the other vaccine, reported similarly positive results with 
its clinical trials and plans to seek approval in Europe and 
other countries in 2006. 
Once a vaccine is in widespread use, experts predict 
an immediate 44 to 70 percent reduction in abnormal 
Pap smears and a long-term reduction of close to 95 percent 
“It used to be a job to convince 
people that viruses were an 
important part of the cancer 
story. There had been a lot of 
research, but people just didn’t 
believe it.... Now people pretty 
much accept the idea.” 
—George Miller 
in cervical cancer rates. As promising as these numbers are, 
the vaccine also has limitations, chief among them being 
that three injections are required and the vaccine must be 
kept refrigerated. Especially in developing countries, where 
the need for a vaccine is the greatest, these obstacles have 
the potential to limit the vaccine’s efficacy. Another limita¬ 
tion is that, although the vaccine prevents infection by the 
most common high-risk hpv types, less common high-risk 
hpv types are not included. 
Beyond that, the vaccine raises thorny social issues. To 
maximize its effectiveness, it should be given to girls between 
the ages of 9 and 12, before they become sexually active. 
Already, some religious groups have raised concerns that this 
will be interpreted as a license to engage in premarital sex. 
“These vaccines could provide a huge public health 
benefit,” Lockwood says. “To allow their introduction to be 
blocked because of some extreme ideological position is 
unconscionable and irrational. It would be a huge cost sav¬ 
ings, and could save some young person from dying in her 
20s or 30s.” 
Putting cancer genes to sleep 
Vaccines are not the only approach to controlling cancers 
with viral origins. Using the HeLa cell line, which contains 
hpv dna, researchers have figured out that the proliferation 
of cervical cancer cells requires the expression of the hpv 
oncogenes E6 and E7, which are expressed by cervical carci¬ 
noma cells. These oncogenes inactivate the cancerous cells’ 
major tumor suppressor pathways, thereby allowing the 
cells to proliferate. 
An effective way to combat this, scientists have learned, 
is to induce a biological phenomenon known as senescence, 
an irreversible suspended animation of the cell, which acts 
as an important tumor suppressor mechanism. DiMaio and 
his colleagues have determined that the introduction of the 
papillomavirus protein E2 to the cell represses E6 and E7, 
halts cell growth and induces senescence. So, although the 
tumor cells have accumulated essential mutations, they still 
depend on the viral proteins. DiMaio likens it to a house of 
cards. “You need many cards to build a multistory house, but 
the whole edifice tumbles down if you remove the crucial 
card at the bottom. 
“When we added E2, it induced senescence in a day 
or two,” DiMaio says. “This creates an important barrier to 
tumor formation and growth. It also gives us a new model 
to study senescence.” DiMaio says this is important because 
the hope is that senescence can be applied to other cancers 
as well. Also, there’s great interest in someday inducing 
senescence to block aging and age-related disease. “Half of 
my lab is focusing on senescence,” he says. 
As the study of tumor virology continues to grow in 
importance and application, a growing number of Yale 
researchers are investigating other pieces of the puzzle. John 
K. Rose, ph.d., professor of pathology, is interested in vac¬ 
cines constructed from virus vectors. He is collaborating 
with Brandsma’s and DiMaio’s labs to develop hpv vaccines 
using a slightly different approach. The same antigen is 
involved, but instead of injecting dna into the animal, as 
Brandsma does, he uses virus vectors. Rose is also in charge 
of a small unit that has recently recruited two junior tumor 
virologists. Michael D. Robek, ph.d., assistant professor of 
pathology, studies replication of hepatitis B virus, and Robert 
E. Means, ph.d., assistant professor of pathology, studies 
ways that herpes viruses avoid the immune response. 
More than 50 years ago, Henrietta Lacks was helpless 
against the cancer that destroyed her body, but today, thanks 
in part to her cells, researchers are closer than ever to defeat¬ 
ing that enemy, and the hope is that with the knowledge 
gained by studying hpv, other cancer-fighting breakthroughs 
will soon follow. 
Jennifer Kaylin is a contributing editor of Yale Medicine. 
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The final chapter 
Once routine, autopsies are rarely performed, and pathologists 
lament the loss. Despite advances in medicine and laboratory science, 
only a post-mortem can tell the full, and final, story. 
By Marc Wortman 
With every autopsy, Art Belianger, 
manager of the autopsy service at 
Yale-New Haven Hospital, draws a 
diagram of the body, noting scars, 
tattoos and previous injuries. 
Shortly after lunch on a midsummer’s day, Charles Slater 
felt ill. (His name and identifying details have been altered.) 
Complaining of indigestion, the 5 5-year-old administrator 
at a New Haven-area social services center headed home. 
Soon after, though, the pain became unbearable. He called 
for emergency medical service and paramedics arrived 
within five minutes, but he had already collapsed. The para¬ 
medics could find no pulse and tried to restart his heart 
and breathing. In the Yale-New Haven Hospital (ynhh) 
Emergency Department, physicians continued efforts to 
restore a heartbeat, but gained no more than a slight systolic 
fluttering. An hour after Slater telephoned for help, the 
doctor in charge declared him dead. 
In most respects, the end of Slater’s life, although sud¬ 
den and unexpected, was identical to that of all others. A 
biological event of catastrophic proportions overwhelmed his 
body. In reviewing the medical records, John H. Sinard, 
m.d,, ph.d., hs ’93, fw ’94, director of the autopsy service at 
ynhh, says that Slater had no serious apparent health prob¬ 
lems before that day and kept himself in decent physical 
shape. A heart attack seemed the likely culprit, but the body 
holds many secrets. His family agreed to an autopsy. In this, 
the end of Slater’s life stands out. 
While every death is ultimately the same, in the eyes 
of those who deal with death for a living, “each death is 
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TOP An autopsy, says John Sinard, 
director of the autopsy service 
at Yale-New Haven Hospital,"is 
one of the few times you consider 
the whole patient and the whole 
disease process.” 
above As manager of the 
autopsy service, Art Bellanger per¬ 
forms most autopsies, with the 
assistance of pathology residents. 
and of ophthalmology and visual science. Every time a 
patient dies at ynhh, the family is asked to consider an 
autopsy, even when the cause of death is apparent. Very few 
consent. About 20 percent of patients who die at ynhh 
are autopsied. As in most teaching hospitals, that rate is sig¬ 
nificantly above the average for private and community hos¬ 
pitals, which is typically below 10 percent—and half of those 
are required for forensic or legal reasons. (In Connecticut, 
forensic autopsies are performed at the Office of the Chief 
Medical Examiner and, in the case of crime-related deaths, 
are often attended by representatives from the state police.) 
Pathologists at Yale worry that even the hospital’s 
comparatively high rate of autopsies is barely sufficient— 
in the 1960s, more than 70 percent of ynhh patients were 
autopsied at death. (The Mayo Clinic, which has one of 
the highest rates in the nation, autopsies more than 35 per¬ 
cent of patients who die in its care.) “Around the 20 percent 
level is the minimum to provide a reasonable statistical 
basis for what is seen in the hospital,” contends Raymond 
Yesner, m.d., a professor emeritus of pathology who, at 91, 
continues to serve as a research scientist in the department. 
“Below that level, a hospital may not be monitoring care 
sufficiently, and you may see problems in quality control.” 
Adds Rosemarie L. Fisher, m.d., hs ’75, professor of 
medicine and associate dean for graduate medical education, 
“From an internist’s point of view, I would like to see the 
rate higher, although we are probably higher than a lot of 
other institutions. Autopsies should be performed because 
they often contribute to knowledge about other illnesses 
that may be important for the care providers or the family 
to know about.” 
With such low rates nationally, many pathologists are 
concerned that medical practices may be suffering. “If you 
get in the range of 10 to 15 percent these days, a hospital is 
doing very well,” says Kim A. Collins, m.d., who chairs the 
autopsy committee of the College of American Pathologists, 
the world’s largest organization of board-certified pathologists. 
“Many people think we can diagnose everything 
before death,” says Collins, a professor of pathology and 
laboratory medicine at the Medical University of South 
Carolina. “But studies show that in close to half the cases, 
autopsies find something contributory or that the whole 
cause of death was different than physicians believed before¬ 
hand.” With investment in health care and biomedical 
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research based in part on mortality statistics, the evidentiary 
basis for that investment may now be distorted or even false. 
“Without enough autopsies,” Collins contends, “we really 
can’t be accurate with our epidemiological facts.” 
In the age of genetic studies and imaging technologies, 
autopsies still provide a unique means for studying certain 
diseases and identifying previously unknown public health 
issues. Jon S. Morrow, ph.d., m.d. ’76, hs ’79, fw ’81, the 
Raymond Yesner Professor of Pathology, chair of pathology 
and professor of molecular, cellular and developmental 
biology, says: “Even to this day, autopsies are essential to 
the identification of a number of our latest scourges, like 
sars, much of aids and other new diseases.” Moreover, he 
notes that even when no questions about cause of death 
may remain, an autopsy still provides a unique picture of a 
patient’s health and health care, which otherwise remains 
incomplete. “A patient is served by many different physi¬ 
cians,” he says. “The pathologist’s evaluation is where the 
data come together.” Those data can serve to improve teach¬ 
ing, research and medical care. He worries that the decline 
in the rate of autopsies may undermine the entire system. 
“We’re in danger of losing a critical piece of infrastructure.” 
Nothing routine about death 
Less than a day after Slater’s death, I don a head-to-toe 
jumpsuit and enter the autopsy room in the morgue in an 
extension to the Brady Memorial Laboratory. Half a dozen 
people cluster around Slater’s body, which lies on a long 
aluminum tray. Water flows continuously along a trough 
beneath the tray. A loud and powerful fan evacuates the air 
in the brightly lit room. With masks muffling our mouths 
and surgical caps pulled down over our ears, the echoing 
fan and splashing of the water make hearing difficult. 
Perhaps it is my own expectation, but all of us in the room 
seem intensely alert and attentive. There may be as 
many as five more autopsies performed this day, but the 
awesome presence of the dead and the seriousness of 
the investigation of death make nothing routine about any 
individual case. 
An odor of bowels, cleansers and preservative chemi¬ 
cals—not quite sickening but enough to make a shower 
afterward a must—filters through the mask. Slater’s body 
extends straight except for his head, which is braced by a 
block beneath the neck and cocked upward. A white man, 
his skin is yellow, waxy and splotched with patches of pur¬ 
ple, except for the lower third of his back, which is bruised a 
deep burgundy. As I soon see, his blood has pooled there. 
He is tall, almost as long as the table, and appears to have 
been in pretty good shape for his age, with little fat bunched 
around his waist. 
He still has most of his auburn hair, which is swept 
back from his forehead. His brown-green eyes stare straight 
into the harsh overhead spotlights. His elbows, bent rigidly, 
hold his forearms and hands a few inches off the table, 
as if he died while reaching for something with both hands. 
He looks alive enough that it appears he could 
bend his elbows and push himself off the table when Arthur 
J. Belanger III, m.h.s., manager of the autopsy service, 
approaches Slater’s body and announces the present time, 
shortly after 1 p.m. Belanger is a jovial man with black-rim 
glasses and dark hair and a Navy tattoo on his thick forearm. 
He likes his work, enjoys explaining what he is doing and 
talks about it freely. With practiced swiftness, he picks up a 
scalpel and inserts the blade into Slater’s chest just beneath 
the top of the left collarbone. No blood flows from the wound. 
A young college student considering a future as a 
pathology assistant flees the room. The others—two pathol¬ 
ogy residents and an aide—watch intently. Belanger swiftly 
slices downward and toward the center of the chest, cutting 
into the rib cage. He cuts at the tip of the right collarbone 
and continues down until the wound intersects with the 
other slice. In one swift, practiced cut, he sweeps straight 
down the abdomen to the top of the pelvic bone. With a pair 
of heavy-duty snips, he snaps the last resisting bones in the 
rib cage and hinges open Slater’s chest, exposing a sunken 
tangle of bluish gray, green and red organs. Belanger 
reaches inside Slater’s body cavity. He calls out his actions 
as he feels with his knife to cut all the central organs free 
of the arteries, muscle, thorax, bone, nerves and connective 
tissue holding them in place. 
Much to learn from the dead 
Death was once the greatest biological mystery, other than 
life itself. No longer. Medicine and health care have pro¬ 
gressed to the point that, when a person dies, the physiologi¬ 
cal reasons are usually apparent. In some cases, the actual 
time of death becomes a matter of when the switch on the 
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The decline in autopsy rates reflects many factors, 
including costs (not borne by families of patients) of up to 
$3,000 per autopsy and advances in diagnostic imaging and 
testing methods, endoscopic exploration and surgical inter¬ 
ventions that make cause of death all but certain in most 
cases. Nonetheless, “As good as those ancillary studies are, 
we can’t diagnose everything pre-mortem," insists Collins. 
“Even if you know the accurate cause of death, there’s still so 
much you can learn.” According to Sinard, who serves with 
Collins as vice chair of the College of American Pathologists’ 
autopsy committee, “It is one of the very few times you con¬ 
sider the whole patient and the whole disease process. It 
shows the physicians the extent of the disease process and 
the effectiveness of therapy for a patient. We may discover 
things that are entirely unexpected.’’ For the family and the 
doctor, it will usually answer any outstanding questions. 
Given that so much is already known about a patient's 
poor health and the causes of death, families often fail to 
grasp why an autopsy is needed at all. Many families resist 
what they perceive as a violation of the body after an often- 
arduous end of life. Perhaps as a result of all the forensic 
medicine series on television, many also think autopsies 
serve only to solve mysteries or to demonstrate a failure in 
their loved one’s health care. They worry that the request for 
an autopsy indicates a problem. Yet even when it reveals no 
surprises, says Sinard, an autopsy can be reassuring to the 
family. “We’re not policemen,” says Morrow. “We’re not look¬ 
ing for bad practices. We’re looking for accuracy and the 
quality of care. An autopsy almost always substantiates that 
the hospital and the physician did nothing wrong.” 
How the news about a death is communicated can 
affect a family’s willingness to “help” medicine. “It’s the 
way it’s presented that matters,” Morrow says. “Physicians 
are often uncomfortable around death. They would often 
rather move on. The rates of autopsies, though, are higher 
when families are asked appropriately.” Few physicians 
ever bother to ask; most know little about autopsies or their 
value and have never attended one. And few medical 
schools require that their students attend autopsies. At 
Yale, medical students attend autopsies as part of the sec¬ 
ond-year pathology course, but as with all courses in the 
first two years, attendance is not mandatory. “It should be 
a routine part of a student’s education,” says Collins. 
“Everyone needs to know about it.” 
Fisher, who directs Yale’s residency programs, notes 
that residents are less likely to observe an autopsy than in 
years past. “There used to be a 15 percent autopsy rate 
required for internal medicine residency program accredita¬ 
tion purposes,” she says. “That has just disappeared. Some 
programs now see only one or two autopsies a year. That’s 
a concern.” 
Writing the last chapter 
Even though all outward signs pointed to acute myocardial 
infarction—a sudden, devastating heart attack—as the cause 
of death, Charles Slater’s family agreed to an autopsy. 
With two pathology residents looking on and occa¬ 
sionally assisting, Belanger cuts Slater’s organs—from the 
trachea to the testes—free of connective tissue and bone. 
Grasping the innards as a single mass in his arms, Belanger 
lifts the shiny, wet, shifting clump out of Slater’s body and 
sets it on a large white plastic surface that covers the other 
leg of the L-shaped autopsy table. The pathology residents 
then dissect the mass of organs, paring away the connective 
tissue, viscera and fat. Soon, the major organs are revealed. 
One by one those organs and major arteries are cut free. 
Belanger and an assistant turn their attention to the 
head. After opening Slater’s skull cap with a vibrating saw, 
the gray brain is removed by cutting it loose from the brain¬ 
stem and other soft-tissue attachments. 
Meanwhile, the residents separate the removed 
organs, slicing the larger ones and examining the cut sur¬ 
faces carefully for any signs of pathology. These are then 
placed on display trays for presentation to the attending 
pathologist. Some of the tissues, such as calcified coronary 
arteries, must be further prepared before they can be com¬ 
pletely dissected. 
Sinard enters the room and, with the pathology resi¬ 
dents, reviews tissue from the organs. A resident presents 
the deceased’s clinical story, which is then discussed in 
the context of the pathological findings. Sinard and the resi¬ 
dents select tissue for further, microscopic examination. 
Finally, the attending and the residents will review the case 
and determine the most likely sequence of events that led 
to Slater’s death. Slater, the deceased, has provided a 
valuable teaching tool. The residents participating in his 
autopsy would never otherwise have the chance to view 
a body’s organs whole, fresh and in context. They have also 
benefited from viewing the consequences of biological and 
medical processes. 
Their inspection shows that Slater’s lungs were con¬ 
gested with blood, a telltale sign of heart failure. The heart 
itself had a slight grayish discoloration in the left ventricle 
wall, evidence of a sudden, devastating thirst for blood. To 
the touch, the pinkish white coronary arteries were brittle. 
Although it would take later decalcification to allow them to 
be sliced open, that appeared to be the “smoking gun,” a 
single factor capable of causing death. Arteriosclerosis, by 
far the most common cause of sudden death in middle-aged 
men, was clearly present. 
Belanger returns the remaining viscera to Slater’s 
body cavity and replaces the crown of his skull. His assistant 
sews both shut. The pathology residents remain in the 
room, examining the organs and helping to catalog them 
for preservation. They have witnessed the conclusion of a 
life, from within a profession that pays special respect to 
the patient who has died. 
“I tell my residents to handle with care,” says Yesner. 
“What you are doing is writing the last chapter in some¬ 
body’s life.” 
The death certificate is filled out, and Slater’s body is 
released in condition for an open-casket funeral. A veteran, 
he will be buried three days later with military honors in a 
cemetery outside New Haven. 
Help for the living 
Two weeks later, the laboratory report is ready. In fact, 
one of the arteries had been entirely blocked by a fatty 
plaque that had dislodged from the artery wall, starving 
the heart of blood and sending it into lethal spasms as it 
strained for oxygen. The report also shows benign tumors 
developing in Slater’s adrenal glands and intestine. The 
tumors had yet to cause symptoms, but had Slater lived, 
he would have encountered medical difficulties within 
a few years. They had not contributed to his death, but, 
says Sinard, “We are trying to catalog all of the disease 
processes in the patient.” Armed with the report, his 
family members, who could themselves face similar con¬ 
ditions, will be in a position to take action. Such findings 
remind Collins that “there’s so much you can learn 
about your own health by having an autopsy done on a 
deceased family member.” 
At Yale, tissue samples from every autopsy are frozen, 
placed in fixative solution or embedded in paraffin blocks 
for permanent storage. If questions should arise, tissue will 
be there for study—potentially avoiding exhuming a body. 
Longer term, the tissue may be used for teaching or research 
purposes. Yale possesses millions of tissue samples dating 
back to 1917, many of which have proven valuable for 
research, even decades after first being cataloged and stored. 
Autopsy-based research at Yale has led to a greater under¬ 
standing of the worldwide flu pandemic of 1918-1919, 
resulted in descriptions of new forms of liver cancer and 
various pneumonias and expanded insights into the way 
blood reaches tumors. Today’s research on Alzheimer’s dis¬ 
ease and other central nervous system disorders, which in 
most cases cannot be directly studied during a patient’s life¬ 
time, depends on autopsy material. “The speed of collecting 
and preserving the material is critical to the value of the 
specimen,” says Morrow. 
The national rate of autopsies has been in decline for 
decades. Since 1970 the Joint Commission on Accreditation 
of Healthcare Organizations has no longer required an 
autopsy rate of 20 percent to maintain accreditation. Morrow, 
Sinard, Collins and other autopsy pathologists have been 
trying to educate the medical community and the wider pub¬ 
lic about the need to reverse the trend. While there is no 
rate of autopsies considered minimally necessary by any 
national organization, ‘Too percent would be ideal,” says 
Collins. “I wish we coidd have at least 20 percent nationally. 
Every family ought to be approached for the opportunity 
an autopsy offers them.” 
One day, a genetic factor may be found to underlie 
sudden cardiac death. Tissue collected in autopsies from 
patients such as Slater will almost certainly prove crucial in 
the development of new diagnostic methods and preventive 
therapies. The post-mortem picture of Slater’s health may 
also prove directly beneficial to his own children and other 
relatives. “All of us will die,” says Sinard. “That doesn’t end 
what we can do for the living.” 





















When Capt. James Cook first 
visited Hawaii in 1778, he brought 
animals previously unknown 
on the islands—and against which 
native species had no defenses. 
The ships that followed brought 
goats, cattle, sheep and mosqui¬ 
toes, altering the environment in 
unforeseen ways. 
When animals 
sound a warning 
Under the umbrella of a Yale center, 
ecologists and epidemiologists try to 
understand the not-always-felicitous 
interactions among humans, their 
environment and disease. 
By Rhea Hirshman 
Illustrations by Einat Peled 
The native birds of Hawaii are vanishing. Of more than 100 
species actively breeding on the islands when Capt. James 
Cook landed there in 1778, barely half remain and many 
of those are endangered. Having evolved in island isola¬ 
tion, with no mammalian predators, the birds were easy tar¬ 
gets for alien rats—escapees from ships—which preyed on 
their eggs and their young. At the same time, bird habitats 
have been degraded by a range of human activities that date 
back more than 200 years, when cattle introduced to provide 
food for European settlers began to chew their way through 
the foliage. 
But even though human activity has been damaging 
the Hawaiian bird population for centuries, the beginning of 
the population’s drastic decline can be traced more precisely 
to 1826, when the encroachers were not bulldozers flatten¬ 
ing delicate ecosystems or pesticides spread for agribusiness 
(those threats came later), but mosquitoes brought by a 
whaling ship from Mexico. Two weeks after the ship left, 
after taking on water and washing out its casks, locals 
were complaining to missionaries about a new kind of fly 
that flew at night and buzzed. 
“There had been no mosquitoes in Hawaii before then,” 
says Stephen C. Stearns, ph.d., “and these mosquitoes could 




















34 When animals sound a warning 
native bird population, Stearns notes, “but when humans 
brought yellow fever to Hawaii, the mosquitoes were there to 
transmit the human disease as well.” 
The interplay among human behavior, human health 
and disease, animal behavior and health and the ecology 
of the planet is the foundation of the activities of the new 
Center for EcoEpidemiology, which was established as part 
of the Yale Institute for Biospheric Studies and began 
operation on July 1 last year. Stearns, the Edward P. Bass 
Professor of Ecology and Evolutionary Biology and chair of 
ecology and evolutionary biology, is one of more than a 
dozen Yale faculty affiliated with the center. A specialist in 
the life history consequences of infections and disease, 
co-author of a widely used textbook on evolution and the 
founding editor of the Journal of Evolutionary Biology, Stearns 
calls the center “an important cross-disciplinary effort to 
both understand and anticipate the consequences of human¬ 
ity’s interacting with the environment.” 
Faculty from the School of Medicine (departments of 
Internal Medicine and Epidemiology and Public Health), 
the School of Forestry and Environmental Studies (fes), the 
Graduate School of Arts and Sciences and Yale’s Department 
of Ecology and Evolutionary Biology are among those partici¬ 
pating in center activities. The center’s director, Durland 
Fish, ph.d., notes that—through fostering the creation of 
new undergraduate and graduate courses, hosting seminars 
and symposia, coordinating Yale’s existing cross-disciplinary 
curricula and helping to develop an interdisciplinary doc¬ 
toral program in epidemiology and ecology/environmental 
science—it will be addressing two main themes. 
“The first,” Fish says, “is how do we integrate environ¬ 
mental and ecological sciences into infectious disease epi¬ 
demiology? The focus in combating diseases has traditionally 
been to concentrate on individual humans or discrete groups 
of humans—for instance, by developing diagnostic tech¬ 
niques or vaccines. But many important human pathogens, 
whether transmitted human to human, animal to human 
or vector to human, originate in the environment. The risks 
of incurring or transmitting infection have everything to do 
with what happens in the environment.” Fish adds, “I view 
infectious diseases as environmental threats—measurable 
and predictable. So we want to look at how to get the ecologi¬ 
cal sciences as equal participants in understanding and 
combating infectious diseases.” 
A professor of epidemiology (microbial diseases) at the 
School of Public Health (eph) and principal investigator of 
the Centers for Disease Control and Prevention’s Fellowship 
Training Program in vector-borne diseases, Fish notes that he 
had experienced a “lack of communication between ecology 
and epidemiology” throughout his career. “I studied the ecol¬ 
ogy—the abundance and distribution—of insect-borne 
pathogens. There wasn’t much support for this kind of work, 
because in the 1960s we thought we had conquered all kinds 
of infectious diseases with drugs and vaccines.” 
However, Fish points out, diseases thought to be con¬ 
trolled or eliminated have re-emerged, while “new” infections 
including Lyme disease and West Nile virus have also sur¬ 
faced. Suburbs that encroach on once-natural areas bring 
humans in closer contact with deer and the deer ticks that 
carry Lyme disease. In parts of Central and South America, 
a decade-long pandemic of dengue fever is attributable to 
an increase in the number of items such as tires and cans— 
used as containers or left as garbage—that hold the standing 
water that becomes a breeding ground for mosquitoes. In 
these and a wide range of other instances, zoonotic diseases— 
those caused by infectious agents that can be transmitted 
between (or are shared by) animals and humans—have every¬ 
thing to do with environmental disturbance, human popula¬ 
tion growth and the speed with which people, animals, plants 
and materials are transported around the world. 
The second theme of the center, Fish says, is “getting 
the tools of human medical science into the hands of those 
studying disease ecology and environmental health.” He 
notes, for instance, that David K. Skelly, ph.d., another faculty 
member affiliated with the center, is using ultrasound technol¬ 
ogy originally developed as a diagnostic tool for humans to 
study parasitic cysts in frogs. Amphibians, he notes, have been 
central to the development of biological knowledge and have 
become icons for environmental decline. 
“We can learn a lot about human health by looking 
at nonhuman systems, and the development of the field 
of ecoepidemiology is a recognition of that,” says Skelly, a 
professor of ecology at fes and of ecology and evolutionary 
biology, and a 2003 recipient of a Guggenheim fellowship 
to write a book on amphibians aimed at the general public. 
“Animals and plants can be sentinels—whether we’re deal¬ 
ing with risks that are infectious or chemical. What sorts 
of environmental conditions are conducive to disease? How 
does the exposure of a frog in a pond to infection or toxins 
or pollutants translate into possible human exposure, and 
what are the effects of that exposure? Our message as scien¬ 
tists should not be only about risks to humans. But if we are 
modifying our environment so that reptiles are becoming 
hermaphrodites, we have to ask if there is a relationship to 
the decrease we’re seeing in human male sperm counts.” 
While Skelly uses tools of biomedical science in his 
work as an ecologist, he talks in turn about the relevance of 
ecological tools and methods to medical research. “As an 
ecologist, I know that the emerging field of disease ecology 
shows us a discernible relationship between infectious 
agents and species distribution and abundance.” Skelly says 
that the tools of ecology, including field experimentation 
(going out into the environment where infection happens, 
modifying some part of the natural world and comparing it 
to a control location), “are now spreading into the biomedi¬ 
cal world—medical researchers are building models and 
testing them in nature, taking the study of disease outside 
the laboratory and looking at the environmental contexts 
of disease and infection.” 
Using Lyme disease as an example of changing per¬ 
spectives on managing infection, Skelly asks, “Can we decrease 
Lyme disease risk by intervening with nonhuman hosts?” 
Fish, who has worked on Lyme disease “since the 
beginning,” also talks about taking a different approach. 
“An ecological perspective to preventing Lyme or any 
other vector-borne disease involves thinking about how 
populations are regulated by nature and how we can 
work within the natural environment to reduce the pres¬ 
ence of disease vectors.” 
He points out that in the case of Lyme disease, refor¬ 
estation of the Northeast has caused changes in the population 
density and distribution of the white-tailed deer and, corre¬ 
spondingly, its natural parasite, the deer tick. These changes 
have caused a Lyme disease epidemic as humans have increas¬ 
ingly come into contact with ticks infected with Lyme disease 
bacteria. “We did an experiment—using the vaccine originally 
developed for humans, we vaccinated mice in the woods out¬ 
side of New Haven. Over the next several years, we found 
fewer infected ticks. While human vaccination turned out not 
to be an effective defense against Lyme disease, this research 
path is promising.” The point, Fish emphasizes, “is that there 
is a range of options for us to work with.” 
From his discipline, Stearns also notes the importance 
of looking at “ecological context,” which he describes as 
standard evolutionary thinking. “Every organism ‘wants’ to 
survive,” he says. “We can’t really understand the develop¬ 
ment of virulence or resistance or the emergence of diseases 
like Ebola or sars or aids unless we look at that ecological 
context, one that humanity has often affected.” 
To illustrate his point, Stearns tells what he calls a 
cautionary medical tale—the consequences of the spread 
of a cattle disease (rinderpest) into Africa. Rinderpest first 
evolved in Eurasia, entering Africa either with General 
Charles Gordon’s attempt to lift the siege of Khartoum in 
1885 or with the Italian invasion of Ethiopia in 1895. In 
Africa rinderpest encountered a continent with no evolution¬ 
ary experience of—or immunity to—the disease. “The 
rinderpest virus spread rapidly all the way south through 
Africa, reducing native herds of hoofed animals down to 
about 1 percent of their former levels,” says Stearns. “Lions, 
whose prey were dying off, began eating people. 
“In true ecological fashion,” Stearns says, the effects 
of these events on the human population were significant. 
Without the grazing animals, bushes grew up along creeks 
and river beds—and created ideal environments for tsetse 
flies. “So when people tried to move back after the virus had 
gone through,” Stearns continues, “they encountered sleep¬ 
ing sickness.” Now, decades later, those areas that experi¬ 
enced a high incidence of sleeping sickness are the national 
parks of Africa, because giraffes and antelopes and many 
other wild animals are not affected by sleeping sickness, 
which kills both cattle and humans. 
“The interactions between predators, prey, pathogens, 
vectors and vegetation reshaped the human ecology of a 
continent for a century,” Stearns says. “No one could have 
predicted this when some sick cows came along with an 




















36 When animals sound a warning 
Looking beyond the immediate and the obvious and 
paying attention to the possibility of the unpredictable are 
central to the interdisciplinary mission of the Center for 
EcoEpidemiology. The overall goal is to develop an innova¬ 
tive curriculum among the participating schools and depart¬ 
ments to provide training that cannot be obtained at any 
other American academic institution. “I’m also hoping to 
see more emphasis on prevention in a much more global 
way. We want all sorts of new ideas to emerge,” says Fish, 
“and there is a lot of excitement about what we’re doing. 
When the creation of the center was announced I was inun¬ 
dated with e-mails and phone calls from people wanting to 
be involved or to know more.” 
A listing of just some of the topics under considera¬ 
tion for the center’s fall seminars—the impact of global 
warming on infectious disease, biodiversity, environmental 
change, wildlife as sentinels for environmental hazards, 
health implications of fossil fuel use, potential bioterrorism 
threats to the environment—illustrates the range of interests 
of participants and the possibilities that the center holds. 
Stearns envisions the center as “a place to train a new gen¬ 
eration of graduate students to observe the world in new 
ways and come up with syntheses that my generation was 
not trained to be able to see.” Slcelly adds, “We want to train 
people who are oblivious to disciplinary boundaries. Once 
faculty and students from different disciplines start talking 
to each other, there’s no telling what can happen.” 
For more informa tion about the Yale Institute for Biospheric 
Studies Center for EcoEpidemiology, and a list of 
upcoming events and courses, check the center’s website at 
http://www.biology.yale.edu/oib/resources/yibs.htm. 
Rhea Hirshman is a freelance writer in New Haven. 
Rigging the roulette 
wheel to slow the spread 
of viruses 
Avian flu virus is not new. AM the 
influenza strains that affect peo¬ 
ple have avian origins—including 
the virus that caused the 1918- 
1919 influenza pandemic, accord¬ 
ing to Durland Fish, ph.d., profes¬ 
sor of epidemiology. That outbreak 
killed at least half a million people 
in the United States and more 
than 30 million worldwide. As 
with such other “emerging” dis¬ 
eases as Ebola hemorrhagic fever, 
Lyme disease and severe acute 
respiratory syndrome, or sars, 
what is “new” about avian flu is 
a heightened awareness of the 
role of other species in the devel¬ 
opment of this human health 
hazard, says Fish. That makes it a 
perfect case study for the new 
center Fish directs, the Center for 
EcoEpidemiology, part of the Yale 
Institute for Biospheric Studies. 
The center’s purpose is to bring 
together experts in ecology and 
epidemiology in areas where their 
studies intersect. 
Fish highlighted one such inter¬ 
section in a talk at a conference on 
campus last May,"Ethical Aspects 
of Avian Influenza Pandemic 
Preparedness, Part i: Vaccines,” 
when he discussed the necessity 
of focusing more resources on 
understanding how the virus 
evolves and functions in wildlife 
populations so that we can keep 
it from developing into a strain 
transmissible to humans. 
Of the numerous strains of the 
influenza virus, of most concern is 
the H5Ni strain. "A common sce¬ 
nario is that avian viruses in wild- 
bird populations are transmitted 
to domestic birds or sometimes to 
pigs. New strains can evolve when 
animals are in proximity to each 
other,” Fish says. This process is 
known as “recombining.” Although 
humans have developed some 
immunity to various influenza 
genotypes through exposure, they 
would be highly susceptible to the 
new strain were it to become wide¬ 
spread in the human population. 
What could make that happen? 
Fish says that we do not know 
why some strains jump the species 
barrier to humans and others do 
not. “We do know,” he says, "that 
the H5N1 strain recombined in 
domestic animals and is now back 
in the wildlife population. We saw 
the first human cases in the late 
1990s. When several people in 
Southeast Asia died of a previously 
unknown influenza virus, the virus 
was studied and we now know it 
as H5N1.” 
A pandemic occurs when a virus 
introduced into the human popula¬ 
tion through another species moves 
from person to person. Rather than 
relying on the wholesale destruc¬ 
tion of infected and susceptible bird 
populations, or pouring resources 
into developing a human vaccine 
(he notes the impracticality of vacci¬ 
nating billions of people quickly), 
Fish suggests other ways to keep a 
pandemic at bay. 
“The first,” he says, “is to vacci¬ 
nate carrier species against viral 
genotypes with pandemic potential 
by developing oral vaccines that can 
be distributed to wild birds through 
feed.” Another approach would 
involve the introduction of a varia¬ 
tion of the virus that produces a 
milder form of the infection but still 
maintains itself in appropriate bird 
populations, thus rendering the birds 
immune to pandemic genotypes. 
Fish would like to see greater 
cooperation between the disciplines 
of ecology and epidemiology. “We 
should preserve wildlife, while at 
the same time figuring out how to 
keep it from being a threat. If we 
can buy time and learn more about 
the evolution of viruses in nature, 
we can rig the roulette wheel rather 
than just waiting for it to turn.” 
—R.H. 
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Making a better doctor, 
and better patients 
After Hurricane Katrina, a day at a 
convention center in Texas provided 
lessons in dignity and sympathy. 
|| What exactly did I think I was getting 
myself into? As I approached the 
Austin Convention Center’s loading 
dock, which was swarming with 
; people, it felt like an enormous hospi¬ 
tal—a hospital not only for the sick but 
also for the weary-hearted. I had come 
; simply to see whether I could help 
other evacuees; I didn’t expect them to 
teach me a lesson in clinical medicine. 
I had been living in New Orleans 
for only six days before leaving town. 
I never got the chance to start at 
Tulane’s School of Public Health and 
Tropical Medicine. Along with my 
landlord and his family, I rode out 
; Hurricane Katrina in Houma, La., a pre¬ 
dominantly Cajun town southwest 
of New Orleans. I awoke the morning 
after the storm, surprised that I’d slept 
through the brunt of it. Slivers of light 
invaded my room through boarded- 
up shutters. Lawn furniture, branches, 
leaves and other debris lay strewn 
across the backyard, and the gusting 
wind carried an eerie chill. What next? 
I asked myself. 
When I heard of the devastation of 
New Orleans, I left my refuge to stay 
with friends in Austin, Texas. I volun¬ 
teered to help at the convention center, 
which housed 4,000 evacuees: some 
riding the high of a miraculous escape, 
others succumbing to depression after 
seeing their homes and livelihoods 
swept away. All, however, were emo¬ 
tionally fragile. 
I discovered their vulnerability 
while distributing toiletries and cloth¬ 
ing to people lined up for showers. 
Grown women reluctantly asked me 
for clean underwear. They’d make a 
request, and I would search for the 
right size. Sometimes I had to turn 
back for a larger size, embarrassing 
the woman I was serving. One woman 
asked me for a feminine hygiene 
product and I wasn’t sure what she 
needed. I felt flustered and she told me 
to forget the request. As she walked 
away I knew I’d seriously messed up. 
I did better when my job was to 
help elderly and disabled men at the 
showers. As I wheeled one man into 
the changing room, he recounted the 
story of a treacherous week. Together 
we peeled off his clothing one piece at 
a time; His legs wobbled as he hovered 
above the wheelchair. His soiled under¬ 
wear dropped to his ankles, and I 
tossed the garment in the trash heap. 
Steam from the showers and the mid¬ 
day Texas sun cooked the air inside the 
shower room; the smell was nauseat¬ 
ing. I had to fight the urge to rush out¬ 
side for a breath of fresh air. The man’s 
eyes showed me his underlying feel¬ 
ings of humiliation. I knew that regis¬ 
tering my revulsion would only make 
him feel worse. So I held back my feel¬ 
ings and told him how wonderful his 
shower would feel, hot water hitting his 
back for the first time in 10 days. Ahh. 
It doesn’t take much to make a 
patient feel afraid or ashamed. Some¬ 
times a reflexive shudder will do it. 
Or maybe a grimace or an unthinking 
remark. The consequences are serious. 
Once people are made to feel inferior or 
disgusting, they shut down. They’re not 
as likely to be open, honest or compliant. 
1 often thought about Austin after 
finding a home for the fall at the 
Yale School of Public Health. I began 
using my experiences there as a 
lens for understanding my classes. In 
the health policy course, for instance, 
Mark }. Schlesinger, ph.d., professor 
of public health, explained how stigma 
can compromise the quality of health 
care. Patients with a stigmatized ill¬ 
ness, he explained, are less likely to 
seek care. Furthermore, he told us, 
physicians are more likely to sidestep 
critical issues related to conditions that 
carry a stigma. My mind reeled back 
to the Austin Convention Center and I 
understood that when 1 embarrassed 
the woman who needed sanitary prod¬ 
ucts, I had unintentionally denied her 
appropriate care. Later, my ability to 
overcome my discomfort with the man 
in the shower allowed me to help him 
without compromising his dignity. 
I didn’t work in a hospital, help out 
in an ER or scrub for surgery, but in 
Austin I learned something about clini¬ 
cal medicine. I have promised myself 
that when I become a physician, I will 
remember the lessons the evacuees 
taught me about the importance of 
unabashed sympathy. I think those les¬ 
sons will make me a better doctor and 
help my patients to be better patients. 
David Grew, of West Hartford, Conn., returned 
to New Orleans this spring to complete his 
public health studies after spending the fall 
semester at Yale. He hopes to enter medical 
school in August. 
WE WELCOME SUBMISSIONS 
Do you have an opinion to share on a vital 
topic in medicine, health or science? Send 
yours to Essay, Yale Medicine, P.O. Box 7612, 
























New center to focus 
on neuroscience and 
brain disorders 
The School of Medicine has 
launched a new interdepartmen¬ 
tal program, Cellular Neuro¬ 
science, Neurodegeneration and 
Repair (cnnr), to be led by 
PIETRO DE CAMILLI, M.D., FW 
’79, the Eugene Higgins Professor 
of Cell Biology, and STEPHEN 
M. STRITTMATTER, M.D., PH.D., 
the Vincent Coates Professor 
of Neurology and professor of 
neurobiology. 
The cnnr will build on Yale’s 
tradition of excellence in the neuro¬ 
sciences through the departments 
of neurobiology, molecular and 
cellular physiology, pharmacology, 
cell biology, psychiatry, neurosur¬ 
gery, neurology and others, and 
the Child Study Center. Its goal is 
to foster cutting-edge basic 
research in cellular and molecular 
neuroscience, promote research 
on neurodegeneration and repair, 
translate scientific insights into 
therapeutic strategies to prevent 
or delay neuronal loss, and facili¬ 
tate neural repair and restoration 
of function. This interdisciplinary 
program could have a signifi¬ 
cant impact on diseases such as 
Alzheimer’s and Parkinson’s, 
amyotrophic lateral sclerosis and 
multiple sclerosis, as well as dis¬ 
eases related to polyglutamine 
expansion, such as Huntington’s. 
De Camilli’s pioneering work 
on synaptic vesicles, the intra¬ 
cellular packets that deliver neuro¬ 
transmitters into the synapse, 
could advance the understanding 
of brain function, as well as the 
causes of Alzheimer’s, Parkinson’s 
and other diseases. 
Strittmatter’s identification of 
Nogo, a protein that blocks the 
regeneration of axons, has opened 
promising avenues in the search 
for therapies to repair the adult 
nervous system after injury, and 
has given new hope to those who 
suffer from spinal cord injuries, 
stroke and neurodegenerative dis¬ 
orders such as Alzheimer’s. 
De Camilli and Strittmatter, 
who will retain their appointments 
in cell biology and neurology, 
respectively, will recruit up to 
seven new scientists for the cnnr. 
The searches will be carried out 
in collaboration with colleagues 
in the basic-science and clinical 
departments who work in the neu¬ 
rosciences, and the new recruits 
will have primary appointments in 
existing departments. In addition, 
the cnnr will provide a scientific 
home for more than 100 neuro¬ 
scientists who now work across 
the Yale campus, sparking greater 
interactions and enhancing the 
scientific environment. 
European group 
elects cell biologist 
as foreign member 
IRA MELLMAN, PH.D. ’78, chair 
and Sterling Professor of Cell 
Biology, is one of three American 
scientists elected as foreign mem¬ 
bers of the European Molecular 
Biology Organization (embo) at 
its annual meeting in Warsaw, 
Poland, last October, embo mem¬ 
bership is a lifelong honor, and 
scientists are elected on the basis 
of proven excellence in research. 
Among its members are some 
of Europe’s leading researchers, 
including 38 Nobel laureates. 
embo was established in 1964 to 
create a central molecular biology 
laboratory and a network that 
would enhance interactions 
among European laboratories. 
Currently there are more than 
1,200 embo members in Europe, 
and only 100 investigators out¬ 
side of Europe have been named 
as associate members. 
“It is a real honor to be one of 
the very few U.S. scientists to be 
recognized by our most distin¬ 
guished European colleagues by 
election to embo membership,” 
said Mellman.“Science is truly an 
international endeavor, and I cer¬ 
tainly plan to use this connection 
to further scientific exchange at 
all levels.” 
Mellman uses a combination 
of biochemical, genetic and imag¬ 
ing methods to understand 
complex functions of cell biology. 
His work has revealed basic bio¬ 
logical mechanisms that regulate 
immune responses, particularly 
how dendritic cells initiate and 
control all antigen-specific immune 
responses. Another area of his 
research involves cell polarity and 
asymmetry and the molecular 
mechanisms that sort, target and 
transport cell membrane compo¬ 
nents to appropriate membrane 
locations in different types of cells. 
Mellman joined the Yale faculty 
in 1981 after completing his under¬ 
graduate training at Oberlin 
College, receiving his doctorate in 
human genetics from Yale in 1978 
and beginning his academic career 
at Rockefeller University. From 
1997 to 2001 he served as found¬ 
ing director of the Combined 
Graduate Program in Biological 
and Biomedical Sciences. 
Mellman, who holds a joint 
appointment in the Department 
of Immunobiology, is an affiliate 
member of the Ludwig Institute 
for Cancer Research. He was 
named scientific director of the 
Yale Comprehensive Cancer 
Center in 2004. He is a fellow of 
the American Academy of Arts 
and Sciences and the Leukemia 
& Lymphoma Society, and he has 
received a Swebilius Award, the 
President’s Research Development 
Award (Leukemia & Lymphoma 
Society) and the Yale Science and 
Engineering Society Medal. 
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Zeev Kain Christopher 
van Dyck 
Agnes Vignery Margaret Bia 
Margaret J. Bia, m.d., professor of 
medicine, received the George 
F.Thornton Award at the annual 
meeting of the Connecticut 
chapter of the American College 
of Physicians in October.The 
award is given annually for out¬ 
standing contributions to medi¬ 
cal education. 
Linda K. Bockenstedt, M.D., the 
Harold W. Jockers Associate 
Professor of Medicine, has been 
named director for professional 
development and equity at the 
medical school. In this new posi¬ 
tion Bockenstedt will be respon¬ 
sible for creating programs to 
support the academic develop¬ 
ment of all faculty members and 
to encourage the growth of a 
diverse faculty body at the 
school. A special focus will be 
on the needs of women and 
underrepresented minorities. 
Rosemarie L. Fisher, M.D., HS ’75, 
associate dean for graduate 
medical education, has won the 
2006 Courage to Lead Award 
from the Accreditation Council 
for Graduate Medical Education. 
The award honors designated 
institutional officials who have 
demonstrated excellence in 
overseeing residency programs 
at their sponsoring institutions. 
Designated institutional offi¬ 
cials are responsible for all 
graduate medical education pro¬ 
grams in a teaching hospital, 
community hospital or other type 
of institution that sponsors resi¬ 
dency programs. Fisher oversees 
residency programs at Yale-New 
Haven Hospital. 
Nora E. Groce, PH.D., associate 
professor of public health 
(global health) and anthropol¬ 
ogy, chaired unicef’s Thematic 
Group on Violence Against 
Disabled Children, which in 
November issued a report that is 
part of a larger report on vio¬ 
lence against children. The study 
is a collaborative effort by the 
United Nations Secretary Gen¬ 
eral’s Office, the World Health 
Organization and unicef and is 
a follow-up to a 1999 U.N. study 
on children and armed conflict. 
The new report is intended to 
bring the issue of violence 
against children to the atten¬ 
tion of policy-makers, govern¬ 
ments and civil society around 
the globe. Corrie E. Paeglow, a 
graduate student in the Global 
Health Division at the School of 
Public Health, served as research 
associate on the project. 
Sharon L. Kagan, D.ED., professor 
(adjunct) in the Child Study 
Center, has become the first 
woman to win three of the 
nation’s most prestigious educa¬ 
tion awards. Kagan, a leader in 
early childhood education, won 
the 2005 Harold W. McGraw Jr. 
Prize in Education, the 2005 
James Bryant Conant Award 
from the Education Commission 
of the States and the 2004 
Distinguished Service Award 
from the Council of Chief State 
School Officers. 
Zeev N. Kain, m.d., m.b.a., HS ’92, 
fw ’93, professor of anesthesiol¬ 
ogy, pediatrics and child psychia¬ 
try and vice chair of anesthesi¬ 
ology, has been appointed to the 
editorial board of the Journal 
of Pediatric Psychology, the first 
anesthesiologist to hold this 
honor. Kain, who is also a mem¬ 
ber of the editorial boards of 
Anesthesiology and Pediatrics, is 
an international expert in the 
area of perioperative behavioral 
and physiological stress. 
Each year the graduating class 
honors its teacher of the year 
with the Francis Gilman Blake 
Award, but this year the other 
three classes chose their own 
teachers of the year. The Class of 
2006 honored Laura R. Ment, 
m.d., professor of pediatrics and 
neurology, and I. George Miller, 
m.d., the John F. Enders 
Professor of Pediatrics and pro¬ 
fessor of epidemiology and of 
molecular biophysics and bio¬ 
chemistry. The Class of 2007 
selected Margaret J. Bia, m.d., 
professor of medicine, and the 
Class of 2008 named James D. 
Jamieson, M.D., PH.D., professor 
of cell biology and biology, and 
Shanta E. Kapadia, m.d., lecturer 
in surgery (gross anatomy). 
Jennifer P. Ruger, PH.D., M.SC., 
assistant professor in the Global 
Health Division of the Depart¬ 
ment of Epidemiology and 
Public Health, was awarded the 
2005 Labelle Lectureship in 
Health Services Research, given 
annually by McMaster Univer¬ 
sity in Ontario, Canada.The 
lectureship is given to a young 
investigator who has a back¬ 
ground in health economics and 
research that spans disciplines, 
and who challenges existing 
methods or accepted ideas in 
the health services community. 
Ruger's lecture, “Health and 
Global Governance: What’s 
Justice Got to Do With It?,” was 
presented on October 19. 
Christopher H. van Dyck, M.D., 
fw ’91, associate professor of 
psychiatry and neurobiology 
and director of the Alzheimer’s 
Research Unit at the School of 
Medicine, was among six hon- 
orees at the “Removing the 
Mask" gala celebration held in 
October at the Omni New Haven 
Hotel. The mask motif is a 
metaphor for the devastating 
loss of identity and cognition 
caused by Alzheimer’s disease. 
Gov. M. Jodi Rell was the event’s 
honorary chair. 
Agnes M. Vignery, PH.D., D.D.S., 
associate professor of orthopae¬ 
dics and rehabilitation, has 
been named Yale-Pfizer Global 
Discovery Visiting Professor for 
2005. Vignery, whose research 
focuses on the developmental 
and reconstructive processes of 
bone, will serve as a consultant 
at Pfizer’s Groton (Conn.) labora¬ 
tories. She will conduct collabo¬ 
rative research while gaining 
practical knowledge of the drug 
discovery and development 
process through interactions 
with the project teams. The pro¬ 
gram, which offers a 12-week 
position for one Yale faculty 
member to consult and do 
research on-site at Pfizer Global 
Research and Development, 
strengthens Yale-Pfizer alliances 
and provides Yale faculty with 
new collaborations and a better 
understanding of the pharma¬ 
ceutical industry. 
SEND FACULTY NEWS TO 
Claire M. Bessinger, Yale Medicine, 
P.O. Box 7612, New Haven, CT 






















top Joxel Garcia, former commissioner of 
health for the state of Connecticut and current 
deputy director of the Pan American Health 
Organization, was the Commencement speaker. 
above Kristin Noell-Casey, Susanna Cho, Laura 
Desilets and Jeff Donnelly applauded speakers 
at the ceremony. 
right Daniel Walsh received his diploma from 
Dean Robert Alpern. 
PA grads urged to 
keep learning 
Only through constant learning 
can health professionals keep up 
with medicine. 
At their Commencement in September 
the 29 members of the Physician 
Associate Program’s Class of 2005 
heard words of encouragement from 
Joxel Garcia, m.d., m.b.a., former 
ommissioner of public health for the 
state of Connecticut and current 
deputy director of the Pan American 
Health Organization. 
“These are exciting times to be in 
the health care field,” Garcia said, 
citing new technology and new medi¬ 
cal discoveries. But this day, he con¬ 
tinued, would be a benchmark in the 
new graduates’ careers. “Anything 
you do from today on is going to have 
an impact five, 10, 20 years from 
now. Today is all about you and how 
you are going to fulfill yourself as a 
person. Just make sure you do what 
you love to do. Never compromise 
yourself for things that are going to 
be short-lived or are not going to 
make you happy.” 
His closing admonition to the gradu¬ 
ates was to “keep learning. ... If you are 
not learning you won’t be able to adapt 
yourself... to the new realities of life.” 
In keeping with Garcia’s advice, 
Robert J. Alpern, m.d., dean of the 
School of Medicine and Ensign Profes¬ 
sor of Medicine, said, “Medicine is 
changing so fast that what you’ve learned 
will probably be completely out of 
date five years from now.” Noting the 
unequalled academic achievements 
of the Class of 2005, he said, “People 
will look to you for leadership—not just 
to practice health care, but to lead it.” 
This year’s Didactic Instructor 
Award for dedication and excellence in 
the classroom went to J.G. Collins, 
ph.d., professor of anesthesiology and 
lecturer in pharmacology. David Spiro, 
m.d., m.p.h., assistant professor of 
pediatrics (emergency medicine), and 
John Roney, pa-c, lecturer in pediat¬ 
rics, shared the Clinical Instructor’s 
Award, given to recognize exemplary 
teaching at a clinical rotation site. 
John P. Hayslett, m.d., hs ’65, profes¬ 
sor of medicine (nephrology) and of 
obstetrics, gynecology and reproductive 
sciences, received the Jack Cole Society 
Award for contributions in support 
of the physician associate profession. 
—John Curtis 
Proposing a new paradigm 
as international health hits 
dose to home 
Each October, students in medicine, 
nursing and public health present 
their findings from a summer of 
research abroad at the Committee on 
International Health Symposium 
Poster Session and Reception. But last 
year Hurricane Katrina cast a shadow 
as Curtis L. Patton, ph.d., director 
of International Medical Studies and 
professor of epidemiology, suggested 
that health issues once thought to 
occur only in the developing world 
have emerged in this country. 
“The United States is clearly part 
of the globe,” Patton said. “We have all 
thought of ourselves as separate and 
distinct and immune from disasters. 
We should seriously consider having 
students who want to do international 
health, do international health in the 
United States. Problems we have had 
this past fall suggest that there are 
opportunities to do in the United 
States the kind of work that is truly 
international.” 
Three students made oral presenta¬ 
tions at the symposium. Sayaka Ogata, 
a nursing student, described the 
integration of hiv/aids services with 
family planning in rural China. Public 
health student Vidya Angundi studied 
placental malaria in western Kenya. 
The placenta, she noted, is susceptible 
to the most severe form of malaria. 
Carolyn Graeber, a medical student, 
measured central corneal thickness, 
a gauge of intraocular pressure that is 
a factor for the development of glau¬ 
coma, in Puerto Rico. 
-i-c. 
Still going strong-Hunger 
and Homelessness Auction 
nets $32,000 for local groups 
Thirteen years ago a second-year stu¬ 
dent asked his classmates to join him 
in a fund-raising activity in which he’d 
participated as an undergraduate at 
Haverford College. Now that activity, 
the Hunger and Homelessness 
Auction, has become a tradition at the 
medical school, growing from a one- 
day affair to a flurry of activities spread 
over several days, including a football 
game, a dinner and a silent auction 
with hundreds of offerings. This year 
the auction raised $32,225 for seven 
organizations in New Haven. 
The first auction in 1994 netted 
$3,500 and had far fewer activities, 
recalled Jeffrey A. Meyerhardt, m.d. 
’97, who organized it. “The silent auc¬ 
tion,” he said, “was just two tables.” 
Meyerhardt, now at Harvard Medical 
School and the Dana-Farber Cancer 
Institute, returned to Yale in 
November to relate the history of the 
auction. Some things don’t change, he 
said in a subsequent interview. 
William B. Stewart, ph.d., associate 
professor of anatomy, is still auction¬ 
ing off his trademark bowtie, and 
Frank J. Bia, m.d., m.p.h., fw ’79, pro¬ 
fessor of medicine and laboratory 
medicine, is still called upon, as he 
was this year, to serve as an auctioneer. 
Richard Belitsky, m.d., associate pro¬ 
fessor of psychiatry, shared this year’s 
auctioneering chores. 
Items on the block included, as in 
past years, weekends in faculty vaca¬ 
tion homes, meals at restaurants or 
faculty homes, baby-sitting services, 
rides in planes and on yachts, various 
far left Sayaka Ogata, a nursing student, 
examined how family planning workers 
in the Chinese province of Henan integrated 
hiv/aids services into their work. 
left First-year medical student Matty Vestal 
and his girlfriend, Sarah Hunt, looked over 
items up for auction. 
types of lessons (language, sports, 
music, art) and lots and lots of food 
items. Perhaps the most unusual offer¬ 
ing, with a starting price of 50 cents, 
came from second-year student Maggie 
Hatcher: “Former rugby champ will 
tackle you three times this year when 
you least expect it.” Her offer netted 
$50 from a bidder who preferred to 
remain anonymous. 
-J.C. 
Medical student receives 
psychiatry fellowship 
Second-year medical student mallika 
lakshmi mendu has received a 2005 Jeanne 
Spurlock Minority Medical Student Clinical 
Fellowship in Child and Adolescent Psychiatry 
from the American Academy of Child and 
Adolescent Psychiatry. The fellowship provides 
minority medical students with opportunities 
to work with outstanding child and adolescent 
psychiatrist mentors. James F. Leckman, M.D., 
the Neison Harris Professor of Child Psychiatry 
in the Child Study Center and professor of 
pediatrics, wiM serve as her mentor. 
THE YALE MEDICAL BOOKSTORE 
"All Things Medical" 
From books to YSM sweatsh 
and more. 
Now available online: 
www.yalemed.bkstore.com 
(203) 789 2124 
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Sauces, sunflowers 
and letters home 
An Air Force surgeon in Iraq talks 
of his soldiers, Iraqi families and his 
feelings about the war. 
Christopher P. Coppola, m.d., hs 01, 
didn’t get much sleep during the 
four months he spent as a surgeon at 
Balad Air Base about 40 miles north 
of Baghdad. 
The injured would arrive without 
warning. For instance, soon after 
Coppola, an Air Force major in the 
332nd Expeditionary Medical Group, 
arrived in January 2005, insurgents 
attacked a police graduation ceremony 
in the nearby city of Baqubah. Six 
surgical teams, including Coppola’s, 
rushed to Balad’s tent-and-shipping- 
crate hospital as one helicopter 
after another delivered gruesomely 
injured policemen. 
On other days-—and nights—the 
burned and wounded who kept Coppola 
from his rest were American troops, 
Iraqi National Guard soldiers, children 
caught in the cross-fire and men and 
women hurt in fights or accidents on 
the base that housed 25,000 American 
troops and 7,000 civilian employees of 
Halliburton subsidiary i<br. Frequent 
mortar attacks led soldiers to nickname 
the base “Mortaritaville,” Coppola said, 
but many of the insurgents’ decades- 
old shells failed to detonate. “When 
they did go off, they would startle me 
and I usually couldn’t sleep for the 
rest of the night," he said. 
Coppola did relax a bit when the 
violence abated. On those days, his 
only responsibilities were scheduled 
procedures—inserting stomach tubes, 
cleaning wounds. But going back to his 
hooch to catch up on sleep provided 
the unwelcome opportunity to reflect 
on his situation. “When you’re cut¬ 
ting off someone’s leg, you just do it, 
because they’re going to die if you 
don’t,” Coppola explained in an inter¬ 
view from Lackland Air Force Base 
near San Antonio, Texas, where he 
now works. “When you have nothing 
to do, you start thinking about it. So 
I couldn’t sleep.” 
The 37-year-old Coppola used some 
of his restless nights to write long 
letters to family and friends. His wife, 
Meredith, has assembled them in a 
self-published book, Made a Difference 
for That One: A Surgeon's Letters Home 
From Iraq. 
Coppola described in the letters 
how he distracted himself from miss¬ 
ing Meredith and their three sons and 
from the despair he felt about the suf¬ 
fering surrounding him. He ran for 
exercise, always wearing 35 pounds of 
armor and a helmet, occasionally wav¬ 
ing to shepherds just beyond the fence; 
planted cilantro and sunflowers in the 
sandbags banked against his sleeping 
quarters; and earned modest fame 
in a moustache-growing competition. 
To make edible such meals as “tan 
stuff over rice,” Coppola assembled 
an arsenal of sauces. In March, for 
instance, faced with an entree of “meat 
chunks ... diluted with unmentionable 
adulterants,” he saluted St. Patrick’s 
Day by dousing it with Goodall’s of 
Dublin Irish Steak Sauce. 
Coppola owed the Air Force six 
years of service in exchange for stipends 
while training in pediatric surgery at 
Children’s National Medical Center and 
for medical school tuition at Johns 
While stationed in Iraq, surgeon Christopher 
Coppola used an assortment of spices to liven 
up meals full of "unmentionable adulterants.” 
Hopkins. He did his general surgery 
residency at Yale, serving as chief resi¬ 
dent in 2000-2001. Although he 
worked as an all-purpose trauma sur¬ 
geon at Balad, word got around that he 
was a pediatric surgeon, and Iraqis 
brought their children to him for care: 
a girl with kidney failure, a boy with a 
prolapsed bowel. Coppola also treated 
children hurt in the war, including two 
sisters burned when their house was 
fire-bombed. One child recovered, but 
the other died. Soon after, Coppola 
discovered that he had unknowingly 
saved the life of the man who threw 
the bomb. “I instantly conceived of a 
variety of ways I could have meted 
justice on him with my own hands,” 
Coppola wrote. “I’ve taken care of 
drunks who have plowed into a family 
of five on the highway, in the bed next 





j killed in the crash, but nothing prior 
had been as difficult as this. I was 
thankful I didn’t know who he was 
I while he was here.” 
Coppola recalled becoming inured 
to the carnage, only to be shocked yet 
again. “You feel like you’ve seen it all, 
but you haven’t. There’s always some¬ 
thing worse around the corner.” 
Coppola opposes the war. “I want 
out of there, yesterday. I can’t see how 
any father or any doctor could feel dif¬ 
ferently.” And yet the work itself was 
rewarding. In Texas, Coppola knows 
that if he does not care for a patient, 
someone else will. In Iraq, he said, 
“I had the privilege of feeling that if I 
wasn’t there, the person would prob¬ 
ably die.” And although he believes the 
war hurts American interests more 
than it helps, “If there were Americans 
shot at, that was the place I had to be. 
Trying to get those guys and women 
home to their families is probably the 
most rewarding thing I’ll ever do." 
Coppola expects to be sent back to 
Iraq this September. 
—Cathy Shufro 
Made a Difference for That One is sold by 
online booksellers and also on www.iuniverse. 
com. Profits go to Fisher House Foundation, 
which provides housing for family members 
of military personnel getting treatment at 
military medical centers. 
A long, full and active life— 
keeping fit and taking on lots 
of jobs 
“The trouble with retirement is that 
you never get a day off,” is a saying 
quite familiar to Henry E. Markley, 
m.d. ’43. At 87, Markley went into 
full-time retirement when Greenwich 
Hospital’s Home Care/Hospice 
Program, where he worked as part- 
time medical director, closed in 
September 2004. Although he bristles 
at the closing of the program, which 
served up to 300 patients, he has no 
plans to slow down. An avid tennis and 
golf player, he continues to exercise 
up to an hour and a half each day, a 
testament to the notion that a healthy 
lifestyle leads to a long and healthy life. 
Markley’s ties to the hospital’s home 
care program go back half a century, 
when an anonymous donation enabled 
the hospital to set up a pilot home care 
study for chronically ill patients who 
often required lengthy hospital stays. 
The only nursing home in Greenwich 
had a long waiting list, so there was a 
dire need for alternate long-term care. 
After visiting Montefiore Hospital’s 
home care program in New York, 
Markley helped set up the Greenwich 
service, which initially accommodated 
only 10 patients. “By the seat of our 
pants we built up the program,” he said. 
“We were a pioneer service.” After a 
year, in 1956, the medical staff voted 
unanimously to request that the hospi¬ 
tal make home care a department, and 
Markley continued as medical director 
for almost 50 years. The program was 
recognized across the state, serving 
patients from Greenwich and its sur¬ 
rounding communities. 
Markley’s medical career began 
with a lingering doubt. When he 
applied to the School of Medicine in 
1939 he had little hope of being 
accepted. He was a top student at Penn 
State, but most medical schools then 
had an unspoken quota limiting Jews 
to 10 percent of any given class. One of 
his Jewish classmates from Penn State 
had already been accepted at Yale, and 
Markley thought it unlikely that, with a 
class of only 48 students, the school 
would accept two Jewish students from 
the same college. Much to his surprise, 
however, he entered the medical school 
with the Class of 43. After being 
drafted, he joined the Reserve so that 
he could postpone his Army service 
until Ire graduated. The war ended not 
long after he went on active service, 
and following an internship at 
Philadelphia General Hospital, he did 
a residency at Greenwich Hospital. 
He eventually received an Army 
assignment to Puerto Rico, which he 
followed up with additional training 
in internal medicine at Johns Hopkins. 
When he was offered a position on 
the staff at Greenwich Hospital in 
1950, he returned for good to practice 
internal medicine. 
Markley has worn many hats over 
the years, in addition to founding and 
directing the home care program. He 
served as the hospital’s electrocardi- 
ographer for 24 years; formed the first 
professional medical corporation in 
Greenwich in 1963 with three of his 
fellow internists; served as chief of 
medical services from 1967 until 1974; 
and after selling his internal medi¬ 
cine practice in 1979, became medi¬ 
cal director of Greenwich Health 
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In 2004 Henry Markley retired after a 60-year 
career in medicine, mostly at Greenwich 
Hospital in Connecticut. He keeps fit with 
tennis, golf and a healthy lifestyle. 
physicals for executives. In 1993, at 
75, an age when most people would 
have been retired, he cut back his 
professional activities, limiting himself 
to running the home care program. 
Although it wasn’t a full-time commit¬ 
ment, he spent a few hours each day 
at the hospital reviewing charts and 
coordinating services. 
Markley said he continued to work all 
these years because his father, who lived 
until the age of 102, retired at 75 and 
regretted it for the rest of his life. Even 
though longevity runs in his family, 
Markley practiced preventive medicine. 
He is trim, has never smoked, has only 
an occasional glass of wine and is very 
active, although age has taken a slight 
toll. “I’m not any good at tennis any 
more,” he admitted. “I know where I’m 
supposed to be on the court, but it takes 
me a while to get there.” 
Markley married his wife, Nicki, 13 
years ago after twice becoming a wid¬ 
ower. “The first time ! was married 
for 25 years, the second for 20 years. 
I told Nicki we’re not fooling around 
this time; we’re going for 30 years,” he 
said. Meanwhile, he has other mile¬ 
stones to look forward to. I went to my 
60th medical school reunion,” he said. 
“I'm looking forward to the 65th.” 
—Jill Max 
A Montana doctor’s 30 
years of medicine without 
a safety net 
On January 7, 1984, Ron Losee, m.d. 
'44, tramped out the front door of the 
hospital in Ennis, Mont., and into 
the snowy fields, intent on walking to 
his death. Losee, a general practitioner 
skilled in orthopaedic surgery, had just 
learned that he was being sued for 
malpractice by a woman who claimed 
that his operation on her ankle caused 
her undue pain during bowling. “If 
this was my reward by society for all 
my years of service, then I didn’t want 
to live anymore. I have always tried to 
be the best damned doctor I could pos¬ 
sibly be,” said Losee, who since 1949 
had devoted himself to his patients— 
even offering his own bed to patients 
before Ennis had a hospital. Fortu¬ 
nately for Losee and his loved ones, 
fresh bobcat tracks in the snow jolted 
him back to reality. 
“I was fine with falling asleep in 
the snow and dying, but I didn’t want 
my b***s clawed off by a bobcat,” 
Losee said with characteristic frank¬ 
ness and good humor. He retraced his 
steps and made it home safely, 
although cold, cramped and tired. 
In the dread-filled, six-month 
stretch that followed, the claim against 
Losee was deemed baseless; the 
woman’s discomfort was actually 
caused by an injury she had sustained 
after Losee’s surgery. However, the dis¬ 
taste this event left him with created 
the medical maverick that he is today. 
At the time of the lawsuit, Losee 
had no medical malpractice insurance. 
Today, at 86 vigorous years of age, 
Losee boasts the wherewithal and 
gumption to give medical consulta¬ 
tions, perform tennis elbow operations 
and practice medicine without mal¬ 
practice insurance, just as he has done 
for the past 55 years. 
Losee’s decision not to carry insur¬ 
ance was born of practicality and the 
intimate nature of his practice in a 
rural mountain hamlet 55 miles south¬ 
west of Bozeman. He carried an insur¬ 
ance policy until 1975, when the cost 
jumped from $8,000 to $30,000— 
slightly more than his net income for 
the year. Losee simply could not abide 
passing the financial burden on to 
the cowboys, farmers, miners and wait¬ 
resses who were already scraping 
together as much money as they could 
to pay for his services. 
After the single 1984 lawsuit 
brought against him, Losee quite hap¬ 
pily continued practicing medicine 
without malpractice insurance. But his 
insurance ire was rekindled by a letter 
he received in May 2005 from Blue 
Cross Blue Shield of Montana inform¬ 
ing him that—because he does not 
carry malpractice insurance—he was 
no longer a recommended provider. 
The decision has had little effect on 
Losee, as patients still seek out his 
medical services. But after 55 years of 
sound medical practice, Losee finds 
it ludicrous that he is being “kicked 
out” of the medical system, especially 
since he believes that, depending on 
the circumstances, some doctors who 
commit malpractice deserve to be im¬ 
prisoned. He penned a letter to Blue 
Cross Blue Shield sharing his strong 
views about the malpractice insurance 
industry and, as he said, “to teach them 
some manners.” In their response, 
Blue Cross Blue Shield said requiring 
Ron Losee dropped his malpractice insurance 
30 years ago when the cost more than doubled, 
and he felt he could not in good conscience 
pass the expense along to his patients. 
malpractice insurance is an industry 
standard designed to protect members. 
In his letter, Losee detailed what he 
considers serious flaws in the system. 
“In Montana, about one-third of mal¬ 
practice claims progress to lawsuits. Of 
these, only a small proportion end in 
jury trials, with physicians prevailing 
in the bulk of those cases,” wrote Losee, 
who has served on the nonbinding 
Montana Medical Legal Panel, which 
comprises three doctors and three 
lawyers who evaluate malpractice 
claims to recommend whether they 
should proceed to trial. Malpractice 
insurance is, he believes, rarely needed, 
but the insurance industry has instilled 
a sense of fear in both doctors and 
patients to maintain the system. This 
fear, Losee asserted, is largely accom¬ 
plished by a “bribeocracy” system 
of government: congressmen and sena¬ 
tors receive large financial backing 
from trial lawyers and insurance- 
industry lobbyists to fund their re- 
election campaigns, while the elected 
officials, in return, fuel the malprac¬ 
tice insurance fire. 
As an alternative, Losee advocates a 
no-fault medical liability compensation 
system. Instead of going to court, a 
malpractice claim would go to an expert 
panel that would assess whether an 
injury has indeed been caused by a 
physician or other health care provider. 
Compensation would be doled out from 
a pool of money collected from tax rev¬ 
enues or premiums charged to doctors. 
Sitting on his porch and looking out 
over the Madison River to the snow¬ 
capped peaks of the Rocky Mountains, 
Losee often reflects on his many joyful 
years of practice in Ennis, which began 
when he, his wife and their 2-year-old 
daughter trekked to Montana from 
Connecticut in 1949 in their Army 
Jeep. Being dropped from Blue Cross 
Blue Shield’s provider network has 
certainly not slowed Losee’s practice. 
Widely acclaimed as a physician who 
made major headway toward under¬ 
standing and surgically repairing the 
“trick knee” (the Losee tests bear his 
name), he still sees patients and oper¬ 
ates on tennis elbows. Patients seek 
Losee out and return to him time and 
again, based on his medical expertise 
and sincerity rather than the amount of 
malpractice insurance he carries. 
—Kara A. Nyberg 
Familiar Faces 
Do you have a colleague who is making 
a difference in medicine or public 
health or has followed an unusual path 
since leaving Yale? We’d like to hear 
about alumni of the School of Medicine, 
School of Public Health, Physician 
Associate Program and the medical 
school’s doctoral, fellowship and 
residency programs. Drop us a line at 
ymm@yale.edu or write to Faces, 
Yale Medicine, P.O. Box 7612, New Haven, 
CT 06519-0612. 
The passing of two 
with years of service 
to the medical school 
As the new year opened, Yale 
Medicine received word of the 
passing of two people with 
long-standing connections to 
the School of Medicine. 
Connie Quick Tolliver, who 
worked for more than 30 years 
in the Office of Alumni Affairs 
at the School of Medicine, died 
in Hamden, Conn., on December 
24 of heart failure. She was 66. 
Tolliver, who retired in 1995, 
served as assistant to the direc¬ 
tor of alumni affairs. 
Henry Martone Sr. died in 
Daytona Beach, Fla., of compli¬ 
cations of diabetes on December 
27. He was 69. Martone was a 
familiar presence at the annual 
reunions, driving a van that 
shuttled alumni among various 
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Robert Finkel Ralph Greco 
Mary L. Warner, M.M.SC., PA-C, 
assistant dean and director of 
the Physician Associate (pa) 
Program, met with pa alumni in 
Falmouth, Maine, in August. 
Joining them was Ruth Cole, 
widow of Jack W. Cole, m.d. ’66, 
former chair of surgery, who 
founded the pa program in 1970. 
Attending the gathering were 
Frank J. Noreika, pa ’94; his wife, 
Stacy; Lauren T. Ormsby-Pieri, 
pa ’85; Cary J. Stratford, pa-c ’80; 
Michelle A. Roy, pa ’98; Lisa 
Brown, pa ’04; and Sherrie A. 
Downing, pa-c ’93. 
1940s 
David E. Morton, M.D. ’48, HS ’55, 
writes to say that his third grand¬ 
daughter, Kan Kojima, was born 
last year and that he has been 
working on the biography of his 
great-grandfather, Edwin Emery. 
Emery, a hero on the Union 
side during the Civil War, was an 
instructor for the Revenue Cutter 
Service, a forerunner of the 
Coast Guard. 
1950S 
Gerard N. Burrow, M.D. ’58, HS ’66, 
has been named chair of the 
board of the University of Con¬ 
necticut Medical Center and a 
trustee of the University of Con¬ 
necticut. Burrow, who is presi¬ 
dent and ceo of the Mystic 
Aquarium & Institute for Explo¬ 
ration, is the David Paige Smith 
Professor Emeritus of Medicine 
and dean emeritus of the Yale 
University School of Medicine. 
196OS 
Robert I. Finkel, m.d. ’65, writes 
to say that he retired on July 1, 
2005, after 32 years of practicing 
Noreen Rossi Rock Positano and Rudolph Giuliani Anu Gupta and Arnab Ghatak 
rheumatology at the Toledo Clinic. 
He plans to devote his energies 
to other interests, hobbies and, 
hopefully, travel. 
Ralph S. Greco, M.D. ’68, HS’73, 
the Johnson & Johnson Distin¬ 
guished Professor and chief of 
general surgery at Stanford 
University School of Medicine, is 
one of io recipients of the 2006 
Parker J. Palmer Courage to Teach 
Award, given by the Accredita¬ 
tion Council for Graduate Medi¬ 
cal Education. 
Karen H. Toker, M.D. ’67, received 
the first Francis Edwards Rushton 
Award last year from the Univer¬ 
sity of Florida Department of 
Pediatrics for her work in com¬ 
munity pediatrics and child 
advocacy. 
1970S 
Robert H. Posteraro, M.D. ’73, 
hs ’78, fw ’79, a radiologist with 
Lubbock Diagnostic Radiology 
in Lubbock,Texas, graduated 
from Oregon Health and Science 
University with the degree of 
Master of Biomedical Informat¬ 
ics last June. 
Noreen F. Rossi, m.d. ’78, professor 
of medicine and physiology at 
Wayne State University School 
of Medicine, has been awarded 
a $1.6 million, five-year grant 
from the National Heart, Lung, 
and Blood Institute of the 
National Institutes of Health. 
She will study how regular exer¬ 
cise decreases blood pressure. 
Alvin H. Strelnick, m.d. ’75, chief 
of the Division of Community 
Health in the Department of 
Family and Social Medicine at 
Montefiore Medical Center, 
received the 2005 Honorary 
Alumnus Award in June from 
the Albert Einstein College of 
Medicine of Yeshiva University 
in New York. In October he 
received the "Family Medicine: 
The Power to Change Our 
World" award at the northeast 
regional meeting of the Society 
of Teachers of Family Medicine. 
198OS 
Troyen A. Brennan, M.D. '84, J.D. 
'84, m.p.h. '84, professor of medi¬ 
cine at Harvard Medical School 
and professor of law and public 
health at the Harvard School of 
Public Health, has been elected 
to the Institute of Medicine. His 
research group focuses on the 
interwoven issues of improving 
patient safety and addressing 
the crisis in medical malpractice. 
Rock G. Positano, D.P.M., M.SC., 
m.p.h. ’89, received a Spirit of 
Cabrini Award at the Cabrini 
Mission Foundation 2005 Gala 
and Awards in New York City on 
November 3. Also honored were 
nbc “Today” co-host Katie Couric 
and former mayor Rudolph W. 
Giuliani, and his wife, Judith S. 
Giuliani. 
Positano, co-director of The 
Foot Center at the Hospital for 
Special Surgery in New York, 
delivered the keynote address. 
199OS 
Lee M. Akst, M.D. ’99, was mar¬ 
ried in October to Jodi S. Wilkoff 
in Cleveland. Akst, who gradu¬ 
ated from Yale College in 1995, 
is a fellow in laryngology at 
Massachusetts General Hospital, 
His wife is a partner in The New 
Teacher Project, an educational 
consultancy in New York. 
Pauline W. Chen, M.D., HS ’98, has 
won the Staige D. Blackford Prize 
for Nonfiction from the Virginia 
Quarterly Review, for her article, 
“Dead Enough?:The Paradox of 
Brain Death,” published last fall. 
Anu Gupta, M.D. ’97, HS ’00, FW 
’02, was married in November to 
Arnab Ghatak, m.d., m.b.a., in 
Roslyn, N.Y. Gupta directs philan¬ 
thropic programs for hiv/aids 
and women’s and children’s 
health at Johnson & Johnson in 
New Jersey. Ghatak consults on 
pharmaceuticals and medical 
devices for McKinsey & Co. 
Tim Melio, pa ’99, and Alice 
(Hofmann) Mello, pa ’99, 
announce the birth of their sec¬ 
ond child, Margaret Ella.Tim 
practices at Connecticut Valley 
Orthopedics and Sports Medicine 
in Springfield, Vt., and Alice prac¬ 
tices in pediatric neurology at 
Dartmouth-Hitchcock Medical 
Center in Lebanon, N.H. 
Gualberto Ruano. PH.D. ’92, M.D. 
’97, president and ceo of the 
biomedical company Genomas, 
received the beacon Medical 
Technology Award in September 
in recognition of his contribu¬ 
tions to personalized medicine. 
beacon (Biomedical Engineering 
Alliance and Consortium) is 
the professional association of 
the medical device industry 
in Connecticut. 
SEND ALUMNI NEWS TO 
Claire M. Bessinger, Yale Medicine, 
P.O. Box 7612, New Haven, CT 
06519-0612, or via e-mail 
to claire.bessinger@yale.edu 
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Remi J. Cadoret, M.D. ’53, died of 
prostate cancer at his home in 
iowa City, Iowa, on November 12. 
He was 77. After graduating from 
the School of Medicine, Cadoret 
spent two years in the U.S. Air 
Force, during which time he de¬ 
livered 500 babies. He did research 
at the Duke University Parapsy¬ 
chology Laboratory in North 
Carolina before taking a position 
at the University of Manitoba 
College of Medicine in Canada. 
From there he went to Washing¬ 
ton University in St. Louis and the 
University of Iowa. He was direc¬ 
tor of the Iowa Consortium for 
Substance Abuse and Evaluation. 
After his retirement in 1998 he 
continued his research, using 
adoptee studies to study gene- 
1 environment interaction, with a 
focus on antisocial behavior 
and substance dependence. 
Ludmil A. Chotkowski, M.D. ’42, of 
Berlin, Conn., died on October 6 
at the age of 89. Chotkowski 
was an internist for more than 
50 years at New Britain General 
Hospital, the Rocky Hill (Conn.) 
Veterans Home and Hospital 
1 and Connecticut Valley Hospital. 
He was also a self-published 
author, columnist, community 
activist, naturalist and farmer 
with a 14-acre fruit orchard. In 
Berlin, where he was born and 
raised on a family farm, he 
served as health officer, improv¬ 
ing water quality and introduc¬ 
ing innovative public health 
measures. He established one of 
the first clinics to administer 
polio vaccinations, and he per¬ 
formed kidney dialysis and rec¬ 
ommended inhalers to treat 
asthma before these practices 
were widely used. In another 
way, however, he remained old- 
fashioned, continuing to make 
house calls. 
Michael T. Cronin, D.V.M., PH.D., 
m.d., hs ’67, assistant clinical 
professor of pathology, died in 
Branford, Conn., on November 23 
of Parkinson’s disease. He was 
8i. Cronin’s medical career 
spanned 30 years at Yale, the 
Hospital of Saint Raphael and 
Memorial Hospital in Meriden, 
Conn. Early in his career, Cronin, 
a native of Ireland, did veteri¬ 
nary research at the Irish Racing 
Board and the Equine Research 
Station in England. From 1971 to 
1989 he was a consulting editor 
for the magazine American 
Scientist. 
Armin F. Funke, m.p.h. '60, died 
on June 24 in Roseville, Calif. He 
was 78. Born in Germany, Funke 
came to the United States in 
1948 and worked at the state of 
California Department of Health 
for 30 years. 
Joshua C. Gibson, m.d. ’01, died 
on November 14 in New York 
of a cardiac arrhythmia. He was 
34. Gibson was a fellow in infec¬ 
tious diseases at the Mount 
Sinai School of Medicine, where 
he co-founded the Advancing 
Idealism in Medicine Curriculum 
to help residents get involved 
in international programs that 
focus on improving the plight of 
others. Gibson himself worked 
at a refugee camp in Tanzania 
for Rwandan refugees, volun¬ 
teered at a rural health center 
in India and tracked the health 
impact of the World Trade Center 
attacks on rescue workers. At a 
memorial service, Daniel S. 
Caplivski, m.d. ’00, an assistant 
professor at Mt. Sinai, recalled 
his classmate, friend and col¬ 
league: "We had seen each other 
as first-year medical students 
just learning to listen through a 
stethoscope. Now I was watch¬ 
ing his wonderful bedside man¬ 
ner and I saw his deep compas¬ 
sion and his meticulous attention 
to detail. He had become a great 
doctor.’’ 
James H. Greenwald, M.D. ’58, 
died on November 14 in 
Chicago. He was 73. Greenwald 
served his internship and resi¬ 
dency at Cook County Hospital 
in Chicago, then practiced 
nephrology and internal medi¬ 
cine in the Chicago area until 
he retired in 2000. He was a 
member of national medical 
societies and the author of sev¬ 
eral research papers. 
Martha F. Leonard, M.D., a former 
professor of pediatrics long 
affiliated with the Child Study 
Center, died on December 27 
in North Branford, Conn. She 
was 89. Leonard came to Yale in 
1961. As an early-childhood spe¬ 
cialist, she provided compassion¬ 
ate care to children and their 
families. She also worked to 
influence legislation affecting 
children. She was active in the 
Center Church in New Haven, 
the Interfaith Cooperative 
Ministries and the Community 
Foundation for Greater New 
Haven. In 1979 she received an 
honorary m.a.h. degree from 
the Yale Divinity School and 
later served as chaplain at the 
Evergreen Woods retirement 
community in North Branford, 
where she lived. 
Mary Ann Lillie, R.N., M.P.H. ’87, 
died on October 4 at the Con¬ 
necticut Hospice in Branford, 
Conn. She was 54. Lillie worked 
for many years at Yale-New 
Haven Hospital and was an 
active member of St. Andrews 
United Methodist Church in 
New Haven. 
Patrick J. McLaughlin Jr., MED ’48, 
died on September 8 in Mas¬ 
sachusetts at the age of 82. 
McLaughlin was a social worker 
for the city of Lowell and the 
Commonwealth of Massachu¬ 
setts. For many years McLaughlin, 
who started but did not com¬ 
plete his medical education at 
Yale, and his wife lived in Andover, 
Mass., but recently moved to 
Concord to be near one of their 
daughters and her family. 
Kay Tanaka, m.d., D.SC, professor 
emeritus in the Department of 
Genetics, died on August 21 in 
New Haven. He was 76. Before 
coming to Yale in 1973, Tanaka 
held faculty positions at Baylor 
College of Medicine, Harvard 
Medical School and Massachu¬ 
setts General Hospital. He 
founded and, from 1977 to 1989, 
directed the Biochemical 
Disease Detection Laboratory at 
Yale, and in 1987 he received a 
merit award from the National 
Institutes of Health. He was a 
pioneer in the use of gas-liquid 
chromatography and nuclear 
magnetic resonance in the iden¬ 
tification of inherited metabolic 
diseases. 
Wilbur D. Van Buren, MED ’78, 
m.d., ph.d., died on November 
6 in Kansas City, Mo., of pan¬ 
creatic cancer. He was 57. Van 
Buren began his medical studies 
at Yale, but obtained his degree 
at St. Louis University. Known as 
"the singing doctor,” he was in 
private practice and worked at 
hospitals and nursing homes in 
Kansas City. He was a major in 
the U.S. Army Reserves, a Grand 
Knight of the Knights of Colum¬ 
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A decade ago, when Kelly D. Brownell, ph.d., first started 
attracting national attention, his critics called him a “wacko,” 
a “food fascist” and the “grand poobah of the anti-consumer 
movement.” His crime? Accusing the food industry of creating 
a “toxic food environment” resulting in an “obesity epidemic” 
(See “Fighting the Good Food Fight,” Winter 2004).Three 
years ago he outlined the problem and proposed solutions in 
Food Fight, written with Katherine Battle Horgen, ph.d. 
His goal since then has been to "change the world's 
diet,” he said. "It took a long time to take the first few steps, 
but now things are starting to happen quickly.” 
One of those advances is Yale’s new Rudd Center for 
Food Policy & Obesity, which Brownell, professor and chair of 
psychiatry and professor of epidemiology, directs. Made possi¬ 
ble by a gift from Leslie Rudd, a vintner who hopes to affect 
attitudes toward food and wine in this country, the center’s 
goal is to improve the world’s nutrition, prevent obesity and 
reduce weight stigma through science-based public policy.The 
center opened its new offices on Edwards Street in October. 
"We need to do strategic science in the interest of 
informing policy leaders,” said Brownell, “and we also want to 
make policy-makers more responsive to science.” As an exam¬ 
ple, Brownell cited the debate over soda machines in schools. 
“While educators may know that soft drinks aren’t especially 
healthy, health isn't the main reason schools are in business. 
But if we can show that diet affects standardized test scores, 
you’d see an immediate application for public policy. That’s 
strategic science.” 
The center’s work will involve both domestic and global 
initiatives, said Brownell, a reflection that the obesity crisis is 
worldwide. “The health minister of China recently announced 
that obesity and diabetes were huge problems there. The 
same is true in India,” he said. "You can’t understand the mod¬ 
ern food environment without a global view. National trade 
policies, subsidies to the agricultural industry—all these things 
affect the food supply worldwide.” In addition, much obesity- 
related policy innovation—taxing junk food, for example—is 
occurring outside the United States. 
“We really do want to make a difference,” said Brownell, 
who was named to the Institute of Medicine in October. 
—Jennifer Kaylin 
The Dean’s Report 
“In his annual report to the 
alumni of the School of Medicine 
on February 22, Dean Lippard 
reviewed the progress of the 
school over the past thirty-five 
years and outlined plans for its 
future development. 
“Under the guidance of Drs. 
Blumer and Winternitz and with 
renewed interest of the university, 
the school underwent a major 
transformation shortly after the 
First World War. The faculty 
was reorganized, new buildings 
were erected, financial support 
was improved and enrollment 
increased. Graduating classes, 
which averaged 13 in the decade 
1910-20, have increased to 80.... 
“This program [the Yale System] 
also requires a superior faculty, 
including a substantial nucleus 
of men who are dedicated to 
full-time teaching, research, and 
care of patients within a univer¬ 
sity hospital.... 
“The school has been successful 
over the years in attracting such 
men, and the full-time faculty now 
numbers about 200. Efforts have 
been made in recent years to 
strengthen clinical fields such as 
psychiatry, dermatology, hematol¬ 
ogy, neurology, and cardiovascular 
surgery, not previously repre¬ 
sented on the full-time staff, and 
to broaden the range of special 
interests in the basic science 
departments. ... 
“Improvement in facilities has 
kept pace with other develop¬ 
ments. Most of the Medical Center 
has been built since 1920. The 
most impressive additions in the 
last five years are the Edward S. 
Harkness Memorial Hall, the 
Memorial Unit of the Grace-New 
Haven Community Hospital, 
and an extension of the Lauder 
Building for animal quarters.” 
“From This Small Sapling ... 
“On December 1, shortly after 
noon, five men from the School of 
Medicine gathered in the courtyard 
outside the Medical Library. Some 
had shovels. They had come to 
plant a rare Oriental plane tree 
sapling, alleged to be a descendant 
of the ‘Tree of Hippocrates,’ under 
which the 5th-century Greek physi¬ 
cian taught the art and science of 
medicine. 
"The sapling was grown from 
seeds presented to Dr. Silver for 
the School of Medicine by Dr. 
William C. Gibson, chairman of 
the Universities Council of British 
Columbia, and a former student 
of Dr. John F. Fulton, the first chair¬ 
man of the Department of the 
Hospitals of Medicine at Yale. 
Dr. Shope took 25 of them to 
his brother, William Flemer Ml 
(m.a. ’47) of the Princeton 
Nurseries, Kingston, N.J., who 
planted and nurtured them. 
“Seven of the rare seeds germi- ( 
nated. If the one planted in the 
library courtyard survives the win- j 
ter, the others will be planted 
nearby. Admittedly, the sapling is \ 
scarcely more than a twig, but 
historians typically are optimists. < 
‘The purpose of this endeavor 
is to establish a small park—a 
‘Hippocratic Grove,’ with benches a 
and a patio,’ said Dr. Viseltear. 
‘It would be a place for contem¬ 
plation and study, or a pleasant 
spot to enjoy one’s lunch and , 
pass the time of day.’ 
Stay connected 
Yale Medicine can help you stay connected with fellow alumni 
of the School of Medicine, School of Public Health, Physician 
Associate Program and the medical school’s doctoral, fellowship 
and residency training programs. Share your personal and pro¬ 
fessional news for publication in the Alumni Notes department 
of Yale Medicine and on the Web, using this card or the online 
form at info.med.yale.edu/ayam. 
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NEW BUILDINGS REFLECT COMMITMENT TO SCIENCES 
The dedication of two new buildings on the main campus in 
October highlighted the university’s commitment to scientific 
research and education. The Department of Biomedical 
Engineering got a new home in the Daniel L. Malone Engineering 
Center, a five-story, 63,ii7-square-foot building on Prospect Street. 
Research there will focus on biomedical engineering, materials sci¬ 
ence and nanotechnology. The construction was made possible by 
a $24 million gift from John C. Malone, a 1963 Yale College alum¬ 
nus and chair of the Liberty Media Corp., and is named for his 
father, an engineer at General Electric. 
“It stands as a statement to all that Yale engineering is an 
integral part of this university’s most vibrant intellectual life,” 
said Paul A. Fleury, ph.d., dean of the Faculty of Engineering. “The 
research and teaching that will take place here will center upon 
those forefront areas of biomedical engineering, materials science 
and nanotechnology that underpin 21st-century progress.” 
Also on Prospect Street is the 105,000-square-foot, three- 
story Class of 1954 Chemistry Research Building, the result of the 
largest class gift in the university’s history. Each floor is dedicated 
to one of three areas: synthetic organic chemistry, inorganic 
chemistry and chemical biology. Projects under way include devel¬ 
oping new materials for solar energy and new catalysts to facili¬ 
tate hydrogen storage as a fuel source, and investigating the 
molecular basis for energy transduction in plant photosynthesis. 
Provost Andrew D. Hamilton, ph.d., said a collaboration 
among the administration, the faculty and the Class of 1954 made 
the building possible. At the dedication Hamilton had a repre¬ 
sentative of each group help create a chemical reaction in which 
three clear liquids were mixed together before the solution turned 
to Yale blue. “It only works when all three components of the 
reaction are present,” Hamilton said. “Cooperation is vital for con¬ 
tinued Yale success, as this reaction continues again and again 
and again.” 
The Daniel L. Malone Engineering Center is one 
of two new buildings on Yale’s central campus 
that is devoted to science. 
—John Curtis 
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